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ABSTRACT 
 
Silica nanoparticles are effective fluorophore carriers with high potential in 
imaging, diagnostics, and therapy. The particles are resistant to drastic change 
of environmental conditions (pH, temperature etc. and insulate the dyes so as to 
protect them from photobleaching. Silica chemistry is also versatile and affords 
an easy modification of the particle composition and surface to integrate 
targeting ligands or to integrate other nanoparticles. Regardless of their 
advantages, there exists a lack of dye diversity in the literature that is connected 
to a low affinity for  
 potential tools for biology and medicineThis thesis describes the development 
of an alternative method for the synthesis of fluorescent silica nanoparticles and 
their modification to incorporate iron oxide and gold. 
 
The first part of the thesis describes the application of the amino acid route to 
the design of multifluorescent nanoparticles 20 nm in diameter and containing 
up to three fluorophores. The nanoparticles were subsequently used to label 
two cell lines in view of their imaging with a confocal microscope: the cancerous 
type took up a large concentration of nanoparticles and stored them under the 
form of aggregates that act as strong contrast agents whereas the normal line 
barely internalised the nanoparticles. 
In a second time, the composition of the ceramic particles was modified and 
VTEOS was co-condensed with TEOS in via L-arginine catalysis to create a 
new hybrid structure with a size comprised ranging from 20 to 100 nm. In one 
embodiment, the procedure constantly yielded 40 to 50 nm nanoparticles that 
were employed as fluorophore carriers. Half of the selected fluorescent dyes 
were successfully entrapped and combined to generate distinctive spectral 
patterns. The second half required an alteration of the matrix to take into 
ii 
account the chemical structure of the molecules and ensure that the affinity 
between the nanoparticles and the fluorophores is optimal. By this new 
approach, it becomes possible to virtually entrap and combine any fluorophores 
in a single pot. 
Lastly, the hybrid structure was applied as a coating onto iron oxide 
nanoparticles for a novel class of luminescent magnetic nanoparticles taking 
advantage of the flexibility of the organic-inorganic composition of the silica 
layer. The particles were further improved by firstly decorating their surface with 
small gold seeds in order to impart plasmonic properties and secondly red-
shifting the plasmon resonance towards longer wavelength matching 
conventional near-infrared laser sources by growing a gold layer. This led to an 
original magnetoplasmonic platform that can be altered to incorporate 
fluorescent dyes. 
The work presented here shows the potential of the amino acid to produce very 
small fluorescent nanoparticles and its ability to coat other nanomaterials. 
Further, this report highlights the possibility of nanotechnology in medicine and 
how the multifunctional nanoparticles can find application in imaging, therapy, 
and diagnostics indistinctly. 
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1 Introduction and literature review 
Nanotechnology has the potential to deeply impact on society with as much 
strength as computing in the 1960s or biotechnology in the 1980s. The idea of 
controlling and using materials at the atomic and molecular scales can be 
traced back to Richard Feynman and his famous presentation “Plenty of Room 
at the Bottom” at Caltech in 1959 [Feynman, 1960]. The term nanotechnology – 
from greek nanos, dwarf - appeared and was defined by Norio Taniguchi in 
1974. Although nanotechnology as a science and technology is relatively 
recent, men have unwittingly employed it for centuries: ancient Egyptians used 
gold colloids for healing whereas Romans employed silver and gold 
nanoparticles in craftsmanship (Lycurgus cup, 4th century AD). Later the same 
metallic particles were applied in stained glasses of German and French 
churches to display strong and bright colours. Many examples of 
nanotechnology applications are found throughout the millennia in all kind of 
craftsmanship and sciences.  
The National Nanotechnology Initiative (NNI), a United States federal program 
established in 2001 to coordinate nanotechnology research and development, 
has defined nanotechnology as “research and technology development at the 
atomic, molecular, or macromolecular scale, leading to the controlled creation 
and use of structures, devices, and systems with a length scale of 1-100 
nanometres (nm)” [National Nanotechnology Initiave, 2011]. Consequently, 
structures with a least one dimension below 100 nm and exhibiting new 
properties resulting from their small size, or methods to control and manipulate 
matter at the nanometre scale enter into the nanotechnology definition. Yet, no 
universal definition of nanotechnology exists and the limit at which an object is 
considered as a nanostructure may be larger than the 100 nm proposed by the 
NNI. Nanotechnology is one of the critical research endeavours of the early 21st 
century; for this reason, almost all countries have started their own programs. 
USA started its investments in 2001 through the NNI, whereas Japan prioritised 
nanotechnology closely after USA. In Europe, research programs in 
nanotechnology were embedded within national projects through the 
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Framework Programmes that coordinate the projects and aims of all EU 
members. If USA, Japan, and Europe are the strongest investors, other 
countries have also invested in nanotechnology. China has devoted more and 
more resources and has rapidly caught up with USA and Europe, while South 
Korea has embarked in a ten-year program [European commission, 2002, 2007 
and 2008]. 
Nanotechnology is interdisciplinary in nature and gathers together various 
domains of science, blurring the barriers between traditionally well-defined fields 
such as chemistry, physics, biology, and medicine. This is both an advantage 
and a complication: on the one hand this approach is more likely to create 
synergies and to increase the pace of innovation in all other domains. On the 
other hand the previously well-defined domains may no longer be valid and 
scientists will have to gain knowledge in various fields rather than in a single 
one, which is a particular issue in term of education. Many applications have 
already been envisioned that show the multidisciplinarity of nanotechnology 
[European Commission, 2006 a; Wood, 2004]: 
Ø Information technologies and electronics: new data storage media 
with high recording capacities, semiconductors for light-emitted diodes or 
lasers for optoelectronic devices and sensors, plastic electronics, 
spintronics, quantum computing, etc.; 
Ø Materials science: new lighter and stronger alloys to reduce the amount 
of materials necessary to create structures or to reduce the fuel 
consumption of vehicles and planes, new functional surfaces such as 
scratch-proof, stain resistant, self-cleaning, sterile, etc.; 
Ø Energy production and storage: materials for fuel cells or battery, 
nanostructures for hydrogen storage, low-cost photovoltaic cells, but also 
materials for insulation, transport, and light-efficiency; 
Ø Manufacturing: development of new techniques for top-down (starting 
from micro-systems and reducing their size) and bottom-up (building 
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from the atomic and molecular level to create nanostructures) fabrication 
processes, for example new lithography or vapour deposition processes, 
etc.; 
Ø Instrumentation: new tools and techniques to study the properties of 
materials at the nanometre scale and to control the production of 
nanodevices; 
Ø Food, water, and environment:  detection and neutralisation of micro 
organisms or chemicals, tracking the origin of food, reparation and clean-
up of polluted soils and environments, etc.; 
Ø Medical applications: bioactive and biocompatible coatings for implants, 
scaffold for organ growth (tissue engineering), novel systems for targeted 
drug delivery, contrast agents and therapies for diseases, laboratory-on-
a-chip for fast and accurate diagnostics. 
These are but a few applications of nanotechnology foreseen and more 
applications not yet envisioned ought to appear in the future. The assessment 
of economic implications of nanotechnology is still blurry and there is also a lack 
of clarity concerning products already containing nanomaterials. Certain 
products currently accessible to the public such as cosmetics (shampoos and 
sun-screens) or hard-disks already contain nanoparticles or are nanostructured. 
Some other products are not related to nanotechnology but employ this term as 
a marketing strategy to attract technophiles. However, the majority of nano-
labelled products on the market apply to nanotechnology research more than 
public uses and viable products targeting public will be commercialised within a 
few years. 
Figure 1-1 highlights the four phases that segment the commercialisation of 
nano-products timeline. The first generation of nanostructures are said to be 
‘passive’, i.e. they provide specific properties and maintain them all along their 
use. This category encompasses nanoparticles, coatings and nanostructured 
materials, etc. and has more or less entered the commercialisation step. The 
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second generation represents ‘active structures’ or structures that modify their 
properties with time or with change in their environment. This category begins to 
emerge from laboratories and commercialisation should start within a few years. 
The third generation includes systems of nanostructures for complex 
applications such as tissues and organs growth and the fourth generation are 
also complex systems where each molecule has a specific function. The third 
category is barely starting in laboratories and may not arrive before a decade, 
followed later by the fourth generation [Renn, 2006]. 
 
Figure 1-1: Timeline of nanotechnology development and industrialisation 
divided into four overlapping phases [Renn, 2006]. 
 
Nanotechnology is still in its early development but already many new systems 
and structures have been developed in nearly all scientific and engineering 
fields. In that respect, the application of nanotechnology to the biomedical field 
has given birth to new fields generally referred to as nanomedicine and 
nanobiotechnology. 
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1.1 Nanomedicine: applications of nanotechnology to the 
biomedical field 
1.1.1 Overview of the nanomedicine field 
By operating at the scale of biomolecules, nanotechnology brings new methods 
to probe or to modify biological systems [McNeil, 2005]. Therefore, the scope of 
applications as can be seen in Figure 1-2 is wide and concerns all aspects of 
the biomedical field, from drug and gene delivery to nanostructured coatings for 
implants and contrast agents for imaging, while new possibilities still not 
envisioned might emerge in the coming decades [Sutter, 2006; European 
Commission 2006 b]. Of all applications, imaging, cancer therapy, and 
diagnostics stand out as the most prioritised areas of research. 
 
 
 
Various imaging modalities such as magnetic resonance imaging, as well as X-
ray, nuclear, ultrasound or optical imaging are well-established methods to 
diagnose diseases or lesions, yet they are generally not sensitive enough to 
Health and  
medical sectors 
Genomics 
Tissue engineering 
Drugs delivery 
Drugs discovery 
Diagnostics 
Imaging 
Surgery 
Implants 
Therapies 
Figure 1-2: Potential applications of nanoparticles and nanostructures in 
medicine. 
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detect molecular changes that are usually the first signs of evolution of healthy 
tissues into diseased ones. Further development of imaging involves the design 
of contrast agents and other nanostructures targeting specific biomarkers or 
biomolecules resulting from abnormal conditions in order to detect a disease in 
its earlier stage and treat it with as little consequences for the patients. Typical 
examples are quantum dots, gold nanoparticles under various shapes, or 
fluorescent silica nanoparticles that are progressively replacing fluorescent dyes 
in optical imaging, both in vitro and in vivo.  
Likewise, nanotechnology offers new strategies to treat diseases and disorders 
such as Parkinsons and Alzeihmers or cardiovascular diseases, to improve the 
specificity or efficiency of existing treatments such as chemotherapy, 
photodynamic therapy, and other drug-based treatment. Nanoparticles have 
proved efficient carriers of drugs and other compounds, able to deliver their 
charge at precise locations due to the easy conjugation with antibodies, 
peptides, etc. For instance, chemotherapy generates strong side effects since 
the drugs are not able to distinguish between healthy and unhealthy tissues, but 
their entrapment within bioconjugated nanoparticles ensures that the 
chemotherapy drugs only target the right cells and spare the patients painful 
and long periods of treatment. Similarly, new possibilities such as hyperthermia 
or photothermal effects open new strategies to cure diseases and infections in 
the near future.  
Lastly, nanotechnology has the potential to deeply impact on sensors, arrays, 
and chips technologies, offering smaller devices able to detect trace amount of 
proteins, antibodies, DNA/RNA and other analytes at high speed and reduced 
costs while requiring very small samples. New biosensors based on colorimetry, 
fluorescence and other physical mechanisms have born, based on the judicious 
employ of gold and other nanoparticles to improve the quality of in vitro 
diagnostics tools. At terms, nanotechnology offers the possibility to carry out 
measurements in parallel or to integrate multiple analytical tools into a single 
device. 
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1.1.2 Biocompatibility criteria and nanoparticle structures 
Similarly to any medical devices, a material must not elicit deleterious or toxic 
effects once in contact with biological samples. This biocompatibility criterion is 
the key parameter for any medical devices and drastically restricts the type and 
number of materials suitable for in vivo, and potentially in vitro applications.  For 
instance, titanium dioxide, stainless steel 306L, and cobalt-chromium alloys 
represent the majority of the prostheses replacing hard tissues such as bone 
(for example hip prosthesis), whereas certain glasses are bioactive or 
resorbable and are ideal for bone filling. Polymers such as polyethylene 
terephthalate have found applications as blood vessel replacement. Even 
though certain nanostructures exhibit outstanding optical or electrical properties 
suitable for photonics or electronics, their composition or their behaviour once in 
a biological environment may become problematic. The toxicology ambiguity of 
nanomaterials will be discussed later but quantum dots are the typical example 
of a nanomaterial with outstanding (fluorescence) properties but their heavy 
metal composition poses a threat in case of degradation of the particles and 
hampers their in vivo potential. On the other hand, they prove invaluable when 
the particles have little contact such as diagnostics or in vitro uses. From a 
general point of view, it is not possible to transpose the biocompatibility of a 
bulk material to its nanoscale counterpart: if gold in its bulk and particulate 
states is biocompatible, the same cannot be said of titanium dioxide that 
exhibits certain toxicity in regard to its photocatalytic effect. 
Toxicology of nanomaterials remains under investigation because the 
organism’s reaction towards the introduction of nanoparticles as well as the 
cellular uptake and interactions with nanostructures are not fully understood yet. 
To date, a limited number of nanomaterials have proved successful and have 
found a real application in nanomedicine as seen in Table 1-1 [McNeil, 2005; 
Salata, 2004]. With both a better understanding of cells-materials interactions 
and the development of - or combination into - new structures, the list is bound 
to expand in the coming years. 
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Table 1-1: Classes of nanoparticles of interest in nanomedicine and their 
principal applications. 
Class of 
nanomaterials Description Applications 
Polymeric 
nanoparticles 
Particles made of biodegradable 
polymer (polylactic acid, 
polyglycolic acid, etc.) 
Drug delivery, 
therapeutics, imaging 
Liposomes Vesicles made up of a lipid bilayer Drug delivery 
Dendrimers 
Spherical branched polymers 
providing vast amounts of surface 
area 
Drug delivery, imaging 
Quantum dots 
Semiconductor nanocrystals 
generally made of a heavy metal 
core surrounded by a metallic shell 
Imaging 
Carbon nanotubes and 
fullerenes 
Distinct molecular forms of carbon 
atoms with the shape of cylinders 
and of sphere respectively 
Drug delivery, 
photothermal ablation 
Superparamagnetic 
nanoparticles 
Iron oxide particles of magnetite 
(Fe3O4) or of maghemite (Fe2O3) 
Drug delivery, imaging 
agent, hyperthermia 
Noble metal 
nanoparticles 
Particles typically made of gold or 
silver 
Imaging agent, drug 
delivery, photothermal 
ablation 
Gold nanoshells Silica particles (core) coated with a thin gold shell 
Imaging agent, drug 
delivery, photothermal 
ablation 
 
Nanosystems are usually designed as a core-shell structure. The core material 
possesses the key characteristics that will make a particle an efficient contrast 
agent for imaging or a good carrier for drug. The direct delivery of core 
materials can be envisioned as a passive targeting where the nanoparticles 
travel throughout the organism to reach a particular cell type/tissue or interact 
with biomolecules. This is for example one way for nanostructures to 
accumulate into tumours via the enhanced permeability and retention effect 
(EPR). The incessant growth of cancerous tissues requires a vast supply of 
nutrients that a normal vasculature cannot provide. Then, new blood vessels 
are formed to provide more nutrients but these new blood vessels are irregular 
in shape and dilated so that the vasculature is leaky. This leaky vasculature and 
accompanying poor lymphatique drainage mean that particles can evade the 
blood stream and accumulate within the tumours without risk of clearance and 
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can exert their effects unhampered [Lyer, 2006]. However, passive targeting is 
an ideal case but is not a viable strategy for two reasons: 
Ø Clearance from the organism by the action of the complement system 
and phagocytic cells (as discussed later); 
Ø The necessity of EPR effect that exists principally in tumour but not in 
other tissues, including diseased tissues. 
Hence, engineering the surface of the particles is a requirement to make the 
action of nanostructures more specific. For this reason, the typical architecture 
is based on a core-shell structure where the core is one of the materials 
aforementioned and the shell is designed according to the mission of the 
nanoparticles. Polymers and biopolymers are favoured to increase the 
biocompatibility of a nanomaterial as well as to increase the lifetime in blood. In 
that respect, coating with polyethylene glycol (PEG) is the principal strategy to 
obviate or at least delay the action of natural defenders because macrophages 
and complements proteins need more time to detect the neutral polymer. The 
specific recognition of cells and molecules – or active targeting – is the result of 
surface modification with particular ligands. Conjugation of antibodies at the 
surface of nanoparticles has been one of the first strategies for the recognition 
of antigen and directing the nanosystems towards the right target. Peptides 
soon followed as an answer to the large size of antibodies that increases the 
chance of macrophage recognition. Some peptides helps in penetrating cells 
such as trans-activating transcriptional activator (Tat) from Human 
Immunodeficiency Virus 1 whilst other help in escaping endo- and lysosomes to 
enter into the cytoplasm. A large range of peptides and proteins are available 
and proved highly effective in the detection and targeting of cancerous cells. In 
diagnostics, the conjugation of DNA and RNA is central and many assays rely 
on the conjugation of nanoparticles with oligonucleotides [Lin, 2010; Tahnh, 
2010].  
Nanomedicine relies on three major features: the new properties that the 
nanoscale induces, the relative size of nanostructures in comparison to 
biological entities, and the engineering of nanoparticles surface for active 
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targeting and specific recognition. Several nanomaterials have already been 
identified and have already made strong contribution to the biomedical field but 
this thesis is focused on inorganic nanoparticles exclusively. This choice is 
motivated by the new physical and chemical properties that are absent from 
polymeric nanoparticles, the higher robustness, and because the first 
toxicological studies of gold, silica, and iron oxide indicate that these 
nanomaterials are biocompatible. 
 
1.2 Noble metal nanoparticles 
1.2.1 Plasmon resonance and optical properties 
Noble metal nanoparticles are an important class of materials in nanomedicine 
and in many other fields such as optics, solar energy, etc. Gold and silver 
nanoparticles have fascinated men for centuries, even though the realisation of 
what these particles are capable of – or simply of their existence – is more 
recent. For example, gold nanoparticles give the astonishing properties to the 
Roman Lycurgus cup dated from the 4th century and displayed in the Figure 1-3. 
The particularity of the cup is to shine a green or red colour when the light 
source is outside or inside the cup. Similarly medieval glass windows of French 
and German gothic cathedrals contain metal colloids that give the intense red 
and blue hues to the windows. Faraday came up with the idea that small 
particles of gold and silver were responsible for the intense colours of these 
items but it is only in 1908 that Gustav Mie developed the theory that explain 
the optical properties of gold colloidal systems [Jain, 2007]. 
The exposition of noble metal nanoparticles to an electromagnetic field leads to 
the collective oscillation of the atoms electrons. This phenomenon known as 
plasmon resonance causes a considerable enhancement of the electromagnetic 
field around the nanoparticles. Mie applied the Maxwell’s equations to an 
electromagnetic light wave interacting with spherical particles and applied the 
appropriate boundary conditions. 
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Figure 1-3: The Lycurgus cup appears greenwhen illuminated from 
outside but glows red when light source is inside the cup 
[britishmuseum.org]. 
 
The optical properties are commonly expressed in term of scattering and 
absorption cross-sections σsca and σabs related to the intensity loss of a beam of 
incident light due to elastic scattering and absorption respectively. In practice, 
absorption and scattering both contribute and the term of extinction, 
characterised by the extinction cross-section σext is preferred: 
.scaabsext σσσ +=  (1-1) 
The extinction, scattering, and absorption cross-sections are calculated by 
series expansion of the electric and magnetic fields into multipole oscillations: 
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Here, m=n/nm with n and nm the refractive indices of particle and surrounding 
dielectric media respectively, k is the wavector, and x = |k|r, with r the radius of 
the nanoparticle. ψL and ηL are the Ricatti-Bessel cylindrical functions. The 
summation term index L represents the order of spherical multipole excitation in 
the nanoparticles. For example, L=1 corresponds to a dipole field, while L=2 
corresponds to a quadrupole field, etc. [Bohren, 1998; Maier, 2007].  
Scattering and absorption contributions of spherical nanoparticles differ with the 
size of the spheres. For particles with a diameter d larger than the wavelength λ 
of incident radiation, the extinction cross-section decomposes as a 
superposition of oscillating electric dipoles, quadrupoles, and higher-order 
multipoles. Contrariwise, particles with a diameter smaller than the wavelength 
of incident radiation are exclusively considered as electric dipole. The latter 
case has been developed by Rayleigh and is sufficient to understand the 
plasmon resonance mechanism. If the size of a nanoparticle is small compared 
to the wavelength of incident light, the light penetrates in the whole particle and 
grasps all of the conduction electrons. Consequently, the electrons are 
displaced and the nanoparticle forms an oscillating electric dipole as 
schematised in the Figure 1-4. This approximation is referred to as quasi-static 
regime or discrete-dipole approximation and results in a simplification of the 
cross-section expressions: 
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.scaextabs σσσ −=  (1-9) 
Here, V is the volume of particle, ω is the angular frequency of incident light, 
and c is the speed of light; εdiel is the dielectric constant of the surrounding 
media and  εmet is the wavelength-dependent complex dielectric function of the 
metal nanoparticles,  
εmet = ε’met + iε’’met. From equation (1-7), a resonance behaviour manifests 
whenever |ε’met(ω) + 2 εdiel |² + | ε’’met(ω) |² reaches a minimum. Provided that 
ε’’met(ω) is small in the vicinity of the resonance (ε’’met << 1), the resonance 
condition is fulfilled when ε’met = –2 εdiel [Yguerabide, 1998]. For silver and gold 
particles, plasmon resonance falls into the visible region of the electromagnetic 
spectrum, respectively at ~430 nm and at ~ 520 nm, which explains the intense 
colours exhibited by gold and silver colloid solutions and their use in stained 
glass. 
 
Figure 1-4: The interaction of light with a nanoparticle induces a coherent 
dipolar oscillation when the dimension of the particle is much smaller 
than the incident wavelength [Jain, 2007]. 
 
No geometric factors are present in equations (1-7) and (1-8); the volume 
determines the magnitude of the scattering and absorption cross-sections but 
not the spectral position of plasmon resonance. So, with an increase in size (still 
within the discrete dipole approximation) the position of the plasmon frequency 
is only slightly shifted as can be seen in Figure 1-5. For larger particles (d > 
λ/20), the quasi-static regime is no longer valid and higher multipole effects 
emerge. Consequently, the plasmon bandwidth broadens, additional peaks 
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(shoulders) emerge because of the influence of higher order multipole 
oscillations, and plasmon resonance red-shift. Moreover, the scattering cross-
sections of equation (1-8) quadratically vary with the volume while the extinction 
cross-section of equation (1-7) varies linearly. Therefore, the smallest particles 
will mostly absorb light while relatively “larger particles” will scatter light. 
Moreover, extinction, absorption, and scattering cross-sections equations 
indicate that the resonance frequency is strongly related to the dielectric 
constant of the surrounding media. This effect is already employed in surface 
plasmon resonance to detect presence of biomolecules onto gold surfaces that 
translate in a slight change in plasmon resonance frequency.  
 
Figure 1-5: Mie extinction coefficient K (K = Cext/Vpart) and evolution of the 
plasmon feature of gold nanoparticles of different diameters [Yguerabide, 
1998]. 
 
1.2.2 Red-shifting and effect of shape 
It is often desirable to shift the plasmon resonance of gold towards longer 
wavelength, for example to match the excitation/emission of fluorescent dyes or 
quantum dots, matching the excitation of a laser source for optimal scattering 
and/or absorption, or to work in the therapeutic window that spans the near-
infrared part and infrared of the electromagnetic spectrum. Increasing the size 
of noble metal nanoparticles red-shift their plasmon resonance but in a limited 
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range and the change has detrimental effects on the final scattering/absorption 
efficiency due to the multipolar interactions arising. Other strategies have been 
devised to red-shift the plasmon resonance via a modification of the particles 
composition and/or shape.  
In the 90s, Halas and co-workers have. devised and controlled the synthesis of 
noble nanoshells, layered, spherical nanoparticles consisting of a dielectric core 
- typically silica- surrounded by a thin metallic shell (gold or silver) [Oldenburg, 
1998]. The presence of silica near the gold layer modifies the environment of 
the noble metal and deeply affects the plasmon resonance frequency. Varying 
the size of the silica core or the thickness of the metal layers shifts the plasmon 
wavelength to the near-infrared without inducing a dramatic increase of size of 
the final nanoparticles as can be seen in Figure 1-6 [Hirsch, 2006]. 
 
Figure 1-6: Extinction spectra of gold nanoshells as function of the shell 
thickness ([Jain, 2007]). 
 
Changing the composition of gold nanoparticles is not the only way to tune their 
optical properties and a change of shape elicits analogous effects. Typically, 
rod-shaped nanoparticles best exemplify the effect of shape on the plasmon 
resonance of gold and silver nanoparticles. Nanorods display two plasmon 
resonance bands: one plasmon band around 530 nm that corresponds to the 
transverse plasmon excitation - perpendicular to the major (long) axis - and a 
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stronger band at longer wavelengths related to plasmon oscillations of electrons 
along the long axis of the particle as depicted in the Figure 1-7. The longitudinal 
absorption mode strongly depends on the aspect ratio of nanorods, i.e. the 
value of the long axis divided by the short axis of the rod-shaped particles. It is 
the variation of this ratio that allows the tunability of nanorods and the possibility 
of designing particles with a plasmon band in the near-infrared. In comparison, 
the transverse oscillation of electrons is independent on the nanorod 
dimensions and fluctuates between 520 and 530 nm [Jain, 2006]. Variation of 
the aspect radio enables to tune the plasmon resonance of the longitudinal axis. 
In the same vein, other shapes exhibit unusual optical behaviour such as gold 
nanostars that possess multiple plasmon resonances according to their number 
of points, or gold nanocages with long range plasmon resonance frequencies 
[Chen, 2005 b; Nehl, 2006]. 
 
Figure 1-7: Absorption spectra of gold nanorods with different aspect 
ratios R (value of the long axis divided by the short axis) (Jain, 2006]). 
 
Finally, aggregation is one way to alter the properties of noble metal 
nanoparticles: in an array or an aggregate of noble metal nanoparticles 
additional shifts appear because the respective plasmon resonance of each 
particle interact one with another. Incidentally, the plasmon frequency red-shift 
and the plasmon bandwidth broadens whilst the electric field is far more 
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amplified than with single particles. The effect is valid for nanospheres and for 
other shapes as long as the nanoparticles are sufficiently close, typically less 
than 2.5 times the particles radius, for the plasmon resonance coupling to occur 
[Maier, 2007; Rechberger, 2003; Chien, 2008]. Light polarization is another 
factor intervening in the enhancement of the electric field: considering a chain of 
nanoparticles regularly spaced, a polarization direction of the incident light 
parallel to the particle chain red-shifts the plasmon resonance frequency and 
contrariwise slightly blue-shift it when the light is polarized orthogonally. This 
phenomenon is more easily understandable when considering nanoparticles as 
dipoles. When light is polarized in parallel to the particle chain, the positive 
charge of a particle faces the negative charge of the particle at its left as 
schematised in the Figure 1-8. As a result, the repulsive forces are weakened 
and the plasmon resonance is lowered. On the other hand, when the electric 
field is orthogonal to the particle chain the charge distribution of both particles 
acts cooperatively to enhance the repulsion between the particles and the 
resonance frequency is increased. Predicting the optical properties of clusters is 
complicated because aggregates usually form randomly. Inducing in situ 
aggregation remains nevertheless of high interest in various biomedical fields, 
such as bio-imaging and therapy because of the red-shift and the enhancement 
of plasmon resonance. 
 
Throughout the history of humanity: Ancient Egypt, China, medieval time, 
civilisations used the bulk and colloidal forms of gold to treat various ailments. 
With a better understanding of the physical properties of gold nanoparticles, 
new possibilities emerged in fields such as bio-imaging, treatment, or detection 
of biomolecules. 
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Evidence of the employment of gold for medical applications is found  
 
1.2.3 Contrast agent for bio-imaging 
Gold nanoparticles are versatile contrast agents suitable for multiple imaging 
modalities. Their high electron density makes of noble metal particles 
particularly apparent under x-ray, be it computed tomography or any other 
electron microscopy, including scanning and transmission electron microscopy 
that are more dedicated to materials analyses. Gold is likewise very effective 
with acoustic imaging and has been show to enhance the quality of such 
modality [Cai, 2008; Labhasetwar, 2007; Li, 2007]. Yet, optical modalities 
remain where gold has made a serious breakthrough: in comparison to 
fluorescent dyes that are traditionally employed as stain and contrast agents, 
the metallic nanoparticles are not prone to photobleaching – a loss of 
fluorescence resulting from photodegradation – and may be detected over 
prolonged period of time. Moreover, the optical cross-section under plasmon 
resonance is in no comparison to that of fluorophores and the important light 
scattering generates a signal that is easily detected. Last but not least, the 
possibility of tuning the plasmon resonance towards the near-infrared, i.e. in the 
therapeutic windows that span between 650 and 900 nm, where little 
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Figure 1-8: Schematic representation of an isolated and of a pair of closely 
spaced gold nanoparticles, with polarisation of light parallel and orthogonal to 
the l ng particle p ir axis. 
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endogenous fluorophores and other species are susceptible to absorb or scatter 
light or to fluoresce is invaluable for in vivo imaging [Jain, 2007].  
Gold nanoparticles have been detected using various optical modalities. For 
instance, darfield imaging is a traditional optical modality equipped with a dark 
field condenser so that only allows the collection of highly diffracted rays after 
illumination of a sample with white-light source. The light source covers a large 
wavelengths range, including that matching the plasmon resonance of gold 
nanoparticles. At such wavelengths, light is strongly scattered and is collected 
by the dark-field condenser and display on images. When a heterogeneous 
sample of gold nanoparticles is imaged, each population of particles can be 
discriminated by a different colour bound to their respective plasmon resonance 
wavelength. The effect is limited with nanospheres, but dark field imaging is 
particularly suited to the imaging of gold nanorods and nanoshells as 
exemplified in Figure 1-9 [Sonnichsen, 2002]. Confocal imaging – a variation of 
fluorescence microscopy able to reduce the autofluorescence background and 
to provide three-dimensional pictures of a sample – has also frequently 
obtained good results in the detection of gold nanoparticles. The lack of intrinsic 
fluorescence is compensated by the possibility to collecting imaging in 
reflectance mode, where the light scattered by the metallic contrast agents is 
detected. Two-photon microscopy is another optical imaging modality that is 
less common than the former two  but is a very powerful apparatus: instead of 
illuminating the sample with white-light source or a UV/visible laser, two-photon 
and multiphoton microscope employs pulsed laser emitting in the near-infrared, 
which is of high interest for gold nanoshells and nanorods [Wang, 2005 a]. 
The procedure to conjugate gold surface with antibodies, peptides, and other 
ligands is well documented due to the frequent employ of gold (thin films, etc.) 
in biomedical applications. The same procedure are transposable to the 
nanoparticle form and has allowed the conjugation with epidermal growth factor 
receptor (EGFR) and other ligand able to recognise the biomarkers 
overexpressed on cancer cells: oral, cervical, skin and other cancers have 
successfully been detected after appropriate surface design of gold 
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nanospheres and nanorods under all of the optical modalities mentioned 
previously [Durr, 2007; El-Sayed, 2003; Oyelere, 2007, Sokolov, 2003 a]. 
 
Figure 1-9: Dark-field microscopy picture of gold nanorods with various 
aspect ratios [Sonnichsen, 2002]. 
 
1.2.4 Photothermal therapy 
A distinctive capacity of gold and silver nanoparticles is their ability to rechannel 
light energy into the form of heat provided that the particles are strong 
absorbers [Govorov, 2007]. This photothermal effect is principally achieved 
through the use of pulsed lasers at the plasmon resonance frequency and the 
raise of temperature is restricted to the direct vicinity of the nanoparticles. 
Practically, the absorption of light creates a heated electron gas that cools down 
by exchanging its energy with the particles lattice through electron-phonon 
interactions. Subsequently, the lattice cools rapidly by exchanging its energy 
with the particles environment. The laser parameters, i.e. power, pulse duration, 
time of exposure, etc. induces various effects on the particles vicinity and on the 
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particles themselves as schematised in the Figure 1-10 [Pustovalov, 2008]. At a 
first level, the raise of temperature is limited, without consequences for the 
particles but sufficient to affects cells or proteins (hyperthermia). At higher 
temperature, the heat front diffuses away from the particles and affects a larger 
space around the particles. At a second level, the heat front diffuses further 
away and the conditions may be sufficient to induce cavitation phenomena, with 
the formation of bubbles that expand and collapse, reaching very high 
temperature and pressure. In the next step, the photothermal conversion 
crosses the melting point of noble metals and the particles start degrading, 
firstly melting, then evaporating up to the point where the particles fragment. 
Each of these phenomena provokes interesting effects on biological media and 
has found potential therapeutic applications, principally in cancer therapy. For 
example, cancerous cells are more sensitive to changes of temperature than 
normal cells and a slight increase of temperature may elicit deleterious effect for 
abnormal tissues while sparing the healthy one [Pissuwan, 2006]. As often in 
nanomedicine, the objective is to firstly target the cancerous cells via 
bioconjugation to bring as many gold nanoparticles in contact with the tumours 
and therefore induce plasmonic amplification phenomenon to promote 
hyperthermia or to give birth to cavitation and bubbles generation [Zharov, 2005 
and 2006]. Even fragmentation of the nanoparticles offer therapeutical 
perspective as the diffusion of the fragments is limited in space, but sufficient to 
pierce the membrane of cells. Treatment is not the sole purpose of the 
photothermal conversion and the generation and propagation of bubble or the 
expansion of heated liquid are precisely the physical features that photothermal 
and photoaccoustic imaging modalities detect.  
A certain number of studies have proved the effectiveness of photothermal 
treatment towards cancer. For instance, El-Sayed et al. used  anti EGFR 
antibodies-conjugated nanoparticles to target human oral squamous cell and 
illuminated the particles with a normal argon laser at various laser intensities, 
using dark-field microscopy to observe the effects on cells [El-Sayed, 2006]. 
Yet, such therapy would be more effective with near-infrared or infrared 
sources: Halas’ group has demonstrated at several occasions that gold 
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nanoshells are suitable contrast agents as well as photothermal agents, proving 
suitable to resect tumors in mice [Gobin, 2007]. El-Sayed’s groups took 
advantage of the near-infrared longitudinal plasmon resonance of gold 
nanorods to achieve similar results on two malignant oral epithelial cell lines 
[Huang, El-Sayed, 2006]. 
 
 
1.2.5 Plasmon resonance and optical properties 
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Figure 1-10: Excitation of gold nanoparticles with short pulses laser leads to 
various photophysical reactions such as diffusion of heat away from the 
particle, generation of pressure waves and bubble  formation, melting of the 
particle, evaporation or fragmentation. 
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1.2.6 Diagnostics 
Gold has a long history in diagnostics and sensing of proteins, not only as 
nanoparticles but as thin films. Gold nanoparticles have been traditionally 
employed in immunostaining, where the gold particles are conjugated to an 
antibody against specific biomolecules or cellular compartment. The high atomic 
weight of gold generates a high contrast when imaged by transmission electron 
microscopy. Yet, it is the peculiar interactions between gold and silver surface 
with organic molecules that have drawn the attention for sensing and 
diagnostics [Chen, 2010]. In sensors, the noble metal particles are highly 
sensitive to the presence of analyte molecules in their vicinity as it affects their 
plasmon resonance and may be detected by dark-field microscopy. Similarly, 
plasmon resonance is modified after aggregation of nanoparticles which is 
interesting to design colorimetric assays. The original work of Mirkin et al. 
involved the conjugation of gold nanoparticles with single strands of DNA. When 
particles conjugated with complementary strands were added to the same 
solution, particles bound one to the other due to the hybridisation of DNA 
strands. As a consequence, the originally red suspensions turned violet/blue 
once gold aggregates formed [Mirkin, 1996]. Similar results were obtained with 
gold nanoshells for the detection of antibodies in blood samples and with 
aptamer-modified gold nanospheres for the detection of cancerous cells and 
can be extended to any process where aggregation at small or large scale 
occurs [Hirsch, 2003; Medley, 2008] 
Noble metal surfaces quench the fluorescence of dyes when the distance 
metal-fluorophore is very close and this effect is used in several sensors to 
quantitatively measure the concentration of analytes. The strategy proceeds in 
two steps: first of all, the nanoparticles are conjugated with a ligand that binds 
specifically to the analyte of interest. The particle suspension is afterwards 
saturated with analyte molecules conjugated with a fluorescent dye: due to the 
close proximity between the gold surface and the fluorophore, the signal of the 
dye is quenched. In a second time, the particles are added to the sample to 
analyse: if no analyte is present, no fluorescence is detected because of the 
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quenching. On the contrary, the analyte molecules compete with the 
fluorophore-tagged molecules present on the particles to have access to the 
ligands and progressively replace the tagged-biomolecules. As a result, the 
fluorescence in solution increases with time, even more that the concentration 
of analyte originally present in the sample is high [Sperling, 2008]. 
Noble metal surfaces induce a strong increase of the Raman scattering signal 
of molecules in their vicinity. When molecules scatter light, the scattered 
photons carry the same energy/frequency and same wavelength than the 
excitation photons (elastic or Rayleigh scattering). However, the frequency of a 
small fraction of the scattered photons is different from that of the excitation 
photons (inelastic or Raman scattering). The Raman signal is intrinsically weak 
and requires a consequent analyte concentration for being detected, but when a 
gold or silver surface is present near the molecules of interest, the Raman 
scattering is strongly enhanced. This surface enhanced Raman scattering is 
linked to the plasmon resonance of noble metal nanoparticles and its electric 
field enhancement so the probability to scatter light is much higher and the 
Raman scattered signal is several order of magnitude higher than without 
nanoparticles [Sperling, 2008; Li, 2008]. 
Similarly to Raman spectroscopy, the strong light scattering under plasmon 
resonance elicits an enhancement of fluorescence excitation and/or emission of 
dyes nearby under strict conditions. This phenomenon, exhibited by films and 
colloids, is referred to as metal enhanced fluorescence (MEF) or radiative decay 
engineering and it offers the possibility to improve the technologies based on 
fluorescence, for instance DNA analysis, sensors and probes, imaging, etc. 
MEF occurs when the absorption and/or the emission of a fluorophore overlap 
with the plasmon resonance frequency of the metal nearby as schematised in 
the Figure 1-11. On the one hand, the incident light interacts with the metallic 
surface to generate the plasmon resonance and the enhanced electric field 
subsequently excite a fluorophore in the vicinity of the gold or silver. In that 
case, plasmon resonance is used to enhance the excitation of the fluorophore. 
On the other hand, the effect may be opposite and it is the emitted light from the 
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fluorophore that induces the oscillation of electrons responsible for the electric 
field light enhancement, in which case the dye molecule acts as a source for the 
metallic object [Lakowicz, 2005]. The MEF has a potential application in surface 
assays based on fluorescence where silver and gold nanoparticles can increase 
the signal of fluorophores and quantum dots to achieve higher sensitivity [Aslan, 
2004]. 
 
 
 
 
In summary, gold nanoparticles are highly versatile and play or will play a 
fundamental role in many applications and in particular in imaging, diagnostics, 
and potentially therapy. The possibility to carefully tune the plasmon resonance 
coupled to the ease of surface modification enables to match the commercially 
available laser sources and to precisely target the right species. There already 
exists report of tumour treatments and in vivo imaging in mice but the limited 
depth penetration of light in tissue - a few centimetres with NIR light – is at 
present the principal limitation to gold nanostructures and limits the detection to 
hν 
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Dye 
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hν 
Dye  
emission 
Plasmon 
Figure 1-11: Metal enhanced fluorescence occurs either when 
fluorescence excitation or emission matches the plasmon resonance 
of a noble metal nanoparticle nearby. 
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superficial area in skin and regions accessible to endoscopy exclusively. 
However, advanced in photonics and plasmonics may be able to circumvent 
this setback and make it possible to detect and treat deep tissue targets. 
 
1.3 Magnetic nanoparticles 
1.3.1 Magnetic nanomaterials and iron oxide 
Magnetic nanoparticles are a fundamental class of nanomaterials with high 
potential in medicine and other applications in relation with the health sector. 
Similarly to other nanomaterials encountered so far, magnetic nanoparticles are 
potential drug and gene carriers, contrast agents for magnetic resonance 
imaging, and even therapeutic mediators in hyperthermia treatment [Gould, 
2006]. The obvious feature of this class of nanomaterials is its specific reaction 
towards magnetic field and the small dimension of magnetic nanocrystals give 
birth to a brand new magnetic behaviour named superparamagnetism. Various 
alloys have been engineered throughout the last decades, made of chromium, 
cobalt, neodymium, and other rare earth and transition metals, but only a few 
are or may be biocompatible. Of all nanomaterials alloys developed so far, iron 
oxide is the most widespread, although a few iron and cobalt alloys have 
occasionally proved viable biomedical products. Iron oxide exists naturally 
under various crystalline forms that exhibit specific magnetic behaviours, but 
magnetite Fe3O4 and maghemite γ-Fe2O3 are preferred due to their 
biocompatibility, chemical stability in biological and physiological conditions and 
because their synthesis is easy and inexpensive compared to other magnetic 
nanocrystals [Figuerola, 2010; McBain, 2008]. They are in principle gradually 
recycled by the organism and therefore more tolerated than other magnetic 
materials so long as the dosage remains controlled [Park, 2006 a]. Iron oxide 
crystals are generally categorised into superparamagnetic iron oxide (SPIO) for 
particles with a hydrated diameter superior to 50 nm and ultrasmall 
superparamagnetic iron oxide (USPIO) for smaller structures. 
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The oldest and most common method – which is also the simplest and fastest –
is the wet precipitation (also called co-precipitation) of iron salts in alkaline 
conditions. In the case of iron oxide nanoparticles, Massart developed a method 
that has since then become a standard [Massart, 1981]. The method consists in 
mixing ferrous chloride (FeCl3.6H2O) and ferric chloride (FeCl2.4H2O) in water 
at a molar ratio 1:2 in presence of a base, either potassium hydroxide or 
ammonium hydroxide: 
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Massart’s method yield nanoparticles 8 to 15 nm in size. Depending on the type 
of iron salts (nitrates, sulphates, etc.), as well as on the Fe3+/Fe2+ molar ratio or 
the pH, the size and shape of the particles can be tailored.  Maghemite is 
obtained from magnetite when a Fe3O4 suspension is washed with nitric acid, 
not only to neutralise the remaining base in solution, but also to convert the 
Fe3O4 structure into maghemite Fe2O3:  
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The principal limitation of the co-precipitation procedure is the low degree of 
crystallinity as well as a relatively important size dispersity of the nanoparticles 
due to the limited reaction temperature of the reaction. An alternative route is, 
as often with nanomaterials, the water-in-oil microemulsion to produce 
monodisperse samples, but once again the presence of water as media limit the 
reaction temperature and consequently the crystallinity of the crystals is not 
optimal. However, crystallinity is directly connected to the performance of the 
magnetic nanomaterial and a high crystallinity is desirable for optimal 
performance. 
Proceeding at high temperature (hydrothermal synthesis) is the common route 
to obtain highly crystalline particles. After the iron salts are dissolved in water, 
the temperature is increased well above the boiling point of water: the 
synergetic combination of high temperature and high pressure resulting from 
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water vaporisation improve the crystallinity of the particles at the cost of size 
and shape control. Other techniques include decomposition of organometallic 
reagents in high-boiling point organic solvents and chemical vapor deposition to 
produce small crystalline nanoparticles but both are non-environmentally 
friendly and chemical vapor deposition requires specific and expensive 
equipment [McBain, 2008]. 
Because of the tendency of iron oxide nanoparticles to agglomerate, an 
additional step is engaged where complexes agents such as citric or oleic acids, 
dextran, silica and other hydrophilic polymers are added to stabilise the crystals. 
This step is usually processed after the formation of nanoparticles, but some 
groups coupled particles growth and stabilisation with polyvinylpyrrolidone or 
other stabilisers [Mornet, 2004]. 
 
1.3.2 Magnetism behaviours 
The magnetic properties of iron oxide nanoparticles and of magnetic materials 
in general are the consequence of the response of their electrons magnetic 
moments to an external magnetic field. The magnetic moment of electrons has 
two origins: their rotation around their respective nucleus (orbital component) 
and their spinning in “up” and “down” directions. In other terms, electrons are 
like small magnets with orbital and spinning moments.  
The net magnetic moment of a substance is the sum of its electrons magnetic 
moments and the large numbers of atoms in materials is such that the electrons 
are arranged to cancel out their magnetic moments. In particular, electrons are 
paired with opposite magnetic moments, (Pauli Exclusion Principle) or 
combined into filled electron shells (subshells) with zero net orbital motion. Yet, 
in certain case the subshell of material is not entirely filled and its atoms 
possess unpaired electron that induce the magnetic properties of the material.  
When an external magnetic field H is applied to a material, its atomic magnetic 
moments respond to the external source in the form of magnetic induction B 
31 
that represents the internal field strength within a material (the magnitude of the 
field strength within the material) and is defined by [Andrä, 1998]: 
B = µ0 (H+M); (1-12) 
where µ0 is the permeability in a vacuum and M is the material magnetisation, 
that is the magnetic moment per unit volume that results from the tendency of 
atomic magnetic dipole to align with an external field.  
Magnetisms falls into three categories: diamagnetism, paramagnetism, and 
ferromagnetism to which two subclasses of ferromagnetism are added: 
ferrimagnetism and antiferromagnetism [Callister, 2001]. Diamagnetism is the 
tendency for a material to oppose any magnetic field it is subjected too. The 
electrons of a diamagnetic material are all paired so that the net magnetic 
moment is null, which translates macroscopically by an absence of any intrinsic 
magnetic effect schematised in the Figure 1-12. In presence of an external field, 
a magnetic moment is generated in a direction opposite so that diamagnetic 
materials tend to be repelled by any external magnetic sources. Aluminium 
oxide, gold and silver, silicon, and zinc are some examples of diamagnetic 
substance. 
In contrast, paramagnetic materials possess unpaired electrons, for example 
because of unfilled electron shells where atomic or molecular orbitals contain a 
single electron. The unpaired electrons are free to align in any direction and 
electron magnetic moments naturally get a random orientation that result in a 
null net magnetic moment. The second difference with diamagnetism is that 
instead of opposing to an external magnetic field the magnetic moments of 
unpaired electrons align with it and contribute to reinforcing the total magnetic 
field. Common paramagnetic materials include aluminium, chromium, titanium, 
or zirconium. 
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Likewise, ferromagnetic materials possess unpaired electrons, but do not 
exhibit a random orientation. Hence, the magnetic moments naturally orient 
parallel one to the other to maintain a low energy state. Microscopically, the 
order existing in ferromagnet translates into magnetic domains where all 
magnetic moments are parallel as exemplified in the Figure 1-13. However, the 
order is maintained until a certain temperature called Curie temperature, above 
which the thermal disorder that installs into the materials is strong enough to 
overwhelm the ferromagnetic order and make the magnetic lose its magnetic 
properties.  
In their natural state, each domain is magnetised to its saturation magnetisation 
(the maximum value of magnetisation a material reach under sufficiently high 
magnetic field) and neighbouring domains have a slightly different 
magnetisation orientation. The magnetisation M in absence of external field is 
then the sum of the magnetisation of all domains and is equal to zero when the 
H 
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Figure 1-12: Schema of the electron magnetic moment alignment in 
absence and in presence of external magnetic field in diamagnetic and 
paramagnetic materials and respective M-versus-H behaviour curves. 
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material is unmagnetised. When a H field is applied, the magnetic induction B 
increases with H until it reaches a threshold value: the saturation magnetisation 
of the ferromagnetic material. Microscopically, the external magnetic field 
influences the domains and as H increases, more and more domains change 
their shape and size to align to the external field via the movement of 
boundaries. In fact, the domains oriented favourably will grow at the expense of 
those that or not favourably aligned. At the saturation magnetisation, the 
specimen is composed of a single domain nearly aligned to H.  
When the external field is suppressed, the domains do not regain their original 
orientation. Instead, they conserve the saturation value or their magnetisation 
decreases at a slow rate. Even when the source is entirely suppressed, a 
residual magnetic field – or remanent magnetisation - resides in the 
ferromagnetic substance. This phenomenon of magnetisation lagging behind 
the magnetic field is called hysteresis and plays a fundamental role in most of 
the magnetic events encountered in our everyday life. The number of 
ferromagnetic elements is limited to rare earth gadolinium and dysprosium, 
metals iron (ferrite, magnetite), cobalt, nickel, and some of their alloys such as 
FePt and FeCo likewise display a ferromagnetic behaviour. 
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Figure 1-13: M-versus-H behaviour of a ferromagnetic and evolution of its 
magnetic domains at different stage of the magnetisation process. 
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The organised orientation of magnetic moments into their respective domains 
may lead to two sub-categories of ferromagnetism. Antiferromagnetism differs 
from ferromagnetism in that the magnetic moments of neighbour electrons are 
in opposite directions as can be seen in the Figure 1-14. As a result, the net 
magnetic moment of a ferromagnetic material is equal to zero since all electrons 
magnetic moments cancel. The case of ferrimagnetic lays somewhere in-
between ferromagnetism and antiferromagnetism: the magnetic moments of 
neighbour electrons are in opposite directions similarly to antiferromagnetic 
substances. However, the magnetic moment of one of the sublattice thus 
created (i.e. electrons pointing in one direction) is higher than the other so that 
the net magnetic of a ferrimagnetic material is not null and the material retain its 
magnetisation even in absence of an external magnetic field. 
 
 
 
When the size of a crystal is smaller than the dimensions of ferri- or 
ferromagnetic domains (typically 30 nm), the whole crystal behaves as a single 
magnetic domain. This is the case for nanoparticles that can be envisioned as 
single magnetic monodomains where all magnetic moments are parallel. The 
consequences are first the alignment of all particles with an external magnetic 
field, and secondly the absence of remanent field after magnetisation of the 
particles since all monodomains regains a random orientation. This new 
behaviour is called superparamagnetism as the saturation magnetisation 
reached by superparamagnetic nanoparticles is far superior to that of 
Ferromagnetic Antiferromagnetic Ferrimagnetic 
Figure 1-14: Orientation of magnetic moments in a ferromagnetic, 
antiferromagnetic, and ferromagnetic substances. 
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paramagnetic substances as highlighted in the Figure 1-15 [Jun, 2008; Leslie-
Pelecky, 1996]. Yet, the saturation magnetisation of nanoparticles may 
decrease as the crystals dimensions diminish. In particular, iron oxide 
nanoparticles suffer from a dramatic drop of their magnetic properties when 
their dimensions become too small, although parameters such as crystallinity, 
presence of impurities, or stabilisers or surfactants play a role on the magnetic 
properties as well. 
 
 
 
 
1.3.3 Applications in bio-imaging 
Superparamagnetism is the core of some of the newest applications of 
magnetic nanoparticles as it affords a strong saturation magnetisation without 
retaining any remanent field that would induce the nanoparticles to clump one to 
the other. There is a wide range of applications of iron oxide and other magnetic 
nanomaterials, from separation to drug delivery [Figuerola, 2010; Pankhurst, 
2002]. The primary application of superparamagnetic nanoparticles is 
undoubtedly as contrast agent for magnetic resonance imaging (MRI). Several 
SPIO and USPI are commercially available or in the latest phase of clinical trial 
Superparamagnetism 
H 
M 
H 
Figure 1-15: Effect of an external field on superparamagnetic nanoparticles 
and comparison of M-H curves of superparamagnetic (red) and paramagnetic 
substances (blue). 
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[Qiao, 2009 a]. The MRI signal is correlated to the magnetic relaxation of water 
proton after application of a magnetic field. The role of contrast agent is to 
create inhomogeneities in the magnetic field than translate in a change of 
protons relaxation. Practically, a first snapshot is taken prior to injecting the 
particles or other contrast agent. A second picture is acquire afterward and 
compared to the pre-contrast picture. SPIO and USPIO typically create a 
hyposignal, i.e. produce a very strong negative contrast on post-contrast MRI 
picture [Nam, 2009]. Gadolinium ions, a paramagnetic substance has be the 
principal contrast agent for MRI but raises some question about toxicity, but 
SPIO and USPIO offer the double advantage of a lower toxicity and higher 
saturation value that generates a stronger contrast on images. 
The natural reaction to the injection or intrusion of particles is the recognition 
and clearance by macrophages that subsequently transport the foreign agents 
to the organs of the reticuloendothelial system (spleen, liver, bone marrow, 
nodes). Larger particles are quickly detected and cleared from the circulation to 
get mainly stocked in liver and spleen. Smaller are able to escape – temporarily 
– and remain for longer period in the organism, translocating and travelling into 
deeper tissues prior to being cleared up and gathered up in bone marrow and 
nodes. Through surface engineering and proper choice of particles size, iron 
oxides are able to target –actively or passively - specific tissues for MRI 
imaging. A common practice is to inject SPIO and larger particles that will 
accumulate in the liver and spleen preferentially. When the SPIO-loaded 
macrophages arrive in the reticuloendothelial system organs, they appear as 
dark areas due to the crystals effect, but tumours and other unhealthy areas are 
devoid of macrophage and are not subject to the particles effects. In 
consequence, a strong contrast establishes between the healthy and diseased 
tissues on MRI images. The same strategy was followed with USPIO to 
differentiate healthy nodes from tumoral ones [Bellin, 2000; Semelka, 2001]. 
Polymer coating and stabilisers have an impact on the potential tissues and 
organs that SPIO and USPIO are able to reach. For instance, silicon-coated 
particles have been employed to differentiate the gastrointestinal tract from its 
surrounding organs. Likewise, macrophage, stroke, atherosclerosis and a 
37 
certain other ailments-related changes have been imaged using SPIO and 
USPIO at several occasion [Corrot, 2006]. For more precise location, however, 
particles surface has to be modified for specific antigen recognition and hereby 
to prove more specific in their targeting. Active targeting originally involved 
engineering of the crystals to express antibodies at their surface; later on, 
peptides and small ligands have started to replace antibodies because of the 
large size of the latter, bringing iron oxide nanoparticles on the path of 
molecular imaging, enlarging the potential target not only to organs but to 
smaller, less attainable regions [Corrot, 2006; Figuerola, 2010]. This may be 
extended to the tracking of stem and transplanted cells to follow their evolution 
through time [Elias, 2009].  
Active targeting is still prone to certain barriers, such as the necessity for the 
targeting ligand not to hamper the bioactivity of the magnetic crystals. 
Furthermore, size remains an important criterion for in vivo imaging since it not 
only the fate of the particles – although coating modulates the final reaction of 
the organism – but also the entry in smaller vessels or translocation through 
natural barrier such as the blood-brain barrier. Another challenge is to find 
nanomaterials with higher intrinsic magnetisation than SPIO or USPIO. With 
better magnetic properties, the dose of particles necessary to obtain similar – or 
better – contrast is lessened. Certain alloys start making their way as MRI 
agents but the question of their biocompatibility remained to be entirely solved. 
For example, Lee et al. doped the spinel structure of iron oxide with metals such 
as manganese, iron, cobalt, or chromium. Manganese-doped iron oxide had 
superior magnetic properties than all of their counterparts and the first 
cytotoxicity studies did not reveal toxicological effects [Lee, 2007; Maenosono, 
2008]. 
 
1.3.4 Magnetic guidance and separation 
A second important feature of iron oxide nanoparticles is magnetic guidance, 
i.e. the capacity to drag the particles directly to the sites of interests using an 
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external field or to separate species. The direct application of magnetic 
guidance is the delivery of drugs, gene (transfection), or other therapeutic 
agents right to the proper location. When current treatments such as 
chemotherapy rely on large dose of drugs delivered through the systemic 
circulation, affecting all cells on their track, magnetic guidance afford a more 
precise and sensitive approach and avoid the side-effects of drugs. A more 
specific delivery of drugs also means lesser doses since the majority of 
therapeutic molecules reach their dedicated target. The therapeutic is usually 
embedded into a polymer corona to be slowly released by change of 
temperature or pH, enzymatic clivage of the polymer chain or other 
biodegradation, or magnetically trigger. In principle, drugs-loaded particles are 
firstly injected to a patient, then dragged either throughout the whole process or 
via a magnet surgically implanted at the site of interest. The magnetic force that 
exerts on the particles will attract and concentrate them right into the proper 
location as schematised in the Figure 1-16 [Dobson, 2006]. 
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Figure 1-16: Schema of magnetic guidance of magnetic nanoparticles in blodd 
vessel as a mean to drag and concentrate the particles to a defined target. 
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In vivo application of magnetic guidance still faces obstacles. First of all, the 
magnetic field strength decreases quickly with distance. Penetration depth of 
the magnetic field of typical magnets is of few millimetres, although the distance 
has been augmented to 15 cm with neodymium iron boron magnets as well as 
via alteration of the geometry and duration of the external field. Yet, treatments 
may be more effective close to the surface or in areas with slow blood flow with 
average permanent magnet or low level of external magnetic field values. 
Alternatively, a magnet can be surgically placed in the tumours to treat deeper 
located lesions. Secondly, particles distribution is not focused in a small area 
and may accumulate in nearby tissues as well. In other terms, the field 
geometry is an important factor but its control is not as easy as with a laser. 
Thirdly, the accumulation of particles due to the close proximity of the external 
source may lead to embolisms as the particles agglomerates block the blood 
vessels, unless the blood flow is slow [Arruebo, 2007; Neuberger, 2005].  
In spite of the apparent difficulties that magnetic guidance may be facing, drug-
delivery via magnetic carrier is comparatively not new. In fact, microspheres 
made of albumin or biodegradable polymer such as poly (lactic acid), as well as 
liposomes may be loaded with magnetic particles to deliver. Attempts with 
nanoparticles are more recent and the first clinical trial dates from 1996, and 
although unsuccessful, revealed than more of 50% of the nanoparticles ended 
up in the liver. More recent attempts have been more promising and even 
successful, whilst at the same time drugs for other diseases or for inflammatory 
sites destination showed that cancer is not the only ailment that is treated, even 
though it is the focus of most studies. Rather than delivering biomolecules, 
magnetic nanoparticles may be used as a mean of separating species or cells, 
possibly in view of concentrating samples prior to analyses, in immunoassays 
and in other sensing tools [Arruebo, 2007]. The principle is that the magnetic 
nanoparticles label a particular biological entity and the complex is separated 
from its media by application of a magnet or any other external source. The 
strategy implies that the magnetic are bound to the proper markers beforehand 
similarly to an active targeting. Since in vitro conditions do not poise the same 
requirement in term of size, larger particles can be employed, although 
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superparamagnetic nanoparticles remain as valuable as ferro- or ferrimagnetic 
crystals and other magnetic microspheres. Similarly, the requirements on the 
external magnetic field are not as restrictive as in in vivo applications. In some 
case, a permanent magnet is placed along the wall of glassware and the 
supernatant is discarded. In some other cases, the media passes through a flow 
column to speed up the accumulation of magnetically retrieved species, in 
which case the magnetic gradient must prove stronger than the hydrodynamic 
force that the flow exerts on the particles. 
 
1.3.5 Hyperthermia 
Lastly, magnetic nanoparticles are also suitable thermal agents for 
hyperthermia treatment consisting in raising the temperature up to 42°C and 
maintaining it for 30 minutes or more. The specificity of hyperthermia lies in the 
higher sensitivity of cancerous cells compared to healthy one that are 
unaffected at the 42°C threshold. Although procedures exist to induce 
hyperthermia such as radiofrequency capacitance hyperthermia, whole body 
hyperthermia or injection of hot water in situ, none proved satisfactory and 
some even proved risky due to the damage of all tissues indistinctively. Yet, 
magnetic hyperthermia involves nanocrystals to target the right areas and to 
convert the energy of an alternative field into heat. In itself, magnetic 
hyperthermia is analogous to photothermal conversion of gold nanoparticles 
except for the physical mechanism responsible for the heat generation.  The 
main difference with the previous applications of magnetic nanocrystals is the 
strength and frequency of the external field as it is necessary to send an 
alternative field to obtain the expected raise of temperature. The principal 
challenge is to define the proper magnetic fields conditions – in term of strength 
and frequency – that are clinically acceptable. Alternating magnetic field may 
end up in deleterious physiological effects such as muscles or cardiac 
stimulation or unwanted heating due to Eddy currents.  
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The mechanisms behind heat generation depend on the magnetic behaviours of 
the materials. In ferromagnetic materials, heat release occurs through 
hysteresis losses or losses during magnetisation reversal: part of the magnetic 
energy is lost during the hysteresis loop as the magnetic domains grow and re-
orientate. The losses are proportional to the field frequency and the area of the 
hysteresis loop and take the form of heat. In monodomain crystals the losses 
proceed via rotational motion: the rotation may be of the particles themselves 
(Brownian rotation) or of the atomic magnetic moments within each particle 
(Néel relaxation) because of the torque exerted by the external field. The heat 
generation during Brownian rotation is due to the friction that creates between 
the particles and the surrounding media. Néel relaxation implies that the 
alternative field is able to overcome the magnetic anisotropy energy barrier in 
order to reverse the crystals magnetisation as can be seen in Figure 1-17. 
Typically, both Brown and Néel mechanisms are responsible for the raise of 
temperature that superparamagnetic nanoparticles generate [Levy, 2008]. 
 
Figure 1-17: Origins of hyperthermia in ferromagnetic substance and in 
superparamagnetic nanoparticles [Levy, 2008]. 
 
For a long time, finding the proper parameters to the magnetic field hampered 
the clinical applications of magnetic hyperthermia since the conditions were not 
safe for patients. Nowadays, the treatment is underway as the first systems are 
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being clinically evaluated:  Thiesen and Jordan have reported the feasibility of 
magnetic hyperthermia on prostate cancer in rats and later on used 
superparamagnetic iron oxide fluid to treat human patients suffering from 
glioblastoma multiforme and patients with recurrent prostate cancer [Thiesen, 
2008]. Besides, an increasing number of studies suggest that the particles can 
be tracked by MRI before applying the alternative field so that the nanocrystals 
act as both a contrast and a thermal agent. The major drawback associated to 
magnetic hyperthermia is the potential overheating of tumours and heat 
propagation to the neighbouring tissues. Ferromagnetic particles may be made 
so that their Curie temperature, i.e. the temperature above which the particles 
become paramagnetic, equals 42°C or slightly above so self-regulating the 
maximal temperature attainable and avoid the risks of overheating. Yet, this 
strategy is not applicable to all materials and ferromagnetism is not entirely 
desirable for in vivo application due to the potential magnetically-induced 
aggregation of the particles. 
 
1.4 Silica nanoparticles 
1.4.1 Sol-gel process 
Silica differs from other nanomaterials: where quantum dots are subject – as 
discussed later - to quantum confinement, gold nanoparticles possess plasmon 
resonance, and iron oxide reacts to magnetic field, silica nanoparticles do not 
exhibit any intrinsic property. Instead, silica is a highly robust matrix able to 
carry and protect various biomolecules, from drugs to fluorescence dyes and 
even other nanoparticles. The synthesis of silica nanoparticles is based on a 
sol-gel process, a versatile solution for the processing of ceramics and glasses 
at low temperature that produces a large variety of forms such as ultra-fine 
powders, coating, fibres, membranes, monolithic ceramics and glasses, 
extremely porous materials, or particles as represented in the Figure 1-18. 
Ceramics processed by sol-gel find applications in various fields such as 
photonics and electronics (laser elements, capacitor, transparent 
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semiconductors), energy (solar cells, electrolyte for fuel cell), materials 
(refractory ceramics, fibres, scratch-resistant coatings) or biomedical (implant 
coating, entrapment of enzyme) [Dimitriev, 2008]. 
 
 
 
A sol-gel process requires precursors in solution that react with water and yield 
an oxide network through inorganic polymerisation. In a first time, precursors 
are hydrolysed and condense into oligomers of various degree of 
polymerisation to eventually evolve into a colloidal system (particles in 
suspension in a liquid) or “sol”. During the next step, particles coalesce and 
assemble into a single oxide network where some liquid is still present inside 
the pores or “gel” as schematised in the Figure 1-19 [Celzard, 2002]. Further 
Precursor in solution Sol 
Thin film Fiber 
Wet gel Particles 
Aerogel 
Xerogel Dense ceramic 
Figure 1-18: The sol-gel process allows the elaboration of material under 
various shape and form. 
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treatments include aging and drying to stabilise the structure as well as heating 
treatment and sintering to obtain more or less porous materials. Gelation, i.e. 
passage from precursors/sol to gel is not an absolute step and the sol may be 
stabilised to produce nano- or microparticles. 
 
 
 
Typical precursors are metallo-organic compounds such as metallic alkoxides 
M(OR)n, where M is a metal or metalloid (titanium, zirconium, aluminium, 
silicon, etc.) and R is an alkyl group (methyl CH3, ethyl C2H5, etc.).  Silica is one 
of the most studied metals of the sol-gel process, historically because it was the 
first system reported, but also because of the lower costs of its precursors and 
the greater flexibility of silica chemistry. Tetramethoxysilane (TMOS) Si–(CH3)4 
and tetraethoxysilane (TEOS) Si–(C2H5)4 are the most common silicon 
precursors. Besides, the introduction of organosilanes Si(OR)4-xR’x (with x = 1 or 
2 and R’ is an organic group) has become more and more popular since 
organosilanes allow the formation of hybrid organic-inorganic systems, more 
flexible than pure silica network. Vinyltriethoxysilane, phenyltriethoxysilane or 
aminopropyltriethoxysilane are some examples of the precursors commonly 
employed that impart organic character to silica gels [Schubert, 1995]. 
Hydrolysis 
 
Condensation 
 
Gelation Gel 
Oxide network  
+ 
Interstitial liquid 
Sol 
Particles in 
suspension 
Precursors 
M(OR)n 
Figure 1-19: Schematic representation of a sol-gel process, with the transition 
from precursors in solution to particles (sol) and to an inorganic network (gel). 
45 
Generally silicon alkoxides are not miscible in water and therefore require a co-
solvent, mainly an alcohol, for the reactions to proceed. 
Addition of water to the the precursor initiates the hydrolysis during which 
alkoxide groups are converted into hydroxyl:  
Si
OR
ORRO
OR
H2O+
Hydrolysis
Esterification
Si
OR
OHRO
OR
+ ROH
 
 
(1-13) 
Then two partially hydrolysed molecules link together in a condensation reaction 
(polymerisation) by creating an oxo bridge M-O-M, or siloxane Si-O-Si for silica 
systems. The link occurs either through oxolation where two hydroxyl groups –
OH react together and release water: 
Si
OR
OHRO
OR
+
Water condensation
Hydrolysis
Si
OR
ORHO
OR
Si
OR
ORO
RO
Si
OR
OR
OR
H2O+
 
 
(1-14) 
or through alcoxolation where a hydroxyl group –OH react with an alkoxide –OR 
and results in the release of alcohol:  
Alcohol condensation
Alcoholysis
+ ROHSi
OR
ORRO
OR
+ Si
OR
ORHO
OR
Si
OR
ORO
RO
Si
OR
OR
OR  
 
(1-15) 
The presence of a catalyst is indispensable to initiate the process since silicon 
precursors react very slowly (if at all) with water under neutral conditions. 
Hydrochloric acid and ammonia are the typical catalysts, although fluorhydric 
and acetic acid and amines are sometimes employed. The choice of catalyst 
has a deep impact on the final morphology of sol and gel as highlighted in the 
Figure 1-20:  
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Ø In acid-catalysed conditions, particles aggregate before their growth so 
that the final network is mostly build from low density polymers and are 
poorly connected; 
Ø In basic-catalysed conditions, precursors form either highly branched 
clusters that link one to the other or a colloidal system where particles 
coalesce and evolve towards a colloidal gel. 
The difference of morphologies lies in the competition of hydrolysis and 
condensation as the two reactions are strongly affected by pH. Other 
parameters such as water-to-precursor molar ratio, temperature, and 
concentration of reagents influence the final structure although catalyst nature 
and concentration provides the most significant effects. 
 
 
 
Hydrolysis is acid- or base-catalysed and it is generally admitted that it 
proceeds by bimolecular nucleophilic substitution (SN2 reaction) where the 
electron-rich oxygen of water (nucleophilic) attacks the electron-poor silicon 
atom (electrophilic) and replaces an alkoxide group (leaving group). Under 
acidic conditions an alkoxide group is protonated in a rapid first step. The 
Si-(OC2H5)4 
Hydrolysis  
Condensation 
Figure 1-20: Influence of pH on the final structure of gels 
[Brinker, 1990]. 
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protonated alkoxide withdraws electron density from silicon and therefore 
renders it more electrophilic. As a result a water molecule attacks silicon 
whereas the protonated alkoxide group leaves the coordinate: 
H+ Si
OR
OR
ORO R
H
Si
OR
OR
ORRO
 
 
(1-16) 
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(1-17) 
Alcohol condensation
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(1-18) 
Under basic conditions, however, a hydroxyl anion directly attacks the silicon 
atom and induces the departure of an alkoxide group: 
Si
OR
OR
ORROHO + Si
OR
OR
OR
RO
HO
δ-δ-
Si
OR
OR
ORHO RO-+
 
 
(1-19) 
Condensation leads to the formation of siloxane bonds Si–O–Si. The reaction 
occurs through attack of a silanol group on a silicon atom with expulsion of 
water or of alcohol. Under acidic conditions, mechanism involves the formation 
of protonated silanols similarly to acid-catalysed hydrolysis. Consequently the 
silicon atom becomes more electrophilic and more prone to nucleophilic attack. 
Protonated species react and connect with neutral ones, either through siloxane 
bonds with either formation of water or alcohol: 
H+ Si
OR
OR
ORO
R
H
Si
OR
OR
ORRO
Fast
 
 
(1-20) 
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(1-21) 
Above pH 2-4.5, an alkoxide is deprotonated and the resulting silanol 
(nucleophilic) attacks a neutral species following a nucleophilic substitution 
reaction: 
HO-+ Si
OR
OR
O-ROSi
OR
OR
OHRO
 
 
(1-22) 
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(1-23) 
Hydrolysis and condensation are concomitant. Furthermore the rate of the two 
reactions is very sensitive to pH and to the steric and electronic environments 
that result from each step of hydrolysis and condensation. The substitution of 
alkoxide groups with hydroxyl and siloxane modifies the electronic environment 
of the silicon atom and creates steric hindrance. Hydroxyl, silanol and siloxane 
change the acidity of silicon and consequently influence the nucleophilic attack 
on silicon as can be seen in Figure 1-21.  
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Figure 1-21: Inductive effects of substituents attached to silicon 
[Brinker, 1990]. 
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In acid conditions, transition states positively charged are favoured by 
electrodonnor substituents such as alkoxides. However the hydroxyl groups that 
form during hydrolysis are less electrodonnor than the alkoxide –OR groups so 
that the hydrolysis rate decreases with each new hydrolysis step. Similarly 
siloxane groups O–Si are electron withdrawing and cause more steric hindrance 
than hydroxyls so that condensation rate is even slower. Consequently, in acid 
conditions, hydrolysis usually ends up before condensation starts and the 
polymers are mainly long extended chains weakly branched.  
Inversely, in basic conditions, hydroxyl anions attack on the silicon atom: 
Electron withdrawing groups such as –OH and –O–Si favour the nucleophilic 
attack. As hydrolysis proceeds, more hydroxyl groups replace the initial alkoxide 
so that hydrolysis rate increases with each subsequent step. Similarly formation 
of siloxane bonds increases the condensation rate and proceeds at the same 
speed than hydrolysis. The resulting polymers are compact and highly 
reticulated. 
 
1.4.2 Stöber method and particle synthesis 
The gelation process is blocked under certain environmental conditions to 
produce spherical particles of various dimensions. The principal method of 
production of silica nano- and microparticles was developed in 1968 by Stöber 
and Fink [Stöber, 1968]. Their method involves the hydrolysis and condensation 
of TEOS in a water-alcohol mixture under basic conditions, typically catalysed 
by ammonium hydroxide NH4OH: 
Si(OC2H5)4 + 4 H2O è Si(OH)4 + 4 C2H5OH 
(1-24) 
Si(OH)4 è SiO2 + 2 H2O (1-25) 
According to the two reactions, 4 moles of water are necessary to hydrolyse 
TEOS or 2 moles when condensation goes to completion. Practically, however, 
the water content in Stöber method ranges from 7 to 53 whereas pH is kept 
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high by the employ of ammonium hydroxide. These conditions promote the 
TEOS condensation and the formation of dense spherical nanoparticles over 
polymeric networks and gels. Gelation does not occur because of the negative 
charges at the surface of the particles that repulse the spheres. The size of 
submicroparticles depends principally on the water content and catalyst type 
and concentration but Stöber method covers sizes ranging from few tens of 
nanometres up to a micrometer as can be seen in the Figure 1-22. 
 
Figure 1-22: Variation of water on TEOS ratio and catalyst concentration 
control the final size of nanoparticles [Stöber, 1968]. 
 
The Stöber method was further developed and the influence of various 
parameters, including reagents concentration, temperature, solvent, or addition 
rate, was investigated. However, effects of these parameters are difficult to 
isolate and are usually interdependent, albeit certain trends emerge [Park, 
2002; Rao, 2005]: 
Ø Nature of precursor: the change of alkoxide group modifies the 
hydrolysis and condensation rate of the silane. For example rates of 
tetramethoxysilane are ten times faster than that of TEOS. More 
generally increasing the alkyl chain length of the alkoxide groups 
increases the reactions rates; 
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Ø Concentration of precursor: studies on the silane concentration effect 
indicate an increase of the particles size with increased concentration. 
Nevertheless, the effect is strongly related to the water content and 
invert effect may also occur according to the domains of reagent 
concentration; 
Ø Nature of solvent: generally solvent is of the same nature than the 
alkoxide so that no transesterification occurs. The effect remains 
obscure although reactions rates seem faster in the most polar solvent; 
Ø Effect of catalyst: ammonia and ammonium hydroxide are typical 
catalysts in the Stöber method. They promote the condensation 
reaction and the formation of spherical, regular particles. Similarly to 
the precursor concentration, results on the effect of catalyst 
concentration are often contradictory from one study to the other and 
depend on the range of reagent concentration. Other catalysts such as 
rginine and lysine have been investigated and yield smaller and more 
uniform particles than ammonia-catalysed particles; 
Ø Effect of temperature: studies tally on a reduction of particles size with 
increase of temperature. Authors suggest that higher temperature 
yields more nuclei and lead to the formation of more numerous but 
smaller particles than in room temperature;  
Ø Effect of water to Si ratio (r): results are contradictory with some studies 
observing a decrease of the size as r increases whereas other found 
the opposite. 
Although the Stöber method has been refined since its report, the principal 
drawback lies in the relative polydispersity of particles below 100 nm. Besides, 
the negative charge of silica particles is generally not sufficient to totally prevent 
aggregation or is not reactive enough so that an additional layer of organosilane 
is necessary to satisfactorily disperse the spheres or allow bio-conjugation. 
Nevertheless the procedure is an easy, flexible, and inexpensive way to 
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produce silica particles. A new solution referred to as amino acid catalysis and 
consisting in replacing ammonium hydroxide by amino acid to catalyse 
hydrolysis and condensation reaction has recently been proposed [Yokoi, 
2006]. Among other advantages, this method offers the possibility to 
dramatically decrease the particle diameter to a few tens of nanometer and 
make the whole process cleaner by operating in milder conditions. 
Reverse microemulsion is the second route to produce silica nanoparticles and 
circumvent the problem of size and size dispersity [Yamauchi, 1989]. Micelles 
encapsulate water and ammonium hydroxide so that hydrolysis and 
condensation proceed inside the nanodroplets as TEOS molecules become 
progressively soluble in the water pools. Through micelles collision, the micelles 
exchange their content and allow the sol-gel reaction to occur. Furthermore, the 
cavity of the micelles confine the particles grow and therefore a high 
monodispersity is achieved [Bagwe, 2004]. The size and shape of micelles, and 
by extension of particles, are controlled by varying the parameters of the 
microemulsion: molar ratio of water to surfactant, nature of surfactant, and 
concentration of reactants.  
In order for hydrolysis to take place, TEOS molecules have to diffuse from the 
surrounding organic phase into the micelles and the water pools. After addition 
of TEOS to the system, the molecules get partitioned between droplets and 
organic phase by formation of monomers with one silanol group (Si(OR)3OH). 
Further, hydrolysis renders monomers more hydrophilic, and they eventually 
solubilise entirely inside the water nanodroplets. Since ammonium hydroxide is 
already present inside the micelle, nucleation proceeds [Arriagada, 1999 a and 
b]. The rate of hydrolysis and nucleation strongly depend on the water on 
surfactant ratio (R): at low R value, many small micelles are present in the oil 
phase. The water molecules are mostly bound to the surfactant and cannot 
react with the few TEOS molecules around the micelles. Since the water 
concentration is very small, hydrolysis and condensation are not favoured. On 
the contrary, at high R values many TEOS are present in the micelles while the 
water pool is big enough to favour the hydrolysis of silane molecules and initiate 
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the nucleation. In consequence, reverse microemulsion requires relatively high 
water on surfactant ratio and high concentration of reagents to promote small 
nanoparticles. The employ of surfactant is also the mean by which mesoporous 
nanoparticles are produced. This role is principally attributed to 
hexadecyltrimethylammonium bromide (CTAB), the same surfactant required in 
the synthesis of gold nanorods and some other nanoparticles with specific 
shape or porosity [Qiao, 2009 b]. 
 
1.4.3 Fluorescent silica nanoparticles (FSNPs) 
The principal interest of silica nanoparticles is their insensitivity to environmental 
changes: high variations of temperature or pH do not degrade the silica matrix, 
a property that makes of silica particles a carrier of choice for many 
biomolecules and occasionally to transport drugs. More precisely, drug delivery 
is mostly devoid to mesoporous structures, which controlled porosity is more 
favourable to the slow release of compounds. Denser architectures are more 
suited to biomolecules that need to be sequestered. Although quantum dots are 
highly promising fluorescent probes, fluorescent dyes remain the principal agent 
for most fluorescent-based technology. Fluorescent dyes – or fluorophores – 
are molecules able to absorb light at specific wavelengths and reemit it at 
longer wavelengths under a process called fluorescence. They have a long 
history – dating from the late 1800s – and were initially introduced in fluorescent 
microscopy, although their extensive use is more recent [Prasad, 2003]. Typical 
dyes emit in the UV or visible, but new fluorophores emitting in the near-infrared 
or in the infrared have been elaborated since then. In parallel, contrast agents 
for multiphoton microscopy have attracted attention and provide new 
possibilities for the bio-imaging science [Frangioni, 2003; Wu, 1999]. Other dyes 
exhibiting new physico-chemical properties were later discovered, generating 
heat, reacting to other stimuli than light (temperature, pH, etc.) or inducing 
chemical reaction with their environment. For instance, photosensitisers 
employed in photodynamic therapy generate singlet oxygen when illuminated 
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with the proper light wavelength and are potential therapeutic agents for the 
treatment of cancer, skin diseases and some other ailments [Pervaiz, 2006; 
Unger, 2004]. Fluorophores suffer from photobleaching, i.e. a loss of 
fluorescence with time principally because of photo-oxidation. Photobleaching is 
a fast process that binds fluorophores to a few minutes illumination at best. 
Although this side-effect has not hampered the development of fluorescent 
dyes, the possibility of circumventing this problem and proceeding for longer 
period of time is desirable. Furthermore, many dyes such as near-infrared and 
multiphoton dyes are hydrophobic and aggregate in many physiological media, 
losing their optical properties. Encapsulating dyes within a carrier offers a 
solution to insulate and then to protect the dyes from their environment while 
gathering thousands of molecules into a single sphere for more intense signal.  
Contrary to polystyrene and latex microparticles are generally polydisperse, and 
swell or dissolve in certain solvent, silica is more robust and entirely shields the 
dye from their environment. Moreover, the large variety of organosilane is ideal 
to express functional groups necessary to the surface engineering of 
nanoparticles. 
Dyes can be covalently or physically entrapped within the silica particles 
depending on the synthesis route and nature of the fluorophores. The major 
contribution to dye-doped nanoparticles is undoubtedly that of van Blaaderen 
that is a variation of the Stöber method where fluorescein isothiocyanate (FITC) 
was conjugated to an organosilane so that the sylilated dye was able to be 
covalently bound to the silica network of the particles [van Blaaderen, 1992 c]. 
The advantage of this approach is the covalent link between the dye and the 
silica matrix that prevents any leakage whilst the high number of fluorescent 
molecules per particle considerably increases the signal of each particle and 
considerably reduces the photobleaching issue [Santra, 2006]. Similar results 
were obtained few years later with rhodamine isothiocyanate and were later 
extended to maleimide-derivative rhodamines and even to near-infrared dyes; 
the common point is the necessity to firstly conjugate the fluorophores with an 
organosilane in order for the complex to co-condense with TEOS as 
schematised in the Figure 1-23 [Verhaegh, 1994].  
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Physical entrapment consists in simply introducing the fluorophore during the 
growth of the particles. The network retains fluorophores through electrostatic 
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Figure 1-23: Preparation of fluorescent dye-doped silica nanoparticle via 
van Blaaderen’s procedure where a fluorophore is covalently bound to an 
organosilane and get integrated to the silica nanoparticle. 
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interactions and affinity with the hydrophilic silica matrix, although the weak 
interactions between dyes and matrix may result in leaking out of the 
nanoparticles and a loss of fluorescence with time. The method is sometimes 
found with the Stöber method but is mostly involved with reverse 
microemulsion. To entrap lanthanide chelates. The main limitation is the 
preference of organic dyes for the oil phase rather than the water pools and 
reverse microemulsion usually fails in entrapping organic fluorophores. The 
solution consists in either proceeding with a normal oil-in-water emulsion or 
choosing inorganic dyes, typically lanthanide chelates such as Tris(2,2’-
bipyridyl) dichlororuthenium (II) hexahydrate (RuBpy) and Tris (2,2’-bipyridyl) 
osmium (II) bis (hexafluorophosphate) (OsBpy) or europium complexes, that are 
highly hydrophilic and penetrate within the micelles [Bagwe, 2004; Jiang, 2010; 
Wang, 2005 b]. 
 
1.4.4 Applications 
In respect to the traditional application of fluorescent dyes, fluorescent silica 
nanoparticles (FSNPs) have proved their worth as contrast agents in optical 
imaging. Rhodamine-loaded FSNPs have been employed to label many type of 
cancer types including oral, lung, cervix, liver or breast using proper ligand such 
as folic acid to recognise overexpressed antigen specific to each cell line 
[Santra, 2005 a; Shi, 2010]. Silica particles were also employed as a substitute 
to quantum dots and magnetic particles to image sentinel lymph node in vivo in 
mice [Jeon, 2010]. Yet, most common fluorescent dyes emit in the visible range 
and their signal is hampered by the autofluorescence of tissues and the low 
depth penetration of visible light (a few millimetres at best). Progressively, near-
infrared and two-photon dyes were loaded into the silica matrix and the particles 
become more suited for scattering and thicker samples [Ohulchanskyy, 2010, 
Yao, 2006]. In particular, the C-dots are an improvement to van Blaaderen’s 
FITC-doped particles with a considerably reduced size of 20 to 30 nm that have 
been engineered to contain various near-infrared dyes and obtained promising 
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results as contrast agent for live imaging in mice [Burns, 2009]. Likewise, the 
same strategy has been followed with photosensitisers in order to impart more 
specificity to photodynamic treatment.  The specific targeting that silica 
nanoparticles obviate the risks of systemic distribution of the drug into the whole 
organism and the retention time during which patients are light-sensitive 
(including daylight) and that is source of severe burning due to the improper 
activation of the photosensitisers [Ohulchanskyy , 2007; Roy, 2003].  
Organosilanes are able to condense onto silica surface by reaction with free 
silanol and is a very versatile way to modify the surface of FSNPs with a great 
variety of chemical functions that can in turn be used as an anchor for targeting 
ligands. Coupled to their high brightness, silica nanoparticles are especially 
powerful as a replacement to fluorescent dyes in assays and methods relying 
on fluorescence. Using FSNPs in immunoassays has become a standard 
procedure, for example in the detection of hepatitis B surface antigens with an 
ELISA assay but also in the detection of bacteria and other pathogens [Yan, 
2007, Yang, 2004, Zhao, 2004 a]. The use of FSNPs entrapping different dyes 
engineered to recognise a specific analyte is one way to achieve multiplexed 
system, although they lag behind quantum dots and their narrower emission 
peaks [Knopp, 2009]. Similarly, FSNPs are used in the detection of DNA or 
RNA for gene expression or profiling and for procedure requiring the 
hybridisation of nucleic acid [Tan, 2004]. For instance, Zhao et al. designed an 
assay where a first DNA strand was immobilised onto a glass surface and a 
second sequence was conjugated to FSNPs in order to capture a third target 
sequence complementary to the first two strands as can be seen in the Figure 
1-24 [Piao, 2008; Zhao, 2003]. Therefore, FSNPs have a high potential in 
sensing and diagnostics and provide a solution to the photobleaching of dyes 
and to the low sensitivity of certain assays relying on fluorophores. 
58 
 
Figure 1-24: Schema of a DNA assays where DNA-conjugated FSNPs are 
used for the recognition of DNA [Yan, 2007]. 
 
1.4.5 Multifunctional nanoparticles 
Taken separately, all of these particles belong to the “first generation” of 
particles, structures exhibiting one or two characteristics but with restricted 
possibilities. With better control over the synthesis and physico-chemical 
properties of nanomaterials, particles have evolved to the “second generation” 
where nanostructures are – ideally – able to react accordingly to the 
environmental conditions. In a first time, the objective behind combining 
nanomaterials was to solve certain issues that individual nanoparticles face. An 
example is the coating of quantum dots with silica in order to improve the 
stability of the semiconductor nanocrystals and confine them within a resistant 
shell to limit the risk of degradation and resulting leakage of heavy metal 
leakage [Koole, 2008]. Similarly, depositing a first silica layer onto gold or silver 
particles completed by a second layer entrapping fluorescent dye is theoretically 
the best way to benefit from the metal enhanced fluorescence effect. In fact, the 
first attempts saw the creation of nanocomposites where the nanoparticles 
made of iron oxide, noble metal and other materials were integrated within a 
silica matrix for protection, stabilisation, and/or functionalisation purpose. In 
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parallel, bi- or multimodal architectures that fulfil multiple tasks have elicited 
more and more interest. For example combining the fluorescence or plasmonic 
imaging of quantum dots and other gold nanoparticles with the effect of iron 
oxide nanocrystals on magnetic resonance imaging has become popular. Step 
by step, the idea of combining nanomaterials into theragnostics agents, i.e. 
structures similar to the Figure 1-25 with dual imaging and therapeutic 
applications, has progressed. In a sense, multifunctional platforms are closer to 
the ideas lying behind the concept of second generation of nano-objects, being 
more flexible than the first nanocomposites developed. A typical multifunctional 
system is able: 
Ø To detect a specific target via surface modification;  
Ø To be magnetically or optically driven by an external source; 
Ø To reveal its location by fluorescence, photothermal, magnetic or any 
other imaging mean; 
Ø To deliver drugs, gene or to elicit therapeutic effects such as 
hyperthermia or photothermal ablation; 
Ø To follow in real-time the changes occurring during the therapeutic 
phase; 
Ø To be cleared without harmful effect for the organism. 
 
Silica is the most popular matrix to link all components altogether due to the 
uniform size and versatility of its chemistry, low cost, ease of bio-
functionalisation, and low toxicity. As reviewed, silica is a host of choice for 
fluorescent dyes but also to other nanoparticles, assembled into a core-shells 
structure [Klichko, 2009; Piao, 2008]. Iron oxide nanoparticles play a key role in 
the multifunctional architectures and have been including within the silica matrix 
at length. The choice other components depends on the modalities and purpose 
of the nanoplatform, with a large preference for gold - frequently under the form 
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of a final shell – and at lesser extent of quantum dots for optical imaging. Gene 
and drug delivery are generally entrusted to mesoporous particles but the 
change of porosity is not an issue and other nanoparticles have been integrated 
to this slightly different matrix. For instance, Liong et al. engineered a 
multifunctional mesoporous silica nanoparticle to confine iron oxide 
nanoparticles for magnetic guidance and MRI imaging, incorporating FITC 
covalently bound to the silica network for optical imaging, and loaded with 
Paclitaxel (anticancer drug), the whole targeting cancer cells via folic acid 
conjugation [Liong, 2008]. 
 
 
 
 
 
Drugs 
Biocompatible polymer 
Antibodies 
Quantum dots 
Metallic nanoparticles 
Dyes 
Magnetic nanoparticles 
Protective shell 
Figure 1-25: Representation of a multifunctional platform made of the 
combination of several nanomaterials and biomolecules. 
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1.5 Quantum dots 
1.5.1 Composition and origin of fluorescence 
Quantum dots are newer that the other nanomaterials introduced so far. They 
consist in semiconductor nanocrystals 1 to 10 nm in size possessing unique 
optical and electrical properties and are potential candidates for solar cells, 
electronics, as well as in certain biomedical applications. The distinctive feature 
of quantum dots lies in their size-dependent emission, i.e. the light the particles 
emit is directly related to the size (and composition) of the crystals, and range 
approximately from 400 nm to 2 µm [Seydel, 2003; Walling, 2009]. Quantum 
dots usually have core-shell architecture: the core is made of semiconductors 
from groups II-VI, IV-VI, or III-V, in particular cadmium selenide CdSe, cadmium 
sulphide CdS, indium arsenide InAs, and indium phosphide InP are the most 
widespread materials. The shell is also composed of semiconductor with higher 
bandgap energy such as zinc sulphide ZnS or zinc selenide ZnSe.  
The quantum dots properties stem from their core: it is the bandgap energy, i.e. 
the difference of energy between the lowest level of the conduction band and 
the highest level of the valence band that controls the emission of the 
nanoparticles. The material must firstly absorb a photon with sufficient energy to 
promote an electron from the valence band to the conduction band, with 
creation of an exciton (electron-hole pair) during the process as represented in 
the Figure 1-26. The electron stays momentarily in the conduction band and 
falls back to its origin, firstly falling down to the bottom of the conduction band 
then relaxing to the valence band. During the transition, a photon with energy 
equivalent to the bandgap energy is emitted and the electron recombines with 
its corresponding hole. 
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The bandgap energy of quantum dots is directly correlated to the size and 
composition of the material with the consequence that the semiconductor 
emission is totally tunable. The bandgap tunability is linked to the quantum 
confinement effects –confinement of electrons and holes in semiconductors by 
a potential well - occurring in semiconductor nanoparticles. This effect occurs 
when the size of particles becomes smaller than the electron-hole distance in 
an exciton (Bohr’s radius) that might be formed in a bulk semiconductor. Under 
the Bohr’s radius, the energy levels of nanoparticles cannot be treated as 
continuous anymore but must be treated as discrete levels instead as 
schematised in the Figure 1-27. Because the energy levels are discrete, a 
change of atoms in the structure has deeper repercussions, for instance altering 
the bandgap energy [Alivisatos, 1996]. Typically, smaller particles generally 
exhibit higher bandgap energy and are blue-shifted compared to bigger 
particles or to bulk materials. The shell role is to passivate the core: the 
bandgap energy of ZnSe and ZnS is chosen very high to ensure that the 
excitation and emission originate from the core exclusively. The role of the shell 
is also to increase the photoluminescence of the nanoparticles and to limit or 
suppress the phenomenon of “blinking” - intermittent switching off and on of the 
particles - quantum dots suffer from and is an important issue for real-time 
processes.  
Energy levels 
Conduction 
band 
Valence 
band 
Bandgap 
Photon absorbed Photon emitted 
Excited electron 
Hole 
Figure 1-26: Mechanisms of absorption and emission of a photon in a 
semiconductor  
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The fluorescence properties of quantum dots are superior to that of fluorescent 
dyes on several points. First of all, semiconductor nanocrystals are not prone to 
photobleaching or photodegradation and can be imaged over extended period 
of time without loss of fluorescence. In addition, the luminescence of quantum 
dots is more intense and the emission profile is narrower and entirely tunable. 
Finally, a single UV source is sufficient to excite a quantum dots solution and 
even an array of quantum dots. 
 
1.5.2 Reverse microemulsion 
A common synthetic route of quantum dots involves the mixing of heavy metal 
salts in high temperature solvents that act as both reacting media and capping 
agents for limiting the growth of particles. However, reverse microemulsion is 
the preferred approach [Foglia, 2001; Pileni, 1993]: a reverse micellar system is 
composed of water and oil (organic solvent) that are naturally immiscible. 
Band-gap 
Exciton Bohr’s Exciton Bohr’s 
Energy levels 
Figure 1-27: At the difference of bulk material, the energy level of 
semiconductor quantum dots must be considered as discrete when their size 
falls below the Bohr’s radius. 
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Surfactant is added to the system at a concentration where it assembles into 
aggregate - or micelles - at the water/oil interface. In an oil-in-water 
microemulsion, the hydrophobic tail forms a core where oil is encapsulated, 
whereas the hydrophilic head stretch outside to remain in contact with water. 
Structure is inverted in a water-in-oil microemulsion, with hydrophilic heads 
forming the core of micelles and tails in contact with the exterior oil phase as 
exemplified in the Figure 1-28.  
 
 
 
The preparation of nanoparticles requires that the salts used as precursors 
solubilise within the micelles. The reactions proceed during the collisions 
between the droplets, where the micelles exchange their content and 
progressively form the nanoparticles. Additionally, microemulsions confine the 
synthesis within the cavity of the micelles so that the growth of the particles is 
mechanically limited by the dimension of the cavity. The reverse microemulsion 
Organic solvent 
Surfactant 
Water 
Water-in-oil 
microemulsion 
Oil-in-water 
microemulsion 
Figure 1-28: Water-in-oil and oil-in-water emulsions and schematisation of the 
micelle collision resulting in the growth of nanoparticles. 
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approach is common to many nanomaterials and may be modified into an oil-in-
water emulsion when the precursors and reagents are hydrophobic. Surface 
modification with capping ligand and polymer coatings render the particles 
soluble in water and polar solvents whilst conjugation with aptamers, antibodies, 
or peptides provides a mean for more specific targeting and help in increasing 
the biocompatibility of the quantum dots. 
 
1.5.3 Imaging 
The strong fluorescence of quantum dots is an undeniable advantage in bio-
imaging, in particular because the nanocrystals are able to emit light in the 
near-infrared [Gao, 2004]. Since UV lamps are the best sources of excitation, 
quantum dots are interesting contrast agents for normal epifluorescence 
microscopy. Usual laser sources of confocal microscope - 488, 514, 543, and 
633 nm - are less optimal, although confocal microscope can be upgraded with 
blue diode and UV laser sources. On the other hand, multiphoton excitation 
microscopy, whose features are discussed below, benefits more from the 
employ of quantum dots due to the high 2-photon absorption cross-section of 
the semiconductor nanoparticles [Deerinck, 2003; Larson, 2003]. Therefore, 
several studies focused on the labelling of cells and their subsequent imaging 
and an important in vivo study already show the potential for imaging in small 
animals. For instance, Maysinger et al. injected quantum dots in mice and 
observed a peak of fluorescence after three days and the signal persisted up to 
seven days [Maysinger, 2007]. In particular, the article demonstrated that QD 
705 (emission 705 nm) injected in the brain cortex were visualised through the 
skull that otherwise screened the signal of fluorescent agents emitting in the 
ultraviolet and visible range. The long wavelength emission of quantum dots is 
particularly helpful for the tracking of nanoparticles in blood and to determine 
their fate after injection [Jiang, 2008; Tada, 2007 a]. However, the limited 
penetration of depth mark quantum dots out for skin or superficial targets that 
can be accessed by enodscopy [Jiang, 2008]. In fact, quantum are slowly 
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getting their way in surgery where surgeon use quantum dots to better visualise 
lesions and not letting damaged tissues non-operated [te Velde, 2010].  
The capacity of imaging multiple populations of quantum dots with a single 
source has often been point up: for instance, Kobayashi and co-workers used 
multicolour imaging - five quantum dots types with distinct emission profiles –to 
study the lymphatic drainage in the neck and upper trunk after injection of the 
quantum dots in various sites as can be seen in the Figure 1-29 [Chan, 2002; 
Kobayashi, 2007]. The study is a good example of the advantage of colour-
coding to detect multiple targets simultaneously. Such example of imaging of 
multiple location in one go have multiplied and are not limited to organs but also 
to the imaging of organelles within single cells so long as the surface of the 
nanoparticles is designed to bind to the proper markers [Chan, 2002; 
Yezhelyev, 2007]. 
 
Figure 1-29: In vivo imaging distinctive lymphatic drainages injected with 
five carboxyl-modified quantum dots colours [Kobayashi, 2007]. 
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1.5.4 Diagnostics and microbeads 
Quantum dots are likewise powerful assets for the sensing of very small 
concentrations – picomolar to attomolar range – of proteins and other analytes 
[Wagner, 2007]. Quantum dots have been employed in fluorescence-based 
assays to detect changes in biomarker expression that may translate a 
differentiation into diseased cells. Yet, such markers are generally present at 
very low concentration in saliva, urine, or other fluids tested and require very 
sensitive assays to be detected. Quantum dots have been used as substitutes 
to the fluorescent dyes of ELISA assays and, although they did not demonstrate 
higher sensitivity than conventional ELISA, easily detected multiple analytes 
simultaneously [Goldman, 2004; Smith, 2006]. Nucleic acid biomarkers are 
another target for bioconjugated quantum dots to detect early mutations or 
hereditary predisposition towards cancer. New biosensors based on 
fluorescence resonance energy transfer (FRET) may use quantum dots as 
donors to detect proteins and nucleic assays and were found superior to 
sensors relying on conventional fluorophores [Gerion, 2003].  
The real potential of quantum dots lies in their multiplexing potential: rather than 
employing a single particle population to target one specific analyte, the 
nanoparticles can be gathered into a larger structure such as a microsphere. 
Even though detection of five or more targets is easily achievable with a five 
colour assay, basing the detection on the sole emission wavelength aspect 
become quickly limited when the number of targets increases. In comparison, 
loading microparticles with well-defined set of quantum dots appear as a more 
flexible alternative. Technologies exist that afford a precise control of the 
particles fluorescent pattern and intensity profile so that the spectral signature - 
or barcode - of the microsphere is precisely tuned both in terms of emission 
profile and in term of intensity level [Han, 2001]. For instance, six quantum dots 
colours with ten level of intensity lead theoretically to one million potential 
combinations. Consequently, simultaneous detection of multiple analytes from 
the same sample volume is possible if the microspheres are conjugated with 
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proper ligands and considerably reduce the time for analyses and costs of the 
procedure [Algar, 2010]. 
Thus, quantum dots are powerful fluorescent nanoparticles with the potenttial to 
replace certain fluorescent dyes to gain more sensitivity and to allow 
multiplexed detection. However, the composition of quantum dots is a major 
barrier to their application in vivo but is less of an issue for in vitro and 
diagnostics applications. Originally, many studies highlighted that quantum dots 
progressively exert toxic effects on cells. Release of cadmium ions – one of the 
principal components of quantum dots - after endocytosis caused damages to 
mitochondria and other subcellular components, and at certain occasion causes 
cellular death [Walling, 2009]. In comparison, iron oxide, gold and at some 
extent silica do not pose the same threat that the semiconductor particles. This 
is precisely the major downside of nanomedicine: the lack of paradigm in 
assessing nanoparticles toxicology impedes the full development of 
nanomedicine. As long as clear regulation is not declared and that 
nanotoxicology does not provide the fist clear evidence of the toxicity or lack of 
toxicity of nanomaterials, the decelopment of nanotechnology will be slowed 
down. 
 
1.6 Toxicology and biological responses of the organism 
1.6.1 Historical perspective of particles toxicology 
The environmental and health impact of nanomaterials is of great importance in 
the development of nanotechnology. The reduction of materials to the 
nanometre scale goes in par with the apparition of new, unique properties. At 
the same time, the small size and large specific area of nanostructures elicit 
their own specific biological responses that cannot be predicted based on the 
reaction of biological systems to bulk materials of similar composition. 
Therefore, all of the uncertainties about the response of an organism towards 
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nanomaterials raise questions about the possible toxicologic effects on humans 
and ecosystems.  
The recognition and the categorisation of nanoparticles toxicology as a 
distinctive branch of toxicology are relatively recent: the real emergence of 
“nanotoxicology” as a full discipline is strongly bound to the work of Oberdöster 
on fine (< 1µm) and ultrafine particles (< 0.1 µm) [Oberdörster, 2007]. 
Paradoxically, interactions of nanoparticles with biological entities and their 
unusual behaviour were already observed twenty to thirty years ago.  It has 
been long known that fine and ultrafine particles are naturally present in the 
environment or generated through natural events (volcanoe eruption, forest 
fires, etc.) in substantial amount. These natural nanoparticles are generally 
considered as harmless, except in certain specific cases.  Since the industrial 
revolution, the society has developed at a frenetic pace and new sources of 
particles appeared. These “anthropogenic” particles are often the results of 
combustion and other industrial processes (cars, power plants, etc.) and more 
broadly of pollution and toxicological studies established that anthropogenic 
particles are responsible for several cardiac and pulmonary diseases. More 
recently, the development of nanotechnology initiated the manufacture of new 
materials reduced to the nanoscale - or engineered nanoparticles - and thereby 
have become a new source of particles. The necessity to assess 
nanotechnology risks where additionally urged by stormy debates between 
nanotechnology promoters and opponents regarding hazard and social impacts, 
and the will of industrial to start commercialisation as soon as possible. Actually, 
the uncertainty about toxicology of nanoparticles represents the principal brake 
to the development and industrialisation of nanotechnology: if carbon nanotubes 
and some other nanoparticles (gold and silver colloids, silica Ludox ©, quantum 
dots, etc.) are now commercially available, their safety or toxicity is not proved 
and the studies often contradictory. Yet, a few products already include 
nanomaterials: sporting goods, tires, clothing, cosmetics (in particular 
sunscreens), electronics, etc. but their number is still limited (about 1020 
products referenced in 2010 [The Project on Emerging Nanotechnologies] and 
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the distrust of consumers is certainly what prevents more goods to enter onto 
the market.   
At the beginning, nanoparticles were loosely studied alongside ultrafine 
particles, principally because respiratory toxicologists were the first to fully 
recognise that very small particles may behave differently than bigger structures 
when they studied the inhalation of ultrafine particles and their effect on the 
lower respiratory tract. Oberdörster et al. compared 20 nm TiO2 and Al2O3 
particles to their 500 and 250 nm respective counterparts and observed a more 
acute pulmonary inflammation when nanoparticles were employed 
[Oberdörster, 2007]. Additional studies of carbon and TiO2 correlated the 
increased toxicity of ultrafine particles with the higher specific area of these very 
small structures. Poland’s comparison of carbon nanotubes to asbestos fibres 
triggered strong negative reactions from the scientific community as well as 
from the media and the public. Poland found that both materials induced strong 
inflammatory response of lung tissues and at some extent carcinogenicity 
resulting from the inhalation of nanoparticles [Poland, 2008]. A striking result 
was the detection of macrophages attempting to phagocyte fibres: the cells 
struggled to incorporate the long tubes into phagosomes and the tubes ended 
up protruding beyond the cell membrane limits (frustrated phagocytosis), with 
high oxidative stress immediately afterwards and induction of chronic 
inflammation. The only solution was for the macrophages to fuse together into a 
foreign body giant cell to attempt to clear the particles. Incidentally, Poland’s 
work indirectly fuelled an amalgam that nanoparticles necessarily behave like 
asbestos. Yet, a direct comparison of fine or ultrafine particles with engineered 
particles is too hasty.  
However, the initial toxicological assessment of engineered particles was based 
on similar criteria to that of anthropogenic particles, but steadily the toxicology 
of engineered nanoparticles diverged from their fine and ultrafine counterparts 
and called for a different approach. 
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1.6.2 Nanotoxicology: a distinctive branch of toxicology 
Oberdörster’s work on TiO2 nanoparticles did not take into account the higher 
reactivity of nano-objects. Therefore, at similar weight dosage, the toxicological 
assessment necessarily detected a more acute and deleterious response 
towards the smaller particles. In comparison, the toxicity of nano- and 
submicrometric particles were found similar when the dosage was brought back 
to a specific surface dosage [Oberdörster, 2007]. In the same vein, inhalation of 
nanoparticles was the principal way of assessing their toxicity since fine 
particles are mainly air-borne. If this is true for carbon nanotubes, which 
production method poses risks of air dispersion, most of the other nanoparticles 
for biomedical preparation are synthesised in liquid phase. Although not exempt 
from potential inhalation risks, it is more probable that the particles will be 
employed under the form of hydrocolloids, i.e. dispersed in water or dispersed 
in another liquid medium and injected, swallowed, or taken by other route that 
inhalation. Another important difference between anthropogenic and engineered 
particles lies in the size dispersity: fine and ultrafine particles are often 
heterogeneous when engineered particles are designed with a narrower size to 
ensure that the particles exhibit identical properties and the biological response 
they elicit should be more uniform. This difference of characteristics has its 
importance in the reaction of organisms to nanoparticles and in the end 
engineered nanoparticles and ultrafine particles behave differently and must be 
screened separately.  
With these differences in mind, nanotoxicology started to be considered as a 
separate branch of particle toxicology. The number of reports and studies of 
engineered nanoparticles progressively grew in number but still faced an 
important barrier. Small alterations of the structure are sufficient to induce totally 
different physico-chemical properties. Furthermore, biological activities of 
nanoparticles depend on more numerous, more complex, and more interrelated 
parameters than usually encountered in bulkier material, and if size and dosage 
remain important factors, other parameters must be taken into account. 
Oberdörster defined up to 16 factors that ought to be screened when 
72 
considering a nanoparticles sample: size, size distribution, concentration, 
shape, surface area, composition, surface chemistry, surface contamination, 
surface charge, crystalline structure, agglomeration state, porosity, method of 
production, preparation process, heterogeneity, and storage of material 
[Oberdörster, 2005]. To make the assessment more arduous, all these factors 
are inter-related and their importance occurs at different stage of the toxicology 
assessment (long material storage increase the change of aggregation but do 
not affect directly cells behaviour for example). In spite of the growing number 
of studies, teams eventually did not compare the exact same nanomaterials and 
systems and a direct comparison between these studies is consequently 
impossible. Yet, a few trends have already started to emerge and give a better 
understanding of the effect of many of Oberdöster’s parameters. 
 
The size of nanoparticles remains of primary importance as it is the small scale 
of nanostructures that enables them to cross natural barriers (translocation from 
the lung to blood or from the nose to the brain, blood brain barrier, etc.) or to 
enter within cells. At some extent, reducing size helps in escaping the 
macrophages recognition and reduces the chance of clearance from the 
organism. Nevertheless, it is often considered that smaller size of particles goes 
in par with higher toxicity. An example is the high toxicity of Au55, a gold 
nanoparticle composed of exactly 55 atoms (1.4 nm) and has been found 
cytotoxic whereas larger gold nanoparticles are considered as biocompatible 
and do not elicit toxicity  [Tsoli, 2005]. It is important to keep in mind that this 
finding is valid for unmodified gold and may not be transposable to other 
nanomaterials because of a change of size or may be invalidated were a proper 
coating found. 
Strongly related to the particles size is the specific surface of nanoparticles: 
even though the particles dimension becomes smaller, a greater number of their 
atoms are displayed at the surface and are therefore susceptible to react with 
the molecules in their vicinity. For instance, metal oxide nanoparticles are 
famous for their pro-oxidative effects depicted in the Figure 1-30: some such as 
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titanium oxide are photo-activated by UV, other are electron acceptor or donor 
or are responsible for redox reaction that lead to the generation of radical 
species, or degrade and have high chances to induce cell injuries via oxidative 
stress [Nel, 2006].  
 
Figure 1-30: Possible mechanism behind the interaction between 
nanomaterials and biological media and example of particles reactivity –
induced phenomena that lead to increased oxidative stress in cells [Nel, 
2006]. 
 
Crystallinity and composition of nanoparticles also enter into consideration. 
Titanium dioxide nanoparticles are frequently found in sunscreen, solar cells, or 
self-cleaning surfaces. TiO2 exists under various crystalline forms – principally 
rutile, anatase, and brookite – and is known for its capacity to generate radical 
species under UV illumination. It has been shown that the toxicity of TiO2 
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particles is linked to the phase of the nanomaterial and that anatase phase is 
100 times more toxic than the rutile phase [Sayes, 2006]. Crystallinity has less 
to do with the most common inorganic particles of interest in biology than with 
nanoparticles found in other application where the crystalline structure is often 
related to particular properties. 
The chemical composition of nanoparticles is another parameter of paramount 
importance, not only the nature of the material, but also the presence of 
contaminant or of doping elements within the nanomaterial or the degradation 
products. Contaminants may issue from the chemical or physical process that 
gave birth to the nanostructures. For example, single-walled carbon nanotubes 
were reported to induce oxidative stress in several cell lines, but the main 
reason was later identified as residual metals, necessary to catalyse the 
synthesis of nanotubes but improperly removed. Likewise, the toxicity of gold 
nanorods was identified and attributed to remaining CTAB surfactant that were 
still stuck on the surface of the nanorods; after proper purification, the gold 
nanoparticles proved non toxic. On the other hand, doping a nanomaterial with 
another element has sometimes led to a diminution of the toxicity. George et al. 
detected an important decrease of toxicity of ZnO nanoparticles once doped 
with iron. They hypothesised that the presence of iron modifies the dissolution 
characteristics of the metal oxide, which is the reason of the high cytotoxicity of 
pure ZnO while other teams recorded similar effect on single-walled carbon 
nanotubes [Connor, 2005; Fadeel, 2010].  
In the same vein, surface chemistry has an overall impact on the particles 
stability and on the interactions between nanoparticles and their environment. 
The surface modification of a particle acts as a way to prevent aggregation or to 
render the particles soluble in aqueous media. Aggregation is a major source of 
concern as it modifies the chemical and physical properties of primary particles 
and their larger sizes augment the chance of macrophages recognition and 
following clearance although some studies suggest that small clusters of 
particles are sometimes desirable and necessary to enter cells [Lévy, 2010 b].  
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The fate of nanoparticles after achieving their aim must be taken into 
consideration. Many inorganic nanoparticles will not be degraded by enzymes, 
pH, or other parameters and their clearance is more likely to be driven by urine 
and faeces [Choi, 2007]. There is a time period between the moment 
nanoparticles are taken up and the moment they are cleared from the system, 
but the longest this period the more chance they elicit detrimental effects on the 
cells. For this reason, the degradation products resulting from the action of pH 
and enzyme have to be carefully assessed. For instance, quantum dots pose 
the threat of leaking heavy metals when corrode, whereas polymeric 
nanoparticles are highly sensitive to solvents and pH and the effects oligomers 
and monomers resulting from the degradation of a polymer are impossible to 
predict, even if the starting polymer chains are relatively biocompatible. 
 
Considering all nanomaterials existing so far, the variety of size, synthesis 
procedure, surface modification and coatings reported in the literature, a 
consensus about how assessing the safety of nanostructures is dramatically 
missing. For all of the alterations that groups bring, the in vitro testing is not 
automatically taken into account and even when toxicity assessment is carried 
out, groups test different cell lines and different conditions that further blur the 
prediction of nanomaterials safety. In addition, in vitro studies provided the first 
information of potential cellular responses, but many important effects such as 
inter-cellular communication, transportation in blood, bile, or lymph and so forth 
cannot be incorporated in such models, but at the same time, it is absolutely 
impossible to tests all of the nanoparticles and their characteristics on animals 
[Oberdörster, 2005]. The fact that nanotoxicology is unregulated is the primary 
reason of the absence of clear evidence regarding the safety or dangerousness 
of the most common nanosystems and the most urgent challenge is to define 
and develop a paradigm to standardise assessment of nanomaterials. 
Gradually, radical oxygen species measurement has made its way and appears 
nowadays as a paradigm to assess nanoparticles toxicity [Meng, 2009]. This 
choice is strongly bound to the effects of fine and ultrafine particles inhalation 
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on lungs reported by atmospheric toxicologists and was adopted based on the 
evidence of strong oxidative stress that some nowadays current nanoparticles 
elicit on cells. 
 
1.6.3 Oxidative stress paradigm 
The viability of cells is tighly bound to the highly regulated equilibrium between 
pro-oxidants and antioxidants [Kohen, 2002; Li, 2003]. Pro-oxidants, also called 
reactive oxygen species (ROS), are able to damage the cell membrane, DNA, 
and proteins as represented in the Figure 1-31. They are classified into: 
Ø “Radical” group that includes nitric oxide (NO•), superoxide and hydroxyl 
radicals (O2• and HO•), singlet oxygen (1O2)and other species containing 
at least one unpaired electron that make the species highly reactive; 
Ø “Nonradical” group that are highly reactive – though not as much as 
radicals - such as hydrogen peroxide (H2O2), aldehydes, ozone, or 
dioxygen. 
Radicals must be produced at the same site as a biological target to induce 
damage, for example close to DNA strands, mitochondria membrane, or close 
to proteins. However, transition metals such as copper and iron are generally 
bound to such sensitive targets but are also involved in the chemistry of radicals 
via the Fenton and Haver-Weiss reactions [Kohen, 2002]. Consequently, the 
transition metals convert nonradical species into radical species in situ and 
cause oxidative damages. The source of radicals generation are exogenous 
(ionising and nonionising radiations, food, drugs, pollutants, etc.) and 
endogenous (mitochondria actions, by-products of enzyme activity, action of 
NADPH-oxidase produced by white blood cells, etc.) and the production of 
oxidants is a continuous flux.. 
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Figure 1-31: Radical and nonradical species thought to be involved in 
cellular oxidative stress [Kohen, 2002]. 
 
The organism erects defensive mechanisms against the constant exposure to 
ROS, for example through the tight regulation of the enzymes activity 
responsible for the (direct or indirect) production of radicals, or through the 
action of enzymes and small molecules dedicated to repairing the oxidative 
damages (DNA repair system, molecules donating hydrogen atoms, etc.). The 
key mechanism involves antioxidant molecules, typically low-molecular-weight-
antioxidant (LMWA) and antioxidant enzymes that directly interact with ROS or 
sources of pro-oxidants to neutralise them as can be seen in the Figure 1-32. 
The mechanisms of action of LMWA may indirectly suppress ROS, for example 
by chelating transition metals to prevent their involvement in reaction yielding 
oxidants, or directly scavenge the radicals.  Glutathione (GSH) is a primordial 
LMWA present at high concentration in humans, animal, and plants and works 
in conjunction with peroxidase in the decomposition of H2O2 but also in ascorbic 
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acid metabolism, communication between cells, and many other processes. It 
also directly scavenges HO•, RO, ROO and a few other radicals and becomes 
in its turn a radical that is regenerated in the oxidised form glutathione disulfide 
(GSSG) that results from the binding of two GSH [Kohen, 2002, Dikcinson, 
2002].  
 
Figure 1-32: Action of antioxidant as a defence mechanism towards 
radical species [Kohen, 2002]. 
 
Oxidative stress arises when the cell redox equilibrium between antioxidants 
and pro-oxidants is unbalanced and the ROS overwhelmed the natural 
defences of the cells [Meng, 2009; Xia, 2006; Chang, 2010]. The oxidative 
stress model posits that the cellular response is organised into three phases. In 
Tier 1 – the normal protection against pro-oxidants - the transcription factor 
nuclear factor erythroid 2-related factor 2 (Nrf2) induces the production of more 
antioxidant and detoxification enzymes and LMWA such as GSH. When the 
response is not sufficient to curb the oxidative stress level and fails in re-
establishing the redox equilibrium, the responses become more damaging and 
evolves to inflammation (tier 2) or to cell death (tier 3). In tier 2, the action of 
antioxidants is insufficient to restore the hemostatic balance and the increase of 
intracellular calcium concentration activates the mitogen-activated protein 
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kinase (MAP kinase): the kinases of the MAPK family are intimately integrated 
to the signal transduction via their ability to phosphorylate transcription factors 
and proteins. They also remodel the chromatin to express genes involved in 
inflammation, apoptosis, proliferation, differentiation, etc. [Seger, 1995]. Among 
the kinases, C-Jun N-terminal kinase (JNK) and p38 kinase play a role in the 
protein 1 (AP-1) and nuclear factor κβ (NF- κβ) pathways [Chen, 1999; Karin, 
1997]. NF- κβ and AP-1 are two transcription pathways that upregulate the 
expression of chemokine and cytokine that mediate the inflammation of tier 2 as 
summarised in the Figure 1-33 [Mazzoli-Rocha, 2010; Donaldson, 2003].  
 
 
 
In Tier 3, the mitochondria membrane is disrupted and the consecutive cascade 
of reactions brings the cells to its death. The mitochondrial membrane is highly 
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Figure 1-33: Oxidative stress pathways resulting from the internalisation of 
nanoparticles. 
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sensitive to many physiological parameters including ROS and may trigger the 
mitochondrial membrane permeabilisation (MMP) that is a major event in 
apoptosis. Mitochondria release the pro-apoptotic cytochrome c in the 
cytoplasm that binds to apoptotic protease and activate factors that initiate the 
apoptosis of cells. Furthermore, the release of cytochrome c in turn activates 
caspase 9, triggering the caspase cascade that likewise plays an essential role 
in apoptosis and necrosis [Kroemer, 2003]. 
A number of assays can be used to assess viability and/or toxicologic signs 
such as DNA damage or oxidative stress. For instance, 2’,7’-dichlorofluorescein 
diacetate, and dihydrorhodamine123 directly react with ROS; thiobarbituric acid 
assay to malondialdehyde detects signs of lipid peroxidation; and 5,50-dithio-
bis(2-nitrobenzoic acid) combined with glutathione reductase measures the 
GSH/GSSG ratio that is a direct sign of potential depletion of the antioxidant 
and therefore an indicator of oxidative stress [Marquis, 2009]. With a 
appropriate choice of dyes, Georges and Xia were able to detect simultaneously 
signs of oxidative stress. The later probed the mitochondrial membrane 
potential to detect a loss of MMP (5,5’,6,6’-tetrachloro-1,1’,3,3’-
tetraethylbenzimidazolylcarbocyanine iodide), the intracellular calcium 
concentration (Fluo-4) and cell integrity (propidium iodide) using a confocal 
microscope. The later probed DNA cleavage (DyeCycleOrange), caspase 
activation (D2R trifluoroacetate), lysosomal integrity (acridine orange), and 
cytoplasmic and mitochondrial free calcium (Fluo-3 and Rhod-2 respectively) 
[George, 2010; Xia, 2008] Additionally, proteomics brings elements that display 
protein modification or expression of new proteins that are as many clues of 
oxidative stress, for example expression of JNK and p38-MAPK, release of 
cytochrome c after mitochondrial disruption, or the phosphorylation of 
transcription factors NF- κβ  or Nrf2 [Xiao, 2003].  
 
The physicochemical features of nanomaterials, however well characterised 
they may be, represent only one aspect. It is however the interactions between 
nanoparticles and biological entities that ultimately define the fate of 
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nanoparticles and their potential safety or toxicity. At present, several barriers 
need to be overcome such as reducing or obviating the surface fouling with 
proteins, escaping the macrophages recognition and the retention of particles 
into the organs of the reticuloendothelial system, and ensuring that the particles 
do not pose any threat on the long term and are ultimately cleared from the 
organisms. The first step to overcome these challenges is to firstly understand 
what is the organism overall reaction towards the introduction of nanoparticles 
and then to understand how the particles interact with the cells and what factors 
promote their internalisation.  
 
1.6.4 Complement and reticuloendothelial systems 
The active and passive targeting envisioned through the use of nanoparticles 
and nanocarriers is an ideal case. In practice, the organism is in constant 
vigilance to the apparition of new and foreign bodies that may pose a threat to 
the general systems and promptly deals with them. Nanoparticles are no 
exception and have to face the traditional defence mechanisms personified by 
the complement system and the cells of the reticuloendothelial system. 
Biological media are complex fluids containing among others a large variety of 
nonspecific proteins that cover foreign bodies (opsonisation) and help 
phagocytic cells in recognising these alien elements. Only a few minutes in 
blood are sufficient to form a full protein corona, which composition is dictated 
by the particles surface properties such as hydrophilicity/hydrophobicity, charge, 
curvature radius, etc. It is believed that the fate of nanoparticles and their 
recognition is directly connected to the nature of the opsonin proteins 
[Vonarbourg, 2006]. The complement system proteins are in the front line of the 
defence mechanisms and the principal actors in the recognition of foreign 
bodies that will lead to immune reaction. About 30 proteins compose the 
complement system, some travelling in the plasma, other on the membrane of 
cells were they act as receptors and in particular on the surface of cells of the 
82 
immune system. Activation of the complement systems follows three pathways 
that can be seen in the Figure 1-34: 
Ø Fixation of the C1q protein to an antibody or on C1q receptors 
Ø Spontaneous binding of C3 fragments to the surface of the foreign 
bodies 
Ø Binding of lectin on certain carbohydrates found in viruses and 
bacteria 
 
Figure 1-34: Schematisation of the cascade reaction resulting from the 
complement system activation [Vonarbourg, 2006]. 
 
All three pathways lead to an enzymatic cascade that ends up in the formation 
of the C3 convertase enzyme that cleaves the abundant C3 protein. The C3b 
fragment initiates the cleavage of C5 to C9 proteins that assemble into a 
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membrane attack complex but C3b is equally recognised by phagocytic cells 
receptors. In parallel, C3a as well as C4a and C5a that results from the 
cleavage of C4 and C5 are strong inflammatory agents which role is to recruit 
cells able to initiate the inflammatory such as eosinophils and basophils. 
It is unlikely that the membrane attack complex is able to pierce or destroy 
nanoparticles - especially inorganic nanomaterials - then the complement 
system eventually mediates the interactions between nanostructures and the 
second line of defenders that are the cells of the reticuloendothelial system 
(RES). These cells are mostly phagocytic cells such as monocytes and 
macrophages, dendritic cells, or neutrophils. By themselves, phagocytes are not 
– or hardly – able to recognise and clear the nanoparticles and need to bind to 
opsonins first. The specialised receptors present at the surface of the RES cells 
recognise some of the opsonin proteins naturally or after they underwent a 
conformational change after adsorption onto the nanoparticles. The second 
option is the nonspecific adhesion of opsonised particles onto the cells without 
receptors as intermediate. In both case, the same fate await the particles since 
the RES cells phagocyte them and get activated [Nie, 2010; Vonarbourg, 2006]. 
After phagocytosis, the cleared particles are brought to the organs of the 
reticuloendothelial systems, principally in the liver and spleen, followed by the 
lungs, lymph nodes, and bone marrow. After a period of time that depends on 
the surface properties of the nanoparticles and the protein corona, the particles 
accumulate in the RES but the fate afterwards is not well understood. It has 
been reported that the particle either induce deleterious effects on the 
macrophages of the liver and spleen if they remain for extended periods of time 
in these organs, but in vivo studies suggest that the organism get rid of the 
nanoparticles by urine and faeces excretions. 
 
1.6.5 Internalisation of nanoparticles 
Although the action of some nanoparticles such as photocatalytic activity, 
dissolution of material, or redox potential may affect the cells from the exterior, 
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notably through membrane degradation, it is more likely that nanoparticles will 
be taken up and exert their effects intracellularly. Not only the particles must not 
elicit adverse effects when inside the cells, but some are engineered to 
purposefully carry and release therapeutic compounds directly within the 
cytoplasm or the nucleus. The mechanisms that underlie nanoparticles 
internalisation are still unclear apart from the fact that the uptake depends on 
the physicochemical properties, cell type, and nanomaterials microenvironment 
such as the type of proteins that adsorb onto the particles once in biological 
media.  
The cell membrane is a dynamic structure that coordinates and regulates the 
exchanges of molecules between the extracellular media and the cytoplasm: 
small molecules such as ions and sugars are able to diffuse through via pumps 
and channels, but larger molecules must be captured and enclosed within a 
membrane to finally enter within the cells in a process called endocytosis. 
Endocytosis follows multiple pathways that differ in their mode of uptake but 
each of them has been shown to be equiprevalent in the internalisation of 
nanoparticles. The first pathway is the clathrin-mediated endocytosis, an 
essential route for most cells for the internalisation of nutrients that has the 
specificity of relying on receptor-ligand recognition. Clathrin is a protein with a 
three-legged structure (triskelion) that creates patches onto the plasma 
membrane: it complexes with AP2 to assemble into polyhedral lattices that 
gradually curves the membrane and form a pit (clathrin-coated pit) where cargo 
molecules and nanoparticles accumulate. The budding structure evolves and 
becomes more and more invaginated and the neck narrows to the point of 
creating a constricted pit. Dynamin forms a spiral around the neck to form a full 
vesicle roughly 100 nm that pinches off the membrane and moves into the 
intracellular domain, where the clathrin coating is disassembled to free the 
vesicle to fuse with other vesicles (endosomes) as represented in the Figure 1-
35 [Doherty, 2009; Conner, 2003; Lodish, 2003]. 
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Figure 1-35: Schematisation of the clathrin-mediated endocytosis pathway 
[Pollard, 2007]. 
 
Phagocytosis is another pathway triggered by receptor-antigen binding but is 
mostly found in specialised cells such as macrophages/monocytes, neutrophils, 
and dendritic cells in order to clear large debris and pathogens including 
remnant of dead cells, foreign bodies, or bacteria. Phagocytosis enables to 
internalise large objects (larger than 750 nm) by creating a protrusion of the cell 
membrane that surrounds the foreign body. More precisely, the recognition of 
the targets ligands triggers the assembly of actin filaments adjacent to the 
pathogen. The growth of the actin filament supports the membrane extension 
from both side of the target (phagocytic cup). The phagocytic cup finally closes 
and zippers tightly around the foreign body into a phagosome that is directed 
through the membrane and to the cytoplasm. At the same time, all membrane 
components are removed and replaced by other component that will induce the 
fusion with lysosomes - that contain hydrolytic enzyme- to result into a 
phagolysosome as schematised in the Figure 1-36 [Lodish, 2003]. 
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Figure 1-36: Schematisation of the phagocytosis of bacteria [Pollard, 
2007]. 
 
In the same vein, macropinocytosis is a non-specific pathway where the 
membrane protrudes and engulfs large volume of surrounding extracellular 
fluid. Then it collapses and fuses with the membrane, creating a pocket up to 
several micrometers large - or macropinosome - containing cargo, particles, and 
fluid. The resulting vesicle further travels into the cytosol where it fuses with 
lysosomes, endosomes, and other vesicles.  
Lastly, caveolae-mediated endocytosis is another non-specific pathway where 
cargo and particles accumulate in flask-shapes pits 60-80 nm diameter in the 
membrane coated with cholesterol and the cholesterol-binding caveolin protein. 
After closure of the caveolae, the vesicle transports its content through the 
membrane and into the intracellular domain where its fate is similar to the other 
pathways seen in the Figure 1-37. There exists clathrin- and caveolae-
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independent pathways as well but the mechanisms that sustain them are not 
elucidated.  
 
Figure 1-37: Summary of the different endocytosis pathways that can be 
involved in the uptake of nanoparticles [Conner, 2003]. 
 
Reports of nanoparticles uptake are contrasted and there exists no general rule 
to predict the fate of nanoparticles once in biological systems. For instance, 
some studies reveal that macrophages take up SPIO by receptor-mediated 
pathways but pinocytosisis the major way of access with gold nanoparticles and 
scavenger-receptors for carboxylate-modified polymeric nanoparticles. In some 
cases, particles diffuse within the cells without going through any membrane-
dependent pathway and have a direct access to the cytoplasm and by 
extension to the nucleus and cellular compartments [Unfried, 2007]. It is 
generally admitted that the nanoparticles surface characteristics, particles 
microenvironment, and cell types are the key parameters in the interaction 
between nanomaterials and cells.  
Smaller dimensions are not a guarantee of facilitated access to the cytoplasm. 
Instead, an optimal size, correlated to the radius curvature, accelerates the 
membrane wrapping that is at the core of some endocytosis pathways. 
Nanosphere optimal size appears to be 50 nm and explain the tendency of 
smaller particles to form some clusters to undergo internalisation. It has long 
been believed that the wrapping time of nanorods was longer than that of 
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nanospheres, but some new evidences tend to indicate that the tendency may 
be inverted with proper coating [Chithrani, 2006]. Furthermore, modelling 
suggest that certain shape such as cylinders and hemispheres are more 
promising to escape the RES detection and circulate in the blood unhampered 
for longer time. 
Findings on the surface charge are contrasted: for example positively charged 
albumin nanoparticles were internalised in high quantity but the same effect was 
not detected with cationic polystyrene particles. From a general point of view, 
the uptake of negatively charged particles is limited on account of the negative 
charges of the plasma membrane. However, this uptake is not inexistent and it 
is believed that anionic particles cluster and accumulate on the scarce positively 
charged regions of the membrane. In contrast, cationic nanoparticles do not 
face this problem and bind to some of the numerous negatively charged groups 
onto the cells membrane and are easily internalised.  Neutral particles present 
the lowest affinity for cells and are little or not taken up [Verma, 2010]. However, 
the intrinsic surface features are usually modified by coating with polymers and 
other ligand that introduce steric hindrance as well as charge changes. The 
well-known PEG coating is a popular strategy to impart stealthiness to 
nanoparticles as the polymer chains are neutrally charged and readily escape 
the RES system, if only for a certain period of time, but this coating although 
affect the endocytosis by other less specific cell lines. Hydrophobic interactions 
with cell membranes are complex, but some groups suggest that hydrophobic 
particles are quickly engulfed possibly because of the highly hydrophobic 
conditions that exist in the interior of the membrane, but their lifetime is also 
generally shorter due to their propensity to aggregate in aqueous media, which 
facilitate the macrophages recognition and phagocytic actions [Nel, 2009].  
The other complicating factor is the non-specific adsorption of proteins onto the 
nanoparticles as soon as they are suspended in a biological medium. This is a 
parameter of utmost importance considering that it is not the surface of the 
nanoparticles that enters into contact with the cells but instead all interactions 
occur through the protein corona that covers the nanomaterials. Even PEG 
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coating usually said to be insensitive is still subject to non-specific adsorption 
but the first, effective strategies to control or totally prevent the protein corona 
formation start to appear [Park, 2010]. Lastly, the cell types that may be in 
contact with nanomaterials are not limited to macrophages/monocytes or to 
endothelial cells in the lung in relation to the potential inhalation of particles. 
Instead, the particles will be in contact with multiple types of cells ranging from 
endothelial cells to fibroblasts, without mentioning cancerous tissues, and 
focusing on the single macrophage uptake is not adequate. The interactions 
with non-phagocytic cells results from a specific design of the particles surface 
where a ligand is tasks to target a specific cell line and where PEG and other 
neutral polymers decrease the opsonisation and the recognition by the RES 
agents. Since cells metabolisms are different, their reactions towards 
nanoparticles and the way they internalise them ought to be different as well 
[Napierska, 2010]. 
 
To put it simply the numerous in vitro studies involving a large range of 
nanoparticles interacts with different cell lines and the few in vivo highlight that 
there is not a single pathway defining the uptake of nanoparticles. Many points 
remain obscure such as the exact effect of surface aspect or the fate of the 
nanoparticles once in the intracellular domain. All of these unknowns reflect the 
difficulty to assess nanomaterial toxicology and the impossibility to apply the 
traditional assessment methods. 
 
1.6.6 Overview of the toxicology of key nanomaterials 
Gold in its bulk form is inert and biocompatible and it is assumed that 
nanoparticles do not exert cytotoxicity for the same reasons. Many studies 
agree on the lack of toxicity of gold nanoparticles: for instance, Chithrani and al. 
assessed the toxicity of gold nanospheres with sizes ranging from 14 to 100 nm 
but did not detect any deleterious effects on cells [Chithrani, 2006]. Gold 
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nanorods produced analogous results but require a perfect purification and 
removal of CTAB contaminant that has been found to be the principal source of 
toxicity of the rod-shape particles [Connor, 2005]. The surface modification and 
capping ligands may be responsible for a slight toxicity: this was the case with 
cationic gold nanospheres that induced a slight toxicity at very high dose whilst 
the anionic version was not found cytotoxic at all [Goodman, 2004]. From a 
general point of view, most of the usual ligands, including citrate, cystein, biotin, 
etc., were not found to elicit any response from cells over time and the results 
tend to indicate the high biocompatibility of gold nanoparticles under their 
spherical and rod shaped [Connor, 2005], although the toxicity of the new 
shapes has not yet been investigated. 
There is however one exception with the Au55 cluster, a particle composed of 
exactly 55 atoms of gold for a diameter of 1.4 nm. This particle was found highly 
toxic in certain cells, although the toxicity differed from one cell line to the other.  
It is suspected that the particular geometry of the cluster that ay interacts with in 
a unique manner with the DNA strands by fitting perfectly in the DNA grooves 
[Pan, 2009; Tsoli, 2005]. Small clusters were likewise found to induce some 
toxic effects, although not acute than that of Au55 but capping with proper 
ligand may help in suppressing the cytotoxic effects [Pan, 2007]. 
Investigation of the cellular uptake of gold nanoparticles highlighted the 
existence of an optimal size of 50 nm for the endocytosis (clathrin-mediated 
pathway) of nanospheres. Smaller 14 nm spheres create clusters of 5 or 6 
particles to favour their internalisation whilst larger particles uptake kinetics was 
slower [Chithrani, 2007]. After their endocytosis, nanoparticles accumulate in 
endosomes where they aggregate and are further exocytosed. In contrast, a 
PEG contrast renders the particles totally invisible and prevented the uptake of 
gold whereas a small number of TAT peptide-conjugated nanoparticles were 
localised in the cytosol. Gold nanoparticles were rarely found in the nucleus and 
remain principally in vesicles unless their surface are engineered with ligands 
such as TAT or peptides helping in the evasion from the endosomes and/or in 
the entrance into the nuclear domain [Nativo, 2008, Shukla, 2005] 
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The few in vivo studies demonstrate a certain discrepancy with in vitro models. 
In one occasion, particles with a diameter comprised between 8 and 37 nm 
were found toxic in mice but not smaller and larger size. The findings contradict 
most of the in vitro studies however the particles were not modified, apart from 
the citrate molecules that resulted from the synthesis process [Chen, 2009 a]. 
Most other in vivo studies agree on the fact the biodistribution of gold 
nanospheres is size dependent and that most of the particles accumulate in the 
spleen and kidneys whereas the smallest are able to diffuse to more organs and 
even in the brain [Alkilany, 2010]. To date, there is no evidence of the long-term 
fate of the particles and their potential degradation or renal excretion: the 
particles are eliminated from the blood stream and retargeted toward the organs 
of the RES, but their accumulation in such organs may be problematic (splenic 
and hepatic toxicity, etc.). 
Iron oxide nanoparticles position differently from other nanomaterials since 
magnetite and maghemite are naturally found in the organism, and it is 
supposed that SPIO and USPIO can be degraded by endogenous iron 
metabolism pathways, for example metabolised in the liver and recycled for 
blood cells formation or secreted via the kidneys.  Iron is both a requirement for 
the maintenance of human life, but also a potentially toxic compound. This 
element is found in oxygen and proteins transport, oxygen sensing, and is 
involved in many biochemical reactions including metabolic purposes. Eighty 
percent of the total iron is incorporated into haemoglobin essential for 
erythrocytes and most of the remaining iron is found in macrophages and 
hepatocytes. Conversely, iron also catalyses the Fenton reaction that sees the 
conversion of hydrogen peroxide into hydroxyl radicals that causes important 
oxidative stress and damage organic molecules including lipids, DNA, proteins, 
but also disrupt the mitochondria membrane potential and induce apoptosis, or 
break the DNA strands and may initiate carcinogenesis or cell death [Singh, 
2010]. Under normal conditions, iron ions in the plasma are harnessed and 
complexed with transferrin that binds to transferrin receptors and get 
endocytosed. Then, iron is chelated, and stored in ferritin, a molecule that 
sequester vast quantity of iron and maintain it in a non-toxic form. 
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Consequently, there is a labile iron pool onto the cells that store or release iron 
in accordance with the cell needs. 
Cells lysosomes contain enzyme and other biomolecules intervening in the iron 
homeostasis pathways and able to degrade iron [Ohkuma, 1978]. It was 
established that iron oxide nanoparticles are indeed degraded in acidic 
condition equivalent to that existing in lysosomes - even in absence of enzymes 
– and that the degradation kinetics depends on the particles coating and may 
range between 3 to more than 30 days [Lévy, 2010 a]. Moreover, the 
degradation within the endosome was not found homogeneous and some 
particles dissolve within the endosomes whereas some kept their integrity and 
more importantly, the particles magnetic properties were still preserved [Arbab, 
2005].The degradation of SPIO and UPIO poses the threat of iron overload that 
would result inthe iron homeostasis unbalance that in turn would induce toxic 
effects. Yet, a coating affording long dissolution kinetics may help reducing the 
toxicity of the iron overload by sequestering the iron and letting time for the cells 
to process the excess of iron and regulating avoiding at the same time the 
formation of high ROS in excess that would induce toxicity [Arbab, 2003]. 
In vitro studies compared USPIO and SPIO with different coating and capping 
ligands and make their comparison arduous. For instance, PEG coated 
nanoparticles did not elicit harmful effects unless short chains polymers are 
employed [Häfeli, 2009]. In some reports, polyvinyl alcohol was shown to 
reduce the cytotoxicity of SPIO compared to their uncoated version but other 
works found that cells did not internalise PVA-coated iron oxide particles 
[Mahmoudi, 2009; Petri-Fink, 2006]. Instead, vinyl alcohol/vinyl amine 
copolymer was necessary do get uptake – modulated by the number of amine 
per chain – and help reducing the toxicity [Petri-Fink, 2007]. Dextran-coated 
USPIO and SPIO are the standard iron oxide nanoparticles but their 
internalisation is not ideal at the difference of some other anionic capping 
ligands [Wilhelm, 2003 and 2008]. Carboxydextran reduced the cell viability in a 
concentration-dependent manner unless the particles concentration fell below a 
100 µg/mL threshold [Lunov, 2010]. As a comparison, Buyukhatipoglu et al. 
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investigated the effect of uncoated USPIO and observed that ROS formation 
increased in a time- and dose-dependent manner. More peculiar, they noted 
morphological changes in the endothelial cells incubated with USPIO such as 
formation of actin stress fibres and increase of the Young Modulus (cells stiffer) 
related to the ROS increase, the phenomenon was suppressed when the cells 
were cultured in presence of ROS scavengers [Buyukhatipoglu, 2011].  
In vivo injection of dextran-coated iron oxide nanoparticles has already proved 
safe enough to be clinically approved. The small size of USPIO helps in 
crossing natural barrier such as the blood-brain barrier, a feat rarely reported 
with other nanomaterials. Occasionally, iron oxide particles (silica-coated) were 
found to cross the blood-testicle barrier in parallel to the organs of the RES 
without inducing lesions, toxicity, or mutagenecity [Kim, 2006 a; Kwon, 2008]. 
Vinyl alcohol/vinyl amine copolymer and PVA-coated USPIO showed an 
opposite trend after injection in sheep that in in vitro study: the former elicited a 
strong inflammation whilst the latter induced a milder inflammation that was 
quickly attenuated as a higher proportion of PVA-modified particles 
accumulated in the tissue. However, the inflammation observed with the first 
polymer may be caused by the conjugation of fluorescent dye rather than 
because of the polymer itself [Schulze, 2005]. 
 
First toxicological data of silica focused on the crystalline form of micro and 
submicrometric, where chronic inhalation is known to induce silicosis - a 
progressive fibrotic lung disease where silica particles are surrounded by 
concentric layers of collagen, macrophages, lymphocytes, and fibroblasts – and 
are also involved in lung cancer and other pulmonary diseases. Amorphous 
silica is generally as less hazardous than crystalline silica and the toxicity of the 
former is less documented, but with the shift of toxicology researched towards 
nanoparticles, the trends has done a turn-about [Napierska, 2010]. Comparison 
of amorphous silica nanoparticles with submicrometric crystalline silica revealed 
a higher toxicity in the nanoparticles, both time- and dose-dependent and the 
tendency of larger particles to induce lower toxicity has been reported at several 
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occasions [Lin, 2006; Napierska, 2009]. Amorphous nanoparticles appear to 
increase the ROS generation compared to crystalline structure, and the 
activation of Nrf-2 but studies do not tally on the activation of the transcription 
factors and the other kinase signalling pathways [Eom, 2009; Liu, 2010; Tao, 
2008].  
Nevertheless, a single parameter is not responsible for the toxicity or lacks 
thereof of silica nanoparticles but it rather the combinations of parameters such 
as porosity, specific surface, cell line, etc. [Rabolli, 2010]. For instance, Trewyn 
et al. observed that cancerous cells eagerly endocytose nanoparticles whereas 
cells such as fibroblasts internalise particles in much smaller quantities and 
more rapidly with spherical particles than with tube-shaped one [Trewyn, 2008]. 
The shape of mesoporous particles were found to affect the internalisation as 
well as the viability of cells: spheres uptake is slower than short and long rod-
shaped particles but the toxicity found in spherical silica particles was also 
found lower [Huang, 2010]. Moreover, surface modification may help in 
reducing the toxicity of silica nanoparticles, although the effect is cell-
dependent. Hence, aminated-mesoporous showed reduced toxicity than 
unmodified one [Tao, 2002]. In another study, He et al. demonstrated that 
phosphor-modified silica particles were less toxic than their aminate- and 
unmodified counterparts, although the effect must be correlated to the lower 
uptake of negatively charged phosphor-expressing structures in comparison to 
positively charged-aminated one [He, 2006]. 
The possibility to impart fluorescent to the ceramic matrix helped in the tracking 
of silica within the cells and the particles quickly gather into lysosome, although 
the extent of internalisation depends on the post-treatment (calcinations, etc.). 
Sun et al. were able to follow the fate of a single mesoporous silica particles 
using differential interference contrast microscopy and clearly distinguished the 
membrane crossing and the surrounding by an endosome [He, 2009 a; Sun, 
2008]. Only one occurrence of FSNPs translocated into the nucleus was 
reported, where the particles inhibit the replication, transcription and cell 
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proliferation but no other group found similar evidence, even with smaller 
particles [Chen, 2005 b]. 
Few in vivo studies have been carried out and often deal with the inhalation fine 
and ultrafine silica particles. For engineered particles, intravenously injected 
particles accumulate preferentially in the liver, spleen, and lung but rarely in 
other organs such as heart or brain. Although their concentration in such organs 
decreases over time, they were still detected 30 days after injection. No 
pathological changes are usually noted, with the exception of liver inflammation 
response but coating with PEG was able to obviate the toxic effect of the 
nanoparticles. A maximal secretion was detected at a period ranging from 24 h 
for urine to72 hours for faeces and the rate decreased afterwards [Cho, 2009; 
Kumar, 2010; Xie, 2010 a].  
 
Quantum dots are not a homogeneous class of nanomaterial: instead of a 
single element such as gold or silica, the semiconductor core (and shell) is 
made of a combination of heavy metals and metalloids, as well as a great 
diversity in their coating and capping ligand present to increase the 
biocompatibility of the nanostructures and impart hydrophilicity. The 
composition of quantum dots is the principal barrier to their employ in vivo: 
rupture or degradation of the coating could reveal the core or enables its 
dissolution and the release of ions that are known to be toxic even at very low 
concentration. Nevertheless, new quantum dots made of silicon have attracted 
interest due to the potentially higher biocompatibility [Erogbogbo, 2008]. 
In vitro studies are often contradictory: many showed a dose- and size-
dependent toxicity of quantum dots at dose often inferior to that tested with 
other nanomaterials, may the effect is also strongly correlated to the capping 
ligands and coatings that may be responsible for the harmful effects of the 
particles. Some studies suggest that the toxicity of quantum dots is the result of 
their degradation, either because of photolytic and oxidative degradation of the 
quantum dots suspensions or because of intracellular processes in a dose-
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dependent manner. Exposition to air and/or UV degrades the coating and 
exposes the metallic core, favouring toxic effects. In cells, the nanocrystals may 
be retains for periods exceeding 10 days and the low pH and enzymes actions 
may causes degradation of the nanomaterials but such studies are still rare 
[Derfus, 2004; Hardman, 2006].  
The variation of composition, size, coating bioactivity, and storage may be in 
turn responsible for variable systemic distribution after injection in organism, for 
example accumulation in lymph node preferentially or on the contrary in spleen 
and liver. However, an increasing number of in vivo studies in rat have 
concluded that injection of quantum dots do not cause appreciable toxicity even 
on the long-term [Hauck, 2010]. At present, it is impossible to get a precise idea 
of the conditions where quantum dots elicit toxic effects, especially considering 
the divergence between in vitro and in vivo experiments, although the first 
applications of nanocrystals in surgery have already arisen as a tool to better 
visualise lesions in tissue. 
 
Although the control over nanostructure accelerates, the use of nanoparticles 
for therapeutic applications still faces some major barriers. Probably the most 
important criterion is the lack of guidance of toxicology assessment and of 
regulation policy. In spite of the oxidative stress paradigm that have arisen as 
strong candidate to determine the potentially deleterious effects of 
nanomaterials, the divergence of systems, conditions, cell tested and 
applications totally throw confusion and makes it impossible - or hardly possible 
– to predict the safety of a nanoparticles. Moreover, even though standard 
characterisation methods provide information on the composition, surface 
aspect, shape, crystallinity and other physicochemical characteristics, the 
dispersion of nanoparticles into biological fluids further complicate the matter by 
generating changes in the properties of the materials, from aggregation to 
dissolution or opsonisation that may dramatically alter the properties of the 
original particles.  
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Beyond the toxicological aspect, the proper targeting of nanostructures remains 
a technological challenge: organism responses towards the presence of foreign 
bodies reduce the half-time of nanoparticles in blood and lead to their 
accumulation in specific organs in view of their excretion. Even though the 
surface engineering of particles surface provide a solution for the active 
targeting of cells or biomolecules, the intracellular fate of nanoparticles, in 
particular the evasion from endosomes and lysosomes into the cytoplasm and 
potentially into the nucleus is still a complicated matter. 
 
1.6.7 Aims and objectives 
The research presented in this thesis is an exploratory project investigating 
different routes to fulfil two aims: 
Ø The development of hybrid organic-silica nanoparticles to carry a larger 
variety of fluorophore than conventional silica nanoparticles and enabling 
the simultaneous encapsulation of multiple dyes into a single structure; 
Ø The development of modular nanoparticles based on a core-shell 
architecture and allowing the combination of gold, iron oxide, and 
(fluorescent) silica indistinctly. 
The objectives to fulfil these aims were defined as follow: 
1. To synthesise fluorescent silica nanoparticles following the traditional 
Stöber and reverse microemulsion synthesis methods in order to identify 
the limitations responsible for the lack of fluorophore diversity in the 
literature; 
2. To test the amino acid catalysis route as an alternative to the 
conventional methods to produce small particles (< 100 nm diameter) 
and to further explore its potential in the design of fluorescent and 
multifluorescent nanoparticles; 
98 
3.  To develop a new type of hybrid organic-inorganic nanoparticles with 
tunable composition based on the amino acid catalysis; 
4. To demonstrate the potential of the hybrid nanoparticles as innovative 
fluorophore carrier by: testing a large number of fluorophores not 
reported in the literature and by creating multifluorescent systems with 
controlled spectral signature; 
5. To design multifunctional nanostructures by coating gold or iron oxide 
with silica and then by combining all three nanomaterials into a single 
structure. 
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2 Synthesis of silica nanoparticles by the Stöber 
method and reverse microemulsion approach 
 
2.1 Introduction 
The first major contribution to the production of silica particles dates back to the 
work of Stöber and Fink (1968), who obtained particles from a simple sol-gel 
process in alkaline conditions and thoroughly studied the influence of 
parameters such as water content as well as the type and concentration of 
solvent and silicon precursors on the final dimensions of particles [Stöber, 
1968]. The advantage of what has since then been known as the Stöber 
method lies in its simplicity: the protocol consists in mixing silicon precursors 
and water in an alcoholic solution containing ammonium hydroxide to catalyse 
the hydrolysis and condensation of the silanes. The highly basic conditions that 
ammonium hydroxide imposes on the system favours the condensation of the 
species over their hydrolysis, which results in the formation of spherical objects. 
Furthermore, the negative charges at the surface of the particles promote the 
repulsion between the spheres and the system stabilises in the sol phase (no 
gelation) whilst maintaining narrow size dispersity. Later on, other teams refined 
the initial Stöber method to produce smaller particles, studying at length the 
effects and interactions of the parameters involved [Rao, 2005; Rahman, 2007].  
Alongside the development and refinement of the synthesis of silica and some 
other oxide colloids by the sol-gel process, various models have emerged to 
explain the mechanisms underlying the particle growth. The most famous model 
is LaMer’s model, which predicts that growth of particles crosses two 
consecutive steps: a nucleation step where the precursors are consumed to 
create nuclei, and a growth step where the remaining precursors add to surface 
and enlarge the nuclei [LaMer, 1950]. Alternatively, Bogush and Zukoski 
reached the conclusion that large particles are the results of aggregation of 
smaller particles - or seeds - that stop their growth once they reach a certain 
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colloidal stability. Other studies advocate that the two mechanisms are 
responsible for particle growth, but from a general point of view, the actual 
mechanism has not been entirely elucidated [van Blaaderen, 1992 a and b].  
While the Stöber method is an easy procedure, it is generally considered that its 
major drawback is the relatively large diameter of particles it produces (typically 
in the submicrometric range). Variation of silane or water concentration is one 
way to decrease the particle dimensions, but reverse microemulsion is generally 
preferred for producing smaller objects. Osseo-Asare and Arriagada paved the 
way to a new method to engineer nanoparticles – not exclusively silica – by 
confining the particle growth within micelles [Osseo-Asare, 1990]. Reverse 
microemulsion yields highly monodisperse of the colloids since the particle 
growth is mechanically restricted by the micelle dimensions. However, the 
presence of surfactant molecules at the surface of the particles requires 
extensive washing and thermal post-treatment for a total removal. The choice of 
surfactant has an influence on the structure of the nanoparticles: silica 
nanowires and silica nanorods or mesoporous structures are examples of 
shapes it is possible to obtain by varying the surfactant nature and synthesis 
conditions [Slowing, 2005].  
 
Silica in itself lacks of intrinsic physical or chemical properties but are excellent 
carriers when compared to other polymeric carriers: 
Ø Silica is usually considered as a biocompatible material and is 
consequently suitable for biomedical applications;  
Ø The silica matrix is insensitive to changes of pH, temperature, salinity, 
and other harsh conditions; 
Ø The mild synthesis conditions enables the addition and encapsulation of 
biomolecules within the particles; 
103 
Ø A large number of organosilanes are commercially available for surface 
modification and subsequent bio-conjugation with antibodies, polymers, 
etc.; 
Ø The inorganic network is optically transparent and does not affect 
magnetic fields. 
The last point is of importance for the carriage of fluorescent dyes, the principal 
application of silica nanoparticles. Organic fluorescent dyes are sensitive and 
can easily photobleach, but silica nanoparticles offer a nearly complete 
insulation from the environment which considerably reduces photobleaching. 
Furthermore, each sphere contains thousands of fluorophores and is brighter 
than free fluorophores in solution [Larson, 2008; Nooney, 2009].  
 
The first major contribution to the design of fluorescent silica nanoparticles 
(FSNPs) is attributed to van Blaaderen and Vrij [van Blaaderen, 1992 c]. Their 
procedure was based on a modification of the Stöber method where fluorescein 
isothiocyanate (FITC) was conjugated to the aminosilane (APTES) and 
subsequently co-condensed with TEOS. The major consequence is the 
covalent binding of the sylilated dye to the silica matrix and the impossibility of 
leaking without degradation of the particles. Furthermore, a small quantity of 
APTES-FITC conjugate was sufficient to yield very bright particles able to 
fluorescence for prolonged period of time. Van Blaaderen took advantage of the 
silica chemistry flexibility to design various architectures based on the 
alternation of blank and fluorescent layers. Later, FITC was replaced by 
rhodamine isothiocyanate and proved that van Blaaderen’s approach works so 
long as a dye is capable of covalently binding to an organosilane [Verhaegh, 
1994]. In the end, isothiocyanate, maleimide and succimidyl esters derivatives 
of dyes are the principal fluorophores used with the van Blaaderen’s method. In 
spite of its advantages, this method typically yields submicrometric particles, 
with the exception of the C-dots (Cornell dots), core-shell silica structures 20-30 
nm in diameter with high brightness comparable to that of quantum dots [Ow, 
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2005]. C-dots are also based on FITC-APTES conjugates but alexa dyes and 
texas red have also been integrated into silica nanoparticles [Larson, 2008]. 
More commonly, the reverse microemulsion approach is preferred for smaller 
particles, although the nature of the fluorophores and the encapsulation 
mechanisms are different since the fluorophores are mostly retain within the 
particles by electrostatic interactions, but van Blaaderen’s method is 
nonetheless compatible with the reverse microemulsion strategy. Yet, it is more 
frequent to find rare earth – and in particular lanthanide chelates – than organic 
fluorescent dyes. Lanthanide chelates such as Tris-(2,2’-bipyridyl) 
dichlororuthenium (II) hexahydrate (RuBpy) and Tris(2,2’-bipyridyl) osmium(II) 
bis (hexafluorophosphate) (OsBpy) or europium complexes are interesting in 
that they possess a very large Stoke’s shift and their brightness is comparable 
to their organic counterparts [Bagwe, 2004; Wang, 2005b; Yao, 2006].  
 
The aim of this chapter is to show the limit of the Stöber method and reverse 
microemulsions in terms of fluorophore compatibility and particle diameter. To 
tackle this aim, the first objective consists in estimating the effects of some 
synthesis parameters (catalyst and water concentrations) on the final particle 
diameter. Production of dye-doped particles was also attempted following van 
Blaaderen’s modification of the Stöber method. The second objective was to 
assess the capacity of the reverse microemulsion to synthesise fluorescent 
silica nanoparticles. Since very few studies have reported the encapsulation of 
organic fluorophores, 3 dyes (acridine orange, and rhodamine 6G and B) were 
chosen to test the electrostatic encapsulation of fluorophores. 
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2.2 Materials and methods 
2.2.1 Materials 
Chemicals were purchased from commercial sources and used as received 
without any treatment. Tetraethyl silicate (TEOS) and acridine orange were 
purchased from BDH. Heptane, anhydrous ethanol (>99.5 %), ammonium 
hydroxide, docusate sodium salt (AOT, >99 %), cyclohexane (>99 %), 1-
hexanol (98 %), 3 aminopropyltriethoxysilane (APTES, >98 %), and fluorescein 
isothiocyanate (FITC, Isomer I) were obtained from Sigma Aldrich. Rhodamine 
B (RB) and rhodamine 6G were purchased from Fluka. Triton X-100 was 
acquired from Promega. Highly purified water (Milli-Q) was obtained from a 
Millipore “Direct-Q 3” water purification system. 
 
2.2.2 Synthesis procedures 
• Preparation of blank and FITC-doped nanoparticles following the 
Stöber method 
APTES-FITC conjugate with a molar ratio of 1:20 was prepared by dissolution 
of 5.25 mg of FITC (1.35*10-5 mol) in 5 mL of anhydrous ethanol, followed by 
addition of 60 µL of APTES (2.56*10-4 mol). The glass vial was covered with 
aluminium foil and kept under magnetic stirring during 24 hours. The conjugate 
was later used without purification. 
Blank nanoparticles were obtained following Stöber’s protocol [Stöber, 1968]. 
Typically, 2.8 mL of ammonium hydroxide was added to 35 mL of anhydrous 
ethanol, followed 5 minutes later by appropriate amounts of TEOS (1.5 or 2.5 
mL) and magnetically stirred for 24 hours. The synthesis of FITC-loaded 
particles followed the same protocol, where ammonium hydroxide (50 or 100 
µL), TEOS (250 or 500 µL) and APTES-FITC conjugate (100 or 250 µL) were 
mixed in 10 mL anhydrous ethanol (Appendix A). In one experiment, the 
temperature was raised to 60°C. The glassware was covered with aluminium 
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foil to protect the dye from light. All samples were recovered by centrifugation, 
three times 15 minutes at 1200 g or until the supernatant remained clear. 
Between each step, the samples were washed with distilled water and vortexed. 
Finally, the pellets were weighed and the particles were suspended in Milli-Q 
water. 
 
• Dye-doped nanoparticles via the reverse microemulsion route 
Microemulsions were initially obtained by mixing 1.77g of triton X-100, 7.5 mL of 
cyclohexane, 1.6 mL hexanol, and appropriate amount of Milli-Q (0.5 or 1 mL) 
and ammonium hydroxide (150 or 300 µL) (Appendix A). Once the solution 
became transparent, 50 µL of rhodamine B (RB), rhodamine 6G (R6G), or 
acridine orange (AO) solution (1mg/mL in water) was added followed five 
minutes later by 500 µL of TEOS. At the end of the procedure, the colloidal 
suspensions were washed with acetone to break the micelles and favour the 
recovery of the nanoparticles. All samples were thereafter collected by 
centrifugation by three cycles of 15 minutes at 1200 g or until the supernatant 
remained clear, with washing in distilled water between each step. Finally, the 
pellets were weighed and the particles were suspended in Milli-Q.  
 
2.2.3 Characterisation 
• Scanning electron microscopy (SEM) 
The particle size and morphology were examined using scanning electron 
microscopy (SEM). The nanoparticle suspensions were firstly diluted: the 
samples were sonicated and subsequently 25 µL of suspension was poured in 
an eppendorf and the total volume was increased to 500 µL with Milli-Q water 
so that the SEM samples were totally transparent. One drop of suspension was 
deposited into a silicon grid and let to dry in a desiccator for at least 24 hours. 
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Finally, the particles were imaged using a high resolution FEI XL30 SFEG 
analytical SEM (Philips, Netherland). 
 
• Dynamic light scattering (DLS) 
The size and size distribution of the particles were measured by dynamic light 
scattering (Appendix B) using a Zetasizer nano series S with an He/Ne laser of 
633 nm wavelength (Malvern Instruments, UK). The particle suspensions were 
firstly diluted: 10 µL of the sample was poured in a quartz cuvette and 
completed with 1 mL Milli-Q. The refractive index and absorption of silica 
nanoparticles were fixed at 1.25 and 0.01 respectively. For each sample, four 
measurements of 20 runs (15 seconds each) were carried out, with the 
temperature maintained at 25°C. 
 
• Fourier transform infrared spectroscopy (FTIR) 
The particle composition was analysed by infrared spectroscopy: a volume of 
nanoparticle suspension was taken, centrifuged, and dried in the oven for 1 day. 
The resulting powders were subsequently analysed in KBr powders using a 
Thermo Nicolet Avatar 370 spectrometer (Thermo Scientific). Infrared spectra 
were recorded over the wavenumber region 4000 to 400 cm-1 with a resolution 
of 4 cm-1. 
 
• Fluorescence measurement 
Absorbance and fluorescence of FITC-doped nanoparticles were recorded in 
96-well plates with a Varioskan Flash Spectral Scanning Multimode Reader 
(Thermo Fisher Scientific) equipped with a xenon flash lamp. All measurements 
were performed on 200 µL of 1 mg/mL suspensions of particles diluted in Milli-Q 
and at room temperature. Excitation and emission spectra of FITC/AO, R6G, 
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and RB were acquired with fixed wavelength set at 450/530, 490/580, and 
500/600 nm respectively. 
 
• Confocal microscopy 
Fluorescent properties of FNSPs were additionally assessed using a confocal 
microscope. A drop of particle suspension was deposited onto a glass slide 
alongside a few drop of glycerol, covered by a cover slip, and kept at 4°C to let 
the water evaporate and to stabilise the particles. The FSNPs were imaged 
using a LSM 510 Meta Invert Laser Scan Microscope (Zeiss). Images were 
obtained using a Plan-neofluar 40X/1.4 oil immersion objective and the 488 nm 
laser source was use to excite FITC. All images were the average of sixteen 
scans and were obtained with the same optical aperture, lens, and scan speed 
and colour-coded in green. The software (Zeiss LSM confocal software) was 
also configured to subject a specific region of interest to a laser power of 15% in 
order to bleach the sample and images were taken every 30 seconds. 
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2.3 Results 
2.3.1 Production of particles by the Stöber method 
The first particles were synthesised following the Stöber method of pure silica 
without any fluorescent dye. The process proved very simple: all reagents were 
solubilised in ethanol and left under vigorous magnetic stirring for 24 hours, and 
the particles were easily collected by centrifugation (white pellet). After a few 
hours of reaction, the initially transparent solution transformed into a white, 
milky suspension due to the formation of silicic acids Si(OC2H5)4-x(OH)x  and 
then of particles. The morphology of the particles was characterised by SEM 
and the images displayed closely packed, highly spherical objects with diameter 
over 550 nm in three of four experiments (Blank 1, 2, and 4) and decreased to 
450 nm in the last sample (Figure 2-1). Water was added to the reacting 
medium because it affects the sol-gel reaction kinetics and because Stöber 
identified it to be one of the parameters influencing the final particle diameter 
[Brinker, 1990, Stöber, 1968]. 
   
Figure 2-1: SEM pictures of nanoparticles produced from 1.5 mL TEOS 
(A), and 1.5 mL of TEOS and 5 mL of H2O (B). 
 
A) B) 
C) D) 
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The protocol was modified to impart fluorescence to the particles. FITC was first 
conjugated to APTES via a covalent thiourea bond between the isothiocyanate 
group of the dye and the amine moiety of APTES (Figure 2-2). The new 
silylated fluorophores were consequently able to co-condense with TEOS 
molecules and covalently integrated into the final inorganic network. The strong 
orange colour that is characteristic of FITC upon binding to APTES (in 
comparison, free FITC exhibit a yellow colour) was a first proof of the dye 
presence. An interesting result was the decrease of particle diameter when the 
reaction temperature was raised to 60°C and where the particles were 125 nm 
in diameter.  
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Figure 2-2: Reaction of FITC with APTES for the covalent binding of dyes 
within silica nanoparticles. 
 
The particles composition was then analysed by infrared spectroscopy. The 
infrared spectrum of blank nanoparticles, i.e. pure silica particles without FITC, 
displayed the characteristic peaks of silica-based materials: a strong band 
centred on 1092 cm-1 accompanied by a smaller peak at 797 cm-1 from siloxane 
bonds Si-O-Si and another intense peak at 955 cm-1 characteristic of silanol 
groups Si-OH (Figure 2-3). The coupling of FITC and APTES replaces the 
isothiocyanate group by a thiourea group N-CS-N. This change translates by 
the disappearance of the 2030 cm-1 of the isothiocyanate N=C=S of FITC and 
the appearance of a new peak at 1350 cm-1 [Gök, 2004]. The peak centred on 
1100 cm-1 of the APTES-FITC spectrum is attributed to a partial condensation 
SiO2 
FITC 
H2O, TEOS 
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of the APTES, although there should not have been any trace of water in the 
solution to induce any polymerisation. The final FITC-doped particle spectrum 
looks like that of blank particles with a strong siloxane band at 1100 cm-1 and a 
smaller silanol around 950 cm-1. The presence of a large band in the 3500-300 
cm-1 region indicates that some free amine groups are still present and that the 
reaction between APTES and FITC was not complete. 
 0
 10
 20
 30
 40
 50
 60
 70
 80
 90
%
T
ra
ns
m
itt
an
ce
 500    1000   1500   2000   2500   3000   3500   4000  
Wavenumbers (cm-1)  
Figure 2-3: Infrared spectra of FITC (red), FITC-APTES (blue), and FITC-
doped particles (green). 
 
Blank silica nanoparticles are naturally white, but the strong orange colour that 
came birthed from the incorporation of the APTES-FITC complex gave a first 
hint of the actual entrapment of the fluorescent dye. The optical properties of 
each sample were measured and compared to that of free FITC and of FITC-
APTES. All batches of particles exhibited identical excitation and emission 
profiles, with a strong absorption at 495 nm and emission at 515 nm (Figure 2-
4). There was a slight shift in the excitation maximum of APTES-FITC and 
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FITC-doped particle compared to that of free FITC (490 nm) that may be 
attributed to a change of the dye local environment. 
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Figure 2-4: Excitation (plain) and emission (doted) spectra of free FITC, 
FITC-APTES and particles produced via the Stöber procedure. 
 
Next, about 15 µL of the FITC-doped particle suspensions were deposited onto 
glass slides and imaged using a confocal microscope. Immediately, the 
particles strongly fluoresced under the green channel (488 nm-laser source 
excitation, bandpass 505-530 nm) and required some attenuation via 
modifications of the microscope setup (Figure 2-5 A). The images confirmed 
the aggregated state of some of the samples, although the exact size of the 
objects could not be measured with precision. A bleaching sequence was 
initiated to test the resistance of the particles to photobleaching. An area of the 
sample was subjected to a more intense illumination over a pre-defined period 
to bleach the fluorophores more quickly and pictures were taken at regular time 
(every 30 seconds) to follow the changes. While many conventional dyes 
bleach after a few minutes illumination at normal laser power, the particles 
retained their activity for more than 10 minutes at high light dose, although 
some bleaching was observed (Figure 2-5 B to D). Considering that the light 
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dose during the bleaching sequence was 3 times that of the normal setup and 
the illumination was kept constant, the silica particles are very robust contrast 
agents able to be imaged over extended periods of time.  
  
  
Figure 2-5: FITC-loaded nanoparticles obtained under a confocal 
microscope (A) and after 5, 10, and 15 minutes of the bleaching sequence 
(C, and D respectively). 
 
2.3.2 Reverse microemulsion 
The reverse microemulsion approach was tested to produce smaller 
nanoparticles than with the Stöber method. The ammonium hydroxide and the 
A) B) 
C) D) 
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silicon precursor and water concentrations were varied in view of detecting their 
effects on the particle diameter. SEM images showed that the first experiment 
(Mic-1) yielded 50 nm particles, although some particles were connected by 
necks that may be the sign of aggregation (Figure 2-6). The particles in the 
second experiment (Mic-2) were much smaller but the diameter could not be 
measured by SEM with precision and the particle dimensions were estimated 
between 10 and 20 nm. However, the sample appeared aggregated and 
displayed chains of linked particles visible throughout the whole sample. Finally, 
Mic-3 and Mic-4 yielded 60 and 70 nm-diameter nanoparticles respectively and 
are visually similar to Mic-1. 
 
 
Figure 2-6: SEM images of RB-doped Mic-1 and Mic- (A and B), R6G-
encapsulating Mic-3 (C), and AO-loaded Mic-4 (D). 
D) C) 
A) B) 
115 
The samples were also characterised by dynamic light scattering (DLS) to get 
information related to the hydrodynamic radius as well as the potential 
aggregated or non-aggregated state of colloids. In the case of Mic-1, the 
hydrodynamic diameter ranged between 185 and 380 nm, although very small 
particles with a diameter of circa 12 nm were detected (Figure 2-7 and Table 
2.1). The large diameter is most likely due to the aggregated structure observed 
on the SEM images. In fact, the zetasier determined a polydispersity index (PdI) 
of 0.618 for Mic-1: this high value is generally the sign of an aggregated state, 
which tallies with the electron microscopy results. In contrast, well dispersed 
suspension should have a PdI of 0.1 or below, but Mic2, Mic-3, and Mic-4 had 
for value 0.334, 0.207, and 0.164 respectively, which suggests a possible 
aggregated state of the samples.  
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Figure 2-7: Hydrodynamic diameter of the microemulsion-based 
experiments. 
 
The composition of the four experiments determined by FTIR is typical of silica 
material with the prominent siloxane peak at 1100 cm-1 and the additional peak 
at 870 cm-1 that derives from free silanol groups within the particles (Figure 2-
8). The only exception appears at 1612 and 1513 cm-1 of Mic-2 spectrum; which 
originates from the C-C bonds of the surfactant molecules’ benzene ring  
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Table 2-1: Average diameter and polydiserpsity index of nanoparticles 
synthesised by the reverse microemulsion method. 
Experiment SEM average diameter DLS average diameter Polydispersity index 
Mic-1 50 nm 224 nm 0.618 
Mic-2 15 nm 388 nm 0.334 
Mic-3 63 nm 185 nm 0.207 
Mic-4 70 nm 231 nm 0.164 
 
[Kimura, 1996]. This contamination exemplifies one of the major weaknesses of 
the reverse microemulsion, which requires a very long purification process to 
get rid of the surfactant molecules. 
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Figure 2-8: Infrared spectra of Mic-1 (red), Mic-2 (blue), Mic-3 (pink), and 
Mic-4 (green). 
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Preliminary tests with APTES-FITC conjugates were successful and produced 
yellow nanoparticles identical to that yielded by van Blaaderen’s method. To 
assess the capacity to encapsulate other organic fluorophore, FITC was 
replaced by rhodamine B (RB), rhodamine 6G (R6G), and acridine orange (AO), 
three dyes that were available in the laboratory and of interest for fluorescence 
imaging (Table 2.2). Mic-1 and Mic-2 were synthesised in presence of RB but 
only Mic-2 exhibited a very weak pink colour whereas Mic-1 remained blank. 
Mic-3 (R6G) and Mic-4 (AO) had a slightly stronger pinkish and orange colour 
respectively but none of the samples exhibited the same strong coloration than 
FITC-doped particles synthesised by the Stöber method. These results indicate 
that a small number of fluorescent molecules have penetrated and remained 
trapped inside the silica matrix during the particle growth, although additional 
characterisation are required to fully determine this number. 
Table 2- 2: Excitation/emission wavelengths and colour of the 
nanoparticles obtained by reverse microemulsion. 
Experiment Fluorophore Excitation/Emission Particle colour 
Mic-1 Rhodamine B 555/580 nm Blank 
Mic-2 Rhodamine B 555/580 nm Faint pink 
Mic-3 Rhodamine 6G 525/555 nm Faint pink 
Mic-4 Acridine orange 502/526 nm White-orange 
 
In contrast, the supernatant of all samples were highly coloured and translates a 
higher affinity of the dyes for the organic phase than for the aqueous phase 
where the particles are formed. The fluorescence measurement of all samples 
showed traces of RB at 550 and 580 nm (excitation/emission), of R6G at 
525/555 nm, or of AO 495/520 nm but the intensity was in no comparison with 
the bright fluorescence recorded with the FITC-doped particles at equivalent 
particle concentration (100 µg/mL) (Figure 2-9).  
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Figure 2-9: Fluorescence spectra of Mic 1 and 2 loaded with RB, Mic 3 
containing R6G, and Mic 4 encapsulating AO. 
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2.4 Discussion 
The results presented in this chapter are preliminary results following the 
protocols developed by other teams. The aim was to acquire a first experience 
of the synthesis of silica and fluorescent silica nanoparticles using the Stöber 
method and the reverse microemulsion, but not to conduct a complete 
characterisation of the particles or optimisation of the process.  
The Stöber method naturally yielded well-defined spherical particles with 
diameter over 500 nm. Water was added to the precursors as well because its 
presence may influence the final particle dimensions: Stöber and Fink were able 
to tune the particle size by varying the alcohol/silicon precursor/water molar 
ratio and to some extent by changing the nature of alcoholic and precursors. In 
most cases, they obtained submicrometric (over 100 nm) and micrometric 
particles. Here, it was difficult to obtain small particles, even in the presence of 
water but proceeding at higher temperature succeeded in reducing the particle 
diameter to circa 125 nm. This strategy is known to promote the formation of 
more nuclei over their growth [Sugimoto, 2007]. A more in-depth study of each 
parameter influence ought to be undertaken to synthesise nanoparticles, yet the 
experiments carried out here to highlight the advantages and potential setbacks 
of the Stöber method. The experiments showed that this method is simple and 
solely involves the mixing of reagents and ammonium hydroxide in an alcoholic 
solvent, but it will not produce nanoparticles unless the precursor and catalyst 
concentrations are strictly controlled [Park, 2002].  
Conversely, the reverse microemulsion technique is favoured for the synthesis 
of small and monodisperse nanoparticles of all compositions (silica, iron oxide, 
quantum dots, etc.). The method is a two phase system where an organic and 
an aqueous phase are separated by micelles, therefore this strategy is not as 
straightforward as the Stöber method. The four emulsions tested produced 
particle between 30 and 70 nm in diameter because the micelles mechanically 
restrict the size of the final nanoparticles. More experiments would be 
necessary to clearly asses how water and surfactant concentrations affect the 
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micelle/particle size, but these experiments are beyond the scope of this thesis. 
The main setbacks are the presence of organic solvent (harmful and potential 
toxic) and the long purification process. The purification of the particles was 
complicated and required several washing step, including washing in acetone to 
break the micelles. After centrifugation, the particle suspensions got a “soaping” 
texture signalling that some surfactant and in one case (Mic-2) it was not 
possible to entirely remove the surfactant. FTIR analyses detected TX-100 
traces in Mic-2, but the fact that no signal was detected in the other samples is 
not a certainty that the particles are free from the surfactant but may be instead 
caused by a low concentration that falls below the detection threshold of FTIR. 
Dialysis and/or thermal treatments are potential alternative but are more time-
consuming that centrifugation. Getting ride of the surfactant is important for cell-
related application because it may be a source of toxicity. In summary the 
reverse microemulsion technique appears as the opposite of the Stöber 
method: it easily produces nanoparticles, potentially with a high monodispersity, 
but the presence of organic solvent and extensive washing and long purification 
process make of the emulsion strategy a less attractive approach than the 
Stöber method. 
 
The entrapment of fluorescent dyes is one of the main interests of silica 
nanoparticles and the natural next phase was to incorporate fluorophores into 
the particles. Van Blaaderen’s modification of the Stöber method was used to 
synthesise FITC-doped nanoparticles. FITC has been the first dye incorporated 
by this method and has since then become a standard. It easily reacts with 
APTES via reaction between the isothiocyanate of the former and the amine 
group of the latter. The bright orange material, the same colour as the FITC-
APTES conjugate, was a first indicator of the presence of fluorophore within the 
particles and fluorescence emissions of free FITC and nanoparticles perfectly 
matched. Van Blaaderen’s modification not only avoids leakage of fluorophore 
owing to the covalent binding of the fluorophore to the silica matrix but allows 
exert a good control over the optical properties of the dyes and is suitable for 
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the design of structures made of multiple layers, potentially containing different 
fluorophores. Nevertheless, the covalent binding is also a weakness by 
restricting the number of fluorophores suitable for the sylilation: few dyes 
possess a reactive organic groups to bind to a fluorophore so that a time-
consuming and often difficult chemical reaction is required to make the 
fluorophore reactive. Few studies explore the possibility to retain the 
fluorophores by electrostatic interactions, even though using commercial 
version of dyes rather than their isothiocyanate or maleimide-derivatives is 
cheaper.  
It is possible to estimate the number of fluorophore molecules per particle by 
measuring the fluorescence of a suspension of known particle concentration 
and size and to report the value to the calibration curve of free fluorophore. By 
this mean, the fluorescence of the sample can be related to the equivalent 
number of fluorophore molecules and to quantify the number of dye molecule 
per particle. The same strategy can be employed to determine the fluorophore 
losses by measuring the fluorescence of supernatant [Traver, 2010]. Because 
of the large number of fluorophore present in individual particles, the samples 
appeared very bright under the confocal microscope. More importantly, the 
signal barely weakened under strong and constant illumination whereas many 
stains and dyes are known to photobleach quickly under similar conditions. It is 
not sure, though, that the effect is due to an actual protection of the fluorophore 
or to the great number of molecule per particle. Part of the signal was however 
lost but growing an additional, protective layer of silica may help circumventing 
the photobleaching issue. Measuring the FSNPs lifetime is one way to quantify 
the fluorescence stability of the particles and to compare to free dyes in 
solution. The strong fluorescence and limited bleaching are fundamental assets 
for contrast agents and explain the high interest in silica carriers.  
 
The optical properties of silica nanoparticles synthesised by reverse 
microemulsion were likewise tested. There exist very few studies of the 
encapsulation of organic fluorophore by microemulsion contrary to lanthanide 
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chelates that are systematically used. Therefore, the experiments carried out in 
this chapter aimed partially at finding a reason for this gap. Here, RB, R6G, and 
AO were selected because they are cheap dyes, matche the bandpass filters of 
the confocal microscope (green and red channel), and because of their 
availability in the laboratory. Both rhodamines have very high quantum yields 
(0.75 for RB and 0.95 for R6G) and close chemical structures but different 
emission/excitation profiles (555/580 for RB and 525/555 for R6G) [Kubin, 
1982]. Their direct encapsulation, i.e. without any chemical modification or 
sylilation, was rarely attempted. Acridine orange is a cheap dye commonly 
employed for cellular staining and with excitation and emission analogous to 
that of FITC. However, its quantum yield is far lower (0.2) than the other 
fluorophores which may explain why it has never been tested with silica 
nanoparticles.  
The initial tests ended in blank particles but eventually the reverse 
microemulsion yielded slightly coloured particles. More precisely, the 
fluorophores molecules barely penetrated within the micelles and remain in the 
organic phase so that most of the dyes were lost after centrifugation. 
Lanthanide chelates are the most frequent fluorophores encountered when it 
comes to reverse microemulsion precisely because these species are highly 
hydrophilic and naturally solubilise into the micelles where the particles form. 
Strategies have been elaborated in order to increase the hydrophilicity of 
organic fluorophores: the molecules can be conjugated to molecules such as 
dextran that will help in localising the dyes in the aqueous phase [Zhao, 2004 
b]. Alternatively, an oil-in-water emulsion may be created instead of reverse 
microemulsion, where the growth of particles proceeds in the organic phase. In 
that case, organic molecules solubilise within the micelles and are entrapped 
during the particle formation. In all cases, the procedure becomes considerably 
more complex and explains why inorganic fluorophores are preferred. 
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2.5 Conclusion 
In summary, this chapter was principally a test of the two principal synthesis 
methods of fluorescent silica nanoparticles. The aim was to determine their 
practicability and their advantages rather than provide an in-depth 
characterisation of the particle and particle fluorescence. On the one hand, the 
Stöber method and the related van Blaaderen’s modification have multiple 
advantages: simplicity, flexibility, design of layered architectures, control of the 
fluorescence properties etc. The major setbacks are the naturally large 
dimensions of the spheres and the fact that van Blaaderen’s method relies on 
covalent bonding of fluorophores, which can restrict the number of fluorophores 
suitable for this method. On the other hand, the reverse microemulsion 
approach yields smaller and potentially more monodisperse particles in the 
nanometre range, but it suffers from the complexity to prepare emulsions (use 
of surfactant and organic solvents), long purification, and difficulty to solubilise 
the fluorophores in the micelles. 
More time could have been devoted to the characterisation of the particles 
(determination of the size dispersity and of the particle stability, quantification of 
the number of fluorophore per particle, etc.) or to study with greater care the 
influence of various parameters over the particle dimension. However, none of 
these methods appeared to provide a satisfactory solution to the synthesis of 
small nanoparticles able to carry a large diversity of dyes. In fact, a novel 
method based on the use of amino acid to catalyse the sol-gel reaction was 
found to produce very small particles in aqueous environment and therefore 
appeared as a promising alternative to reverse microemulsion. Yet, the potential 
of the amino acid route to produce fluorescent silica nanoparticles had not yet 
been explored and consequently the Stöber and the reverse microemulsion 
methods were discarded and the amino acid route was explored instead. 
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labelling and confocal microscopy 
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3 Development of multifluorescent nanoparticles for 
cell labelling and confocal microscopy 
 
3.1 Introduction 
The European Union has identified bio-imaging as one of the key research 
areas where nanotechnology can impact. Numerous imaging modalities are 
available, including MRI, computed tomography, optical microscopy, etc. The 
current trend sees the combination of two or more modalities to provide more 
sensitive, specific, and fast analyses. The principal example is the combination 
of positron emission tomography (PET) with x-ray computed tomography (CT). 
CT creates very sensitive three-dimensional images of tissues through the 
reconstruction of two-dimensional x-ray pictures and allows the acquisition of 
large data volume whilst PET detects the signal of radioactive probes and 
provides information about functional processes that occur within the body. The 
duality of PET/CT enables precise localisation of the biological processes of 
interest and is advantageous for the detection of cancer stage or for the 
planning of surgical operations. New dual diagnostic modalities progressively 
appear on the market such as combined MRI/PET that suppresses the radiation 
burden of x-ray and more can be envisioned such as MRI and ultrasound or 
ultrasound and optical imaging [Schiepers, 2011]. Nanotechnology can improve 
the hardware of conventional imaging modalities to gain sensitivity, speed of 
signal acquisition, etc., to miniaturise the equipment, or to facilitate the 
combination of modalities into a single apparatus. Nevertheless, the main focus 
of attention lies in the development of contrast agents and other beacons. 
Traditionally, certain modalities already rely on beacons such as radioactive 
11C, 18F or 124I for PET and gadolinium ions for MRI which are either necessary 
to generate a signal or to create a strong contrast on the images that helps in 
the diagnosis [Anderson, 2010]. With the exception of PET, the sensitivity of 
most imaging modalities is limited to the organ/tissue level but rarely to the 
molecular level, yet early detection of diseases requires the recognition of 
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molecular events. Loci of inflammation, aberrant vascular structures, 
differentiation of healthy cells into cancerous ones are some examples of 
events where “molecular imaging” would prove invaluable.  
Nanoparticles present two potential advantages for molecular imaging: they can 
elicit their own optical/magnetic/radioactive signal that the imaging modalities 
record and they can be modified to bind and interact with specific targets via 
bio-conjugation or surface modification. Therefore, the aim of nanotechnology in 
the imaging domain is to devise contrast agents that localise with more 
precision and more specificity certain tissues and favour the detection at a more 
sensitive level than what is currently achieved [European Technology Platform 
on NanoMedicine, 2006]. Over the last decades, new probes have been 
developed: quantum dots, gold or iron oxide nanoparticles are the prime 
examples of nanoparticles with high potential in molecular imaging and some 
iron oxide nanoparticles are even clinically approved for MRI application. New 
contrast agents will emerge with the appearance of multifunctional structures 
suitable for dual imaging or matching the requirement for several modalities 
simultaneously. Progress in genomics and proteomics shed light on the 
mechanisms underlying diseases and identified the potential culprit of change 
such as proteins, enzymes, DNA/RNA that are potential targets of molecular 
imaging. The tools exist but the main challenge remains to modify the probes in 
order to bind to the correct antigen or cellular target to ensure that the particles 
reach their destination unhampered.  
MRI and optical modalities are the principal imaging techniques on which 
nanotechnology focuses. Briefly, iron oxide nanoparticles are the principal 
contrast agents for MRI and create a strong disturbance of the local magnetic 
field. They are preferentially used for the detection of tumours or the tracking of 
dendritic cells/macrophages or stem cells and other transplanted cells. Gold 
nanoparticles under their various shapes rely on plasmon resonance to create a 
strong signal for optical imaging, including confocal microscopy or optical 
computed tomography. In contrast, fluorescence-based optical imaging 
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modalities are able to identify quantum dots and fluorescent silica nanoparticles 
(FSNPs) [Sharma, 2006].  
Nanoparticulate systems for the other modalities remain rarer, although strong 
candidates, in particular gold nanoparticles, have emerged. Probes for PET are 
based upon the conjugation of radionuclides into or onto nanoparticles since the 
nanomaterials of interest in medicine lack radioactive features [Nahrendorf, 
2010]. The development of x-ray probes is more recent: high atomic number 
elements are usually ideal for x-ray imaging but they are rarely biocompatible. 
The most widespread probes are iodinated compounds that possess high X-ray 
energy specific mass attenuation coefficient, and mass energy absorption 
coefficient that are critical parameters for CT.  
Lately, small gold nanoparticles have proved to be powerful x-ray contrast 
agents, even surpassing iodine whilst iron oxide has shown promises in a few 
studies as well [Kim, 2007]. Likewise, gold is an excellent probe for 
photoaccoustic imaging as this modality relies on the acoustic response of 
tissue after pulsed laser irradiation. Thus, the tunability of plasmon resonance to 
the NIR infrared where most of the pulsed laser sources emit is ideal. Gold 
nanoshells are the most frequent, but gold nanorods have already obtained 
excellent results and gold nanocages that possess a higher extinction cross-
section are attracting attention. Silica nanoparticles are potential probes when 
combined to indocyanine green, the sole fluorophore approved by the FDA as a 
photoaccoustic agent [Hahn, 2011]. Multimodal probes usually combine the 
described materials to be detected by multiple modalities simultaneously [Cho, 
2010 a]. The advantage of combining modalities is that the probes need a 
single injection instead of one injection per modality, which is time saving, 
cheaper, and avoids the repetitive use of potentially dangerous agents such as 
radionuclides. Gold and/or iron oxide are almost always integrated because 
they are suitable for several modalities or function, including the most clinically 
relevant ones [van Schooneveld, 2010]. 
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PET, MRI, and CT are commonly found in clinics and hospitals but less in 
laboratories. On the contrary, optical modalities are more suited to cell culture 
and thin tissue samples for in vitro experiments. They have the advantages of 
being non-invasive, enable real-time acquisition, possess a high resolution, and 
are cost-effective [Sokolov, 2003 b]. The most widespread techniques are 
based on fluorescence and take advantage of the large number of fluorophores 
commercially available. The principal limitation of optical imaging is the high 
turbidity of tissues, i.e. they are composed of many absorbers, scatterer, and 
other endogenous fluorophores responsible for autofluorescence - in particular 
haemoglobin and melanin - that absorb and scatter light, hampering the 
detection of the fluorophores [Tromberg, 2000]. Consequently, it is difficult to 
uncouple the effects of scattering, absorption and autofluorescence and the 
depth of penetration of visible light usually employed is of a few millimetres 
(even less with UV excitation sources).  
Infrared and near-infrared (NIR) light penetrates deeper in tissue than visible 
light. The region of the electromagnetic spectrum between 700 and 1000 nm is 
known as the “optical window” precisely because few biomolecules in tissues 
are able to interfere at these wavelengths and the depth penetration reaches 
the centimetre range [Frangioni, 2003; Taroni, 2003]. New modalities based on 
nonlinear processes, principally two-photon excitation (TPE), become popular 
because they are powerful tools surpassing the usual fluorescent imaging 
modalities [Helmchen, 2005]. NIR and multiphoton dyes are the best candidates 
for in vivo imaging but traditional dyes emitting in the UV and visible remain 
perfectly suited for in vitro applications. 
 
The previous chapter showed that silica nanoparticles were bright contrast 
agent but are still restricted by their large size or by a limited variety of 
fluorophore. However, the traditional methods are unable to synthesise at the 
same time small particles and particles able to contain a large variety of 
fluorophores. For this reason, another approach based on the catalysis of sol-
gel reactions by amino acid was explored as an alternative to the Stöber 
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method and reverse microemulsion. This strategy is a biomimetic approach 
based on the observation that in certain organisms, proteins containing specific 
sequences of amino acid are able to catalyse the polymerization of silicon 
precursors to precipitate silica and further mould it into complex structures. It 
has been found that these sequences are generally rich in aminated amino acid 
(lysine and arginine). The amino acid route that resulted from this observation 
possesses interesting features: 
Ø Proceeding in water or aqueous environments; 
Ø Production of very small nuclei 1 to 20 nm in diameter; 
Ø Possibility to enlarge the particles and control their final dimension by 
incremented addition of silicon precursors (seed regrowth). 
Overall, the amino acid route combines the simplicity of the Stöber method with 
the small size of reverse microemulsion whilst in milder conditions. Because of 
its novelty, the potential of the amino acid route to produce fluorescent 
nanoparticles has not yet been investigated but the possibility to create 
multilayered structures via seed regrowth opens new possibility to design 
multifluorescent nanoparticles where each layer of the particle can contain one 
type of fluorophore. 
 
The aim of this chapter is to investigate the potential of the amino acid route to 
produce fluorescent nanoparticles that can be used as contrast agents in 
confocal microscopy. The objectives are then divided into: 
Ø The design of core-shell nanoparticles by taking advantage of the seed 
regrowth strategy 
Ø The encapsulation of up to three fluorophore in separate layers and the 
assessment of the “multifluorescent” nanoparticles (MFSNPs) 
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The direct labelling of cancerous cells with MFSNPs for confocal microscopy 
imaging to detect the particle localisation and their capacity to fluoresce in 
multiple canals simultaneously. 
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3.2 Materials and methods 
3.2.1 Materials 
Chemicals were purchased from commercial sources and used as received 
without any treatment. Tetraethyl silicate (TEOS) and acridine orange (AO) 
were purchased from BDH. Anhydrous ethanol (>99.5 %), L-arginine (>98 %), 
3-(trihydroxysilyl)propyl methylphosphonate monosodium salt solution (42 wt.%, 
THPMP), 3-aminopropyltriethoxysilane (APTES, >98 %), and fluorescein 
isothiocyanate (FITC, Isomer I) were obtained from Sigma Aldrich. Rhodamine 
6G (R6G), methylene blue (MB), and tween 20 were acquired from Fluka, 
Fisher Scientific, and Acros Organics respectively. Finally, sytox green (SG) 
and streptavidin, Alexa Fluor 555 conjugate (AF, 2 mg-mL) were obtained from 
Invitrogen. Highly purified water (Milli-Q) was obtained from a Millipore “Direct-Q 
3” water purification system. 
 
Prostate cell line were PC3 (derived from a human prostate adenocarcinoma of 
a 62 years old Caucasian male – ECACC: 90112714) and PNT1A (derived from 
a human post pubertal prostate normal, from a 35 years old male at post 
mortem, immortalised with SV40). All cells were grown from seed culture stored 
under liquid nitrogen and cultured in Dulbeccos modified eagles medium 
(DMEM) containing HAM’s F12 (1:1) 1x nutrient mix plus 15 mM HEPES & L-
glutamine (GIBCO, Invitrogen). The media was supplemented with 10% heat 
inactivated foetal calf serum (FCS), 200 mM L-glutamine (Invitrogen), 1000 
units of penicillin and 1 mg streptomycin (GIBCO, Invitrogen) per bottle. 
Cultures were grown at 37°C in a 5 % CO2 atmosphere and were maintained by 
passage when they had grown to 80-90 %.   
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3.2.2 Methods 
• Synthesis of multifluorescent nanoparticles following an amino 
acid route 
The synthesis of blank and dye-loaded nanoparticles proceeded in five steps 
and all combinations of the three dyes were attempted (Figure 3-1): 
Ø Silica seeds were initially formed by mixing 330 mg of L-arginine with 6.9 
mL Milli-Q water. Afterwards, 555 µL TEOS was added five minutes later 
and the solution was magnetically stirred for 24 hours; 
Ø The first layer was to contain MB: 1 mL of seed solution was mixed with 
3.6 mL of Milli-Q and in some cases with 32 µL of a 15 mM MB solution. 
Then, 255 µL of TEOS was added and the reaction was left to proceed 
for 12 hours under magnetic stirring; 
Ø The second layer was designed to encapsulate R6G: the former 
suspension was mixed with 250 µL of MilliQ, 211 µL of TEOS, and 63 µL 
of a 7.9 mM R6G solution if the particles were to contain the dye. This 
step lasted 12 hours under magnetic stirring; 
Ø The third layer was obtained by addition of 62 µL of an APTES-FITC 
conjugate solution (see preparation in Chapter II) to the particle 
suspension or 1.2 mL of TEOS for a blank layer. The solution was 
magnetically stirred for 12 hours. 
Ø 1 mL of TEOS was introduced to the suspension, followed 30 minutes 
later by 30 µL of THPMP and 5 µL of APTES and left for 12 hours under 
magnetic stirring. 
The samples were centrifuged 3 times at 1200 g for 15 minutes or until 
supernatant remained clear, with washing first with acetone and then with 
distilled water. 
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• Cell culture 
Once PC3 and PNT1A lines adhered, passaging required the use of 
trypsin/EDTA to detach the cells from the surface of the culture flasks. Cultures 
were first washed in 10 ml of sterile PBS followed by the addition of 5 mL of 1x 
0.5 % trypsin/EDTA solution (GIBCO, Invitrogen, UK) to each flask. This was 
incubated at 37ºC for approximately one minute, or until detachment could be 
detected, upon which the cells were removed from the flask and placed into a 
centrifuge tube containing 5 mL of media to inactivate the trypsin. The 
suspension was then centrifuged at 307 g at 4ºC for 5 minutes. The supernatant 
was discarded and the cells resuspended in 3 mL of media. Finally, 1 mL of the 
cell suspension was subcultured into each fresh flask. 
Blank 
MB/R6G 
MB 
MB/FITC 
R6G 
R6G/FITC 
FITC 
All dyes 
NH2 PO4 
H2N 
PO4 
PO4 
NH2 
Figure 3-1: Representation of the synthesis steps of the 
multifluorescent nanoparticles and the dye combinations. 
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• Incunbation with NPs 
Cells were grown in a T75 flask until 80% confluence was reached (~800*104 
cells/mL) and then trypsinised and resuspended in 1 mL of DMEM media. Cells 
were seeded in a 8-well plate (1 µL-Slide 8 well, ibidi Integrated BioDiagnostics) 
at a concentration of 15000 cells/well completed with 300 µL DMEM and 
incubated overnight. At the end of the period, media was discarded, the plate 
was washed with PBS and the wells were filled with nanoparticles suspended in 
DMEM (100 µg/mL). The cells were incubated for a period ranging from 1 to 3 
days. Finally, the particle suspensions were discarded, the plate washed with 
PBS and fixed by dipping the plate 15 minutes in cold PBS and then 15 minutes 
in cold methanol. 
After fixing, the nucleus of cells labelled with FITC-doped nanoparticles were 
stained with sytox green (500 nM) and their cytoplasm was counter-stained with 
AlexaFluor 555 (5 µg/mL). Sytox green was later replaced by acridine orange 
(20 µL/mL) in the multifluorescent nanoparticles experiments. 
 
3.2.3 Characterisation 
• Scanning electron microscopy (SEM) 
The particle size and morphology were examined using scanning electron 
microscopy (SEM). The nanoparticle suspensions were firstly diluted: the 
samples were sonicated and subsequently 25 µL of suspension was poured in 
an eppendorf and the total volume was increased to 500 µL with Milli-Q water 
so that the SEM samples were totally transparent. One drop of suspension was 
deposited into a silicon grid and let to dry in a desiccator for at least 24 hours. 
Finally, the particles were imaged using a high resolution FEI XL30 SFEG 
analytical SEM (Philips, Netherland). 
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• Dynamic light scattering (DLS) 
The size and size distribution of the particles were measured by dynamic light 
scattering using a Zetasizer nano series S with an He/Ne laser of 633 nm 
wavelength (Malvern Instrument, UK). The particle suspensions were firstly 
diluted: 10 µL of the sample was poured in a quartz cuvette and completed with 
1 mL Milli-Q. The refractive index and absorption of silica nanoparticles were 
fixed at 1.25 and 0.01 respectively. For each sample, four measurements of 20 
runs (15 seconds each) were carried out, with temperature maintained at 25°C. 
 
• Fourier transform infrared spectroscopy (FTIR) 
The particle composition was analysed by infrared spectroscopy: a volume of 
nanoparticle suspension was taken, centrifuged, and dried in the oven for 1 day. 
The resulting powders were subsequently analysed in KBr powders using a 
Thermo Nicolet Avatar 370 spectrometer (Thermo Scientific). Infrared spectra 
were recorded over the wavenumber region 4000 to 400 cm-1 with a resolution 
of 4 cm-1.  
 
• Fluorescence measurement 
Absorbance and fluorescence of FSNP were recorded in 96-well plates with a 
Varioskan Flash Spectral Scanning Multimode Reader (Thermo Fisher 
Scientific) equipped with a xenon flash lamp. All measurements were performed 
on 200 µL of 1 mg/mL suspensions of particles diluted in Milli-Q and at room 
temperature. Excitation/emission spectra of FITC and R6G were acquired with 
fixed wavelength set at 450/530 and 490/580 nm respectively. 
. 
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• Confocal microscopy 
FSNP and cells were imaged using a LSM 510 META Inverted Laser Scan 
Microscope (Zeiss). The system is equipped with three laser lines that were 
used separately to excite the samples. Images were obtained using a Plan-
neofluar 40X/1.4 oil immersion objective and the resulting images were colour-
coded in green, red, and blue for excitation at 488, 543, and 633 nm 
respectively. Furthermore, the software (Zeiss LSM confocal software) enables 
overlaying pictures to produce dual-coloured images. All images were the 
average of sixteen scans and were obtained with the same optical aperture, 
lens, and scan speed. 
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3.3 Results 
3.3.1 Synthesis of multifluorescent nanoparticles 
The multifluorescent nanoparticles were based on small seeds obtained by the 
amino acid route and onto which three silica layers were grown. Additionally, 
the surface was modified to express amine and phosphonate groups, a 
procedure usually employed to improve the stability of the particles. Each new 
layer aimed at containing methylene blue (MB), rhodamine 6G (R6G), and 
fluorescein isothiocyanate (FITC) in that order, and all combinations from blank 
particles to structures containing all three dyes were tested. DLS measurements 
were conducted to follow the change of dimensions throughout the whole 
process. The initial seeds were found to be 5 nm in diameter but the protocol 
only yielded trace amounts of nanomaterial. The diameter grew to 6, 8, 11, and 
20 nm respectively (Figure 3-2) but the high polydispersity index of the samples 
indicates that the particles potentially clustered and even aggregated after the 
reaction with APTES and THPMP. SEM pictures confirmed the DLS findings as 
the images displayed very small particles 20 to 30 nm in diameter that formed 
large aggregates despite of the surface modification with the two organosilanes 
(Figure 3-3).  
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Figure 3-2: DLS spectra of R6G-FITC-containing silica nanoparticles. 
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Figure 3-3: SEM picture of R6G-doped nanoparticles (left) and particles 
containing all three dyes (right). 
 
FTIR spectra taken at different steps of the procedure all displayed the siloxane 
and silanol peaks which confirm that the silica matrix formed (Figure 3-4). The 
addition of APTES and THPMP slightly modified the spectrum with a 
broadening of the 3500-3000 cm-1 region as an effect of the amine groups as 
well as of the 1300-1100 cm-1 region. Phosphonate is supposed to create peaks 
at 1244, 1050, and 1026 cm-1, but the large band characterising Si-O-Si 
screens the phosphonate signal. The other possibility is that THPMP did not 
react with the particles in the first place but FTIR is not able to detect it. Zeta 
potential measurement would be the best way to follow the changes of the 
particle surface by detecting the alteration of the particle charge when amine 
and phosphonate are expressed. It can only be said, from the FTIR spectra, 
that APTES has reacted with the particles and amine groups are present but the 
phosphonate groups have yet to be identified. 
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Figure 3-4: Infrared spectra of MFSNP of the different stages of synthesis 
of the particles from the silica seeds to the surface-functionalised final 
particles. 
 
The nanoparticles suspensions exhibited bright colours directly related to their 
dye composition. Hence, blank particles were white, whereas FITC-, R6G-, and 
MB-doped particles were respectively yellow, red, and blue. The colour of the 
nanospheres containing two fluorophores was that of the corresponding mixture 
of colour: orange for FITC-R6G particles, green for MB-FITC, and violet for MB-
R6G. Likewise, the solution containing all three dyes displayed a violet colour 
(Figure 3-5). 
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Figure 3-5: (From left to right) blank, R6G-, FITC-, MB-, R6G-FITC-, MB-
R6G-, MB-FITC-, R6G-FITC-MB-doped nanoparticles. 
 
Absorbance spectra of solution containing FITC presented a peak at 490 nm 
while particles containing MB exhibited a peak at 610 nm with a broad shoulder 
in the 650-670 nm range (Figure 3-6). R6G-doped nanoparticle solutions 
exhibited a peak at 525 nm as well as a shoulder at 500 nm. The latter occurs 
when dyes are in close proximity or because of the formation of dimers during 
the dye encapsulation. The spectra of samples containing two dyes displayed 
multiple peaks, for instance at 495 and 525 nm for the FITC-R6G sample or the 
FITC peak and MB band for the FITC MB-loaded nanoparticles. The same 
effects were visible on the sample containing all three dyes. However, there is 
no certainty that each particle effectively carry all the fluorophores. In fact, the 
suspensions may be composed of mixed particle populations containing one, 
two, or three fluorophores.  
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Figure 3-6: Absorbance spectra of MFSNPs containing R6G, MB as well as 
thei dyes combined to FITC. 
 
Fluorescence measurements confirmed the dye composition of the 
nanoparticles, with excitation/emission at 525/555 nm and 495/515 nm 
whenever R6G and FITC were present respectively. Both dyes signals were 
clearly distinguishable with a single excitation wavelength, although the 
overlapping of FITC and R6G means that part of the FITC signal is used to 
excite R6G (Figure 3-7). In contrast, MB did not display any fluorescence at all 
and the excited light may have been converted into another form that 
photoluminescence. However, additional analyses are required to confirm that a 
single particle effectively contain all of the fluorophores were trapped during the 
particle growth and not that the suspension is composed of different populations 
of particles with random optical signatures. To do so, single fluorescence 
spectroscopy could be sensitive enough to measure the optical properties of a 
single object. In the same vein, the new generation of confocal microscope has 
a sensitivity of a few nm and may be able to distinguish the signal of single 
particles and to subsequently determine their spectral signature. 
FITC R6G 
MB 
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Figure 3-7: Emission spectra of FITC-doped and systems containing FITC 
and a second fluorophore. 
 
 
3.3.2 Cell incubation and confocal microscopy 
The second part of this chapter consisted in employing the new multifluorescent 
nanoparticles as contrast agents for confocal microscopy. Two different cell 
lines, prostate adenocarcinoma (PC3) and prostaste epithelial cells (PNT1A), 
were chosen for this study. Both cells lines possess distinctive morphologies: 
PNT1A are elongated and closely packed whilst PC3 are larger and more 
spherical (Figure 3-8 A and B). A preliminary study with FITC-doped 
nanoparticles synthesised by the Stöber method over a period of 1 to 3 days 
showed difference of particle uptake. After 1 day incubation, very few particles 
were detected near the nucleus but only after bleaching of the nuclear stain 
(Figure 3-8 C and E). Images were similar after 3 days, suggesting a low 
particle uptake for this specific cell line. Conversely, the uptake of particles by 
PC3 cells was important and immediately observed (Figure 3-8 D and F). The 
nucleus staining and cytoplasm counter-staining helped in locating the particles: 
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the images show large aggregates in the cytoplasm and isolated particles and 
small clusters in the vicinity of the nucleus. The acquisition of three-dimensional 
pictures further proved that the particles effectively penetrated within the cells 
and none of the clusters found close to the nucleus penetrated within the 
nuclear domain. 
   
 
   
Figure 3-8: Confocal images of control PNT1A (A) and PC3 (D) cells after 
double staining and PNT1A (B and C) and PC3 (E and F) incubated for two 
days with FITC -doped silica. 
 
Multifluorescent nanoparticles were tested in similar conditions over an 
incubation period of 12 hours. The staining of PNT1A did not proceed properly, 
possibly because the cells were kept for too long prior to imaging. The 
endosomes appeared very bright and the cells lacked of the smooth aspect 
previously observed. No particle was observed in the case of the nanoparticles 
containing a single fluorophores; however FITC-R6G and FITC-R6G-MB 
containing particles were detected in a few cells in the green channel (Figure 3-
9). Reasons for this discrepancy are not known, especially since the particles 
A) B) C) 
F) 
D) E) F) 
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were synthesised following the same procedure. All that can be said is that the 
low particle uptake was once again observed, but additional experiments with 
flow cytometry are required to quantify this uptake and the imaging must be 
repeated to evaluate more clearly the location of the rare particles taken up by 
the cells. 
  
Figure 3-9: Confocal image of PNT1A cells incubated with FITC-R6G-
combined particles (A) and particles containing the three dyes (B). 
 
The results with PC3 cells were very different. Starting with R6G-doped 
particles, large aggregates were detected on the edges of the cells and 
generated a strong red signal that could be discriminated from the fluorescence 
of AF555, even though both dyes were detected in the red channel (Figure 3-
10 A). The principal evidence of the particles presence is the higher 
fluorescence intensity of the FSNPs responsible for the bright red colour 
between the cells. The confocal microscope proposes additional functionalities 
to study cells in details. First of all, the fluorescence intensity can be scaled to 
map the fluorescence distribution in a picture. Here, the red channel depicts 
areas of high intensity that can be attributed to R6G because of their presence 
onto and between the cells whereas AF555 solely delimits the cytoplasm of 
cells and its intensity is weaker than that of R6G (Figure 3-10 B). The 
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scattergram is similar to the fluorescence distribution tool but enables to 
discriminate the signal with more precision by defining a minimal intensity level 
of interest (gating). It is clear from the pictures that the white signal – which 
correspond to the highest fluorescence intensity – are distinct from the stain 
signal and arise from R6G contained within the particles (Figure 3-10 C). The 
lack of distinction between R6G and AF555 hampered the construction of three-
dimensional pictures: this option is less precise than the imaging of a single 
focal plane and the computer was not able to unmix the two dyes so that the 
cells appeared swollen and blistered, with no clear delimitation of each cell 
(Figure 3-10 D). 
  
  
Figure 3-10: Confocal picture of PC3 cells labelled with R6G-loaded 
nanoparticles (A) , fluorescence intensity distribution in the red channel 
(B), scattergram (C), and three dimensional picture (D). 
 
A) B) 
C) D) 
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Better quality pictures can be acquired with longer acquisition time but this 
method increases the chances of AF555 bleaching. Note, however, that the 
confocal microscope used for this study proposes an option allowing 
distinguishing with more precision the difference of wavelength emission and to 
colour each signal with a different colour but it was not possible to use this 
upgrade at the time of the study. 
The tracking of R6G-FITC particles within the PC3 cells proved easier because 
the particles were detected in the green and red channels so that the overlay of 
the pictures taken with the 488 and 543 nm sources ascribed a yellow colour to 
the particles (Figure 3-11 A). 
  
 
Figure 3-11: Confocal picture of PC3 cells labelled with R6G- and FITC-
containing particles (A) and fluorescence intensity distribution in the 
green channel (B). The three dimensional picture was obtained after 
acquisition of images at different focal plane (C) and allows sagittal and 
transversal cuts to determine the localisation of the nanoparticles (D) 
A) B) 
C) D
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The tracking of R6G-FITC particles within the PC3 cells proved easier because 
the particles were detected in the green and red channels so that the overlay of 
the pictures taken with the 488 and 543 nm sources ascribed a yellow colour to 
the particles (Figure 3-11 A). The intensity distribution in the green channel 
depicted bright region matching the position of the yellow areas in the first 
pictures and contrasting with the mild signal of the acridine orange nuclear stain 
(Figure 3-11 B). The three dimensional image coupled to the sagittal and 
transversal cuts provided one more evidence that the particles were located 
within the cytoplasm. It also provided information about the location of the 
particles, present as aggregate along the internal cell membrane and a few 
clusters in the cytoplasm, but in no case the particles seemed to have entered 
the nucleus domain (Figure 3-11 C and D) 
Finally, the particles containing all three dyes also generated a high signal in the 
red and green channels but the lack of MB fluorescence prevented its detection 
by the confocal microscope (Figure 3-13 A). However, there seemed to be two 
different populations of FSNPs: some areas were yellow due to the presence of 
both R6G and FITC but other areas remained green. This may be an indication 
that the APTES-FITC complex condensed into separate particles rather than 
condensed onto the already formed nuclei and tallies with the assumption that 
the suspension of particles are not optically homogeneous. This segregation 
was further highlighted by the fluorescence distribution that clearly shows that 
the strong green signal of the particles does not always superimpose on the 
fluorescence in the red channel (Figure 3-13 B and C). The three dimensional 
picture of the cells showed again that the internalised aggregates were localised 
close to the cell membrane whilst smaller particles migrated closer to the 
nucleus without penetrating into the nuclear membrane (Figure 3-13 D). 
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Figure 3-12: Confocal picture of PC3 cells labelled with R6G- FITC-MB-
containing nanoparticles (A) and fluorescence intensity distribution in the 
green (B) and red channels (D). The last picture displays a three-
dimensional representation of PC3 under a 45° angle (D). 
A) B) 
C) D) 
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3.4 Discussion 
3.4.1 Nanoparticles synthesis 
The aim of this chapter was to explore an alternative way to produce FSNPs 
and multifluorescent nanoparticles. The idea originated from the difficulty to 
obtain small fluorescent particles using conventional procedures as discussed 
in chapter 2. The amino acid route is still ill-explored, but appeared as an 
attractive and elegant method based on natural mechanisms encountered in 
certain organisms such as algae and glass sponges. The method possesses 
two distinct features:  
Ø The replacement of the strong ammonium hydroxide by L-arginine;  
Ø The replacement of organic and alcoholic solvents by water.  
Arginine (and lysine) is a weaker base than ammonium hydroxide but the pH of 
the arginine solution of about 10 and the presence of two amine groups create 
favourable conditions for the condensation of TEOS into particles.  
Here, DLS characterisation indicated that the initial seeds were circa 5 nm. 
These nuclei were further enlarged by iterative addition of TEOS to the system 
(also called seed regrowth) to create three additional silica layers. An additional 
step aimed at modifying the surface of the particles with amine and 
phosphonate groups to ensure stability via electrostatic repulsion and to 
express reactive groups for potential bioconjugation with ligands. The formation 
of new layers is made possible by the presence of free hydroxyl groups at the 
surface of the particles (silanol groups Si-OH) that groups act as anchors for the 
condensation of more silicon precursor molecules. DLS measurements showed 
an increase of the particle diameter from 5 to 11 nm that may be the result of 
the deposition of new layers onto the original nuclei, and the final surface 
modification brought the nanoparticles to about 20 nm in diameter. The 
quantities of TEOS added during each steps were calculated based on the 
equation [Hartlen, 2008]: 
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(3-1) 
In theory, the quantity of TEOS added to the nuclei suspension was calculated 
to grow the nanoparticles by 20 nm after each step in order to bring the final 
particles up to a diameter of 80 nm. Practically, the diameter of the 
nanoparticles only increased by circa 5 nm 5 nm according to the DLS values. It 
must be ponted out that the equation ought to be modified to take into the 
consideration the difference of APTES hydrolysis and condensation rate since 
the silicon atom is connected to three alkoxide groups instead of four. One 
important observation is the small quantities of unmodified seeds obtained (1-2 
mg approximately). It is difficult to assert why such a small amount was 
produced in view of the limited literature dedicated to this method. In contrast, 
about 200 mg of material was obtained at the end of the procedure, perhaps 
because of the nucleation of new particles occurring in parallel to the enlarging 
of the already formed nuclei. 
The surface modification with THMPMP on silica nanoparticles aimed at 
stabilising the suspensions by creating repulsive interactions between the 
nanospheres owing to the negative charge of the phosphonate groups. APTES, 
on the other hand, is generally employed as coupling agent because its amine 
group is able to react with many other functional groups via conventional 
chemistry reactions. However, handling of THPMP was complicated because 
the compound formed a gel prior to its addition to the particle suspensions, 
which may have prevented its condensation onto the nanoparticles. Instead, the 
amine groups were free to cover the whole particle surface and may be 
responsible for the strong aggregation observed on the SEM images. This is 
due to the capacity of amine moieties to create hydrogen bonds with the silanol 
groups at the surface of the particles. The effect is reinforced because of the 
positive charge of the amine groups that attract the negatively charged silanols 
so that eventually, the particles are strongly attracted one to the others. Infrared 
spectroscopy proved that the amine groups were present in the sample but no 
phosphonate was detected. This absence may either originate from a screening 
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of the phosphonate peaks by the strong siloxane band or because the 
organosilane was unable to react with the particles in the first place. Additional 
measurements, in particular of the zeta potential, are required to follow up the 
surface modification of the particles and make sure that the suspensions are 
stable. Overall, the procedure must be refined to 1) increase the nuclei density, 
2) control the particle diameter after each step, and 3) control the functional 
group densities to obtain stable suspensions. 
One of the objectives was to design multifluorescent systems able to carry two 
or more fluorescent dyes. Such systems are rare in spite of the advantages that 
such system provides (multiplexing, multimodality, etc.). The MFSPNs exhibited 
strong colours depending on their fluorophore content, from the yellow, pink and 
blue of FITC, R6G, and MB, to the green, orange, and purple resulting from the 
dye combinations. FITC was chosen to test the covalent binding whereas MB 
and R6G were incorporated within the matrix by electrostatic interaction. These 
dyes were chosen due to their distinct emission wavelengths and their 
availability in the laboratory. Each of them was added at a different step of the 
procedure for integrating the dyes in separate layers when new silica layers 
were grown. Only the initial seed were kept free of fluorophores because of the 
small particle density. However, the absence of centrifugation (to remove 
excess dye molecules) means that MB and R6G are most likely present in 
several layers. In other words, it is necessary to carry out experiments once 
again while centrifugation between each step to confine each fluorophore in the 
separated layer.  
Fluorescence measurements confirmed that the fluorophores were present in all 
samples Excitation and emission of FITC and R6G were distinguishable and the 
emission of the two dyes was obtained with a single wavelength. Nevertheless, 
the plate-reader gives an average of the excitation and emission of a 
suspension but the spectra do not ascertain that all the particles exhibit the 
same spectral signatures. In fact, there are chances that some particles may 
contain a single dye and some other contain combinations of fluorophores at 
different ratios. For example, confocal images (Figure 3-14 A) suggested that 
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some particles contained simultaneously FITC and R6G as shown by their 
yellow colour (overlay) but other particles only exhibited the green colour of 
FITC, proof that the particles do not possess uniform optical properties. Other 
techniques such as new generation of confocal microscopes, flow cytometry, 
and single molecule spectroscopy must be used to better characterise the 
optical properties of the nanoparticles and their dye content. The sensitivity of 
the last generations of confocal microscope is high enough to image single 
nanoparticles and they are able to unmix the signal of fluorophores localised in 
the same area. In other terms, the new generation confocal microscopes can 
image single particles and probe what dye(s) they contain. Likewise, flow 
cytometry may provide more information provided that the fluorophore 
emissions match the cytometer detectors, but the technique may not be able to 
record the signal of single particles. Finally, single molecule spectroscopy may 
be the most sensitive technique of the three and is potentially able to measure 
the optical properties of one or two particles at a time. 
Overall, the core-shell architecture appears to contain more than one 
fluorophore and is a potential alternative to design multifluorescent systems 
without relying exclusively on covalent binding [Wang, 2006]. Additional 
experiments are necessary to gain a better control over the fluorescent pattern 
of the particles and to make sure that the dyes are sequestered in the 
appropriate layers. Moreover, more characterisation the optical properties of the 
suspensions is needed, especially to prove that the particles are spectrally 
uniform. 
 
3.4.2 Cellular uptake 
Before using the MFSNPs on cells, preliminary experiments were conducted 
with FITC-doped particles synthesised by the Stöber method (125 nm in 
diameter). The uptake of the PC3 and PNT1A cell lines qualitatively different: 
the internalisation of particles was reduced in the case of PNT1A but a large 
quantity of FSNPs was detected within the PC3 cytoplasm. Location of the 
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particles could be determined thanks to a double staining of the cells and the 
confocal images displayed a few particles or clusters close proximity to the 
nucleus after partial bleaching of the nuclear stain. Over three days, no 
difference of internalisation was noticed and it was concluded that PNT1A 
affinity for the FITC-doped particles was very limited. In comparison, PC3 cells 
gathered up the internalised particles to form large aggregates localised in the 
cytoplasm (close to the membrane) but the particles never seemed to cross the 
nuclear barrier. 
Labelling with the multifluorescent nanoparticles showed a similar trend with 
little or no internalisation by PNT1A and an important uptake and aggregation 
with PC3, although experiments on the PNT1A must be repeated. The FITC 
signal of the MFSNPs was easily detected and discriminated from that of the 
nuclear stain. The signal of R6G was more difficult to detect, especially because 
R6G and AF555 were both detected in the red channel. The only way to 
discriminate the two fluorophores was by comparing the brightness of the 
particles to the uniform cytoplasm stain. Note, however, that the confocal 
microscope is equipped with a device called the META detector that is able to 
separate the emission signal into various wavelengths (10 nm increment) and to 
display each fluorophore separately on the picture (fingerprinting). This device 
would have enabled to unmix the signal of R6G and AF555 and may have 
revealed the nanoparticles on the 3D images. When both FITC and R6G were 
contained in the suspensions, the overlay created a yellow colour where the 
particles were located. The colocalisation of FITC and R6G was the main aim of 
this chapter and presumes that the nanoparticles can contain multiple 
fluorophores to generate distinct spectral signature. Selecting fluorophores 
appearing in different channels (or distinguishable by the META detector) or 
varying the dye ratios may create suspensions of particles with distinct 
signature. Moreover, it may be possible to target and simultaneously image 
different cell lines or organelles with appropriate bioconjugation of the MFSNPs. 
However, as discussed above, this step is not reached yet and a better control 
over the optical properties and stability of the suspensions must first be 
achieved before allowing multiplexed imaging. Furthermore, even though the 
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study has mostly explored a different strategy to design contrast agents, certain 
questions have been raised linked to the imaging of cells using nanoparticles as 
contrast agents. 
 
3.4.3 The use of nanoparticles for cell imaging 
Although one of the objectives of this chapter was to determine the location of 
the nanoparticles after internalisation, three questions were raised during the 
study: 
Ø What cell line selecting? 
Ø How can the surface modification and/or aggregation affect the cellular 
uptake? 
Ø What is the particle fate after contact with the cell membrane? 
PC3 is a cancerous prostate cell line and PNT1A is a prostate epithelial cell 
line. They were selected because of their availability in the laboratory and 
because one side project was focused on the specific targeting of PC3 using 
biopolymers (hyaluronic acid). However, it occurs that many in vitro studies are 
carried out on pulmonary epithelial cells or macrophages based on toxicological 
criteria. However, cell lines do not behave and do not respond to the presence 
of the nanoparticles in the same way. For instance, Tao et al. found that human 
T-cell lymphoma and neuroblastoma cells reacted differently to two types of 
mesoporous silica nanoparticles [Tao, 2002]: the particles elicited some toxicity 
in the first cell line, but the second was little affected by the treatment (except at 
high dosage). It is true that macrophages are the first line of defence against 
foreign bodies and as such deserved to be selected as a model for in vitro 
testing. Likewise, the selection of pulmonary cell lines makes sense when the 
particles are inhaled (anthropogenic particles, aerosol, etc.) but this choice is 
more arguable when the nanoparticles are to be injected or penetrate by a 
different route than inhalation, especially considering that most nanoparticles 
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with biomedical applications are engineered to be delay their recognition by the 
reticulo-endothelial system or for specific targeting. Furthermore, it is not 
possible to transpose the results from one cell line to the other. Here, the 
epithelial PNT1A did not take up large amount of FITC-doped particles and 
MFSNPs contrary to PC3 but it does not mean that the uptake will always be 
important in cancerous cell lines and limited in epithelial ones. There is no 
guideline as to what cell line using for in vitro study and care must be taken 
when comparing the toxicity or uptake of particles from one study to another. 
 
The results of the FITC-doped particles and the MFSNPs could not be 
compared because their diameter was different and because the MFSNPs 
expressed amine groups (and perhaps phosphonate moieties too). However, 
these two parameters may completely modify the cellular affinity for the 
particles and the particle toxicity. For example, Tao observed that the 
mesoporous nanoparticle toxicity in human T-cell lymphoma and neuroblastoma 
cells was suppressed when the surface of the particles was modified with amine 
groups [Tao, 2002]. He et al. noted that the surface modification of silica 
nanoparticles with amine and phosphonate moieties affects the uptake rate [He, 
2006]. They also showed that amine particles were internalised in higher 
amount and faster than unmodified silica particles whilst very little phosphonate-
modified particles were taken up. The imaging study ought to be carried out 
once again, this time with different surface modification to assess how the 
presence of functional groups (or ligand) affects the particle internalisation. The 
aggregation of the MFSNPs was also an issue because it was not possible to 
assess whether the aggregates observed within PC3 existed before the particle 
internalisation or were formed by intracellular processes. It is true that DLS and 
SEM showed that the particles clustered but the size of the aggregate does not 
tally with the size of the particles taken up by PNT1A. Therefore, a new study 
must investigate the fate of the particles using well-dispersed suspensions of 
nanoparticles and to assess whether or not the cells gather up the particles 
intracellularly. 
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Finally, the fate of nanoparticles after their internalisation is not well 
documented. Many studies focuses either on the mechanisms underlying the 
particle uptake or highlight how particles accumulate in endosomes and 
lysosomes based on TEM pictures. However, no study has ever followed the 
whole process from endocytosis to exocytosis, partly because tracking one or 
more nanoparticles within the cells is technically difficult and partly because 
devices keeping the cells alive and fitting into the imaging modalities are not 
widespread. Sun et al. were able to follow a single mesoporous silica 
nanoparticle before and after endocytosis and showed how the particle crossed 
the membrane using differential interference contrast microscopy [Sun, 2008]. 
Yet, this study focused on a single particle and stopped shortly after the particle 
entered inside the cell. The work of Panyam focused on both endocytosis and 
exocytosis of PLGA nanoparticles and they observed that both mechanisms 
proceed simultaneously. In addition, they found that exocytosis occurred at one 
particular region of the cells and not through the whole membrane [Panyam, 
2003]. This finding may explain why most of the nanoparticles within PC3 are 
gathered in one place, although no publication has reported such aggregation 
within cells. Chithrani was able to track the vesicles containing gold 
nanoparticles: the dynamic study by confocal microscopy showed that the 
particles are firstly gathered into endosomes and that the endosomes move 
away from the membrane into the cytoplasm where they fuse with lysosomes 
[Chithrani, 2009]. Afterward, the particles travel outward and are sent towards 
the membrane, probably in order to be exocytosed. The detection of small 
clusters close to the nucleus membrane in the images presented in this chapter 
(Figures 3-12 and 3-13) goes in that way but Chithrani’s observation does not 
provide any information that could be related to the aggregation observed in 
PC3. The MFSNPs may shed some light on the particle fate if the appropriate 
set of fluorophore is selected. For example a single dye could be used to track 
down the particles whilst a fluorophore which emission is modified by the pH 
could inform on the particles encapsulation in endosomes or lyososomes, 
where the pH is more acidic. This in turn raises the question of whether silica 
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nanoparticles are able to carry all these fluorophores. It is known that silica is 
negatively charged and hydrophilic, but some fluorophores – in particular 
emitting in the near-infrared and the two photon dyes – are said to be 
hydrophobic and as such may be difficult to entrap within the multifluorescent 
particles. In this condition, it is necessary to alter the composition of the 
particles to take into account the potential hydrophobicity of the fluorophores in 
order to design universal dye carriers. 
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3.5 Conclusion 
This chapter was divided into two parts: the development of multifluorescent 
nanoparticles following a new procedure, and the microscopy study of the 
particle uptake. The nanoparticles were obtained using the amino acid route 
and seed regrowth to produce small nanoparticles approximately 20 nm. The 
three dyes selected for this study (MB, R6G, and FITC) showed that a 
fluorophore can either be entrapped by covalent binding or electrostatic 
interactions. An interesting feature of the MFSNPs suspensions is their potential 
capacity to carry multiple fluorophores and possible tuning of their optical 
properties by controlling the type and concentration of fluorophores within the 
particles. However, this study remains exploratory and a more in-depth 
characterization of the particles properties is needed, in particular of the 
suspension stability and of the spectral homogeneity of the particles. 
The in vitro study showed that the MFSPs are potential contrast agents for the 
optical imaging of cells. It was possible to detect the particles using a confocal 
microscope and the MFSNPs were localised in the cell cytoplasm. Interestingly, 
particles containing FITC and R6G saw the signal of the two fluorophores 
overlaid, suggesting that the MFSNPs could be used for multiplexing analysing 
using different sets of dyes or by varying the ratio of fluorophore. The study also 
revealed that the particle uptake is dependent on the cell line since PNT1A 
barely internalised any particles, contrary to the large uptake of particles by 
PC3. More has to be made about the follow-up of the particles after endocytosis 
and more importantly about the toxicity of the MFSNPs, an important criterion 
whenever the application is linked to the biomedical field. 
Although the particles were able to contain FITC, R6G, and MB, it was not 
certain that interesting fluorophores such as NIR dyes, which are said to be 
hydrophobic, could be entrapped within the (hydrophilic) silica matrix. It seemed 
more judicious to alter the particle composition to take into account the possible 
hydrophobicity of the dyes. Fortunately, the sol-gel procedure allows the co-
condensation of TEOS with organosilanes, and in our particular case, certain 
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organosilane possess a hydrophobic moiety that could be of help to stabilise 
hydrophobic fluorophores. The synthesis of these organically-modified silica 
nanocarriers is the subject of the next chapter. 
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Chapter 4 
 
Synthesis of hybrid VTEOS-TEOS nanoparticles and 
surface modification for stabilisation and conjugation 
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4 Synthesis of hybrid VTEOS-TEOS nanoparticles and 
surface modification for stabilisation and 
conjugation 
 
4.1 Introduction 
Several teams have altered the original Stöber method to exert a higher control 
over the particle dimensions, to proceed in different solvents, or to replace the 
catalyst. In chapter 3, the amino acid route was tested to as a replacement to 
the traditional synthesis methods and is developed here in more into details. 
The amino acid catalysis route was firstly reported by Yokoi et al. in 2006 and is 
still in its early development [Yokoi 2006]. The Yokoi’s original work was 
inspired by the natural ability of glass sponges and diatoms (algae) to create 
complex and highly organised silica structures using peptides, proteins, and 
other biomolecules, which led them to choose L-lysine to catalyse the sol-gel 
reactions. As a result, they obtained highly ordered silica particles 12 to 23 nm 
in diameter. They also discovered that a mixture of L-lysine and D-lysine could 
tune the size of the particles. Lastly, they tested other amino acids and came to 
the conclusion that only lysine and arginine lead to the formation of 
nanoparticles owing to their basic nature. Independently, Davis and co-workers 
reached the same conclusion the same year and synthesised 1 to 8 nm silica 
particles using L-lysine [Davis, 2006]. Later, Hartlen et al. extensively studied 
the synthesis conditions of silica nanoparticles with arginine and determined the 
effects of reaction parameters (amino acid concentration, stirring rate, etc.) on 
the final structure and dimensions of the nano-objects [Hartlen, 2008]. The 
amino acid route can be completed by seed regrowth, where the initial small 
seeds are enlarged to the desired size by incremental addition of silicon 
precursor. In principle, the amount of TEOS added is directly connected to the 
final diameter of the nanoparticles and enables a fine control of the 
nanoparticles diameter [Giesche, 1994]. By this mean Hartlen augmented the 
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size of his nanoparticles from 15 nm to 200 nm by successive deposition of 
silica layers, either through the amino acid route or following the Stöber method 
for the largest dimensions. 
Yokoi has also studied with more details the mechanisms underlying the amino 
acid catalysis of silica nanoparticles [Yokoi, 2009]. SEM and SAXS (small-angle 
x-ray scattering) data indicated that the number of seeds becomes constant 
after 30 minutes and the size steadily builds up until it stabilises after 8 hours. In 
the same vein, 1H and 29Si NMR analyses showed that TEOS was completely 
hydrolysed and almost entirely consumed as the particles grew. Lysine was 
principally found at the surface of the nanoparticles rather than within the 
matrix. Yokoi’s hypothesis is that the amino acid molecules interact with the 
silanol groups at the surface of the silica spheres via electrostatic bonds and/or 
via hydrogen bonds and direct and control the particle growth. However, the 
interactions between amino acid and silicon precursor/silica are not entirely 
elucidated and remain under investigation. 
The nanoparticles synthesised following the amino acid catalysis route are 
composed of silica. Hartlen has shown that the particles can contain R6G and 
chapter 3 has shown that they could also contain FITC and MB [Hartlen, 2008]. 
However, it is unlikely that silica could be a universal carrier able to contain 
virtually any fluorophore. Due to its hydrophilic nature and overall negative 
charge, the silica matrix may repel certain dyes of interest with hydrophobic 
nature. In that case, it may be desirable to slightly modify the composition of the 
silica network and integrate an organic component with an affinity for particular 
categories of fluorophores. This class of hybrid ceramic material is referred to 
as ORMOSIL for Organically Modified SILica. ORMOSILs are generally found 
as xerogels (silica gels), but rarely as nanoparticles.  
In fact, ORMOSIL nanoparticles are produced by oil-in-water emulsion, when a 
hydrophobic fluorophore must be encapsulated within silica nanocarriers. 
Because the particle growth occur in the organic phase, the hydrophilic TEOS 
must be replaced by a hydrophobic silicon precursor, typically 
vinyltriethoxysilane (VTES), to make sure that the silane enters into the 
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micelles. This strategy is common for the production of photosensitisers- and 
luminescent dye-doped silica nanoparticles [Law, 2008; Kumar, 2008 and 2010; 
Roy, 2003]. An major contribution to fluorescent ORMOSIL particles is the work 
of Theaker et al., who co-condensed TEOS and Phenyltriethoxysilane 
(PhTEOS) following the Stöber method to encapsulate a variety of fluorescent 
dyes. They reached the conclusion that the stabilisation of fluorophores within 
the hybrid scaffold is related to the hydrophobic interactions between the planar 
rings of the biomolecules and the phenyl group of PhTEOS but also to the 
electrostatic interactions between the negatively charged silanols and the 
positive charges of certain of the fluorophores. Yet, the size of the particles was 
comprised between 400 and 500 nm and the particles were highly hydrophobic 
due to the abundance of phenyl groups [Theaker, 2008]. Vogel and co-workers 
followed a different approach to engineer fluorescent ORMOSIL by using the 
acid catalysis of sulphur-containing silane to create an emulsion, followed by a 
base-catalysed step where the hydrolysed silane reacted with rhodamine B 
isothiocyanate and formed particles 150 nm to 3 µm in size [Vogel, 2007]. From 
these studies, it seems difficult to produce ORMOSIL particles of small size, 
unless the synthesis proceeds by oil-in-water emulsion. However, the amino 
acid route may be able to solve the size problem, although it has never been 
attempted yet. 
The second role of organosilanes is to improve stability by limiting or 
suppressing aggregation and to offer an anchor for other biomolecules to bind 
to the nanoparticles. Amine-, sulphur-, and carboxylic acid-modified silanes are 
the most common coupling agents, whilst a few other commercial silanes are 
already conjugated and ready for use without additional synthesis steps such as 
PEG-silane. Most of the coupling procedures involve one of these three groups 
and the techniques developed to coat thin films and micro- or macroscopic silica 
surfaces in general are transposable to the modification of nanoparticles. 
Antibodies have been the first ligands tethered to nanoparticles due to their 
recognition of specific antigens but the relatively large size of immunoglobulins 
considerably increases the final dimensions of the conjugated particles and 
affects their stability. Smaller molecules, for example peptides, carbohydrates 
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and vitamin, and small polymers and biopolymers were later used as ligands. 
Folic acid (FA) is one of these ligands that has gained importance: FA (or folate) 
is also known as vitamin B9 or pteroylglutamic acid is involvedand it intervenes 
in the nucleic acids synthesis and in particular in the synthesis of thymine due to 
the high folate requirement of certain cancer types. For this reason, FA is found 
in a certain number of studies to target certain cancer lines (ovaries, kidneys, 
lungs, thyroid, the fallopian tube and certain other ovarian cancers [Xia, 2010]. 
To date, iron oxide, gold, quantum dots, and silica nanoparticles have been 
conjugated to folic acid to target cancerous cells in vitro [Geszke, 2011; 
Mansoori, 2010, Rosenholm, 2009; Santra, 2005 b; Zhang, 2002;]. 
Hyaluronic acid (HA) is a polysaccharide present in nearly all biological fluids 
and tissues but only in substantial amounts in soft connective tissues and in the 
extracellular matrix of vertebrae [Kogan, 2007]. Hyaluronan (other name 
encompassing hyaluronic acid and the salt form sodium hyaluronate) is involved 
in many biological processes. The size of the polysaccharide chain triggers 
distinctive phenomena ranging from space filling and anti-angiogenesis for 
larger chains to anti-apoptosis and heat shock proteins inductions for small 
fragments [Stern, 2006]. HA and its derivatives have found numerous medical 
applications, for example in ophthalmologic surgery to protect eye tissues or to 
replace vitreous fluid, in orthopaedic surgery where its rheological properties 
are suitable joints replacement, in wound healing, or even plastic surgery 
[Kogan, 2007]. HA binds to CD44 and RHAMM receptors that are 
overexpressed in certain cancer types similarly to FA and is therefore a 
potential ligand to target CD44 [Ossipov, 2010; Platt, 2008] 
 
The dyes employed in the previous multifluorescent nanostructures were three 
conventional fluorophores that are known to have a good affinity for the silica 
matrix. However, it is unlikely that the silica matrix may be suitable for all 
fluorophores, and the encapsulation of some dyes may be more challenging (in 
particular the hydrophobic dyes). A more efficient carrier may be obtained by 
altering the network composition to include regions with hydrophobic features 
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within the nanoparticles. The sol-gel chemistry allows mixing various silicon 
precursors, including organosilanes, to create hybrid inorganic-organic systems, 
or ORMOSILs, that combine the strength and robustness of silica to the 
flexibility of organic compounds. The co-condensation of TEOS with a silane 
bearing a hydrophobic moiety may favour the interactions between fluorophores 
and ceramic matrix and may be a good strategy for the encapsulation of dyes. 
However, the few studies focusing on the synthesis of ORMOSIL nanoparticles 
often yielded particles several hundred nm in diameter or require the use of oil-
in-water emulsion.  
 
 
The aim of this chapter is to design organically-modified silica nanoparticles 
with diameter inferior to 100 nm by exploiting the advantages of the amino acid 
catalysis. No fluorophore was incorporated yet because it was first necessary to 
synthesise the carrier. Still the idea was incorporate hydrophobic organic 
groups into the silica network to help stabilising fluorophores by creating 
particles with dual hydrophilic/hydrophobic nature and where dye molecules 
could locate according to their affinity. 
Consequently, the objectives were: 
Ø To verify that the amino acid route is suitable for the synthesis of 
ORMOSIL nanoparticles made of VTEOS and TEOS (referred to as VT 
hybrid). To do so, the experimental conditions (VTEOS content, amino 
acid concentration, and water content) were varied to tune both the 
matrix composition and the particle dimension.  
Ø To modify the surface of the hybrid nanoparticles using APTES and 
THPMP in order to improve the suspension stability (avoiding 
aggregation) and make the surface reactive for further modification. 
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To conjugate the surface of the VT hyrbid particles with folic acid (FA) and 
hyaluronic acid (HA) via carbodiimide chemistry to target specifically cancerous 
cells, more precisely for the targeting of PC3 cells tested in Chapter 3. 
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4.2 Materials and methods 
4.2.1 Materials 
Chemical were purchased from commercial sources and used as received 
without any treatment. Tetraethyl orthosilicate (TEOS) was purchased from 
BDH. 3-aminopropyltriethoxysilane (APTES, >98 %), L-arginine (>98 %), 
dimethylsulfoxide (DMSO), folic acid (98 %, FA), heptane, N-
hydroxysuccinimide (98 %, NHS), 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), (3-mercaptopropyl)trimethoxysilane 
(95 %, MPTMS), 2-(N-morpholino)ethanesulfonic acid (hydrate >99.5 %, MES), 
3-(trihydroxysilyl) propyl methylphosphonate monosodium salt solution (42 
wt.%, THPMP), vinyltriethoxysilane (>98 %, VTEOS) were obtained from Sigma 
Aldrich. Hyaluronic acid (HA) was acquired from Lifecore Biomedical. 1-ethyl-3-
(3-dimethylaminopropyl)-carbodiimide (EDC) and N,N'-dicyclohexylcarbodiimide 
(DCC) were obtained from Thermo Scientific and Acros Organics respectively. 
Sodium hydroxide and triethylamine were purchased from Fisher Scientific. 
Highly purified water (Milli-Q) was obtained from a Millipore “Direct-Q 3” water 
purification system. 
 
4.2.2 Nanoparticles preparation 
• Influence of VTEOS content 
Hybrid nanoparticles were prepared using the arginine-catalysed route. First, 18 
mg L-arginine was dissolved in 7 mL Milli-Q water (15 mM) and 250 µL of 
heptane. After five minutes of vigorous stirring, up to 545 µL VTEOS and 775 
µL TEOS were added, with concentrations ranging from 0 % (pure TEOS 
system) to 100 % (pure VTEOS system (Appendix C). The mixtures were 
magnetically stirred for 24 hours and the particles were centrifuged three times 
(1200 g, 15 minutes) and washed with distilled water between each step. In the 
end, the mass of particles was weight and the particles were suspended in Milli-
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Q water. The same experiments were conducted with identical conditions 1) 
without heptane or 2) at 60°C. 
 
• Variation of the synthesis conditions 
Hybrid nanoparticles made of 50 % VTEOS and 50 % TEOS (VT-50) were 
prepared by dissolving 3.2 to 64 mg of arginine in 7 mL Milli-Q (2 to 50 mM) 
(Appendix C). After five minutes, VTEOS (150, 205, or 305 µL) and then TEOS 
(215, 290, or 430 µL) were added drop wise and the solutions were 
magnetically stirred for 12 hours or 1 day if the solution remained transparent. 
The particles were centrifuged three times (1200 g, 15 minutes) with washing in 
distilled water between each step and finally suspended in Milli-Q. 
 
• Surface modification 
VT-50 nanoparticles were prepared by addition of 275 µL of VTEOS and 385 µL 
of TEOS to 7 mL of arginine solution (15 mM) and magnetically stirred for 12 
hours. Then, 5 mL of arginine solution (0.5 mM) was added to the nanoparticles 
suspension, followed by 200 µL TEOS. After 30 minutes, APTES and THPMP 
were added simultaneously (Appendix D) and the suspensions were 
magnetically stirred for additional 12 hours. The particles were recovered using 
the protocol described previously.  
 
• FA and HA modifications 
In a first protocol, three solutions containing FA (7 mg in 1.5 mL of DMSO), 
DCC (35 mg in 1.5 mL of DMSO), and NHS (4 mg in 1.5 mL of DMSO) were 
mixed before 50 mg of AP-00 hybrid nanoparticles (modification with 100 % 
APTES and 0 % THPMP) and 20 µL of triethylamine were added to the solution. 
The suspension was magnetically stirred for 4 hours, centrifuged, and left in the 
174 
oven overnight. The same experiments were carried out with AP-25 type 
particles (modification with 25 % THPMP and 75 % APTES) in water instead of 
DMSO. 
The protocol was next modified. Reagent solutions were prepared as followed: 
Ø 10 mg of FA was dissolved in 100 mL Milli-Q and produced a strong 
yellow-orange solution; 
Ø 1.5 mg and 1.6 mg of EDC and NHS were both dissolved in 100 mL of 
Milli-Q; 
Ø 2 mg of HA (11, 583, or 6457 disaccharides) was dissolved in 1 mL 
HEPES (10 mM, pH 7.0); 
To conjugate FA and HA to hybrid particles, appropriate volumes of FA, NHS, 
and EDC solutions were diluted in arginine solution (Appendix D). Then, 1 or 2 
mg of particles hybrid particles were subsequently added to the first solution 
and the reaction was left to proceed for 5 hours before the suspensions were 
centrifuged and the particles dried in an oven overnight. 
The protocol was modified one last time. FA/HA, EDC, and NHS were diluted in 
MES buffer (4.88 g of MES dissolved in 100 mL Milli-Q and the pH was 
adjusted to 5.0) and stirred for 10 minutes before addition of 25 mg of particles 
(Appendix D). The reaction was left to proceed for 5 hours before the 
suspension were centrifuged and the particles dried in an oven overnight. 
 
4.2.3 Characterisation 
• Scanning electron microscopy (SEM) 
The particle size and morphology were examined using scanning electron 
microscopy (SEM). The nanoparticle suspensions were firstly diluted: the 
samples were sonicated and subsequently 25 µL of suspension was poured in 
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an eppendorf and the total volume was increased to 500 µL with Milli-Q water 
so that the SEM samples were totally transparent. One drop of suspension was 
deposited into a silicon grid and let to dry in a desiccator for at least 24 hours. 
Finally, the particles were imaged using a high resolution FEI XL30 SFEG 
analytical SEM (Philips, Netherland). 
 
• Dynamic light scattering (DLS) 
The size and size distribution of the particles were measured by dynamic light 
scattering using a Zetasizer nano series S with an He/Ne laser of 633 nm 
wavelength (Malvern Instrument, UK). The particle suspensions were firstly 
diluted: 10 µL of the sample was poured in a quartz cuvette and completed with 
1 mL Milli-Q. The refractive index and absorption of silica nanoparticles were 
fixed at 1.25 and 0.01 respectively. For each sample, four measurements of 20 
runs (15 seconds each) were carried out, with temperature maintained at 25°C. 
 
• Fourier transform infrared spectroscopy (FTIR) 
The particle composition was analysed by infrared spectroscopy: a volume of 
nanoparticle suspension was taken, centrifuged, and dried in the oven for 1 day. 
The resulting powders were subsequently analysed in KBr powders using a 
Thermo Nicolet Avatar 370 spectrometer (Thermo Scientific). Infrared spectra 
were recorded over the wavenumber region 4000 to 400 cm-1 with a resolution 
of 4 cm-1. 
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4.3 Results 
4.3.1 Hybrid VTEOS-TEOS system 
Silicon precursors, here VTEOS and TEOS, were co-condensed following a 
modification of Hartlen’s protocol [Hartlen, 2008]. The percentage of VTEOS 
compared to TEOS was varied from 0 mol% (pure TEOS particles) to 100 mol% 
(pure VTEOS nanoparticles) by increment of 25 % and the samples were 
referred to as VT-X, where X is the molar percentage of VTEOS. In addition, the 
molar ratio L-arginine/silicon precursors/water ratio was kept as close to 
0.02/1/150 as possible while a small quantity of heptane was added to the 
solution. A few hours after introduction of the silanes the solutions became 
turbid, except the VT-00 and VT-25 systems where the solutions remained 
clear. As the content of VTEOS increased, the turbidity became more important 
and the solution turned totally white above 50 % of VTEOS while large 
aggregates of white material floated in solution in the pure VTEOS sample. 
However, the method yielded only a few mg of VT-00 and VT-25, which is 
similar to what was observed with the multifluorescent particles. Increasing the 
reaction time or reducing the water volume did little to improve the yield of the 
synthesis. 
The size and size dispersity measurements were conducted by dynamic light 
scattering (DLS): the hydrodynamic diameter graph of VT-00 and VT-25 
displayed a first peak of low intensity around 8 nm and a second more intense 
at 255 and 320 nm respectively. In comparison, the other samples displayed a 
single peak at 100, 115, and 320 nm for VT-50, VT-75, and VT-100 respectively 
(Figure 4-1). 
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Figure 4-1: Variation of hybrid particles hydrodynamic diameter in 
presence of heptane. 
 
For the first two samples (VT-00 and VT-25), the zetasizer warned that the 
conditions were not optimal – possibly due to the low particle concentration of 
the suspensions - and is corroborated by the high polydispersity index (Table 4-
1). The large hydrodynamic diameter coupled to the high polydispersity index 
indicated that the particles clustered but the actual diameter is close to 8 nm. In 
comparison, VT-50 and above were easier to analyse and exhibited a very low 
polydispersity index, but the mismatch between the hydrodynamic and mean 
number diameter suggests that VT-50 and VT-100 had formed clusters of two 
or three particles. 
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Table 4-1: Experimental data acquired by dynamic light scattering of 
hybrid nanoparticles synthesised in presence of heptane. 
Experiment Hydrodynamic diameter 
Hydrodynamic 
diameter (peak 2) 
Number 
mean 
Polydispersity 
index 
VT-00 254.4 nm 7.6 nm 6.0 nm 0.774 
VT-25 318.9 nm 8.2 nm 5.9 nm 1 
VT-50 102.2 nm X 44.8 nm 0.155 
VT-75 114.1 nm X 90.1 nm 0.031 
VT-100 317.5 nm X 243.7 nm 0.136 
 
The composition of each sample was analysed by FTIR. The spectrum of the 
pure TEOS system possesses well-defined bands at 470, 791, and 1110 cm-1 
that originate from siloxane bonds Si-O-Si, as well as a peak at 960 cm-1 due to 
the presence of silanol groups Si-OH (Table 4-2). Presence of VTEOS in the 
particles added more peaks characteristics of the vinyl moiety at 2975 (≡Si-
CH=CH2), 1600 (≡Si-CH=CH2), and 1400 cm-1 (≡Si-CH=CH2) (Figure 4-2) [Ou, 
1997]. As the proportion of VTEOS increased, the vinyl peak intensity increased 
as well in comparison to the siloxane band, although the latter remained the 
most intense. 
Table 4-2: Principal characteristic peaks on infrared spectra and related 
functional groups. 
Wavenumber Mode a Structural unit 
3060 cm-1 νas (CH2) ≡Si-CH=CH2 
2980 cm-1 νas (C-H) ≡Si-CH=CH2 
2955 cm-1 νs (CH2) ≡Si-CH=CH2 
1630 cm-1 δ (H-O-H) H2O 
1600 cm-1 νs (C=C) ≡Si-CH=CH2 
1400 cm-1 δ (CH2) ≡Si-CH=CH2 
1100 cm-1 νas (Si-O-Si) Si-O-Si 
960 cm-1 νas (Si-OH) ≡Si-O 
930 cm-1 νas (C-H) -CH2-R (residual alkoxide) 
790 cm-1 νs (Si-O-Si) Si-O-Si 
470 cm-1 δ (O-Si-O) O-Si-O 
a νs = symmetric stretching vibration; νas = asymmetric stretching vibration; δ = bending 
vibration. 
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Figure 4-2: Infrared of hybrid spectra with 50 % (red), 75 % (blue), and 100 
% VTEOS (pink). 
 
During the centrifugation of the VT-75 and VT-100 samples, some particles 
remained in the top organic phase (heptane) instead of sedimenting at the 
bottom of the tubes and consequently the experiments were repeated in 
absence of heptane (samples are referred to as VTw-X). In that case, no 
segregation between the hydrophilic and hydrophobic particles was observed. 
The hydrodynamic radius steadily augmented with the VTEOS proportion and 
the VT-00 and VT-25 curves, which is similar to what was observed when 
heptane was added to the arginine solution (Table 4-3). 
Likewise, the number diameter increased with the VTEOS/TEOS molar ratio: 
VTw-00 and VTw-25 were the smallest with diameters of 3.6 and 7.8 nm 
respectively. When the VTEOS proportion increased, the diameter rose to 113 
nm for VTw-75 and more than 440 nm for pure VTEOS nanoparticles (Figure 4-
3). The VTw-50 case has to be taken separately because of its polydispersity 
index slightly superior, which suggests that the objects detected by the 
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nanosizer were in fact small clusters of two or three particles so that the actual 
primary particle diameter was closer to 40 nm than 85 nm. 
Table 4-3: Characteristic of the particles synthesised without heptane in 
the reacting medium. 
Experiment Hydrodynamic diameter 
Hydrodynamic 
diameter (peak 2) 
Number 
mean 
Polydispersity 
index 
VTw-00 5.7 418.6 3.6 0.328 
VTw-25 6.8 658.4 7.8 0.253 
VTw-50 143.5 X 85.4 0.179 
VTw-75 142.0 X 113.9 0.022 
VTw-100 480.2 X 445.4 0.069 
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Figure 4-3: Variation of hybrid particles number diameter in absence of 
heptane. 
 
SEM validated the DLS results since the images revealed a change of particle 
diameter according to the VTEOS/TEOS molar ratio (Figure 4-4). The VTw-00 
and VTw-25 samples were the smallest and their dimensions were close to 10 
to 13 nm respectively, larger than the value measured by the zetasizer. In 
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comparison, VTw-50 nanoparticles were 40 nm in size, smaller than the value 
detected by light scattering. The dimension of particles shifted to 110 and 480 
nm for 75 and 100 % VTEOS in that order and are in good agreement with the 
DLS measurements. Two populations of particles co-exist on the SEM pictures 
because of cross-contamination during the SEM sample preparation. The 
pictures were selected nonetheless to highlight the difference of size that arises 
from a modification of VTEOS concentration. Other TEM images of VTw-100 
confirmed the large particle size in comparison to the other hybrids (data not 
shown) whilst the 40 nm diameter of VTw-50 is in agreement with the SEM 
images displayed later in this chapter. 
  
Figure 4-4: SEM micrographs of hybrid VTEOS-TEOS silica nanoparticles 
with 75% (left), and 100% VTEOS (right) in absence of heptane. 
 
4.3.2 Variation of the experimental conditions 
Other parameters than the VTEOS content were varied owing to their potential 
influence on the final particle dimensions. Stirring rate and reaction time were 
the first parameters probed: VT-50 particles were synthesised with the stirrer 
set at different speeds and aliquots (10 µL) were taken for light scattering 
measurement at periods ranging from 30 minutes to 2 or 3 days. At the two 
slowest speeds (300 and 600 rpm) values as high as 280 and 300 nm were 
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measured during the first hours but vanished after the fifth hours (Figure 4-5). 
After 5 to 10 hours, the zetasizer detected a signal but the seed diameter was 
centred around 20 nm and constantly grew until their size stabilised at circa 60 
nm after about 30 hours. At higher speed (900 and 1200 rpm), the seeds 
appeared after 3 hours and reached the same threshold of 60 nm after 8 hours. 
Hence, the stirring rate seems to alter the particle formation kinetics rather than 
the diameter itself. However additional electron microscopy analyses are 
required to confirm that the nanoparticles maintain identical size. 
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Figure 4-5: Variation of the particles diameter with time and in function of 
the stirring rate. 
 
Other parameters of importance are the water and arginine concentrations. 
Silica-to-catalyst and silica-to-solvent molar ratios were attributed three values. 
The water volume was kept equal to 7 mL in all experiments and all structures 
were based on the VT-50 type. The first difference is the striking contrast time 
required to form the particles: at to obtain translucent solutions. Conversely, at a 
highest concentration of catalyst and lower concentration of water, the solutions 
became opalescent within a few hours of stirring. DLS measurements showed 
that lower arginine concentration yields particles with higher number diameter - 
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from 65 to 95 nm – whilst at higher concentration the particle diameter ranged 
between 25 and 40 nm (Figure 4-6). In all cases, the polydispersity index was 
inferior to 0.1 which means that the zetasiser measured the diameter of primary 
particles and not of clusters. It was not possible to image the particles by SEM 
(breakdown during several months) but these analyses are necessary to assess 
the particle diametre. In addition, the experiments were not carried out enough 
times (three times each) to be considered reproducible and more time has to be 
devoted to this part. 
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Figure 4-6: Particles diameter variations in function of arginine and water 
concentration. 
 
In fact, the study was halted because an issue arose when a new VTEOS 
solution was used. First of all, the formation of silicic acid and of nanoparticles 
occurred within a few minutes while it required at several hours for the solutions 
to turn white previously. Secondly, the DLS curves differed significantly and the 
values increased to the micrometer range in almost all cases. Lastly, SEM 
pictures confirmed the high particle diameter and showed that in certain cases 
the particles shape was totally different and took on the form of “cups” (Figure 
4-7). 
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Figure 4-7: SEM pictures of VT-50 particles with arginine/silica/water ratio 
of 0.01/1/200 (left) and VT-75 (right) with the new VTEOS solution. 
 
For the moment, it is not possible to determine whether the process is 
reproducible or not. There are strong evidences that the VTEOS solution was 
responsible for the change of morphology as the phenomenon was not 
observed on other hybrid (PhTEOS, THPMP, etc.) and because the spherical 
shape is in principle the most energetically favourable. One hypothesis could be 
that the solution was contaminated or altered and it is therefore required to 
synthesise new VT hybrids with different commercial VTEOS solutions or by 
varying the VTEOS concentration in comparison to TEOS. This is the only way 
to ensure that the process yields spherical particles and that the first results are 
the genuine particles. 
 
Overall, the light scattering data of VT-50 samples (first samples) indicated a 
tendency for the particles to cluster. Aggregation is a common issue for 
nanoparticles and since the hybrid ones appear to be prone to this 
phenomenon, the next stage of development consisted in modifying the particle 
surface to make the suspension more stable and to progressively move towards 
their functionalisation. 
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4.3.3 Surface modification with APTES and THPMP 
Aminopropyltriethoxysilane (APTES) was first chosen as coupling agent 
because it is the most common organosilane and its amine groups make it a 
powerful coupling agent. The hybrid seeds were synthesised based on the VT-
50 protocol and the organosilane was added directly after the synthesis of the 
particles (no centrifugation). It seemed that more material was produced after 
addition of APTES compared to bare hybrid particles. At the same time, 
sedimentation was more pronounced and occurred faster than unmodified 
particles. DLS measurements indicated a high PdI and the SEM images 
displayed highly aggregated particles (Figure 4-8).  
  
  
Figure 4-8: SEM pictures of silica nanoparticles after coating containing 1 
% APTES (A and B), 25 % (C), and 50 % (D). 
 
A) B) 
C) D
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The smallest concentration of amine (1 % of the total silane concentration) led 
to small clusters but as the APTES-to-TEOS molar ratio increased, aggregation 
became more and more important and SEM pictures displayed large 
aggregates. 
The infrared spectra after modification were different from that of unmodified 
VT-50: the intensity of the vinyl bands was somewhat lessened. A strong band 
appeared between 3500 and 3000 cm-1 as well as another peak around 1550 
cm-1 confirmed the existence of the amine groups in or onto the particles, 
although this second peak was exclusively present at high APTES 
concentration (Figure 4-9). 
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Figure 4-9: FT-IR spectra of nanoparticles after modification with 
increasing concentration of APTES. 
 
To reduce the aggregation phenomenon, 3-(trihydroxysilyl) propyl 
methylphosphonate (THPMP) is generally co-condensed with APTES to 
counteract the action of hydrogen bonds by bringing negative charges that 
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promote the repulsion between nanospheres. Coatings with different 
proportions of APTES and THPMP were tested on VT-50 seeds and are 
referred to as AP-X, where X is the percentage of THPMP compared to APTES. 
DLS measurements showed that the increasing the THPMP content reduces 
the hydrodynamic diameter of the particles (Figure 4-10). Yet, the 
polydispersity index value of 0.2 of AP-75 and AP-100 suggest that small 
clusters of two to three particles were still present in solution and are 
comparable to unmodified VT-50 nanoparticles. 
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Figure 4-10: Hydrodynamic radius of hybrid particles after modification 
with increasing proportion of THPMP. 
 
SEM pictures highlighted that: the presence of phosphonate at the surface 
improves the stability of particles. Where the aminated particles were strongly 
aggregated, samples with THPMP formed clusters made of a smaller number of 
particles and this number decreased with at high THPMP concentration up to 
the point that single particles 40 to 50 nm in diameter were present in the 75 % 
THPMP sample (Figure 4-11).).  
 
188 
 
 
 
Figure 4-11: SEM of nanoparticles of AP-00 (A and D), AP-50 (B et E), et 
AP-75 (C and F). 
A) B) 
C) D) 
E) F) 
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Infrared analyses provided little information about the presence or absence of 
phosphonate. A piece of the xerogel was dried in the oven and analysed by 
FTIR (Figure 4-12) and the spectra were compared to the principal bond 
vibrations from the literature (Table 4-4) [Pezzin, 2008; Bowen, 1988; 
Shagidullin, 2007]. The siloxane bands overlap with most of the key peaks of 
the phosphonate moiety and hinder its identification, even with AP-100, where 
only THPMP is added. As a result, the infrared spectra of silica nanoparticles 
before and after reaction with organosilanes were similar, with a small signal 
from APTES but no obvious sign of THPMP (Figure 4-13). 
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Figure 4-12: Infrared spectra of THPMP xerogel and characterisation of the 
major peaks and bands. 
 
Additionally, THPMP may form a gel very quickly and its high viscosity that is 
not ideal for dilution and homogeneous reaction with the particles. Therefore, 
there are high chances that the modification with THPMP failed and would 
explain why the unmodified particles are similar to that after modification with 
the phosphonate-silane. The best method to detect the modification is in that 
case by measuring the zeta potential of the particles as THPMP-modification 
generates a strong negative charge whilst APTES generates a positive one. 
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Table 4-4: Principal characteristic peaks on infrared spectra and related 
functional groups. 
Wavenumber Mode a Structural unit Wavenumber Mode 
a Structural unit 
2998 cm-1 δs (CH3-P) ≡P-CH3 
1026 cm-1 νas (Si-O-
C) Si-O-CH2-CH2- 
2930 cm-1 δs (CH3-P) ≡P-CH3 916 cm
-1 ρ (CH3-P) ≡P-CH3 
1420 cm-1 δas (CH3-P) ≡P-CH3 895 cm
-1 ρ (CH3-P) ≡P-CH3 
1316 cm-1 δs (CH3-P) ≡P-CH3 824 cm
-1 ν (P-O) O=P-OH 
1244 cm-1 ν (P=O) ≡P=O 791 cm-1 ν (PO2) O=P-OH 
1074 cm-1 νs (Si-O-C) Si-O-CH2-CH2- 768 cm
-1 νs (P-O-C) -CH2-CH2-O-P 
1050 cm-1 νas (P-O-C) -CH2-CH2-O-P 714 cm
-1 ν (P-C) ≡P-CH3 
a νs = symmetric stretching vibration; νas = asymmetric stretching vibration; δ = bending 
vibration, ρ = rocking. 
Moreover, the zeta potential value is directly correlated to the aggregation as a 
strong charge typically prevents the phenomenon from occurring. As the 
reaction with coupling agent is crucial for conjugating nanoparticles with ligands, 
the experiments must be repeated to measure the zeta potential of the 
suspensions and verify whether the two organosilanes have reacted with the 
particles. 
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Figure 4-13: Infrared spectra of hybrid particles after modification with 
APTES and THPMP at different molar ratio. 
0 % THPMP 
25 % THPMP 
50 % THPMP 
75 % THPMP 
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4.3.4 Bioconjugation with FA and HA 
In the last part, the conjugation of FA and HA was attempted using carbodiimide 
chemistry (Appendix E), where the aminated nanoparticles were reacted with 
one of the two biomolecules in presence of 1-ethyl-3-(3-dimethylaminopropyl)-
carbodiimide (EDC) and N-hydroxysuccinimide (NHS). The chemical structure 
of FA is divided into three parts: a pterin ring (PT), para-amino benzoic acid 
(PABA) and glutamic acid (Figure 4-14) [Zhang, 2002 and 2008; He, 2009 c]. 
N
N N
N
OH
H2N
N
H
O
N
H
OH
O
OHO
Pterin Para-aminobenzoic acid Glutamic acid  
Figure 4-14: Chemical structure of folic acid that is divided into a pterin 
ring, para-aminobenzoic acid (PABA), and glutamic acid. 
 
The complex structure of vitamin B9 gives rise to an elaborate infrared 
spectrum (Figure 4-15) but only few peaks are likely to appear after conjugation 
with the nanoparticles (Table 4-6), namely the benzene ring (1483 cm-1) as well 
as the hydroxyl (3540 cm-1) and amine moieties (3414 cm-1) of the pterin part. 
Moreover, the carboxylic acid peak around 1690 cm-1 should disappear after 
reaction with the aminated surface of the nanoparticles. 
192 
44
8.
1
45
07
.5
4
59
3
.9
7
63
6.
10
65
4.
3
6
68
2
.9
0
76
5.
478
1
7.
87
83
9.
3
09
21
.4
0
97
2.
3
7
10
38
.0
2
11
05
.5
1
1
13
4
.6
6
11
60
.5
9
1
19
2
.7
71
22
8
.0
9
12
89
.7
6
13
37
.5
5
14
13
.5
0
14
5
3.
0
5
14
83
.8
9
15
1
8.
8
2
15
45
.6
7
15
6
9.
8
1
16
05
.0
4
16
3
8.
8
3
16
93
.2
2
2
92
6
.2
9
31
03
.6
8
3
32
2
.5
6
34
14
.9
2
35
42
.9
7
-15
-10
-5
 0
 5
 10
 15
 20
 25
 30
 35
 40
 45
 50
 55
%
T
ra
ns
m
itt
a
nc
e
 500    1000   1500   2000    2500   3000   3500   4000   
Wavenumbers (cm-1)
OH (pteryl) 
NH2 (pteryl) 
COOH (glutamic) 
NH- (PABA) 
Phenyl (pteryl) 
 
Figure 4-15: Infrared spectra of pure folic acid. 
 
Table 4-5: Principal band appearing on the infrared spectrum of folic acid. 
Wavenumber Descriptiona Structural unit 
3543 cm-1 ν (O-H) hydroxyl (glutamic acid) 
3416, 3324 cm-1 ν (N-H- - - H) NH2 (pterin) 
2959, 2924, 2844 cm-1 ν (C-H) and νs (C-H) CH2 
1694 cm-1 ν (C=O) COOH 
1640 cm-1 ν (C=O) COOH 
1605 cm-1 δ (NH2)   (bending) NH2 
1484 cm-1  Phenyl ring 
1411 cm-1 ν (O-H) OH (phenyl skeleton) 
a ν = stretching vibration, δ = bending vibration. 
 
HA has a different structure consisting in the repetition of D-glucuronic acid and 
N-acetyl-D-glucosamine units bound by β 1-3 and β 1-4 linkages (Figure 4-16) 
[Hargittai, 2007]. For the purpose of this study, three chain sizes were selected: 
11 disaccharides units (HA 11), 583 units (HA 583), and 6457 units (HA 6457). 
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Figure 4-16: Chemical structure of the D-glucuronic acid and N-acetyl-D-
glucosamine units that constitute hyaluronic acid. 
 
The infrared spectrum of HA is simpler than that of FA(Figure 4-17): the 
principal reactive groups of the monomer are the carboxylic and amide groups 
as well as the glycosidic bond linking glucuronic acid and N-acetyl-D-
glucosamine (Table 4-7) [Alkrad, 2003; Donghui, 2006]. 
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Figure 4-17: Infrared spectra of pure hyaluronic acid. 
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Table 4-6: Principal characteristic peaks on infrared spectra and related 
functional groups. 
Wavenumber Mode Structural unit 
3395 cm-1 ν (NH), ν (OH) OH and amide groups 
2916 cm-1 ν (CH) C-CH2-C 
1615 cm-1 δ (NH) Amide II and carboxyl 
1411 cm-1 ν (CN) and δ (NH)  Amide III 
1377 cm-1 ν (C=O) Carboxyl -COOH 
1044 cm-1 ν (C-O) C-O-C  
945cm-1 δ (O-H) and ν (C-C) C-O-C (ring) and OH 
612 cm-1  ω (N-H)  Amide I 
a ν = stretching vibration,  δ = bending vibration, ρ = rocking: ω = wagging. 
 
The conjugation protocol was based on Santra’s procedure and was gradually 
modified [Santra, 2005 b]. Initially, higher concentrations of folate, carbodiimide, 
and NHS than in Santra’s protocols were used to initiate the esterification of the 
FA with NHS [Santra, 2005 b]. N,N'-dicyclohexylcarbodiimide (DCC) was used 
instead of EDC because this compound was available in the laboratory. In all 
cases, the suspensions had acquired a strong yellow colour characteristic of 
folic acid, but the high quantity of the ligand may result in adsorption rather than 
actual bonding with the amine moieties. Yet, some of the infrared spectra of the 
nanoparticles exhibited two very intense peaks at 1626 and 1574 cm-1 that 
replaced the 1690 and 1640 cm-1 peaks seen in the FA spectrum. These 
changes at 1626 and 1574 cm-1 are respectively caused by the C=O stretching 
vibration and the C-N stretching vibration of the amide group (Figure 4-18). 
When the NHS, DCC, and FA/HA concentrations were decreased to match 
Santra’s protocol, no significant changes on the particle spectra were observed 
in the infrared spectra and the conjugation failed. Consequently, the 
experiments were attempted once again under different conditions, in particular 
EDC was used instead of DCC and the arginine solution that was originally 
chosen was replaced by MES buffer (pH 5.5) because the reaction between FA 
and NHS is pH-dependent and the optimal conditions are between pH 4 and 6. 
New peaks appeared at 1700, 1680, 1535, and 1484 cm-1 (Figure 4-19). The  
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Figure 4-18: Infrared spectra of folic acid (red), hybrid particles with a 25 
molar% APTES coating (blue) and FA-conjugated hybrid particles (pink). 
 
peak at 1700 cm-1 corresponds to the carboxylic acid group (C=O stretching) of 
folic acid whilst the small peak at 1484 cm-1 is attributed to the phenyl ring of the 
same molecule [Zhang, 2008; Asadishad, 2010]. Unfortunately, none of the 
changes are the sign of a covalent bonding of FA to the nanoparticles 
(amidification) but are due to the adsorption of molecules onto the particles 
[Kong, 2007]. Variation of the EDC, NHS, and FA concentrations gave similar 
results and it was not possible to evidence the actual conjugation of FA (and 
HA) on the nanoparticles. It seems that the conditions were not optimal for the 
formation of amide groups, meaning that the experiments must be carried out 
again to detect what part of the process prevent the bioconjugation from 
occurring. 
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Figure 4-19: Infrared spectra of amine-modified hybrid particles (red) and 
AP-00 (blue), AP-25 (pink), AP-50 (green), and AP-75 (purple) 
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4.4 Discussion 
The process developed by Yokoi, Davis, and Hartlen is very flexible [Davis, 
2006; Hartlen, 2008; Yokoi, 2006] and this thesis reports for the first time the 
synthesis of amino acid-catalysed ORMOSIL nanoparticles. The choice of 
VTEOS stemmed from the idea of designing a structure with both hydrophilic 
and hydrophobic properties: since the amino acid catalysis is a one phase 
system where water is the only solvent, it was hypothesised that the 
hydrophobic VTEOS would seek protection from water and hence would create 
the core of the nanoparticles. TEOS would then surround the newly formed core 
in a sort of hydrophobic core-hydrophilic shell. 
 
4.4.1 Structural characterisation of the hybrid particles 
Since VTEOS and TEOS react differently with water, it seemed plausible that 
the VTEOS-TEOS molar ratio may affect the dimensions of the final particles. 
The first experiments showed a variation of the particle diameter with a change 
of VTEOS percentage: the original 10 nm seeds made of TEOS grew larger as 
the VTEOS/TEOS ratio increased and reached 115 nm with 75 % of VTEOS 
and more than 200 nm for pure VTEOS particles. VT-00 and VT-25 were 
produced in very small quantities even when the reaction time was prolonged 
up to two tor three days. This phenomenon was already observed in chapter 3 
where 1 to 2 mg of seeds was produced but it is not clear why the yield is so 
small. Light scattering measurements indicated that the polydispersity indexes 
of VT-00 and VT-25 were high but the hydrodynamic diameter curves 
nonetheless indicated that the particles were circa 10 nm in diameter. This 
value is in agreement with what other studies using arginine and lysine reported 
(1 to 20 nm in diameter). 
Interestingly, several tens of mg of VT-50, VT-75, and VT-100 were produced 
within 10 to 12 hours every time that the experiments were repeated. At the 
198 
same time, the particle size varied greatly from one composition to another. For 
instance, the hydrodynamic diameter of VT-75 was circa 115 nm (actual 
diameter close to 90 nm) with a polydispersity index of 0.1 characteristic of well-
dispersed suspension. In contrast, VT-100’s hydrodynamic diameter was closer 
to 300 nm (actual diameter around 250 nm) without aggregation. VT-50 
nanoparticles were about 45 nm but the polydispersity index slightly superior to 
0.1 is the sign of the formation of small clusters of 2 or 3 particles. This 
tendency was confirmed by electron microscopy since the images displayed 
numerous aggregates with VT-50 that were not observed with VT-75 and VT-
100. Infrared spectroscopy confirmed the dual nature of the particles with the 
siloxane band(1200 to 1000 cm-1) and vinyl peaks (1400 and 1600 cm-1). The 
intensity of the vinyl peaks increased with increasing the VTEOS/TEOS molar 
ratio but remain less intense than the siloxane band in all cases.  
At the beginning, heptane was added to the arginine solution because its 
presence supposedly slows down the hydrolysis of TEOS and favours the 
formation of a larger number of small nuclei [Hartlen, 2008]. This strategy is not 
suitable when a hydrophobic precursor is used because it splits the particles 
between hydrophilic and hydrophobic ones and induces segregation during the 
centrifugation step. This may be due to the fact that some particles with a high 
content of VTEOS must have formed in heptane rather than in water and the 
high density of vinyl moiety in these particles has imparted hydrophobicity. 
Therefore, when the suspensions were centrifuged, the hydrophobic 
nanoparticles were trapped between the organic phase and water. To 
synthesise homogeneous suspensions, heptane was suppressed. This time, no 
segregation was observed after centrifugation of all of the suspensions. DLS 
measurements and MEB images showed no significant difference with and 
without heptane, apart from VT-100 where the particle diameter nearly doubled. 
Infrared spectra of the particles were similar, indicating that the composition of 
the hybrid were unaffected by the change of conditions.  
The VTEOS content exerts a strong influence over the nanospheres size and 
potentially on the hydrophobicity nature of the particles. It is unknown why VT-
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75 and VT-100 changed so much but it might pertain to the high content of 
VTEOS and the use of water as solvent. More importantly, the amino acid route 
appears as an alternative to oil-in-water emulsion for the synthesis of ORMOSIL 
nanoparticles of small dimensions, though the experiments have focused on 
VTEOS only. Of the five compositions, VT-50 nanoparticles appeared as the 
most interesting due to their smaller size compared to VT-75 and because they 
were produced in larger amount than VT-00 and VT-25. For this reason, VT-50 
was kept as the base structure for the next experiments. 
 
4.4.2 Modifications of the experimental conditions 
Since the reactions leading to the generation of nanoparticles remain sol-gel 
reactions, it is possible that the variation of parameters such as arginine 
concentration or water content could alter the particle diameter and/or 
composition. The stirring rate was selected as one such parameter and it also 
serves to assess the particle formation kinetics. Without stirring, silanes and 
water are not miscible and the hydrolysis of TEOS and VTEOS occurs at the 
interface between the two phases at a very slow pace. These conditions are 
impracticable since it would take too much time to eventually obtain the 
nanoparticles. The hydrodynamic and number diameters of VT-50 for all stirring 
speed converged towards the same values of 140 and 70 nm respectively. The 
polydispersity index of 0.179 indicated that in all cases, small clusters of VT-50 
nanoparticles (primary particle diameter between 40 and 50 nm). The principal 
difference is the time necessary to reach the size threshold: the final particles 
were obtained after 8 to 10 hours at higher speed but take more than 24 hours 
at the lowest stirring speeds. The conclusion is that the stirring rate affects the 
time necessary to synthesise the hybrid seeds but not their dimensions and is 
not a parameter of influence when it comes to the structure of the seeds. 
However, the morphology of the particles must be studied with more details 
because they may lose their smooth spherical shape as noted by Hartlen 
[Hartlen, 2008]. 
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Conversely, it was expected that the reagent concentrations - silanes, catalyst, 
and water – would have the deepest impact. It is well-known that these 
concentrations govern the size of the pores in gels and the diameters of 
sols/particles. The silica-to-arginine molar ratio was varied from 0.01 to 0.1 and 
the silica-to-water ratio from 100 to 200 whilst the volume of water was kept 
constant. The particle hydrodynamic and number diameters were larger at the 
highest arginine concentration and smaller at the lowest. The pH of all solutions 
fluctuated between 10 and 10.3 and could not be responsible for the changes 
and it is more likely that the number of arginine molecules in solution is directly 
connected to the variation of diameter. One hypothesis is that at low arginine 
concentration a limited number if nuclei are formed owing to an insufficient 
number of arginine molecules, and the remaining TEOS and VTEOS molecules 
are free to enlarge the seeds. The influence of water is less obvious since the 
diameter remain approximately the same at fixed arginine concentration. More 
experiments are required to clearly assess the influence of arginine and water 
because the particle shape changed when a new VTEOS solution was used. 
The Zetasizer detected micrometric particles in solution and MEB images 
displayed cup-shaped objects for each arginine and water concentrations. In 
absence of additives such as surfactant or growth-directing agents, it seems 
unlikely that the cup-shaped particles could be formed, especially because the 
sphere is the most energetically favourable form for the growth of particle in 
solution and because the co-condensation of TEOS with APTES, THPMP, or 
phenyltriethoxysilane (PhTEOS) as discussed in the next chapter did not create 
such shape. The VTEOS solution may have been contaminated at some point, 
which may explain the sudden change of morphology of the particles 
[Champion, 2007; Gratton, 2008].  
It is not yet possible to affirm that the protocol is reproducible so long as the 
mechanism that led to the cup shape has not been elucidated. There are strong 
evidences that the initial small particles are the genuine particles and that the 
latter results are the products of some contamination of the VTEOS solution. 
From the preliminary results, the arginine catalysis seemed to confine the 
particle diameter below 100 nm and the arginine concentration appeared as the 
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parameter inducing the more significant variations of the nanoparticle 
dimensions. This must be compared to the Stöber method, where small 
variations of ammonium hydroxide may totally change the size of the final 
particle. However, the experiments must be repeated and the DLS 
measurements must be coupled to SEM and TEM images to clearly measure 
the diameter of the particles. Other techniques such as small angle x-ray 
scattering (SAXS) and RMN ought to be carried out to elucidate the kinetics of 
particle nucleation and how VTEOS and TEOS interact one with the other in the 
first steps. 
  
4.4.3 Surface modification and bio-conjugation 
Particle agglomeration and aggregation is a problem encountered with many 
nanomaterials. Here, it has been shown that VT-50 formed small clusters of a 
few primary particles but well-dispersed particles are usually preferable. Thus, 
the strategy consisted in modifying the surface and introducing groups that 
would promote the repulsion between particles. Additionally, some of the groups 
can be used as a way to conjugate ligands to the particles for specific targeting. 
In the case of silica-based systems, silicon precursors bearing sulphur, 
carboxylic, amine, and other organic groups can easily condense onto the 
silanol groups expressed at the surface of the particles. Here, APTES was first 
chosen and added to the VT hybrid suspensions after the particles were 
formed. The changes in the suspensions are immediately noticeable: during the 
centrifugation step, the supernatant was immediately clear and the quantity of 
material collected nearly doubled compared to the basic hybrid seeds. DLS 
measurements showed the presence of large particles in suspension, which 
was corroborated by SEM images that depicted highly aggregated samples. In 
other terms, the addition of APTES promoted the aggregation of the particles 
rather than their stabilisation. 
The phenomenon has been rarely evoked in the literature, in spite of the 
extensive use of APTES and other aminated silanes to modify silica surfaces. 
202 
Bagwe et al. solved this issue and figured out that the amine groups bind to the 
silanol groups via hydrogen bonding [Bagwe, 2006]. Besides, the amine groups 
are positively charged and are attracted by the negatively charged silanols so 
that the outcome is a strong aggregation between particles. In the same study, 
they advocated the use of a second silane with a longer chain and a negatively 
charged group that can insert between amines and silanols to counteract the 
attraction between nanospheres (Figure 4-20). To prove their point, they co-
condensed APTES with the phosophonated silane THPMP and showed that 
increasing THPMP proportion in comparison to APTES decreases the 
hydrodynamic radius and that the zeta potential of the system moves towards 
lower values and stabilise the suspensions. The only requirement for a 
successful condensation of the organosilane onto the silica sphere is that some 
TEOS is reacted with the colloidal suspension about 30 minutes before APTES 
and THPMP [Deng, 2000]. 
 
Figure 4-20: Hydrogen bond between amine and silanol at the surface of 
nanoparticles and action of PO4 inserted on the aminated particles. 
 
Based on these findings, the two organosilanes were tested and both DLS and 
SEM tallied on the reduction of aggregation as THPMP concentration 
increased. One point remained obscured but could not be assessed: FTIR is not 
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sensitive enough to clearly detect the presence of phosphonate if THPMP 
condensed onto the particles (the IR peaks are hidden by the more intense 
siloxane bands). Since the presence of THPMP onto the particles remains 
hypothetic it is unclear whether the change of stability is linked to the 
phosphonate moieties or to the decreasing amount of APTES. Zeta potential 
measurements must be performed to follow the modification surface because 
the presence of phosphonate would lower the potential of the suspension. Zeta 
potential would also indicate whether the particle suspensions are stable or not. 
Since the presence of APTES was certain, the bio-conjugation with FA and HA 
was attempted with the aim of specifically targeting cancerous cells. Folic acid 
(FA) was selected for its availability and because some studies suggest that FA 
can be use as a targeting agent. Hyaluronic acid was chosen for its capacity to 
link to CD44 receptors that are overexpressed in a number of cancers. The two 
molecules possess carboxylic acid groups and can react with aminated surface 
via carbodiimide chemistry. The first attempt with FA saw the appearance of 
peaks common to the nanoparticles and to folate, but also two intense peaks 
related to amide functions while the carboxylic acid peak of FA was no longer 
observed. Yet, amount of FA in the protocol was too high in comparison to the 
protocols detailed in the literature but it was impossible to detect any sign of 
amidification when the concentration of EDC, NHS, and FA were reduced. The 
mistake was to employ arginine solution and water as solvent. The reaction 
between EDC and the carboxylic acid of FA is pH-dependent and optimal 3.5 
and 5.5 and the amine groups must be in their protonated state to react with the 
unstable O-urea [Nakajima, 1995]. The pH of arginine solution and pure water 
was too high to allow the reaction between amine and carboxylic acid to occur, 
plus the amine and carboxylic acid groups of arginine may interfere with EDC 
and FA.  
MES was next used as a solvent to set the pH to a value of 5.5. A few changes 
were visible in the infrared spectra but the new peaks correspond to adsorbed 
or residual FA that was not washed away after centrifugation (solubility of folate 
in water is limited). The protocol developed in this thesis failed at conjugating 
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the biomolecules to the hybrid particles. More experiments with increased 
concentrations of FA and/or of EDC and NHS or adjusting the MES buffer pH to 
4.5 to 5 may help in reacting carboxylic acid and NHS. Additional 
characterisation using thermogravimetry and electrophoresis could prove 
whether the coating of biomolecules is present or not. In particular, 
thermogravimetry may be sensitive enough to quantify the FA and HA density 
on the particles. 
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4.5 Conclusion 
In this chapter, a novel method to synthesise ORMOSIL has been explored 
which appeared simpler (one phase system) and cleaner (no surfactant and 
organic solvent) than the oil-in-water emulsion. The hybrid particles were made 
of TEOS and of the hydrophobic VTEOS and their diameter appeared larger 
than that reported with pure silica nanoparticles, although the size remained 
secluded below or slightly above the 100 nm-threshold. Of the five compositions 
tested, VT-50 appeared as the most promising due to its hydrophilicity and to its 
diameter of about 45 nm. Although the effect of each parameter remain to be 
studied for the VT-50 particles, it occurred from the preliminary results that 
arginine concentration and water content variations do not induce large 
variation of the particle sizes.  
Another aspect discussed in this chapter was the surface modification and the 
subsequent attempt to coat the particles with folic acid and hyaluronic acid. It 
was found that the use of APTES as coupling agents form amine groups at the 
surface of the particles but at the same induce a strong aggregation. In theory, 
the formation of hydrogen bonding can be countered by the addition of THPMP, 
but no phosphonate was detected with the characterisation techniques used in 
this study. The surface modification was not successful and requires more time 
to be refined as well as more characterization. This step is as important as the 
carrier because it is the bioconjugation of the nanoparticles that will decide of 
the application and allows specific targeting and specificity.  
Despite of this problem, this chapter has seen the elaboration of ORMOSIL 
nanoparticles with a dual hydrophilic/hydrophobic nature. The idea is that the 
dual nature would help stabilising the fluorophores by providing an environment 
suitable to any dye regardless of its affinity for water. In particular, considering 
that the particle growth proceeds in water, t is expected that hydrophobic dye 
would go preferentially into the vinyl-rich regions of the particles. Now that the 
particle is ready, the carriage capacity and optical properties must be assessed. 
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5 Applicability of the VTEOS hybrid particles to the 
carriage of organic fluorescent dyes 
 
5.1 Introduction 
Despite its promises, the capacity of silica nanoparticles to entrap fluorophores 
may be limited by its hydrophilic nature and the negative charge of its network. 
The fluorophores used in Chapters 2 and 3 were hydrophilic (or partially 
hydrophilic in the case of rhodamines), or sylilated to make the encapsulation 
easier. The effect was more obvious in the case of reverse microemulsions 
where the fluorophores were not able to penetrate within the micelles. A quick 
review of the FSNPs literature reveals that few of them are employed in 
comparison to the wide diversity of fluorescent dyes available and that: 
lanthanide chelates and isothiocyanate/maleimide derivatives of fluorescein and 
rhodamine represent the majority of the dyes studied. The entrapment of NIR 
dyes, and two-photon dyes is gaining momentum both as labels and 
photosensitisers but mostly via oil-in-water microemulsions towing to the 
hydrophobic nature of the dyes [Bertazza, 2006; Herz, 2009; Miletto, 2010]. 
Very few articles report the encapsulation of conventional fluorophores such as 
Nile red, crystal violet, or even rhodamine B and rhodamine 6G [Mader, 2008; 
Qin, 2008; Sokolov, 2008; Theaker, 2008; Wang, 2009].  
 
There are two major procedures which can facilitate the incorporation of 
fluorophores within silica nanoparticles. The first requires the chemical 
modification of fluorophores for subsequent covalent binding with organosilane 
[Gao, 2009; Ha, 2009; He, 2007; Langhals, 2009]. Chemical modification of a 
fluorophore is often a heavy and complex procedure and this approach is 
usually discarded to the profit of more standard solutions. The second 
procedure uses an oil-in-water emulsion to produce ORMOSIL structures, 
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mostly for the encapsulation of hydrophobic compounds. Yet, oil-in-water 
emulsions face the same weaknesses as reverse microemulsion (organic 
solvent and surfactant, risks that the precursor or fluorophore are not soluble 
enough in the desired phase, etc.). The absence of a “universal” method to 
encapsulate fluorophores regardless of their hydrophobic or hydrophilic nature 
may explain why the design of multifluorescent nanoparticles is rarely reported. 
There are reports of microspheres loaded with quantum dots, but not with silica 
nanoparticles. The only major contribution to the synthesis of multifluorescent 
particles is the FRET system designed by Wang and Tan [Wang, 2005 b]. 
These particles contain 5-carboxyfluorescein, succinimidyl ester, 5-
carboxyrhodamine 6G, succinimidyl ester, and 6-carboxy-X-rhodamine, 
succinimidyl ester at different ratio to modulate the spectral signature of the 
nanospheres. Nakamura et al. were able to co-encapsulate similar succinimidyl 
esters into submicrometric nanoparticles [Nakamura, 2007] but generally 
speaking multifluorescent nanoparticles with more than two fluorescent dyes 
remain ill-explored. 
 
Development of a silica-based nanoplatform hosting multiple fluorophores 
simultaneously may be interesting multifunctional systems. The first application 
would be as a contrast agent for imaging: the combination of two or more dyes 
ascribes unique signature to the nanoparticles than can advantageously be 
used to image different targets simultaneously (multiplexing), for instance to 
distinguish different cell population in a sample or different organelles in single 
cells. Wang’s FRET system was to monitor Escherichia coli, Salmonella 
typhimurium, and Staphylococcus aureus by producing sets of particles with 
different dye ratios and conjugated to target on of the three bacteria [Wang, 
2007 a].  
Photoluminescent dyes for imaging are the principal dyes studies [Estevez, 
2009] but the encapsulation of fluorophores with other physicochemical 
properties are generally underrated. Yet, certain fluorophores are suitable for 
photodynamic therapy (generation of singlet oxygen and radical species), some 
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are potential photoaccoustic agents, and some dyes commonly found in biology 
are sensitive to environmental parameters (pH, temperature, presence of ions, 
etc.). Of these three applications, the encapsulation of photosensitisers (PS) is 
the most documented because it overcomes the diffusion of the 
photosensitisers into the whole organism that make patients photosensitive [He, 
2009 b; Ohulchanskyy, 2007; Chen, 2009 b]. Furthermore, these studies 
showed that oxygen is able to diffuse away from the particles through pores in 
the silica matrix but the dye molecules remain trapped inside the particles [Roy, 
2003]. In other terms, the insulation of the dyes is partial and the smallest 
molecules and ions are able to diffuse through the matrix and reach the dyes, 
but larger molecules susceptible to quench or photodegrade the fluorophores 
cannot penetrate inside the particles.  
The partial insulation is an important feature for the use of environmental dyes 
because it means that the fluorophore inside the ceramic matrix are still able to 
detect changes in the particle surrounding. Under their free form, sensor dyes 
are suitable for optical sensors as an alternative to electrochemical and 
electronic sensors to monitor multiple analytes in a sample and to detect 
specific environmental parameters such as calcium concentration, pH, 
generation of radicals, etc. [Han, 2010; Moczko, 2009]. Unfortunately, like most 
of the organic dyes, sensors fluorophores are prone to fast photobleaching. 
Their encapsulation within silica particles could lead to a new class of 
nanosensors able to probe the cellular environment in situ, detecting the 
potential change of pH or oxygen concentration, or simply measuring sodium or 
calcium ions concentration. Very few silica-based nanosensors have been 
reported so far. Platforms sensitive to pH are the most developed, mostly 
because FITC is a pH-sensitive dye (in the 4.0 to 8.0 pH range) but other 
fluorophores are potential candidates to probe different pH range [Burns, 2006; 
Gao, 2007 and 2011]. Temperature-sensitive sensors are emerging too: Peng 
et al. used a ratiometric nanoprobe to sense temperature between 25 and 45°C 
[Peng, 2010]. The objective is to design ideal sensing platform or PEBBLE 
(Probe Encapsulated By Biologically Localised Embedding) introduced by 
Kopelman and co-workers and where a whole range of sensing molecules are 
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embedded within a spherical carrier as a mobile and functional nanosensor 
[Lee, 2009]. However, nanosensors require at least two fluorophores (one 
sensing dye and one referent dye), which may explain the lack of silica sensor 
nanoparticles. 
Taken individually, fluorescent, PS-loaded and sensor silica particles are all 
desirable for their respective applications (Figure 5-1), but to date a method 
bridging all these functionalities into a single structure is clearly missing. One 
can envision a single nanoplatform tracked by the NIR emission of a 
photoluminescent dye, measuring the emission of sensor dyes in search of 
anomalies, and reacting to correct any defects via photodynamic therapy whilst 
monitoring the changes in real-time.  
Spectral signature and 
FRET 
1O2 
Detection and diagnostics 
Δ pH ΔT 
Probing 
 
 
Radicals 
Therapy 
 
Figure 5-1: Schema of the potential applications of fluorescent and 
multifluorescent silica nanoparticles. 
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At a higher level, such multiplatform may not be limited to simple dyes but may 
include nanoparticles, drugs, or any other compounds that may be relevant from 
a biomedical point of view. Unfortunately, this hypothetic structure conflicts with 
the lack of flexibility when it comes to dye entrapment and there is a dramatic 
need to fill in the gaps that exist in the technology of FSNPs. 
 
In summary, there is a lack of simple protocol suitable for the synthesis of 
FSNPs and MFSNPs suitable for hydrophobic and hydrophilic fluorophores 
indifferently. The hybrid VT nanoparticles of Chapter 4 were specifically 
developed for this purpose: the presence of hydrophobic regions rich in vinyl 
groups within the particles are supposed to help stabilising the hydrophobic dye 
whilst the silica network possesses a strong affinity for the hydrophilic 
fluorophores. The protocol developed in the previous chapter showed that it is 
possible to produce ORMOSIL particles with a diameter below 100 nm, but their 
capacity to entrap fluorophore has yet to be demonstrated.  
The aim of this chapter is to verify whether the VT hybrids present an enhanced 
carriage capacity and are able to entrap a large diversity of fluorophores. The 
first objective was therefore to try encapsulating various fluorophores differing in 
term of excitation and emission wavelengths, water solubility, and charge. As 
will be shown, not all fluorophores were successfully integrated to the particles 
so that two more objectives were added (Figure 5-2):  
Ø With the fluorophores showing a good affinity for the VT structure, the 
first objective was to combine them into multifluorescent nanoparticles 
with controlled fluorescence signature using a core-shell structure similar 
to that detailed in Chapter 3; 
The second objective consisted in altering the particle composition as a way to 
encapsulate the remaining dyes with no or low affinity for the VT-structure. In 
particular, other organosilane were used instead of VTEOS and the optical 
properties of the new ORMOSIL nanoparticles were assessed. 
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Figure 5-2: Schematisation of the chapter's objectives according to the 
fluorophore affinity for the hybrid silica nanoparticles. 
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5.2 Materials and methods 
5.2.1 Materials 
Chemical were purchased from commercial sources and used as received 
without any treatment. Tetraethyl orthosilicate (TEOS), malachite green (MG), 
neutral red (NR), and acridine orange (AO) were purchased from BDH. 
Absolute ethanol, L-arginine (>98 %), 3 aminopropyltriethoxysilane (>98 %, 
APTES), 3-(trihydroxysilyl)propyl methylphosphonate monosodium salt solution 
(42 wt.%, THPMP), vinyltriethoxysilane (>98 %, VTEOS), triethoxyphenylsilane 
(98%, PhTEOS), lucifer yellow (LY), and fluorescein (Fl) were obtained from 
Sigma Aldrich. Rhodamine B (RB) and rhodamine 6G (R6G) were purchased 
from Fluka and methylene blue (MB) from Fisher Scientific. Dextran, alexa fluor 
647 (10000 MW, AF647) and Oregon green 514 carboxylic acid (OG) was 
obtained from Molecular probes and Invitrogen respectively. Highly purified 
water (Milli-Q) was obtained from a Millipore “Direct-Q 3” water purification 
system. 
 
5.2.2 Particles synthesis 
• Choice of dyes 
The fluorophores were selected firstly because they were available in the 
laboratory and secondly because they possess distinctive physical and 
chemical properties (Table 5-1 and Figure 5-3). All fluorophores solutions were 
prepared at a concentration of 1 mg/ml (unless specified otherwise) by diluting 
the dyes in Milli-Q water or in absolute ethanol in the case of oregon green and 
fluorescein. 
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Table 5-1: Physical properties of the chosen organic dyes. 
Dye Solvent Mw (g.mol-1) Excitation/Emission (nm) 
Acridine orange Water 265.35 502/526 nm 
Dextran 
alexafluor 647 Water 
10000 
(dextran) 650/668 nm 
Fluorescein Acetone, methanol 332.31 490/520 nm 
Lucifer yellow Water 457 428/536 nm 
Malachite green Water 364.91 X 
Methylene blue Water, chloroform, partially in alcohols 373.9 609 and 668/X 
Neutral red Water 288.78 X 
Oregon green 
514 DMF 512.36 493/520 nm 
Rhodamine 6G Alcohol, water 479.02 525/555 nm 
Rhodamine B Water 479.01 555/580 nm 
 
 
Figure 5-3: Chemical structure of the fluorophore and stains tested with 
the hybrid particles. 
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• Synthesis of hybrid particles 
Hybrid nanoparticles were prepared following the VT-50 protocol detailed in the 
previous chapter. Typically, 50 µL of fluorescent dye solution (1 mg/mL) was 
diluted in 7 mL of arginine solution (15 mM) and covered with aluminium foil to 
protect from light. After 5 minutes, 275 µL of VTEOS and 380 µL TEOS were 
added dropwise to the fluorescent solution and left under magnetic stirring for at 
least 10 hours. In some embodiments, VT structures with various VTEOS/TEOS 
molar ratio were synthesised as described in Chapter 4 (Appendix C). The 
particle suspensions were centrifuged three times at 300 g for 15 minutes or 
until the supernatant remained transparent and washed with distilled water. The 
pellets were weighed and suspended in Milli-Q. 
 
• Synthesis of two- and three dyes-doped hybrid nanoparticles 
The synthesis of multi-layered structures containing two or more dyes started 
with the preparation of VT-50 seeds. Then, 10 mL of arginine solution (0.5 mM) 
and 50 µL of the second fluorescent dyes were added to the suspension 
immediately followed by 150 µL of TEOS to create a first fluorescent layer onto 
the seeds. The third layer was created by addition of 50 µL of the third 
fluorophore and 100 µL of TEOS. For each step, the reaction was left under 
magnetic stirring for at least 10 hours. The colloidal suspensions were 
centrifuged three times at 300 g for 15 minutes - or until the supernatant 
remained transparent - and washed with distilled water. The pellets were 
weighed and suspended in Milli-Q. 
 
• Variation over the hybrid particles composition 
PhTEOS hybrids with PhTEOS/TEOS molar ratio ranging from 25 to 100 % 
were obtained by co-condensing a volume of PhTEOS (from 65 to 640 µL) to 
TEOS (0 to 635 µL) in 7 mL of arginine solution (0.5 mM) (Appendix F).  
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THPMP-TEOS hybrid were obtained by mixing a volume of TEOS (660 to 735 
µL) to THPMP (79 to 238 µL) in 7 mL arginine solution (0.5 mM) so that the 
THPMP molar ratio rose up to 15 molar%.  Alternatively, VT-hybrids containing 
THPMP or APTES to a maximum of 10 molar% were synthesised by co-
condensing VTEOS, TEOS, and the third silane following the VT-50 protocol. 
The recovery of the particles proceeded as described above. 
 
5.2.3 Characterisation 
• Scanning electron microscopy (SEM) 
The particle size and morphology were examined using scanning electron 
microscopy (SEM). The nanoparticle suspensions were firstly diluted: the 
samples were sonicated and subsequently 25 µL of suspension was poured in 
an eppendorf and the total volume was increased to 500 µL with Milli-Q water 
so that the SEM samples were totally transparent. One drop of suspension was 
deposited into a silicon grid and let to dry in a desiccator for at least 24 hours. 
Finally, the particles were imaged using a high resolution FEI XL30 SFEG 
analytical SEM (Philips, Netherland).  
 
• Dynamic light scattering (DLS) 
The size and size distribution of the particles were measured by dynamic light 
scattering using a Zetasizer nano series S with an He/Ne laser of 633 nm 
wavelength (Malvern Instrument, UK). The particle suspensions were firstly 
diluted: 10 µL of the sample was poured in a quartz cuvette and completed with 
1 mL Milli-Q. The refractive index and absorption of silica nanoparticles were 
fixed at 1.25 and 0.01 respectively. For each sample, four measurements of 20 
runs (15 seconds each) were carried out, with temperature maintained at 25°C. 
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• Fourier transform infrared spectroscopy (FTIR) 
The particle composition was analysed by infrared spectroscopy: a volume of 
nanoparticle suspension was taken, centrifuged, and dried in the oven for 1 day. 
The resulting powders were subsequently analysed in KBr powders using a 
Thermo Nicolet Avatar 370 spectrometer (Thermo Scientific). Infrared spectra 
were recorded over the wavenumber region 4000 to 400 cm-1 with a resolution 
of 4 cm-1. 
 
• Fluorescence measurement 
Absorbance and fluorescence of FSNP were recorded in 96-well plates with a 
Varioskan Flash Spectral Scanning Multimode Reader (Thermo Fisher 
Scientific) equipped with a xenon flash lamp. All measurements were performed 
on 200 µL of 1 mg/mL suspensions of particles diluted in Milli-Q and at room 
temperature. Excitation and emission spectra of LY, FITC/AO/Fl/OG, R6G, and 
RB were acquired with fixed wavelength set 435/540, 450/530, 490/580, and 
500/600 nm respectively. The excitation/emission spectra of samples containing 
AO and R6G and/or RB were obtained at 450/600 nm. 
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5.3 Results 
5.3.1 Integration of usual and less common fluorophores 
To fulfil the first objective (testing the carriage capacity of the VT-50 hybrid 
particles), 10 fluorophores - including MB, R6G, and RB already used in 
Chapter 3 – were selected due to their availability in the laboratory. These 
fluorophores differ in term of excitation and emission wavelengths and two of 
them are not soluble in water. Because the hybrid particles were designed to 
entrap a large variety of fluorophores without having recourse to sylilation or 
chemical modification, only electrostatic entrapment was tested to verify 
whether the dual nature of the material would help stabilising the dyes. 
The colour of the particles at the end of the synthesis and centrifugation 
procedures was the first indicator of the incorporation of fluorophores or lack 
thereof. To begin with, the particles formed in presence of AO, R6G, and RB 
exhibited strong orange-yellow, reddish, and pink colours in that order. UV-
visible spectroscopy revealed that the suspension absorbed light at 495, 525, 
and 550 nm respectively and detected fluorescence emission at 520, 555, and 
580 nm (Figure 5-4). MB, MG and NR exhibited strong blue, weakly green, and 
pale orange colours in that order; the MB spectrum was the only one displaying 
a strong absorbance response with a first peak around 600 nm and a second 
larger one around 633 nm. NR and MG absorbance was very weak, with 
maxima circa 460 and 540 nm for NR and over 600 nm for MG. Conversely, the 
particles synthesised in presence of OG, Fl, LY, and AF 647 remained totally 
white and no optical properties were found. 
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Figure 5-4: Normalised absorbance spectra of AO, R6G, RB, and MB-
doped nanoparticles. 
 
In order to investigate the effect of the matrix composition on the dye 
encapsulation, the experiments were carried out with other VT compositions 
(VT-00, VT-25, VT-75, and VT-100) and in presence of RB, LY, or OG. Similarly 
to VT-50, the experiments with RB yielded very bright pink particles, although 
the fluorescence of the particles cannot be compared directly due to the 
difference of diameter and of concentration (Figure 5-5). However, none of the 
compositions absorbed light or fluoresced in the case of LY and OG. These 
results suggest that the hydrophobicity may not be the characteristic governing 
the entrapment of dyes and in spite of the dual nature of the particles, another 
factor must be taken into consideration to create a universal carrier. 
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Figure 5-5: Fluorescence intensity of RB-doped hybrid particles at 
increasing VTEOS to TEOS molar ratio. 
 
Due to the high concentration of fluorophore in the supernatant, it was decided 
to decrease the initial fluorophore concentration to reduce the losses of dyes. 
The experiments were conducted on RB and R6G owing to the strong 
fluorescence of the VT-50 particles obtained previously for molar concentration 
ranging from 2.10-9 to 2.10-6 mol. The particles diameter remained restricted 
between 40 and 60 nm but no correlation was found between the fluorescence 
intensity and the particle diameter in the case of R6G (Figure 5-6). The 
fluorescence neither increased with increasing the dye molar concentration nor 
reached any threshold. The main effect, though, was that the supernatant 
fluorescence was significantly reduced for the lowest dye concentration. In the 
case of RB; the fluorescence intensity was relatively low between 2.10-9 and 
2.10-8 mol but the intensity suddenly rose for 2.10-7 mol (Figure 5-7). At higher 
concentration, the particle fluorescence decreased slightly but remained 
nonetheless more intense than at low fluorophore concentration. One would 
expect that the particle fluorescence would increase with increasing the initial 
fluorophore concentration. Two other possibilities may happen: (1) the 
fluorescence may reach a threshold corresponding to the maximum dye loading 
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or (2) the intensity may pass by a maximum above which the high fluorophore 
density into the particles may be responsible for quenching due to the close 
proximity between the molecules. Little can be concluded from these results 
and the experiments must be conducted another time to study with more 
precision the loading of particles and potentially to quantify the number of 
fluorophore per particles. 
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Figure 5-6: Mean number and fluorescence intensity of VT50 
nanoparticles with various concentration of R6G. 
 
An important feature of FSNPs is that they must retain the fluorophore 
throughout time, in particular because certain dyes may have toxic effects. 
Therefore, hybrid nanoparticles containing R6G and RB were synthesised and 
kept up to 1 month. The suspensions were centrifuged after periods ranging 
from 30 minutes to 1 hour and the fluorescence of the supernatant was 
measured to detect the trace of R6G and RB. No significant fluorescence was 
detected, even after 1 month, indicating that the particles effectively retain the 
fluorophores. Nevertheless, the plate reader may not be sensitive enough to 
detect trace amount of dyes and techniques such as single fluorophore 
microscopy ought to be used to verify that leakage does not occur at all.  
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Figure 5-7: Mean number and fluorescence intensity of VT50 
nanoparticles with various concentration of RB. 
 
From the results presented so far, it occurs that the hybrid nanoparticles did not 
contain all fluorophores. Some such as RB, R6G, and AO were easily 
entrapped and yielded very bright nanoparticles. On the other hand, the 
particles failed at encapsulating dyes of interest such as LY, OG, or Fl even 
when the particle composition was altered. The hypothesis that fluorescent dyes 
can be divided between hydrophobic and hydrophilic ones may not be correct, 
unless the hydrophobicity of the particles is not the parameter to take into 
account. From this point, the study of the optical properties is divided into two 
parts: 
Ø On the one hand, combining AO, R6G, and RB (three fluorophores that 
were successfully entrapped) into a core-shell structure similar to the 
one detailed in Chapter 3. The objective was to control and tune the 
optical properties of the hybrid particles by variation of each dye 
concentration 
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Ø On the other hand, finding a solution to entrap Fl, OG, and the dyes that 
were not detected inside the hybrid particles via alteration of the 
nanoparticles composition. 
Indeed, it is desirable to control the fluorescence of multifluorescent 
nanoparticles for ascribing distinctive spectral signature to the nanoparticles is 
crucial for the detection of multiple targets simultaneously, which explains the 
first objective. Moreover, the purpose of the hybrid particles is to encapsulate 
any fluorophore without modification of the protocol. This aspect is also 
important for the multifunctionality of the particles via entrapment of 
photosensitisers and luminescent and sensor dyes and is the objective of the 
second part.  
 
5.3.2 Tuning of the spectral signature 
One of the chapter’s objectives is to design multifluorescent nanoparticles 
similar to that developed in Chapter 3 but with a larger diversity of fluorophores. 
Since there is still a limitation on the choice of fluorophore, the multifluorescent 
system was tested with R6G, RB, and AO, that produced bright particles. In a 
first time, AO was combined to either R6G or RB at different ratios in order to 
detect the alteration of the fluorescence pattern and to potentially tune the 
spectral signature of the nanoparticles. The structure was always based on an 
AO-containing hybrid core surrounded by a silica layer obtained from TEOS and 
entrapping one of the rhodamine dyes. The spectra obtained for single dye-
doped particles clearly show that the emission and excitation of the 
fluorophores overlap (Figure 5-8). Note however that the spectra are 
normalised and that the excitation and emission of the three dyes will be 
modified according to the setups of the plate reader. 
AO and R6G emission overlap and because of the close proximity of the 
excitation and emission of the two dyes, the spectra of particles containing 
simultaneously AO and R6G displayed a single broad peak. At low R6G  
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Figure 5-8: Normalised excitation (plain lines) and emission (dotted lines) 
of single dye-doped hybrid nanoparticles. 
 
concentration (100 µL of AO and 10 µL of R6G), the fluorescence of AO 
dominated and the emission maximum was centred on 520 nm. At higher R6G 
content, the emission started to shift towards R6G maximum emission value 
while conserving some features of AO profile so that the maximum emission of 
the dual particles shifted between 520 and 555 nm. 
In comparison, the fluorescence patterns of AO and RB were more separated 
and the effect of dye concentration was more obvious (Figure 5-9). Particles 
with high concentration of AO and low RB concentration (100-25) displayed a 
strong peak at 520 nm followed by a second les intense peak at 580 nm. When 
AO concentration decreased (75-25), the second peak rose to the same value 
than AO emission. The tendency continued this way until the AO contribution 
was a small shoulder before the RB peak. 
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Figure 5-9: Normalised emission spectra of nanoparticles loaded with AO 
(first digit) and RB (second digit). 
 
Next, the three dyes were included together into a single hybrid structure. AO 
was entrapped during the core formation whereas R6G and RB were added 
during the growth of the first and second silica layer synthesis in that order. DLS 
analyses showed that the particle diameter did not vary more than 5 nm and 10 
nm for the second and third layer after each shell growth. Due to the close 
optical properties of the three fluorophores, the resulting excitation and 
emission spectra do not display any particular feature. Instead, AO and R6G 
form a first broad peak immediately followed by RB emission maximum (Figure 
5-10). The emission band was broader than that of the dyes taken individually 
and covered the region between 450 and 600 nm. Yet, the choice of fluorophore 
was not ideal to study changes in the fluorescence pattern and dyes with more 
distant excitation and emission wavelengths ought to be tested instead. 
However, the results showed that the method can produce multifluorescent 
nanoparticles. Additional characterisation is needed, for example to verify of the 
dyes are homogeneously distributed between the nanoparticles. Furthermore, 
the experiments must be carried out with centrifugation between each step to 
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remove the excess of dye to avoid their presence in several layers 
simultaneously and to exert a higher control over the spectral signature. 
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Figure 5-10: Emission spectra of the AO/R6G/RB hybrid nanoparticles at 
various ratios. 
 
5.3.3 PhTEOS-TEOS and THPMP-TEOS nanostructures 
The hybrid particles were initially designed based on the hypothesis that 
fluorophores can be divided into hydrophobic and hydrophilic dyes. This idea 
originates from the fact that, in the literature, some dyes require an oil-in-water 
emulsion for their encapsulation in silica nanoparticles whilst others need a 
water-in-oil emulsion. It was surmised that the dual nature of the particles would 
provide a suitable of environment for any fluorophore regardless of its nature. 
Yet, the first results presented in this chapter said otherwise and some of the 
dyes could not be encapsulated, even when the VTEOS/TEOS ratio was varied. 
This indicates that the hypothesis was not correct and two reasons may be 
proposed: (1) the hydrophobic nature of VTEOS is not strong enough, or (2) 
other interactions than hydrophilicity/hydrophobicity are involved in the 
stabilisation of the dye.  
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In a first time, VTEOS was substituted for phneyltriethoxysilane (PhTEOS) 
because of its bulkier moiety and potential stronger hydrophobicity. The change 
of hydrophobicity strength was especially obvious during the centrifugation 
because PhT-50 and hybrids containing more than 50 molar% PhTEOS were 
not longer soluble in water. Likewise, the particle diameter was modified with 
circa 30 nm in diameter for PhT-50 and 16 nm for PhT-75 whilst PhT-100 rose 
to more than 770 nm (Figure 5-11). Unlike the VT hybrids, where the particle 
diameter increased with increasing the VTEOS/TEOS ratio, the changes in PhT 
hybrid appeared more unpredictable. For instance, SEM picture of a PhT-10 
structure displayed particles about 60-70 nm diameter (Figure 5-12). The 
particles remained spherical but with some aggregation as the particles bind 
one to the other. 
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Figure 5-11: DLS measurement of PhTEOS-TEOS hybrid at various 
PHTEOS molar concentration. 
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Figure 5-12: SEM pictures of TEOS-PhTEOS (10 molar% PhTEOS, left) and 
TEOS-THPMP (10 molar% THPMP, right) hybrid nanoparticles. 
 
The phenyl group induces some modification to the infrared spectra compared 
to VT hybrids (Figure 5-13). The benzene ring signal shows up in three regions: 
three bands at 3070, 3051, and 2975 cm-1 originate from the stretching vibration 
of C-H whereas the peaks at 1596 and 1488 cm-1 are attributed to the ring 
stretch of C-C coupled to the C-H bending. Lastly, the out-of-the-plane C-H 
bending of the phenyl ring is responsible for the peaks at 736 and 694 cm-1. 
Another important band arises at 1433 cm-1 and is the result of both the Si-C 
stretching and C-H bending of the ring (a coupling effect to the 736 and 694 cm-
1). All these peaks combined to the siloxane band and silanol peak indicate that 
the co-condensation of PhTEOS and TEOS proceeded and prove the hybrid 
nature of the particles. On the contrary, the presence of THPMP could not be 
detected and the infrared spectra reverted to a normal TEOS-based silica 
nanoparticle. 
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Figure 5-13: Infrared spectra of PhTEOS hybrid with 25 (red), 50 (blue), 75 
(pink) and 100 molar % (green) of PhTEOS.. 
 
In spite of the structural alteration of the particle matrix, Fl, OG, and LY were 
still not contained within the PhT hybrids. Furthermore, the difficulty to recover 
the particles by centrifugation makes them more complicated to handle than the 
VT hybrids and the strong hydrophobicity of the particles may not be suitable for 
use in vivo (generally aqueous environments). PhTEOS was then replaced y 
THPMP and APTES as potential solutions. THPMP-TEOS hybrids produced 
small particles, for example 30-40 nm (10 % THPMP) as seen on SEM images 
(Figure 5-12). However, FTIR was not able to prove that the particles contained 
any phosphonate groups and, similarly to PhT hybrids, the particles were not 
able to entrap OG, LY, and Fl. APTES-TEOS hybrids were not tested in length 
because of the strong aggregation of the particles due to the hydrogen bonding 
settling between silanol and amine groups. However, the initial results seemed 
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to indicate that the particles were able to contain LY (the only de tested for 
these hybrids).  
 
5.3.4 Alteration of the VTEOS-TEOS hybrid nanoparticles 
A closer look at the chemical structure of the fluorophores provides a first 
reason to why some dyes remained out of the VT (and THPMP and PhT) hybrid 
nanoparticles. Acridine orange, malachite green, methylene blue, neutral red, 
and the two rhodamines are either positively charged or get protonated at pH 10 
(arginine pKa). Owing to the negative net charge of the silica matrix, electro-
attraction settles between nanoparticles and dyes which stabilises the 
molecules within the ceramic particles. On the other hand, alexafluor 647, 
fluorescein, lucifer yellow, and oregon green are not able to acquire the positive 
charge at high pH and are consequently repulsed by the siloxane network. To 
verify this hypothesis, small amount of APTES (less than 10 molar% of the total 
silane concentration) was added during the synthesis of VT-50 nanoparticles. 
The positively charged amine moiety of APTES would help attracting the 
fluorophores whilst the low organosilane concentration should limit aggregation. 
The addition of APTES to TEOS and VTEOS did not alter the hydrodynamic 
diameter of the nanoparticles (around 50 nm) so long as the APTES proportion 
remains low. At 2.5 % APTES, a second peak little intense peak rose at about 
700 nm but remained negligible. On the other hand, a strong aggregation was 
detected with 5 % APTES (polydispersity index of 1) and the particles diameter 
shifted to more than 400 nm (Figure 5-14). 
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Figure 5-14: Hydrodynamic diameter of VT-hybrid containing APTES. 
 
The diameter of the particles has observed by SEM seemed to correlate well 
with the DLS results, but SEM also revealed that large submicrometric and 
micrometric spheres were present as well. For instance, AP-5 picture (5 % 
APTES) principally 45 to 60 nm nanoparticles and occasionally 700 nm spheres 
(Figure 5-15) but AP-10 was composed of micrometric nanoparticles 
exclusively. Note however that some of the suspensions were prepared using 
the VTEOS solution responsible for the exotic shape of the particles described 
in Chapter 4. Therefore, the experiments must be carried out a second to verify 
whether the large particles result from hydrogen bonding (APTES effect) or by 
the contaminated VTEOS solution. 
The effect of APTES on the particle fluorescence was immediately visible: the 
samples exhibited a yellow colour with lucifer yellow, which strongly contrasted 
with the former attempts with VTEOS and PhTEOS. The excitation measured at 
440 nm and the emission at 525 nm further proved the presence of LY inside 
the ceramic matrix. 
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Figure 5-15: SEM pictures of VTEOS-TEOS particles with 5 % displaying 
some very large particles (left) but mostly composed of 45 nm 
nanoparticles (right). 
  
The particle colour and fluorescence intensity seemed correlated to the APTES 
proportion in the network and the fluorescence augmented as the APTES was 
increased from 1 to 10 % (Figure 5-16). However, due to the aggregation in 
AP-10, characterisation must be conducted once again with suspension of the 
exact same to prove that fluorescence intensity is linked to the APTES 
concentration. However, if more APTES is beneficial for a better encapsulation 
of dyes, it likewise increases the chance of binding particles altogether or to 
create large structures because of the hydrogen bonding. The AP hybrids also 
successfully entrapped OG and Fl, which is an important improvement in 
comparison to the VT and PhT nanoparticles. Furthermore, the present of 
APTES was not detrimental to the other fluorophores since AO, R6G, and RB 
were likewise detected in the AP-modified particles (Figure 5-17). Additional 
results showed that the nanoparticles could be recovered by silica layers to 
create two dye-doped systems. For example, some systems were made of a 
hybrid core containing LY and an extra layer entrapping RB and exhibiting the 
fluorescence of the two dyes. The structure still suffers from the same  
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Figure 5-16: Excitation (plain lines) and emission (dotted lines) of AP-
modified hybrid nanoparticles containing lucifer yellow. 
 
uncertainty about the homogeneity of the particle content, i.e. it is not sure 
whether all the particles contain the two dyes and in the exact same proportion. 
As already mentioned, this must be assessed by single molecule microscopy 
and potentially by confocal microscopy of the last generation. 
 
There was not time to assess whether multifunctional nanoparticles made of 
successive hybrid layers can be created. The LY-RB system was made 
possible by the good affinity of RB for silica but this strategy is not suitable for 
negatively charged fluorophores such as Fl or OG. Therefore, the next 
experiments must include the design of multilayered nanoparticles composed of 
hybrid and silica layers. In summary, the AP-modified VT hybrids may be the 
solution to virtually entrap any fluorophore but the system is still limited by the 
threat of aggregation if too high APTES concentrations are employed. If this 
limitation can be overcome, the hybrid particles have the potential to become a 
novel class of fluorescent particles superior to silica nanoparticles. 
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Figure 5-17: Excitation (plain lines) and emission (dotted lines) of hybrid 
nanoparticles with 5 molar% APTES and containing various range of 
fluorophores. 
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5.4 Discussion 
Maleimide/isothiocyanate derivatives of fluorescein and rhodamine (suitable for 
covalent binding with organosilanes) and rare earth chelates (hydrophilic 
inorganic fluorophores) are the principal dyes combined with silica nanoparticles 
via the Stöber method and reverse microemulsion respectively. Additionally, 
more and more studies are devoted to the entrapment of NIR and two photon 
dyes via oil-in-water emulsion due to the hydrophilic nature of the fluorophores. 
It is virtually possible to encapsulate any fluorophore using one of the three 
synthesis method, however it is technically difficult to combine these 
approaches to create multifluorescent nanoparticles In that respect, the 
development of a more flexible method requiring a single solvent regardless of 
the hydrophilicity/hydrophobicity of a dye could be advantageous. This would 
preclude long purification process required to remove surfactant or problem of 
solubility and insolubility in aqueous or organic phase. Furthermore, core-shell 
structures similar to that of Chapter 3 could be easily designed and would be 
suitable for a large variety of fluorophore, including photosensitisers and sensor 
dyes. 
The hybrid particles developed in Chapter 4 are envisioned as the basis for the 
“universal” carrier due to its dual nature. The presence of both hydrophilic and 
hydrophobic regions within the particles ought to create a suitable environment 
for all dye: it was hypothesised that the hydrophobic component (VTEOS) would 
seek to diminish its contact with water and ought to form the core of the 
nanoparticles, whilst the hydrophilic TEOS would cover the budding VTEOS 
seeds and create a protective shell. Consequently, the carriage capacity of the 
hybrid had to be assessed. To do so, the same dyes employed in Chapters 2 
and 3 – namely AO, RB, R6G, and MB - were selected. Additionally, other 
fluorophore were found in the laboratory and tested: dextran alexafluor 647 
(AF), fluorescein (FL), lucifer yellow (LY), malachite green (MG), neutral red 
(NR), and oregon green (OG). The choice of these dyes was motivated by 
different reasons: 
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Ø They possess different optical properties (excitation and emission 
wavelengths; 
Ø Most fluorophores are soluble in water but some (LY, FL, and OG) are 
insoluble; 
Ø The short excitation wavelength of LY makes it ideal for combination with 
other dyes into a single structure, for example LY/RB/MB that all match a 
different laser source of confocal microscopes; 
Ø OG and FL are acid-sensitive dyes that could be interesting for the 
design of nanosensors.  
Addition of all of the dyes led to contrasting results: MB and R6G were 
successfully detected within the nanoparticles but since they were already 
encapsulated in silica nanoparticles in Chapters 2 and 3, it may be assumed 
that the hydrophilic nature of the particle is responsible for their stabilisation. AO 
and RB gave similar results which is interesting because AO has the same 
optical properties as FITC and RB possesses a high quantum dye and matches 
perfectly the laser sources of confocal microscopes and flow cytometry. MG and 
NR led to pale green and red-orange nanoparticles and the lack of intense 
absorbance peak further confirms the weak optical properties of the 
nanoparticles. The dyes were not investigated further in details because their 
absence of fluorescence makes them less attractive for biomedical applications. 
Unfortunately, the other cases failed and no signal was detected with OG, Fl, 
AF, or LY despite of the repeated attempts. The matrix composition was thus 
modified as a way to verify whether the VTEOS concentration can modulate the 
entrapment of the dyes. RB worked equally fine regardless of the network 
composition which sustains the hypothesis that RB has a natural good affinity 
for the silica matrix and that the presence or absence of the vinyl moiety seems 
inconsequential. Note that at the difference of some groups that relied on the 
covalent binding of RB to APTES, the hybrid nanoparticles are able to contain 
RB directly [Gao, 2009]. It was not possible to establish a direct comparison of 
fluorescence for all hybrid composition due to the very low concentration of VT-
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00 and VT-25, but it may be interesting to determine the brightness and 
fluorescent molecule content of the nanoparticles. This may be obtained via a 
fluorescence calibration curve of the free dye of interest and by measuring the 
fluorescence of FSNPs suspension of known diameter and concentration. This 
calculation would in turn help determining if and how the VTEOS concentration 
affects the particle ability to carry fluorophore. Contrariwise, alteration of the 
particle matrix had no effect on OG encapsulation and the hybrid nanoparticles 
remained devoid of fluorophore. LY results were identical, although a very weak 
signal was measured but too low for practical purpose. Therefore, the 
hypothesis that generation of hydrophobic regions within the matrix may help in 
encapsulating a higher diversity of fluorophore is not valid, but the exact effects 
of VTEOS and potential enhancement it brings require additional experiments. 
From these tests, fluorophores can be divided into dyes with a strong affinity for 
the hybrid matrix (AO, RB, R6G, MB) and dyes that failed at being entrapped 
(OG, FL, LY principally). On the one hand, part of the study consisted in 
combining the first group of fluorophores into a single particle similarly to the 
system described in Chapter 3. On the other hand, the aim of creating a 
universal carrier had yet to be reached and part of the project was devoted to 
finding a solution to entrap the second group of fluorophores. 
Before studying the combination of AO, R6G, and RB, the leakage of dye out of 
the particle had to be assessed along with the effect of the initial fluorophore 
concentration on the final optical properties of the particles. Indeed, it was found 
that most fluorescent molecules were not entrapped and were discarded after 
centrifugation the samples. These losses are an issue for dyes in small 
quantities, which are generally expensive. For low fluorophore concentration, 
the particle visual brightness was dim but supernatant was generally 
transparent whilst very bright particles were yielded at high initial concentration 
but the supernatant was highly fluorescent too. It was not possible to correlate 
the particle fluorescence intensity to the fluorophore concentration despite of 
the small size variation of the nanoparticle diameter. However, it seemed that 
the intensity reached a threshold above a concentration of 2*10-7 mol of dye in 
solution and the intensity decreased above this concentration. At some point, 
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the particle may become saturated in dye and the close proximity of the 
fluorophore may induce self-quenching, resulting in the decrease of 
fluorescence observed in the case of RB. In other terms, there may exist an 
optimal concentration where fluoresce predominates over quenching but 
additional measurement are required to confirm this hypothesis [Gao, 2009; 
Imhof, 1999]. The other reason to lower the dye concentration in particles is the 
potential interaction between nearby dye and is frequent in rhodamine dyes: 
these excimers tend to broaden and red-shift the emission band in comparison 
to the monomeric spectrum [Ma, 2009].  
Leakage of cargo may be a source of concerns of FSNPs because of the 
potential weakness of the electrostatic interactions coupled to the natural 
porosity of silica nanoparticles. To verify whether the matrix retains the 
fluorophores, the particles were kept in PBS and water to a period up to one 
month during which the samples were regularly centrifuged and the supernatant 
fluorescent was measured. No leakage was detected in either PBS or water, 
indicating that the fluorophore do no diffuse away from the particles. The 
experiments may be repeated under harsher conditions such as higher 
temperature, a range of pH or highly saline solutions to test the robustness of 
the hybrid matrix but silica has a reputation of robustness and should not be 
degraded [Gao, 2009; He, 2009 b].  
 
Among the ten fluorophores tested, AO, R6G, and RB were easily combined 
and produced very bright particles. Due to the successful incorporation, one of 
the two objectives of this chapter was to combine these three dyes into a core-
shell structure similar to the multifluorescent system described in Chapter 3. 
The hybrid core always carried AO with the same initial volume and the volume 
of the second dye was varied. Due to the close proximity of AO and R6G 
excitation and emission, the effect of combining the two dyes is limited to a shift 
of the maximum emission wavelength and to a broadening of the emission 
band. In comparison, variation of RB at fixed AO concentration led to more 
obvious changes since AO and RB emissions are well separated. The 
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fluorescence of RB is very weak at the excitation wavelength set to measure the 
optical properties of the particles. As the RB concentration increased, the RB 
emission was more easily detected but it is unknown whether this effect is due 
to the higher RB concentration alone or AO emission was involved in the 
excitation of the rhodamine. The interest of the two-dye particles is the higher 
emission of R6G and RB when using the 488 nm source that is equivalent to 
producing systems with large Stokes shift – the difference between excitation 
and emission maxima – desirable to minimise issues with autofluorescence and 
self-quenching. Following this strategy, it may be possible to create systems 
emitting at long wavelength using conventional UV or visible excitation sources 
by exploiting the overlapping of emission and excitation of fluorophores into the 
particles. For instance, several populations of fluorescent nanoparticles with 
distinct emission wavelength could be used simultaneously with a single 
excitation source as a mean of multiplexing detection. 
The only system containing three dyes has been designed by Wang et al. who 
precisely controlled the emission of particles containing FITC and two 
maleimide derivatives of rhodamine [Wang, 2006]. The covalent binding of dyes 
is ideal to tune the fluorophores composition of the particles and ensure that all 
fluorophores have been integrated to the particles. Their first attempts led to low 
FRET efficiency because each dye was present in a different layer due to their 
different hydrolysis rates. When the three sylilated fluorophores were pre-
hydrolysed prior to adding TEOS, the FRET systems were created. This is due 
to the FRET dependency to the distance between dye molecules: because 
Wang’s fluorophores were present in separated layers, FRET could hardly 
occur. 
In the hybrid system, the fact that AO was present in the core and in the layers 
helped in bringing the acridine molecules close to the rhodamine ones and 
possibly helped in the energy transfer. It is not known whether removing the 
dyes after each growth step would impact the fluorescence of the particles and 
if the presence of dye in distinct layers would suppress the FRET phenomenon. 
If that were the case, it may be possible to tune the spectral pattern by adding 
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lower concentrations of dyes simultaneously during the original seed growth 
without need of additional silica layer. To verify this hypothesis, more 
experiments are required where excess of fluorophore is removed by 
centrifugation prior to creating new shells in order to prevent the presence of 
dye in multiple layers: since FRET is distance-sensitive, it is expected that the 
separation of AO, R6G and/or RB in distinctive regions of the particles hampers 
FRET.  
 
The second objective was to find a solution to encapsulate LY, OG, and Fl that 
had no affinity for the VT hybrids. The fact not all 10 dyes is the sign that the VT 
hybrids still not have the potential to be universal carriers and limit their 
multifunctionality. In other term, it is still necessary to find a way to make the 
encapsulation process more flexible and efficient. There are high chances that 
the major limitation lays in the poor affinity of fluorophores for the matrix. In his 
publication, Theaker was able to entrap a large number of fluorophores within 
PhTEOS-TEOS nanoparticles obtained via the Stöber method. Based on the 
chemical structure of the dyes that were encapsulated or remained in the 
solvent, they hypothesised that the particles retain the dyes because of both 
electrostatic interactions and steric hindrance [Theaker, 2008]. The phenyl 
group is more voluminous than VTEOS and may effectively increase the 
chances of incorporating LY and the other fluorophores. However, Theaker’s 
particles suffered from two drawbacks: large diameter superior to 400 nm and 
high hydrophobicity that is not desirable for biological purposes. Considering the 
features of the amino acid routes, it was assumed that the method might help in 
resolving the diameter issue whereas tuning the PhTEOS to TEOS ratio might 
modulate the hydrophilicity or hydrophobicity of the particles as was seen – to 
some extent – with VTEOS. 
Practically, the PhT particles are highly hydrophobic at 50 molar% of PhTEOS 
and above, but the diameter was much reduced than in Theaker’s study and did 
not exceed 75 nm with the exception of pure PhTEOS particles that were more 
than 400 nm in diameter. Yet, the new organosilane modifies the particle 
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dimensions in a more unpredictable manner that VTEOS and no correlation was 
found between the PhTEOS/TEOS ratio and the size compared to the VTEOS 
case. Growing a pure silica layer may help in reducing the hydrophobicity of 
high PhTEOS-content particles but the best solution consists in using only a 
small proportion of PhTEOS. Even at 10 molar%, the size of the particles was 
found close to 50 nm (12 nm with VTEOS), sign that PhTEOS is able to exert a 
strong influence on the network. In spite of the modification induced by the 
presence of PhTEOS, the new hybrids were unable to encapsulate LY, OG, or 
Fl. This finding implies that the initial assumption that creating hydrophobic 
regions within the particles to stabilise the fluorophores is not correct and other 
interactions must take place. Looking at the chemical structure was the first hint: 
the common point between AO, R6G, RB, and the dyes that were combined 
with the hybrid particles is that they either possess or may gain a positive 
charge after protonation. The positive charge is ideal to stabilise the dyes within 
the matrix since silica is negatively charged. In contrast, the other dyes are not 
able to get protonated and remain negatively charged which creates repulsion 
with the inorganic network. Consequently, the organic component of the hybrid 
nanoparticles shifted from hydrophobic moieties to charged one. At first, 
THPMP and APTES were co-condensed with TEOS to impart a negative and 
positive charge to the network respectively. He et al. have shown in one 
occasion that co-condensation of THPMP and TEOS improves the loading with 
MB and the group even measured a strong fluorescence signal from MB where 
usual TEOS particles led to no significant fluorescence pattern [He, 2009 b]. 
Although the modification or doping of the matrix has been suggested, there is 
surprisingly no report of correlating the structure and charge of dyes with the net 
charge of the silica matrix [Shibata, 1997].  
Here, TEOS-THPMP hybrids were small but could not entrap LY and Fl and this 
system was not further studied. Direct co-condensation of TEOS and APTES 
promoted the particle aggregation. Consequently, the VT structure was 
conserved as the main composition, but small amounts of APTES were 
incorporated to impart some positive charges to the network. The modified 
hybrid particles, referred to as AP hybrids, got a strong colour after reaction with 
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LY, OG, and LY and fluorescence measurement proved that the fluorophores 
were effectively encapsulated within the particles. The aminated silane did not 
disrupt the original VT structure and the particles retain similar dimensions 
(circa 50 nm), but agglomeration started to appear at 5 and 10 molar% of 
APTES, indicating that the third organosilane concentration must remain limited 
to avoid negative effects. There must be an optimal concentration that imparts 
good fluorescence without destabilising the colloidal suspensions. Indeed, the 
experiment involving LY showed that as the APTES percentage augmented, the 
fluorescence of the particles increased possibly because the positively charged 
amine helped in attracting and retaining more LY molecules. The effect was the 
same with the other fluorophores but a more consistent model has yet to be 
developed to understand the interactions at the heart of the encapsulation 
process. From the AP structure, it became possible to develop more advanced 
systems containing both LY and RB. At the difference to AO and RB, the 
excitation and emission of the two fluorophores are more distant and prevents 
FRET. With a third blue or NIR dye and the capacity to carefully tuned the 
fluorophore concentration in each layer, the number of combination, and by 
extension the number of analytes that could be simultaneously detected, 
increases. The possibility to co-encapsulate two fluorophores is particularly 
important in nanosensors: in general the sensor dye must be combined with a 
second referent dye to clearly assess the fluorescence modification induced by 
the changes of environmental conditions. This requirement may explain why 
silica-based nanosensors are rarely reported unless the sensor dye is FITC or a 
fluorophores easily silylated. Here, the AP particles may not suffer from such 
limitation since any fluorophores could theoretically be encapsulated by 
selected the appropriate composition (VT hybrid for positively-charged 
fluorophores and AP hybrid for the negatively-charged one). 
A number of points remain to be investigated. First of all, it is necessary to test 
a wider range of fluorophores to validate the “charge hypothesis”. So far, the 
addition of APTES proved a valid strategy provided that the organosilane 
concentration is not so high that it starts inducing hydrogen bonding and 
aggregation. The employ of another organosilane with positively charged moiety 
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but unable to create hydrogen bonds may help circumventing the aggregation 
issue, albeit such new system would require a full characterisation. Another 
point is the necessity to exert a better control of the particles fluorescence 
signature as highlighted with the AO/R6G/RB system. More importantly, it is 
necessary to assess whether the AP composition may be used for the growth of 
additional layers to eventually obtain a universal carrier. The interesting point 
was the successful loading with Fl and OG but there is no certainty that the 
loading results from the positive charges from APTES or whether the VTEOS 
presence is a requirement. More analysis with TEOS-APTES and APTES-
hybrid matrix are necessary to attest of the silane influence. The principal 
setback of the particles reported so far is that the fluorophores were present 
throughout the whole process and were entrapped during the layers growth. 
The higher quantum yield of R6G and RB in comparison to AO was not an issue 
and was in a sense beneficial for the induction of a strong RB emission. 
However, it is less acceptable with expensive dyes or fluorophores supplied in 
small quantities such as AF647. This is also a requirement for ratiometric 
nanosensors where the concentration of the sensor dye and of the referent dye 
must be carefully controlled. Lastly, the next stage of the hybrid particles 
development will consist in transposing the hybrid composition of the core to the 
outer layers. So far, AO, R6G, and RB were entrapped during the layers growth 
because of their good vitreophilicity but other dyes are not likely to present 
similar affinity for the silica matrix. Although a three stages system (containing 
AO and RB plus another distinct fluorophore) already opens new possibilities, 
the number of permutations is still too limited for complete multiplexing arrays of 
nanoparticles. 
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5.5 Conclusion 
This chapter lays the ground for a new generation of flexible FSNPs with 
enhanced carriage capacity. In spite of the versatility of silica chemistry, there 
has not been any report of a universal method for the design of nanoparticles 
able to contain virtually any organic dye. As the testing revealed, the VT hybrid 
nanoparticles are not as flexible as expected since some of the fluorophores 
tested were not contained with the particles. These mitigated results led to the 
exploration of two distinct ways. First, AO, R6G, and RB were combined in a 
core-shell structure similar to that detailed in Chapter 3. Although the three dyes 
were too close (in terms of excitation and emission), the results suggest that it is 
possible to tune the spectral signature of the particles by controlling the 
fluorophore concentration in the particles. It still remains testing the 
encapsulation of dyes with no excitation/emission overlap and to verify whether 
each layer contain a single fluorophore population. 
Second, it was postulated that a better affinity of the fluorophores for the matrix 
could be achieved through an alteration of the particle composition. Indeed, 
neither VTEOS nor PhTEOS hybrids managed to encapsulate fluorescein, 
oregon green, and some other dyes in spite of the hydrophobicity of the two 
organosilanes. Instead, tuning the particles composition with a charged silane 
was more successful and it was possible to incorporate Fl, LY, and OG that 
failed the test of the VT-structure. Even though this approach requires more 
investigation, it is hypothesised that it is possible to encapsulate any 
fluorophore whenever the particle matrix possess an opposite charge.  
In summary, the protocol still needs optimisation, notably verifying that a single 
layer can contain a single fluorophore and testing more fluorophores to ensure 
that the “charge hypothesis” is correct. If the hypothesis proved valid, then it 
would be possible to encapsulate any type of fluorophore, which in turns would 
open new possibility in confocal imaging, flow cytometry and possible other 
fluorescence-based imaging modalities and diagnostics tools. More importantly, 
the possibly to combine multiple dye into a single nanoparticle brings new 
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perspective with nanosensors able to sense changes in their environment and 
may play an important role in the development of new multifunctional and 
intelligent systems that will rely on the probing of their surroundings to match 
their effects. 
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6 Development of multifunctional nanoparticles via the 
amino acid route and deposition-precipitation 
 
6.1 Introduction 
Smart and reactive systems are often envisioned as a more advanced step in 
nanotechnology and nanomedicine development. So far, most nanomaterials of 
interest exhibit one or two key capacities but their potential becomes quickly 
limited and they are often not sufficient to be considered as a smart platform, 
with perhaps the exception of PEBBLE (Probe Encapsulated By Biologically 
Localised Embedding) structure. Combining the properties of nanomaterials or 
compounds into a single structure impart more flexibility and occasionally create 
synergies. Such multifunctional nanoparticles enable the use of a single 
nanoparticle for multiple purposes: in imaging smart particles act as contrast 
agents for two or more imaging modalities to retrieve information at the 
molecular and anatomical level simultaneously whereas theranostic systems 
are suitable for imaging and therapy to ensure that the nanoparticles have 
found their target and make treatments more specific and efficient [Cheon, 
2008; Kobayashi, 2010; Hahn, 2011]. 
 
Gold and iron oxide (or other biocompatible magnetic nanomaterials) are key 
components of multifunctional nanoparticles as both are suitable for imaging 
and therapy indifferently. Their combination gives rise to a so-called 
magnetoplasmonic structure acting as contrast agent for MRI and for optical 
imaging; and for use in magnetically-guided photothermal therapy [Ji, 2007; Xu, 
2008]. Moreover, gold is a versatile contrast agents and magnetoplasmonic is 
an invaluable tool for the development of combined imaging modalities such as 
MRI/CT [Kim, 2009]. Gadolinium-chelated gold nanoparticles were the first 
agents for dual MRI/CT imaging, but due to biocompatibility issues new 
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structures based on magnetite-gold core-shell structures as well as FePt alloys 
have already shown encouraging results, with FePt successfully being detected 
in vivo in mice [Chou, 2010]. Radio-labelled elements such as 64Cu or 124I are 
likewise conjugated to magnetic and metallic nanoprobes to take advantage of 
PET/CT, PET/optical, and PET/MRI dual modalities [Glaus, 2010; Patel, 2011; 
Xie, 2010 b] 
More advanced agents have already been designed and tested on mice, for 
instance the trimodal gold-silica-Gd-Cy5.5 system of van Schooneveld (2010), 
suitable for MRI, CT, and optical imaging, or Hwang’s (2004) quadruple imaging 
agent for luminescence, bioluminescence, PET, and MRI based on a cobalt-
ferrite particle . In these two systems, gold and magnetic particles were not 
combined and in spite of their strengths, other routes are being explored. In that 
respect, quantum dots and fluorescent dyes are also combined with iron oxide 
and gold: quantum dots and dyes may be more detectable by optical means 
than gold nanostructures that are devoid of fluorescence (gold scatter light 
under plasmon resonance but the wavelength remains identical). The 
combination of quantum dots/dyes with superparamagnetic nanoparticles is 
ideal to take advantage of the high anatomical resolution of the magnetic 
modality to the sensitivity of fluorescence-based imaging as well as the high 
freedom in the design of particles morphology [Mistlberger, 2010 a]. For 
instance, Kircher et al. injected near-infrared dye/iron oxide nanocomposite into 
mice for the pre-operative detection of brain tumour in mice and as the 
intraoperative optical beacon to delineate the tumour [Kircher, 2003].  
The better control of nanoparticles synthesis and especially of the surface 
engineering has allowed the progressive evolution from single particles for 
either detection or treatment into more versatile systems. Theranostic (or 
theragnostic) nanosystems are the next generation of targeting agents acting as 
both imaging/diagnostics and therapeutic tools: the term has been coined about 
10 years ago but the field has only steadily grown over the last 5 to 6 years 
[McCarthy, 2009]. The specificity of nanoparticles after surface engineering is a 
tremendous advantage for the delivery of drug and many theranostics systems 
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are based on the vectorisation of active molecules or genes and the beaconing 
and/or magnetic guidance of the nanoparticles [Xie, 2010 c].  
Theranostic agents may be suitable for dual imaging and therapy as well: for 
instance, Yang and co-worker developed a PET/MRI dual agent composed 
64Cu-labelled superparamagnetic nanoparticles and conjugated with an 
anticancer drug [Yang, 2011]. Likewise, the particles may help in the follow-up 
of the drug treatment: a common strategy consists in quenching the 
fluorescence or quantum dots or fluorophores in the initial stage due to the 
interaction with the drug. Once in the organism, the fluorescence emission is 
progressively recovered as the drug is released [Bagalkot, 2007]. Treatment 
triggered by external and controlled stimuli such as light and magnetic field 
have become attractive over time, especially because typical materials such as 
superparamagnetic nanoparticles and gold nanoshells are applicable for both 
applications and because at the difference of drug delivery, the treatment is 
delivered at will and better controlled [Kim, 2006 b; Larson, 2007; Melancon, 
2009]. A hybrid solution consists in loading optically or magnetically active 
nanoparticles with PS and potentially sensing the changes by addition of sensor 
dyes [Chen, 2009 b; Mistlberger, 2010 b]. Hence, Kopelman and co-workers 
were able to track the particles and follow the mass shrinkage of rat brain 
tumour after action of PDT drug [Kopelman, 2005]. 
The in vivo applications of multifunctional nanoparticles are still limited by the 
mismatch between the dose necessary for imaging and for therapy. This is 
particularly true for radio-labelled and/or or drug-loaded nanoparticles but less 
of an issue when the particles properties are triggered by external stimuli. 
Conversely, multifunctional nanoparticles have found their place in in vitro 
studies and diagnostics as well, for exaple in cell/biomolecules separation, 
assays, or cellular and intracellular imaging [Mistlberger, 2010 a]. Luminescent 
magnetic particles are the most prominent multifunctional systems as they allow 
the magnetic manipulation of biological entities and their control and 
quantification via fluorescence-based techniques. The magnetic function may 
be to accumulate particles in the vicinity of a target cell line to favour their non-
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specific uptake and then allow their imaging or alternatively manipulate the 
endosomes or sorting cells (for example metastasis) by magnetophoresis 
[Bertorelle, 2006]. 
In diagnostics, the typical approach consists in targeting non-luminescent 
magnetic particles for the detection of one analyte, separating the particles, and 
introducing a second population of luminescent but non-magnetic particles or 
molecule conjugated to a secondary antibody or DNA fragment [Dressman, 
2003; Mistlberger, 2010 a ]. One such example was the detection of drugs in 
fingerprints using antibody-conjugated magnetic particles to detect the drug, 
with a magnetic brush applied to remove any unreacted particles. Then, 
secondary antibodies modified with dyes were applied as a mean of detection 
and to provide a picture of the fingerprints at the same time [Hazarika, 2008]. 
Additionally, such procedure may be performed in microfluidic devices where 
the magnetic particles are separated from the rest of the sample and directed to 
a specific spot for read-out [Vojtíšek, 2010]. Although rare, the same effects 
were obtained with a single population of luminescent magnetic particles, for 
example Dosev used the luminescence of the particles for internal calibration in 
a competitive immunoassay and the system was extended to the detection of 
three analytes simultaneously [Dosev, 2007; Nichkova, 2007]. The assay relies 
on the binding of the analytes of interest followed by the addition of fluorophore-
labelled secondary antibodies. After magnetic separation, the optical properties 
are measured and the intensity of the fluorophore(s) emission is reported to the 
nanoparticles intrinsic fluorescence, i.e. the fluorescence of the properties acts 
as an internal calibration and the measured signal is relative and not absolute. 
Finally, embedding of multiple quantum dots (or fluorescent dyes) onto 
magnetic particles paves the way for multiplexed assays with the design of 
nano-barcode where each population of nanoparticles display a specific 
fluorescence pattern similar to the quantum dots-loaded microspheres [Wang, 
2007 b]. 
The aim of this chapter is to further expand the potential of the hybrid 
nanoparticles by integrating gold and/or iron oxide to impart plasmon resonance 
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and magnetic properties respectively. To do so, this chapter is divided into three 
parts (Figure 6-1): 
Ø The assessment of the deposition-precipitation method (Appendix G) to 
coat the surface of the hybrid nanoparticles with small gold seeds and to 
further form a complete metallic layer; 
Ø The coating of iron oxide nanoparticles with hybrid silica to design 
fluorescent-magnetic nanoparticles; 
Ø The combination of the deposition-precipitation method and of the amino 
acid route to elaborate multifunctional nanoparticles composed of an iron 
oxide core, a thin silica coating, and an outer gold layer. 
Figure 6-1: Strategies chosen to design gold/hybrid silica/iron oxide 
nanocomposites 
 
Gold Hybrid silica Iron oxide 
Gold-decorated  
hybrid particles 
Magnetic-silica 
nanoparticles 
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Magnetic-fluorescent 
nanoparticles 
Magnetic-silica-gold 
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6.2 Materials and methods 
6.2.1 Materials 
Chemical were purchased from commercial sources and used as received 
without any treatment. Tetraethyl silicate (TEOS), malachite green (MG), neutral 
red (NR), acridine orange (AO), and tri-sodium citrate were purchased from 
BDH. Absolute ethanol, L-arginine (>98 %), 3 aminopropyltriethoxysilane 
(APTES, >98 %), ammonium hydroxide (NH4OH), 3-(trihydroxysilyl)propyl 
methylphosphonate monosodium salt solution (42 %, THPMP), 
vinyltriethoxysilane (>98 %, VTEOS), triethoxyphenylsilane (98 %, PhTEOS), 
hydrogen tetrachloroaurate trihydrate (>99.9 %, HAuCl4), polyvinylpyrrolidone 
(40k Mw), sodium borohydride (~98 %, NaBH4) lucifer yellow (LY), and 
fluorescein (Fl) were obtained from Sigma Aldrich. Rhodamine B (RB) and 
rhodamine 6G (R6G) were purchased from Fluka and methylene blue (MB), 
formaldehyde (CH2OH) and sodium hydroxide (NaOH) from Fisher Scientific. 
Iron (II) chloride tetrahydrate (>99 %, FeCl2) and iron (III) chloride hexahydrate 
(>99 % FeCl3) were obtained from Acros Organics. Highly purified water (Milli-
Q) was obtained from a Millipore “Direct-Q 3” water purification system. 
 
6.2.2 Synthesis of gold nanoparticles and deposition-precipitation 
• Deposition-precipitation on hybrid seeds 
Hybrid silica seeds were synthesised using the protocol described in chapter 4: 
275 µL of VTEOS and 385 µL of TEOS were mixed in 7 mL of arginine solution 
(15 mM) and left to stir for at least 10 hours. Next, 10 mL of arginine solution 
(0.5 mM) and 100 µL of TEOS were directly added to the suspension followed 
30 minutes later by the organosilane(s): 
Ø 40 µL APTES (AP-00) 
Ø 30 of APTES and 20 µL THPMP (AP-25) 
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Ø 20 µL of APTES and 30 µL THPMP (AP-50)  
Separately, a gold solution (6.35 mM) had been prepared by dissolving 125 mg 
of HAuCl4 (trihydrate) in 50 mL Milli-Q. 100 or 500 µL of this solution was diluted 
in 7 mL of arginine (0.5 mM) and the pH was adjusted between 8 and 9. 1 mg of 
hybrid particles was added to this gold solution and the temperature was raised 
to 75°C. After 30 minutes reaction, the particles were collected by centrifugation 
at 150 g for 30 minutes, washed in water, and centrifuged a second time at 150 
g for 15 minutes. Finally, the particles were suspended in 1 mL Milli-Q. 
 
• Growth of gold shells onto hybrid cores 
RB-doped silica nanoparticles were produced based on a VT-50 structure as 
described in chapter 5. Their surface was modified by addition of 30 µL TEOS 
followed 30 minutes later by 50 µL of THPMP and of APTES.  
A gold platting solution was prepared by dissolving 60 mg of K2CO3 in 100 mL 
Milli-Q water to which 1.5 mL of a HAuCl4 solution (25 mM) was added. The 
gold platting solution was left to stir overnight in the dark. 
Gold seeds were nucleated onto the fluorescent nanoparticles following the 
protocol described previously. The particles were centrifuged two times at 150 g 
for 15 minutes and suspended in 1 mL of Milli-Q. The formation of a nanoshell 
was carried out by diluting 200 µL of the gold-decorated silica particle 
suspension into 5 mL of the gold-platting solution. Three different reductants 
(formaldehyde (CH3OH), sodium borohydride (NaBH4), and hydroxylamine 
(NH2OH)) were used to reduce gold onto the particles. Likewise, the influence 
of some parameters was studied: variation of the gold platting volume (2, 5, 10, 
15 mL), different reducing agent volume (100 µL to 1 mL), or variation of the 
deposition-precipitation reaction time (10 to 60 minutes). 
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6.2.3 Magnetite synthesis and magnetic nanocomposites 
• Synthesis of magnetite Fe3O4 and PVP-stabilised magnetite 
Iron oxide nanoparticles were prepared following a co-precipitation method: 
FeCl2 (1.59 g) and FeCl3 (2.16 g) were dissolved in 20 mL HCl solutions (0.2 M) 
each. Then, 1 mL of FeCl2 and 2 mL of FeCl3 and 400 mg of PVP were added 
to 30 mL of Milli-Q and stirred for 5 minutes at 60°C prior to addition of 2 mL of 
NH4OH (conc.). The originally yellow-orange coloured solution turned 
immediately black. After 1 hour, the stirring was stopped and the solution was 
magnetically decanted (the particles sedimented at the bottom of the vessel 
after a few minutes). Then, a neodymium magnet was placed under the vessel 
to retain the particles within the glassware and the magnetite nanoparticles 
were washed two times with 20 mL of distilled water. The particles were finally 
suspended in 30 mL of Milli-Q (1 mg/mL). 
 
• Fluorescent-magnetic nanocomposites 
The PVP-stabilised iron oxide particles were sonicated for 15 minutes and a 
volume was diluted in arginine solution (0.5 mM) containing a fluorophore (1 
mg/mL). After 5 minutes stirring, appropriate volumes of TEOS and VTEOS 
were added to the ferrofluid and the solutions were magnetically stirred for 8 
hours before addition of APTES and THPMP. All conditions tested are 
summarized in the Appendix I (Appendix I). The composite particles were 
magnetically collected using a magnet and three times with distilled water 
before suspending the particles in 1 mL Milli-Q. 
 
• Deposition of an hybrid layer 
he exact same protocol was followed for the hybrid silica shell: 375 µL to 1 mL 
of ferrofluid was diluted in a volume of arginine (0.5 mM) and the required 
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amount of fluorophore solution (1 mg/mL). After 5 minutes, an appropriate 
volume of VTEOS and TEOS were added simultaneously (Appendix I) and the 
suspension was left to stir for 4 hours and collected as previously described. 
 
• Two dyes nanocomposites 
Nanocomposites composed of a magnetite core and a hybrid layer were 
synthesised as described above. After 10 hours reactions, half of each 
suspension was taken out for direct recording of the optical properties of the 
particles. The other half was washed in distilled water to remove the excess of 
fluorophore suspended in 5 mL of arginine solution (0.5 mM) containing a 
fluorophore (1 mg/mL). Then, TEOS was added, the solution were magnetically 
stirred overnight. The particles were washed and suspended as previously 
described. All condition tested are presented in the Appendix I (Appendix I). 
 
6.2.4 Multifunctional nanoparticles 
• Deposition-precipitation on fluorescent nanocomposites 
New batches of iron oxide-silica nanoparticles were prepared by diluting 500 µL 
of sonicated ferrofluid in 35 mL of arginine solution (0.5 mM) to which 100 to 
300 µL of TEOS was added. After 8 hours, the surface was modified with 
appropriate amount of APTES and THPMP and left to stir for additional 8 hours 
before collecting the particles (Appendix J).  
Three solutions containing 5 mL of arginine solution (0.5 mM) and 300, 500, or 
750 µL of HAuCl4 (6.35 mM) and their pH was adjusted between 8.2 and 8.6. 
Then, 5 mL of the silica-iron oxide particle suspensions was washed and added 
to the gold solution. The suspensions were heated to 75°C and aliquots were 
taken at defined periods of time ranging from 30 minutes to 4 hours and washed 
in distilled water. 
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• Growth of full gold layer 
Gold-decorated nanocomposites (Mg Au-1) were synthesised by diluting 750 µL 
of magnetite in 30 mL arginine solution (0.5 mM) to which 200 µL of TEOS and 
75 µL MB .The surface was further modified 4 hours later by adding 40 µL of 
THPMP and 20 µL APTES. Next, 25 mL of the solution was washed and the 
particles were suspended in a solution composed of 30 mL of arginine (0.5 mM) 
and 3 mL of HAuCl4 (6.35 mM) with a pH adjusted to 8.3-8.4. The solution was 
heated at 75°C for 4 hours and divided into 6 solutions, all washed in distilled 
water and suspended in Milli-Q. Two more gold-decorated nanocomposites (Mg 
Au-2 and 3) were prepared: in one case, the deposition-precipitation was varied 
between 1 and 2 hours and in the second case, 80 µL of THPMP was employed 
and the deposition-precipitation lasted 1h30. 
Prior to the gold layer growth, fresh solution of sodium borohydride (6.9 mg 
NaBH4 in 25 mL Milli-Q), formaldehyde (500 µL of formaldehyde in 10 mL Milli-
Q) and hydroxylamine (16 mg in 25 mL Milli-Q) were prepared. The gold platting 
solution was prepared by dissolving 60 mg of K2CO3 in 100 mL Milli-Q water 
and by adding 1.5 mL of a HAuCl4 solution (25 mM). The gold platting solution 
was left to stir overnight in the dark. 
200 µL of particle suspensions was diluted in a volume of K-gold ranging from 2 
to 40 mL. The growth of a full gold shell was studied by varying the type of 
reducing agent and the synthesis conditions as summarized in Appendix J 
(Appendix J). 
 
6.2.5 Characterisation 
• Transmission and scanning electron microscopy (TEM/SEM) 
The particle size and morphology was examined using transmission electron 
microscopy (TEM) and scanning electron microscopy (SEM). The nanoparticle 
suspensions were firstly diluted: the samples were sonicated and subsequently 
260 
25 µL of suspension was poured in an eppendorf and the total volume was 
increased to 500 µL with Milli-Q water so that the SEM samples were totally 
transparent. One drop of suspension was deposited into a silicon grid and let to 
dry in a desiccator for at least 24 hours. Finally, the particles were imaged using 
a high resolution FEI XL30 SFEG analytical SEM (Philips, Netherland) or Philips 
CM20 Transmission Electron Microscope (Philips, Netherland). 
 
• Dynamic light scattering (DLS) 
The size and size distribution of the particles was measured by dynamic light 
scattering using a Zetasizer nano series S provided with an He/Ne laser of 633 
nm wavelength (Malvern Instrument, UK). The particle suspensions were firstly 
diluted: 10 µL of the sample was poured in a quartz cuvette and completed with 
1 mL Milli-Q. The refractive index and absorption of silica nanoparticles were 
fixed at 1.25 and 0.01 respectively. For each sample, four measurements of 20 
runs (15 seconds each) were carried out, with temperature maintained at 25°C. 
 
• Fourier transform infrared spectroscopy (FTIR) 
The particles composition was analysed by infrared spectroscopy: a volume of 
nanoparticle suspension was taken, centrifuged, and dried in the oven for 1 day. 
The resulting powders were subsequently analysed in KBr powders using a 
Thermo Nicolet Avatar 370 spectrometer (Thermo Scientific). Infrared spectra 
were recorded over the wavenumber region 4000 to 400 cm-1 with a resolution 
of 4 cm-1. 
 
• Fluorescence measurement 
Absorbance and fluorescence of FSNP were recorded in 96-well plates with a 
Varioskan Flash Spectral Scanning Multimode Reader (Thermo Fisher 
Scientific) equipped with a xenon flash lamp. All measurements were performed 
on 200 µL of 1 mg/mL suspensions of particles diluted in Milli-Q and at room 
temperature. Excitation and emission spectra of LY, FITC/AO/Fl/OG, R6G, and 
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RB were acquired with fixed wavelength set 540/435, 530/450, 580/490, and 
600/500 nm respectively. 
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6.3 Results 
6.3.1 Gold nanospheres and gold-silica nanocomposites 
Initially, the synthesis of gold-silica nanocomposites was attempted. Indeed, the 
synthesis of gold nanoparticles is easy and well-documented, producing bright 
red or purple suspension according to the particle size (Figure 6-2) 
corresponding to a plasmon resonance ranging from 520 to 560 nm. However, 
the elaboration of gold-silica core-shell structure was more challenging and the 
first attempts led to mixtures of gold, silica, and gold-silica nanoparticles 
altogether and their purification was difficult. For this reason, more attention was 
brought to the synthesis of silica-gold composites and gold nanoshells particles 
using the novel deposition-precipitation method. 
 
Figure 6-2: Example of gold nanoparticles suspension following the 
citrate-reduction protocol. 
 
The deposition-precipitation process requires a “high” of the temperature and 
setting the pH of a gold solution at a specific value to favour the creation of 
seeds onto a surface. In a first time, the reaction time was fixed (30 minutes) 
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but the volume of gold solution used for the precipitation of gold seeds was 
varied [Kah, 2008]. Visually, the originally white suspension progressively 
gained a purple colour and became darker as the quantity of HAuCl4 in the 
medium increased and aggregation was observed at the highest quantity of 
gold solution (500 µL). This change of colour was noticed for amine- and for 
amine-phosphonate-modified particles. The plasmon peak of gold progressively 
appeared on the spectra, although the peak was wider and slightly red-shifted 
than pure gold colloids and displayed a maximum absorption at 545 nm (Figure 
6-3). 
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Figure 6-3 Absorbance spectra of AP-00 sample reacting with increasing 
volume of HAuCl4 proceeded at 75°C for 30 minutes. 
 
In a second time, the volume of gold solution was fixed and the reaction time 
was varied from 15 to 60 minutes. Moreover, RB-containing hybrid particles 
were used instead of blank one in order to observe the variation and potential 
effect of the gold seeds on the fluorescence properties of the FSNPs. The 
initially pink particles became more and more purple as the reaction time 
increased (Figure 6-4), indicating that a higher quantity of gold seeds or 
possibly bigger seeds were present at the surface of the nanoparticles. 
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Figure 6-4: (from left to right) particles suspension after 15, 30, 45, and 60 
minutes reaction time. 
 
This assumption was further confirmed by the absorbance and fluorescence 
spectra. The hybrid nanoparticles displayed a peak at 555 nm, coupled to a 
weaker peak at 520 nm resulting from the gold seeds. When the reaction time 
increased, the plasmon peak widened covering most of the region between 500 
and 600 nm but hiding the RB signal (Figure 6-5). This screening of the RB 
signal was also observed on the fluorescence spectra, where the emission of 
the fluorophore decreased and entirely disappeared after 30 minutes of 
deposition-precipitation time. 
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Figure 6-5: Evolution of the absorbance spectra of hybrid particles with 
the deposition-precipitation time. 
 
The TEM images of the first batch of particles (30 minutes reaction, variation of 
the HAuCl4 volume) showed the evolution of the nanoparticles morphology. At 
low volume (200 µL), black dots 1-2 nm peppered the surface of the particles 
(Figure 6-6 A and B). With 300 µL, these spots were no longer observed but 
energy-dispersive x-ray spectroscopy (EDX) indicated that gold was present in 
substantial amount and it may be assumed that gold recovered the hybrid 
nanoparticles and formed a layer of gold (Figure 6-6 C). At 500 µL, a few areas 
appeared darker than previously (higher electronic density) resulting from the 
aggregation of gold onto the hybrid particles (Figure 6-6 D). Unfortunately, it 
was not possible to performed electronic diffraction of the samples, which could 
have proved that gold was coating the particles and could have provided 
additional information about the phase in presence.  
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Figure 6-6: TEM pictures of hybrid particles after reaction for 30 minutes 
with 200 µL (A and B), 300 µL (C), and 500 µL of HAuCl4 (D). 
 
The deposition-precipitation is a transitional step towards the synthesis of gold 
nanoshells where the gold seeds act as support for the reduction of gold ions 
into a full layer. The gold plating concentration, and the reducing agent nature 
and concentration were investigated. Sodium borohydride (NaBH4) and 
formaldehyde (CH2OH) are two strong reducers but their mixing with the gold 
plating solution initiated the nucleation of pure gold particles, resulting in purple 
or red solution for all conditions tested. The measurement of the supernatant 
absorbance confirmed the presence of gold nanoparticles whereas the 
C) 
A) 
D) 
B) 
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absorbance of the “nanoshells” solely widened to cover the 500 to 600 nm 
region of the electromagnetic spectrum rather than being red-shifted to the 
near-infrared region. 
Hydroxylamine hydrochloride (NH2OH) was then substituted for NaBH4 and 
CH2OH due to its milder reducing capacities (and lower toxicity) [Graf, 2002]. 
The coloration of the gold plating solution was no longer immediate but 
occurred after a couple hours. After reduction of the gold from the gold platting 
solution, the spectra became modified: the plasmon resonance band was larger 
when the volume of reducing agent was increased and displayed a slight red-
shift of the 520 nm-peak of the gold-seeded particles. The effect was maximal 
at the highest volume of NH2OH with a peak at 585 nm. When hydroxylamine 
volume was fixed and the volume of gold plating solution increased, a similar 
red-shift was noted and the initial resonance at circa 525 nm rose up to 550, 
590, and 595 nm (Figure 6-7). Yet, from the absorbance spectra, 
hydroxylamine was not able to form a complete layer because the plasmon 
resonance should go through an important red-shifting and easily reach the 
700-900 nm. TEM analysis must be carried out to shed light on the particle 
morphology. According to the shape and wavelength of the plasmon resonance 
of the gold-hybrid “nanoshells”, no homogeneous layer has been created. 
Instead, it is likely that the gold seeds grew independently in all direction, 
creating large clusters, inducing a resonance between clusters, which explains 
the broad absorbance peak. 
 
In summary, the deposition-precipitation approach is a powerful technique that 
easily covered the surface of hybrid particles with small gold seeds. The gold 
decoration is one step prior to growing a full metallic layer. Nevertheless, the 
results obtained here failed at creating a smooth gold layer and the plasmon 
resonance was only red-shifted to 590 nm at the maximum. Rather than 
continuing on this way, it was decided to first study the coating of iron oxide 
nanoparticles with hybrid silica. Since such particles are easier to manipulate, it 
would be easier to come back to the study of deposition-precipitation on 
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magnetic particles in order to better control the deposition-precipitation 
technique 
 
Figure 6-7: Absorbance spectra of gold-decorated hybrid nanoparticles 
after suspension in increasing volume of gold platting. 
 
6.3.2 Synthesis of magnetite nanoparticles and magnetite-silica 
nanocomposites 
The synthesis of iron oxide nanoparticles proceeded according to Massart’s 
procedure, a co-precipitation-based method consisting in mixing iron salts 
(ferrous and ferric chlorides) under basic conditions. PVP was added at the end 
of the procedure to cap the particles and stabilise the suspension without 
hindering further coating [Graf, 2003]. One of the interesting properties of 
magnetic nanoparticles is their easy purification because the particles can be 
collected using an external magnet, which simplify the washing and suspension 
in water.  
The FTIR-spectra of iron oxide displayed a characteristic band at 580 cm-1 that 
originates from the stretching vibration of Fe-O bonds in magnetite. The 
D 
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adsorption of PVP was seen at 1660 cm-1 due to the C=O bond of the polymer 
and at 1289 cm-1 from the stretching vibration of C-N bonds (Figure 6-8) 
[Arsalani, 2010; Sun, 2007]. 
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Figure 6-8: Infrared spectra of PVP 40k (blue) and PVP-stabilised 
magnetite (red). 
 
Coating with SiO2 was then attempted by adding TEOS to the magnetic 
particles suspended in an arginine solution and MB was added as a visual and 
optical indicator. It must be pointed out that the coating of iron oxide with silica 
usually proceeds following the Stöber method but has never been reported with 
the amino acid route. Batches 1 and 2 were successful and the brown particles 
became green due to the presence of the fluorophore in the nanocomposite but 
none of the other batch seemed to contain the fluorophore. Yet, infrared 
spectroscopy revealed that both silica and magnetite were present in the 
samples since the spectra displayed the siloxane band at 1100 cm-1 and a 
reduced Fe-O stretching mode peak at 580 cm-1 (Figure 6-9). 
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Figure 6-9: Infrared spectra of PVP-stabilised magnetite (red), and batch 1 
(blue), and 6 (pink) obtained after reaction with TEOS. 
 
SEM images displayed very small particles 9, 16, and 14 nmin diameter for 
batches 3, 4, and 5 respectively (Figure 6-10). The magnetite was highly 
aggregated in batches 3 whereas batch 5 was more dispersed. Iron oxide 
nanoparticles produced by co-precipitation are generally 6 to 9 nm in size and 
considering that silica was detected by FTIR the silica layer may not exceed 10 
nm. The green colour was only detected in batches 1 and 2 but not in the other 
samples where the silica was composed of TEOS. The measurement of the 
suspension absorbance confirmed the presence of fluorophores in batches 1 
and 2, but the other samples only displayed flat spectra. The difference may be 
attributed to the higher concentration of MB that was twice higher in the first two 
experiments but the other parameters were kept similar. On the other hand, 
R6G was present in the nanocomposites so the difference in MB case may be 
attributed for a low affinity of the dye for the matrix. 
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Figure 6-10: SEM pictures of silica-magnetite nanocomposite after 
reaction of the magnetic particles with 250 µL (left) and 1 mL (right) of 
TEOS. 
Next, the coating with hybrid silica was tested following an identical protocol. 
Contrary to the previous experiments, the addition of VTEOS appeared to help 
in containing the dye within the coating since the samples exhibited a green 
colour after purification. The absorbance spectra of magnetite with hybrid 
coating possessed a peak at 660 nm. Similarly, batches 8, 11, and 12 that 
contained R6G emitted light at 555 nm whereas TEOS-THPMP and TEOS-
APTES failed at incorporating MB and fluorescein respectively (Figure 6-11). 
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Figure 6-11: Infrared spectra of MB and R6G-doped nanocomposites 
composed of magnetic and hybrid VTEOS-TEOS layer. 
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Infrared spectra of batches 9 and 10 differed although both are made of VTEOS 
and TEOS: batch 9 spectrum is typical of hybrid VTEOS particles with strong 
peaks at 1600 and 1410 cm-1 but new peaks arise at 1461, 1413, and 1379 cm-1 
in the second hybrid that may be due to residual PVP that was still present in 
the sample. In batch 16, no signal from THPMP was detected whereas the 
broad band in the 3500-3000 cm-1 region and the new peaks at 1547 and 1470 
cm-1 are representative of APTES. In all cases, the 580 cm-1 originating from 
Fe-O was present (Figure 6-12). 
 
 
 0
 5
 10
 15
 20
 25
 30
 35
 40
 45
 50
 55
 60
 65
 70
 75
 80
%
Tr
an
sm
itt
an
ce
 500    1000   1500   2000   2500   3000   3500   4000  
Wavenumbers (cm-1)  
Batch 9 
Batch 10 
Batch 17 
Batch 16 
ν (Fe-O) 
=Si-CH=CH2 
=Si-CH=CH2 
NH2 
NH2 
ν (Si-O-Si) 
 
Figure 6-12: Infrared spectra of batches 9 and 10 (made of VTEOS and 
TEOS) and of batch 16 and 17 (made of TEOS-THPMP and TEOS-APTES 
respectively). 
 
The procedure was extended by adding a second fluorescent layer to the 
previous particles. In a first time, batch 2 (700 µL ferrofluid reacted with 175 µL 
TEOS in presence of 75 µL MB) was used as a scaffold and already contained 
MB and a second layer made of TEOS or of VTEOS-TEOS and containing AO 
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was grown onto the nanocomposites. Where the original absorbance spectra 
only displayed a peak at 660 cm due to the presence of MB, the new magnetite-
silica nanocomposites exhibited a second peak at 490 nm revealing the 
presence of the second dye (Figure 6-13). Although the signal was visible in all 
four spectra and the absorbance was of comparable intensities, the emission 
and excitation of the hybrid layer (batches 2-3 and 2-4) was lesser than that of 
pure TEOS. 
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Figure 6-13: Absorbance spectra of MB-containing batch 4 before and 
after modification with either TEOS or TEOS-VTEOS. 
 
The composition of the layer was modified to mimic that of the hybrid particles 
developed in the chapter 5. The samples were based on a similar structure 
where magnetite forms the core of the particles and was recovered by first a 
layer of hybrid silica and second by a pure silica coating. As observed in 
Chapter 5, the addition of APTES to the hybrid coating help in stabilising some 
of the fluorophores with low affinity for the VTEOS-TEOS composition, although 
the aggregation issue seemed amplifyied and the texture of the suspension was 
different, looking like “sand”.  
MB 
AO 
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The particles morphology was characterised by SEM: in batch 23 and 25, the 
images displayed two populations of particles with 140 nm spheres and 700 nm 
cup-shaped particles, whereas smaller spheres 100 nm diameter were visible in 
the same batch after growth of the second layer (Figure 6-14). In contrast, 
batch 26 was mainly composed of particles with size comprised between 100 
and 140 nm after the first and second layer deposition, although the cup-shaped 
structures were occasionally observed. DLS did not provide clear information 
and detected objects nearly 1 µm in diameter – probably the large aggregates  
 
Figure 6-14: SEM pictures of the first hybrid and second TEOS layers of 
batch 23 (A and B), batch 25 (C and D), and batch 26 (E and F). 
  
A) B) 
C) D) 
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detected by electron microscopy - but the size was not necessarily larger after 
the growth of the second layer. In other words, the nanocomposites containing 
VTEOS suffered from the same problem encountered in Chapter 4 (the same 
VTEOS solution was used). For the same reason, it is necessary to repeat the 
experiment with a new VTEOS solution to verify whether the protocol developed 
in this chapter is able to produce nanoparticles rather than cup-shaped 
particles. 
The hybrid nature of the particles was reflected by the characteristic peaks of 
vinyl on the infrared spectra at 1600 and 1410 cm-1 as well as the three peaks 
in the 2950-3050 cm-1 region. Although the 3500-3000 cm-1 band in batch 23 is 
narrower than in batches 25 and 26, the shoulder at 1668 cm-1 evidenced that 
APTES used during the first layer growth had been incorporated into the 
nanocomposite (Figure 6-15). The spectra of layer 1 and layer 2 were identical 
in all three cases. 
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Figure 6-15: Infrared spectra of the final batches 23, 25, and 26 
nanocomposites made of two silica layers. 
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The particles were synthesised in presence of R6G, MB, Fl, or LY for the inner 
layer and AO, R6G, or RB for the outer one. Batch 21, 22, and 24 contained LY 
and AO and the excitation and emission spectra indicated that the two 
fluorophores were present in the particles (Figure 6-16). The absorbance 
spectrum of batch 23 displayed a strong signal from MB and the excitation and 
emission spectra proved that AO was also present. Finally, the excitation and 
emission spectra of batches 25 and 26 displayed intense peaks of Fl as well as 
RB and R6G after the growth of the TEOS layer. 
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Figure 6-16: Excitation spectra of single- and two-layers magnetite-silica 
nanocomposites after coating with the hybrid and TEOS layers 
 
All of these results suggest that the amino acid route is a potential candidate for 
the coating of iron oxide (and potential other material) with thin layers of silica. 
Moreover, the method is also suitable for the deposition of hybrid silica coatings 
in view of developing improved magnetico-fluorescent nanoparticles capable to 
carry a large diversity of fluorophores. Another interesting feature is the 
possibility to drag the particles with an external magnet: this feature may be 
helpful for the deposition precipitation, and more precisely to the formation of a 
homogeneous layer that may require reduction of gold in multiple steps. 
AO 
Fl 
LY 
RB 
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6.3.3 Elaboration of iron oxide-silica-gold nanocomposites 
Due to the easy handling of iron oxide nanoparticles, the deposition-
precipitation process and growth of a gold nanoshell was tested on the 
magnetic-fluorescent nanocomposites. After adjustment of the pH and reaction 
from 15 to 60 minutes the results appeared random. For instance, batch 18 
displayed a strong signal from R6G after 10 minutes and was supplanted by the 
plasmon resonance of gold after 20 minutes followed by a widening of the 
plasmon band over that time. On the contrary, batch 19 did not give sign of gold 
at all, even after 60 minutes (Figure 6-17). Compared to the hybrid particles, 
the decoration with gold seeds of the nancomposites requires more time to 
achieve similar results (usually several hours). This difference may be linked to 
a change of amine density at the surface of the particles or because the amine 
modification proceeded principally on silica particles nucleating as by-product 
during the coating and removed during the centrifugation preceding the 
deposition-precipitation stage. 
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Figure 6-17: Evolution of the optical properties of fluorescent batches 18 
and 19 after 10 and 60 minutes deposition-precipitation. 
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Some of the samples displaying a plasmon resonance were used for the growth 
of a full gold shell by reduction of gold salts from a platting solution. 
Formaldehyde, sodium borohydride, and hydroxylamine were all tested using 
the same protocol than reported earlier. Although all samples eventually 
displayed a large plasmonic band (even samples with very weak initial plasmon 
resonance), none possessed an absorbance over 600 nm but rather covered 
the whole 500-600 nm. As hypothesized earlier, it is likely that the 
nanocomposite are not coated with smooth and uniform gold layers but rather 
by clusters of various sizes. Due to their close proximity, the clusters are able to 
enter into resonance, which is known to produce a broad and slightly red-shifted 
plasmonic peaks.  
 
A different approach called iterative hydroxylamine seeding, relying on the 
repetition of gold reduction, was then applied in order to create a complete layer 
of gold [Lyon, 2004]. Here, the gold reduction was repeated up to 7 times, i.e. 
the iron oxide-silica nanoparticles were suspended in first time in the gold 
platting solution and hydroxylamine was added. The particles were then 
collected, washed, and suspended once again in the gold platting solution. This 
was repeated up to 7 times, always with hydroxylamine to prevent the 
nucleation of pure gold seeds, in order to progressively create a homogeneous 
gold coating. For instance, batch Mg Au-3 was obtained by suspending the 
gold-decorated nanocomposites 4 times in the platting solution: although the 
initial particle did not display any plasmon resonance, a peak around 595 nm 
was visible after the initial reduction round and was shifted after to circa 650 nm 
after the second round. From the second to the fourth round, the spectra 
curvature changed and instead of a peak or a large band, the absorbance rose 
and formed a threshold spanning the 600-1000 nm that was closer to the signal 
from gold nanoshells (Figure 6-18). 
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Figure 6-18: Absorbance spectra of Mg Au-3 after deposition-precipitation 
and iterative hydroxylamine seeding (4 times). 
 
For all experiments proceeding following the iterative seeding, it was possible to 
red-shift the plasmon resonance over 600 nm as well as a broadening of the 
band that spanned the near-infrared region of the electromagnetic spectrum. 
Yet, the spectra eventually looked the same after 3 to 4 repetitions although the 
plasmon resonance should continue red-shifting as the “hypothetic” gold layer 
thickness increases. Consequently, another batch of particles was synthesised 
and the changes of morphology were followed by TEM. The spectra of the 
original composite and of the gold-decorated particles were similar and 
displayed the absorbance of R6G. A large plasmon resonance centred around 
535 nm appeared after the first round of gold reduction and was shifted toward 
585, 640, and 705 nm after the second, third, and fourth passages respectively 
with apparition of the absorbance threshold at the fourth round (Figure 6-19). 
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Figure 6-19: Absorbance spectra of the nanocomposite batch after 
deposition-precipitation and seed mediated regrowth 
 
It was impossible to clearly assess the size of the nanoparticles by TEM 
because of the small size and high aggregation of the samples. The cause of 
the high aggregation may be attributed to both a high concentration during the 
TEM samples preparation and the natural tendency of iron oxide to aggregate in 
spite of the adsorption of PVP. Dark spots on the TEM image of the first round 
are the sign of gold but it does not seem that the particles are all coated. The 
density appeared to increase after 3 passages but the morphology of the final 
structure is not clear enough to verify whether a full layer has been grown and 
how homogeneous this layer might be (Figure 6-20). Unfortunately, these 
images are not exploitable but it was not possible to perform all of the 
characterization required (TEM, X-ray diffraction, etc.). In fact, the experiments 
must be repeated with a full set of characterisation after each step of the 
protocol to follow the changes occurring with the nanoparticles. For the 
moment, all that can be said is that coating of hybrid silica onto iron oxide via 
the amino acid route is possible and the deposition-precipitation and iterative 
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seeding are interesting strategies (still little used) for the formation of gold shells 
and are worth exploring further into details. 
 
 
Figure 6-20: TEM picture of the final magnetite-silica batch (A) and after 1 
round (B), 3 rounds (C), and 7 rounds (D) of seed mediated regrowth. 
 
A) B) 
C) D) 
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6.4 Discussion 
6.4.1 Deposition-precipitation and gold nanoshells 
The deposition-precipitation is a recent and still ill-explored method to coat 
nanoparticles. Initially, gold seeds were nucleated onto titanium dioxide to 
catalyse the decomposition of carbon monoxide but the work of Kah and co-
workers proved that the technique is also suitable for coating the surface of 
silica nanoparticles, becoming a potential alternative strategy for the synthesis 
of gold nanoshells [Kah, 2008]. Contrary to the traditional synthesis protocol of 
gold nanoshells where very small gold seeds 1-2 nm needs are adsorbed onto 
(aminated) silica nanoparticles, the gold seeds grow onto the ceramic particles 
in situ. Kah’s work identified the optimal conditions for the gold-deposition: pH 
comprised between 8 and 9 and a temperature exceeding 60°C maintained for 
30 minutes are essential to obtain uniformly distributed 2 to 4 nm seeds. Longer 
periods of time promote the creation of clusters whereas absence of amine at 
the surface inhibits the deposition of gold particles.  
The effect of phosphonate has not yet been investigated and it is unknown 
whether this moiety strategy may interfere with the deposition-precipitation due 
to its negatively charges that change the particles isoelectric point (IEP). Indeed 
the whole deposition-precipitation process is based on the difference of charged 
between the particle surface and the gold species. The first result showed that 
all samples were modified with gold seeds as seen by the change of colour, 
albeit the conjugation of THPMP has yet to be proved. The pH conditions are of 
utmost importance for the proper creation and precipitation of gold seeds. No 
changes were detected in experiments were this parameter was not controlled. 
This is because deposition-precipitation relies on the hydrolysis of the 
chloroauric ion AuCl4- by the action of a base, resulting in the formation of 
anions of the form [Au(OH)xCl4-x]- [Lee, 2002]. The extent of hydrolysis depends 
on the pH but also on the temperature, which promotes the replacement of Cl- 
with OH-. Of all potential species, only Au(OH)3Cl- precipitates and is able to 
deposit on silica or other substrate and Au(OH)3Cl-  mainly exists in the 8 to 9 
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pH range [Kah, 2008]. Haruta originally designed gold supported on titania 
surfaces for catalytic purposes but the method is suitable for other metal such 
as nickel on various metal oxide substrates [Haruta, 1997]. Nevertheless, the 
DP method does not function for all metal oxide surfaces as the IEP is another 
important critoerion. For example, the IEP of bare silica is equal to 2, meaning 
that the silica surface is negatively charged at higher pH and therefore repel the 
Au(OH)3Cl- ions. To successfully create gold seeds onto silica nanoparticles, 
the surface must be modified with amine groups to raise the IEP of the particles 
to 9. In consequence, the particles become slightly positively charged below pH 
9, which allows the deposition of Au(OH)3Cl- and subsequent gold nucleation 
[Phonthammachai, 2007]. The advantage is that there is no risk of gold particles 
generation since no reducer is added to the solution and the Au(OH)3Cl- specie 
exclusively reacts with the silica surface. The colour changes visible with the 
phosphonated-modified particles showed that the deposition-precipitation was 
achieved even though the surface was not strictly expressing amine groups. 
However, it is necessary to mesure the zeta potential of the potential to firstly 
prove the presence of phosphonate group and secondly to evaluate whether the 
change of IEP that may be detrimental for the procedure. 
 
The optical properties of the gold-decorated hybrid particles highly depend on 
the gold ions concentration and on the reaction time: the higher concentration of 
HAuCl4, the deeper the suspension colour and the broader the plasmon 
resonance band. The effects are equivalent when the reaction time is increased 
because of the structural changes in the particles surface. TEM and EDX 
evidenced the modification that occurred onto the nanoparticles: at low gold 
concentration or reaction time, small seeds were detected and turn into what 
appeared as full yet inhomogeneous layer of gold at medium concentration 
and/or time and finally evolved in the creation of large, dark areas onto the silica 
structures after 60 minutes reactions. The surface of the particles was covered 
of clusters of different sizes close one o the other and this proximity create a 
broad plasmonic band because a phenomenon of resonance between the 
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clusters. The presence of clusters is not desirable for the growth of a complete 
and smooth layer of gold because they compete with the small seeds as 
nucleation site. The deposition-precipitation reaction ought to be stopped based 
on visual and/or spectroscopic evidence to ensure of the optical properties 
quality and to avoid the formation of gold clusters. The main setback to the 
deposition-precipitation and to the coating of silica particles with gold in general 
is the screening of the fluorescence signal of dye contained in the hybrid matrix. 
It was found that as the plasmon resonance/seed density increased the 
fluorescence of dyes in the core of the diminished and was eventually screened 
the dyes fluorescence because gold is not optically transparent. 
 
The logical next step is the growth of a uniform shell onto the gold 
nanocomposites via reduction of gold by action of a reducing agent. Sodium 
borohydride and formaldehyde are the principal reducing agents and were the 
first tested. Their addition to the gold platting solution immediately led to a red 
colour but centrifugation at low speed and recording of the supernatant 
absorbance showed that the colour originated from small gold nanoparticles 
that remained in suspension in the supernatant. The two reducing agents are 
too strong and their addition to the platting solution led to spontaneous 
nucleation of new gold nanoparticles. The sole effect on the nanocomposites 
was a slight broadening of the plasmon resonance peak at 530 nm but no 
nanoshell was created. Hydroxylamine hydrochloride, a weaker reducer, was 
also tested but to no avail: although no immediate gold nucleation occurred (but 
after a few hours reaction), no significant optical changes were observed with 
the nanocomposites [Phonthammachai, 2008]. 
Variation of reducer concentration, gold platting volume, and deposition-
precipitation time had little effect and no absorbance spectra display the 
characteristic features of gold nanoshells (long wavelength plasmon resonance, 
etc.). In only one case, where a higher gold platting volume was used (15 mL), 
the maximum wavelength verged on 600 nm but overall no complete gold shell 
was created in any batch of nanoparticles. The synthesis of gold nanoshells 
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was paused for a while for investigating the production of iron oxide-silica 
nanocomposites. 
 
6.4.2 Magnetic particles and magnetite-silica nanocomposites 
The choice of moving to the magnetic particles rather than optimising the 
synthesis of gold-silica nanoparticles and gold nanoshells was motivated by the 
difficulty encountered with the purification of the samples. Iron oxide 
nanoparticles in that respect are easier to handle since they can be retrieved 
using an external magnet. Moreover, the deposition-precipitation revealed a 
powerful method and was supposed to be directly applicable with silica-coated 
iron oxide particles. The design of nanocomposites and multifunctional 
nanoparticles proceeded in three stages: growth of fluorescent silica and hybrid 
layers using the amino acid route, the functionalisation of the nanocomposites 
with gold seed following the deposition-precipitation approach, and the growth 
of a gold layer using hydroxylamine reduction and iterative seeding. 
Several methods have been developed for the synthesis of iron oxide 
nanoparticles. The co-precipitation is the simplest and most frequent method 
and consists in mixing iron salts and to add ammonium hydroxide to precipitate 
iron under the form of magnetite nanoparticles. The method is able to produce 
very small particles 5 to 15 nm in large quantities but suffers from two major 
drawbacks: the relatively high size dispersity and the low crystallinity (high 
crystallinity goes in par with high magnetisation). Proceeding at higher 
temperature remedies to the size dispersity and low crystallinity, but requires 
another solvent withstanding 200 degrees. In the same way, controlling the 
aggregation of iron oxide nanoparticles helps in both controlling the size of 
clusters and increasing the saturation magnetisation, and render the particles 
more sensitive to moderate external magnetic field [Ge, 2007]. Nevertheless, 
co-precipitation is a perfectly acceptable method and was found suitable for the 
development of multifunctional nanoparticles. 
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Iron oxide nanoparticles can be stabilised by addition of polyvinylpyrrolidone 
(PVP) a biocompatible, neutral polymer that adsorbs onto the surface of the 
nanoparticles and promotes their steric repulsion. The adsorption is only 
provisory and the polymer chains exchange their place with other molecules or 
materials (ligand exchange) whenever the nanomaterial has to be coated [Graf, 
2003, Thanh, 2010]. Yet, PVP effect was found limited in time and did not 
suppress the aggregation. It is however possible that the aggregation is in fact 
intrinsic to the method as the first particles are immediately formed with the first 
drop of ammonium hydroxide. This problem may be overcome by controlling the 
afflux of NH4OH using a pump to ensure that the iron oxide salts are 
progressively transformed into nanoparticles.  
The FTIR characterisation of the silica-coated iron oxide particles showed sign 
of silica but SEM pictures did not display significant changes of diameter before 
and after reaction with TEOS, suggesting that coating thickness may not 
exceed a few nm. Here again, the amino acid route may be interesting to 
produce thinner coating than the Stöber method and may reduce the chances of 
encapsulating multiple magnetite nanoparticles into a single silica particle 
(frequent with the Stöber method). The detection of silica prompted the testing 
of hybrid coating. Where pure silica showed difficulty to entrap MB (perhaps due 
to the thinness of the layer), hybrid VT-coating proved more successful since 
the particle displaying the 600 and 660 nm band found with free MB solution. 
The strategy developed in chapter 5 was attempted on the magnetic 
nanoparticles as well and incorporation of APTES to VTEOS and TEOS led to 
particles containing fluorescein and lucifer yellow (impossible with pure silica) 
as well as AO, RB, and R6G. It was likewise possible to combine all of these 
fluorophores by iterative deposition of hybrid silica, suggesting that core-shell 
structures are achievable. Considering that most fluorescent-magnetic particles 
require covalent binding, use of emulsion, or integration of quantum dots for the 
rest) [Chen, 2009 b; Cho, 2010 c; Corsi, 2009, Zhang, 2010 a], using hybrid 
silica coatings multiply the possibility of the magnetico-fluorescent systems for 
use in diagnostics, imaging, therapy, etc. However, it is necessary to conduct 
more experiments and to optimise the process. For instance, the SEM pictures 
287 
displayed large particles often with form of empty half spheres analogous to the 
VTEOS cups in Chapter 4 and imposes a change of VTEOS solution. The initial 
aggregation of iron oxide and the related instability are a problem and require a 
change of synthesis procedure (beyond the scope of this thesis). The 
fluorescence property and particle homogeneity (in terms of dye content) must 
be assessed. Overall, the experiments presented in this chapter must be taken 
as the first steps in the design of iron oxide-silica nanoparticles and a testing of 
the feasibility of the amino acid route to coat the magnetic particles and of the 
hybrid silica coating to enhance the fluorophore carriage capacity of the 
nanocomposites. 
6.4.3 Multifunctional particles 
The next evolution step towards the multifunctional systems consisted in 
coating the iron oxide-silica nanocomposite with a gold layer. The first step 
required the decoration of the fluorescent magnetic particles with gold seeds via 
deposition-precipitation. The initial experiments were unsuccessful and, 
although the plasmonic response was detected in a few samples, no pattern 
arose that could explain how the gold concentration and time affects the 
coverage. The solution came by increasing the reaction time from 60 minutes 
up to 4 hours where visual changes evidenced that the precipitation occurred. 
The process is still not well controlled and some samples needed less than 60 
minutes to be covered with gold, perhaps because of a higher amine density 
onto the particles, or the thinness of the silica layer. Nevertheless, the 
apparition of a plasmon resonance peak (at 520 to 550 nm) may not be 
desirable: such signal mainly originates from gold clusters that handicap the 
nucleation of gold ions onto the small and result in heterogeneous gold layer 
[Kah, 2008; Park, 2006 b]. Therefore, measuring the absorption of the particles 
during the deposition-precipitation in order to stop the process before the 
resonance peak emerges may be required for a homogeneous gold coating. 
Sodium borohydride and formaldehyde were found too strong and favoured the 
growth of pure gold particles to the detriment of the nucleation of gold onto the 
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seeds. The critical point in the formation of gold shell is that the rate of Au3+ 
reduction onto metallic surface must be greater than the rate of new particles 
nucleation [Brown, 2000]. Because of the reducing strength of the two 
compounds, the later is favoured and new particles nucleated instead of the 
reduction of gold ions onto the nanoparticles. For this reason, the plasmon 
resonance of the final nanocomposite did not differ much from that of the gold-
decorated particles with either the apparition of the plasmonic phenomenon or a 
broadening of the plasmon band. Variation over the type of reducer and 
concentrations did not affect the optical properties of the multifunctional 
particles and the same response was obtained at all time. Hydroxylamine 
induced the same minor changes and it was also observed that the reduction of 
gold on magnetite-silica was achieved in absence of deposition-precipitation. A 
potential mechanism is the formation of small gold particles by the action of the 
reducing agents that were able to bind to the amine groups of the composites 
due to the good affinity of gold surface for this organic group. Although a strong 
resonance occurred, the changes are mainly the action of gold clusters and not 
that of a homogeneous layer. However, hydroxylamine is known to favour the 
reduction of gold ions on metallic surfaces metallic surface of the nucleation of 
discrete particles [Brown, 1998 and 2000] but the experiments in this chapter, 
be they with silica or nanocomposites, showed that pure gold particles were 
grown over time nonetheless. Therefore, the presence of gold onto the 
magnetic-silica particles may be the result of another mechanism that has yet to 
be elucidated. 
Instead of applying a simple seed mediated regrowth, a different approach 
called iterative hydroxylamine seeding was tested. The method is suitable for 
the growth of homogeneous gold particles over 60 nm – technically difficult 
otherwise – and consists in applying hydroxylamine in multiple step to enlarge 
the particles step-by-step [Brown, 2000]. The principle is extendable to the 
growth of metallic shell so long as the surface already contains gold seeds. The 
method is very effective with magnetic particles as the nanomaterials are easily 
and quickly retrieved and suspended in gold platting without need of 
centrifugation or other complex procedure. By this mean, it was possible to red-
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shift the plasmon resonance of the nanocomposite and reached 650 to 700 nm 
after 2 to 5 iterations. Two cases must be considered: when the samples 
exhibited a strong plasmon resonance after the deposition-precipitation, the 
final maximal resonance wavelength was not able to overpass 600 nm. 
Although the plasmon band spanned a larger region including part of the NIR 
region, the spectra are not that expected from smooth, homogeneous gold 
layer. In comparison, absence of original plasmon resonance led to a widening 
of the plasmon band followed by a distortion and a red-shift of the plasmon 
resonance as expected from a nanoshell. Salgueirino-Maceira designed similar 
multifunctional particles and the optical absorption of the particles passed 
through similar stages [Salgueirino-Maceira, 2006; Zhang, 2010 b]. In the case 
of inhomogeneous layer, the plasmon band was even broader and composed of 
multiple maxima that are the high order resonance contributions (mainly 
quadrupole) from clusters and particles of various dimensions [Brinson, 2008; 
Graf, 2002].   
 
The works based on iterative hydroxylamine seeding applied more iterations 
than what was tested in this chapter (up to 18 in certain case), therefore 
continuing the regrowth might lead to full homogeneous layer. Nevertheless, it 
seems more plausible that the success or failure to tune the plasmon resonance 
is linked to the gold coverage and the deposition of gold-seed has been 
identified as the crucial step. The growth of a metallic layer is possible without 
the presence of silica between the two materials (although magnetite must be 
oxidised into maghemite for the gold to attach) but the response is similar to 
most of what has been obtained with deposition-precipitation and the 
impossibility to red-shift the resonance wavelength [Lyon, 2004; Larson, 2007]. 
Switching to a layer-by-layer self assembly technique where the particles 
surface is covered by polyelectrolyte may be an option and proved efficient to 
cover nanoparticles surface with a dense and homogeneous layer of gold 
nanoparticles [Liang, 2003; Wang, 2008; Zhai, 2009]. 
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6.5 Conclusion 
Two methods, the deposition-precipitation and amino acid route, were explored 
to design multifunctional nanoparticles incorporating simultaneously iron oxide, 
(fluorescent) silica, and gold. The former is a recent method that can coat a 
material with small gold seeds but remains ill-explored. The latter method has 
never been used to coat iron oxide (and other materials) nanoparticles. 
Therefore the aim of this chapter was to explore the feasibility to create 
nanocomposites by combining these two strategies. 
The deposition-precipitation led to contrasted results: one the one hand, this 
method proved very efficient at coating the surface of the hybrid nanoparticles 
with small gold seeds, imparting at the same time plasmonic resonance. One 
the other hand, controlling the seed size and density proved difficult which 
prevented from creating homogeneous gold nanoshells and by extension it was 
not possible to design iron oxide-silica-gold nanocomposites. In other words, it 
has been shown that the deposition-precipitation could be applied on the hybrid 
particles but optimisation is required, notably a systematic SEM/TEM study to 
follow the influence of the various parameters on the gold seed morphology and 
density. 
The synthesis of iron oxide-silica particles showed for the first time that the 
amino acid catalysis is suitable for coating magnetic nanoparticles with silica 
and hybrid silica. The results presented in this thesis suggest that the amino 
acid route can create a very thin silica layer, which can be an advantage over 
the Stöber method that is known to create thick layer encapsulating multiple iron 
oxide particles into a single structure. The coating with hybrid silica was also 
tested and the final magnetic-fluorescent composites were able to carry 
indifferently fluorescein, lucifer yellow, and rhodamine B. However, similarly to 
the deposition-precipitation, the procedure must be refined because some 
uncertainties still hang over. For instance, it is necessary to control the silica 
thickness (via SEM/TEM characterisation), verifying the particle morphology 
(problem of cup-shape particle), and assessing the optical properties of the 
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magnetico-fluorescent nanostructure (dye content of individual particles in 
particular, as discussed in the previous chapter). 
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7 Final discussion 
 
The aim of this thesis was to develop an alternative, more flexible method for 
the synthesis of fluorescent silica and multifunctional nanoparticles. The amino 
acid route that underlies the whole process was first tested to develop a 
multifluorescent structure (Chapter 3) and then used for the design of a TEOS-
VTEOS hybrid structure (Chapter 4). The hybrid structure acted as a scaffold for 
the incorporation of a variety of fluorophores in order to fill a gap in the 
development of FSNPs (Chapter 5) and played a key role in the combination of 
nanomaterials into a Fe3O4-SiO2-Au nanocomposite (Chapter 6). 
 
Nanotechnology has the potential to impact on medicine and the biomedical 
field through three features: the new properties of nanomaterials, the surface 
engineering of nanoparticles, and the reduced scale of nanostructures 
comparable to biological species such as proteins. Classes of nanomaterials 
may be divided into particles with intrinsic properties such as iron oxide, gold, or 
quantum dots, and particles devoted to the carriage of molecules such as silica, 
dendrimers, etc. 
Polymers and liposomes were among the first nanocarriers devised for the 
delivery of drugs and biomolecules in general but some compounds such as 
fluorescent dyes are best kept contained within the particles. Organic materials 
are known to break, degrade, or lose their integrity (swelling) when changing 
solvent or under basic/acid conditions. In that respect, silica nanoparticles offer 
certain advantages over polymers: ceramic nanoparticles are more robust and 
usually insensitive to changes of pH, temperature, and other environmental 
parameters. Furthermore, the silica matrix insulates its cargo and the whole 
effect can be modulated by controlling the porosity. Finally, the silica chemistry 
is highly versatile and allows for easy modification of the particle core or of its 
surface via use of organosilanes. 
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Silica is typically processed by sol-gel reactions and the formation of particles 
occurs when hydrolysis and condensation are catalysed by bases. The work of 
Stöber and Fink was the first thorough investigation of the parameters 
regulating the dimensions of silica particles [Stöber, 1968]. The procedure is 
fairly simple and only requires the mixing of silicon precursors, water, and 
ammonium hydroxide in an alcoholic environment. Yet, the particle dimension 
span the submicrometric and micrometric ranges which are not suited for all 
applications and do not strictly fall in the nanotechnology definition (as define by 
the NNI). Although reducing the particle dimension is possible by controlling the 
reagent concentration, the task of synthesising spheres smaller than 100 nm is 
typically allotted to reverse microemulsion. The particle growth is confined 
within micelles and ensures a high monodispersity of the samples. At the same 
time, the necessity to create an emulsion – implying the use of harsh organic 
solvent – and the long purification of the particles required to remove any trace 
of surfactant are limiting factors [Osseo-Asare, 1990].  
Other factors arise during the incorporation of fluorescent dye: van Blaaderen 
modified the Stöber method, co-condensing sylilated fluorophores (FITC and 
RITC) with TEOS to produce bright particles; the hydrophobicity of most organic 
dyes hinders their incorporation into the growing nanoparticles by their inability 
to enter within the micelles [van Blaaderen, 1992 c; Tan, 2004]. In the end, 
fluorescent particles reported in the literature are limited almost exclusively to 
chemically-modified dyes and lanthanide chelates. Alternatively, the use of oil-
in-water emulsions managed to take advantage of the hydrophobicity of organic 
fluorophores by ensuring that both silicon precursors and dyes are located in 
the same phase so that the final particles contain the fluorescent molecules. 
This method has been successful for the incorporation of near-infrared and two 
photon dyes as well as photosensitisers but still faces the long purification 
procedure and risk of remnant surfactant molecule adsorption [Roy, 2003; 
Ohulchanskyy 2007 and 2010]. Chapter 2 highlighted the ease of producing 
silica and fluorescent silica particles via the Stöber procedure and van 
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Blaaderen’s alteration as well as the obstacle to the loading of common organic 
dye encountered with the reverse microemulsion approach and helped in 
identifying the current limitation of the FSNPs technology. 
 
The apparent lack of fluorophore variety is not necessarily an issue: many 
groups such as van Blaaderen’s, Wiesner’s, Tan’s, or Prasad’s have 
established the strength of silica nanoparticles in cellular imaging, 
photodynamic therapy as well as in the tracking of particles in mice. All have 
perfected the Stöber and reverse and oil-in-water emulsions to the point of 
providing solutions to some of their initial limitations. For instance, C-dots are 20 
nm FSNPs produced without recourse to emulsion but work only with sylilated 
fluorophores [Burns, 2009; Ha, 2009, Zhao, 2004 b]. Yet, two major gaps still 
exist and impede the progress of FSNPs: first of all emulsions remain the 
principal technique for the synthesis of small particles and ought to be 
substituted by cleaner methods. Secondly, the limited variety of fluorophores 
found in the literature does not make honour to the whole range of possibilities 
that dyes offer, be it in terms of luminescence or other physico-chemical 
properties.  
A typical example is the near-absence of particles containing two dyes or more: 
Wang’s FRET system is the only significant contribution to the field of 
multifluorescent particles: the system relied on the use of FITC and maleimide-
derivatives of rhodamines co-condensed at a precise ratio to tune the 
fluorescence pattern of the nanoparticles [Wang, 2006]. By this means, Wang 
and co-workers demonstrated how the fluorophores can generate separate 
emissions or on the contrary how one dye can act as secondary excitation 
source by transfer of energy (FRET). Furthermore, they used a different set of 
FRET nanoparticles to label and simultaneously image four bacterial 
populations [Wang, 2007 a]. A few other studies have developed nanoparticles 
containing two dyes via the co-condensation of sylilated fluorophores or the 
combination of two lanthanide chelates but at present, Wang’s particles are the 
only example of a system containing more than two dyes [Nakamura, 2007; Xu, 
298 
2010]. Yet, multifluorescent particles are necessary for multiplexed analyses 
where multiple analytes must be detected in a single sample but must meet 
three requirements: 
Ø The variety of fluorophores must be broad enough to afford a large 
number of permutations; 
Ø The dyes must cover the largest spectral region possible, from UV to 
infrared;  
Ø The particles must potentially be small enough for the detection of minute 
amounts of analyte.  
Even though silica nanoparticles are in theory able to contain virtually any dye 
by selecting the appropriate synthesis procedure, the encapsulation of two or 
more fluorophopores may become more challenging. For example combining a 
hydrophobic and a hydrophilic fluorophore requires first an oil-in-water emulsion 
followed by the purification of the particles and their suspension into a reverse 
microemulsion in view of incorporating the second dye. There is a lack of an 
easy and universal method that would enable the entrapment of the two dyes 
without having recourse to tedious or complex protocols such as emulsion or 
chemical modification of the fluorophores. 
 
Yokoi and Davis have elaborated an alternative synthesis route involving lysine 
to catalyse the sol-gel reactions and their work was completed by Hartlen’s 
study of the production of silica nanoparticles via arginine catalysis [Davis, 
2006; Hartlen, 2008; Yokoi, 2006]. The amino acid route provides a solution to 
the size issue by producing very small seeds while the whole process is easier, 
cleaner, and more environmentally friendly than emulsions. The particularities of 
the amino acid route lies in the absence of organic and alcoholic solvents in 
favour of water and the substitution of the strong ammonium hydroxide by lysine 
or arginine. The milder conditions are such that the two amino acids are basic 
enough to direct the sol-gel reactions towards the creation of colloids while 
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limiting the particles sizes to a few tens of nanometres. In addition, the surface 
of silica nanoparticles expresses silanol groups Si-OH as well as unreacted 
alkoxide groups Si-OC2H5. The same silanol groups are at the heart of the sol-
gel reactions and make the surface reactive to the introduction of more silicon 
precursors. For example, Hartlen proved that the initial small seeds could be 
enlarged by addition of more TEOS in an arginine environment or via a typical 
Stöber reaction in a process called seed regrowth [Hartlen, 2008].  
From the seed regrowth approach germinated the idea of designing a core-shell 
structure where each compartment contains a specific fluorescent molecule 
resulting in the production of a multifluorescent nanoplatform. The particles 
were built up by iterative addition of TEOS and the addition of three dyes, each 
of them added at a separate step to integrate them in different layers. Each 
fluorophore highlighted a specific aspect: FITC was coupled to APTES for 
covalent binding to the silica network and R6G exemplified the electrostatic 
interaction with the matrix. The role of MB was different as it is commonly 
employed in staining procedures and is likely to be found in many laboratories. 
The choice of MB underpins the idea that silica nanoparticles ought to easily 
incorporate any fluorescent dye present in a laboratory and not exclusively 
isothiocyanate and maleimide derivatives or lanthanide chelates. FITC and R6G 
were both entrapped during the particle formation and generated a strong 
fluorescence signal whilst MB was also detected but did not fluoresce. It turned 
out that MB is a weak fluorophore but is a potential photosensitiser, i.e. the 
molecules potentially convert the light energy into radical species. In other 
terms, the structure designed in chapter 3 is a potential theranostic agent 
suitable for imaging and photodynamic therapy. The generation of singlet 
oxygen was not tested, albeit this capacity may be assessed via the use of an 
oxygen sensitive fluorophore [He, 2009 b]. The fact that the blue dye was added 
in the first layer raises the question of whether singlet oxygen would be able to 
diffuse away from the particles and if the radical species degrade the other dyes 
in their way. 
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The particles were not larger than 20 to 30 nm yet the seeds were based on 
Hartlen’s protocol which supposedly produces 20 nm particles and the amount 
of TEOS added at each step was calculated to increase the diameter by about 
10 nm based on a 20 nm seed hypothesis. Considering the very small amount 
of seed produced, it is not known whether the synthesis yield is small or 
requires more time for the particles to fully nucleate. However, the particle 
concentration steadily built up after each step to reach several micrograms at 
the end of the procedure. The reduced dimensions were not detrimental for the 
optical properties of the particles and each suspension exhibited very strong 
colour in accordance with the fluorophores they contained. Moreover, the 
fluorescence emission of the samples containing R6G and FITC displayed two 
maxima corresponding to each fluorophore and suggest that the combination of 
several dyes may help in tuning the emission pattern of the silica nanoparticles 
[Wang, 2006; Xu, 2010]. In summary, the system developed in the chapter 4 is 
an alternative way to produce multifluorescent nanoparticles in a simple way 
and suitable for the entrapment of some common fluorescent dyes and stains 
via electrostatic interactions and/or covalent binding while restricting the 
nanoparticles diameter below 50 nm.  
 
The objective of designing small and fluorescent particles was achieved and 
their capacities as a contrast agent for imaging ought to be investigated. Two 
cell lines were selected prostate adenocarcinoma cell line (PC3) and its 
corresponding normal transferred line (PNT1A). The two cell-lines are well-
characterised and their different state would be a first indicator of a possible 
cell-dependency of particle uptake, especially since cancerous cells are said to 
eagerly take up nanoparticles [Trewyn, 2008]. Many in vitro studies are based 
on lung epithelial cell lines, macrophages, or cancer cell lines. The choice of 
lung-related lines is motivated by the traditional assessment of particles where 
anthropogenic particles are inhaled and potentially interfere with the lungs. 
However, the inhalation of engineered nanoparticles is not automatic and many 
nanomaterials are synthesised under the form of hydro-colloids which thereby 
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limits the risk of inhalation. Furthermore, the entry routes are different for 
particles with biological applications and the nanoparticles would in all likelihood 
interact with other cells and tissues during their time in the organism before 
macrophages clear them from the blood stream and direct them in the spleen 
and liver, potentially in the lymph nodes and a few other organs when the 
nanostructures are small enough [Vonarbourg, 2006]. The complicating factor 
lies in the different cellular response towards the presence of nanoparticles: it 
has been shown that certain nanomaterials may not be toxic for epithelial cells 
but induce deleterious effects on other cells because the metabolism of each 
cell type is different [Rabolli, 2010]. Finally, surface engineering of nanoparticles 
reduces the chance of interactions with unwanted cells when in the organism, 
although macrophages recognition and clearance will eventually occur. Many 
systems aim at targeting cancerous cells via the conjugation with peptides, 
antibodies, carbohydrates, or biopolymers recognised by specific receptors 
overexpressed in cancerous cells. Here, PC3 cells are known to overexpress 
CD44 receptors that can be targeted by hyaluronic acid as discussed below 
[Ossipov, 2010; Platt, 2006]. 
The qualitative assessment of PC3 and PNT1A labelling with the 
multifluorescent nanoparticles was performed by confocal microscopy and 
showed two situations. In the PNT1A case, the uptake was considerably limited 
and only a few small particles were detected. In contrast, PC3 took up large 
amount of particles that formed aggregate within the cells. These findings 
highlight the difference that may exists between related cell lines and the 
impossibility to predict how a cell line will respond to nanoparticles. The result 
also raised questions about the intracellular fate of the particles: the fact that 
“primary” particles were localised in PNT1A whereas the same samples led to 
large aggregates in PC3 suggests that the cancerous cells may have gathered 
the particles into a specific region of the cytoplasm. The intracellular fate of 
nanoparticles is not well-characterised yet at the difference of the endocytosis 
pathways. In one occurrence, it was mentioned that particles were exocytosed 
in one region of the cells instead of throughout the whole membrane, which may 
be consistent with the evidence here [Panyam, 2003]. It is likely that the 
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particles remained encased within vesicles throughout the whole internalisation 
as escaping vesicles requires either the modification with evading peptides or 
the degradation of the particles and this encasement might explain how all of 
the particles are eventually gathered in the same region [Nativo, 2008]. 
The strong optical properties of the nanoparticles helped in their easy tracking 
within the cells. The emission of many fluorophores and cellular stains lies in 
the 500 to 600 nm range and due to a strong overlapping it becomes 
increasingly difficult to distinguish each fluorophore as their number augments. 
For instance, FITC, acridine orange, and sytox green emission are separated by 
5 to 10 nm so that their identification is only possible via the difference of 
intensity when entrapped within silica nanoparticles or via the META detector 
for FITC and sytox green. Similarly, the signal from R6G was masked by that of 
AF555 although the META module would have easily deconvoluted the 
emission of the two dyes. The FITC-R6G-doped particles did not suffer from this 
limitation as the two fluorophores appeared in different channels and their 
signals were overlayed to produce a distinct colour. Coupled to the META 
detector, more two colours-coded populations of particles could be employed at 
the same time and clearly be distinguished, opening the field of multiplexed 
imaging. At another level, the robustness of the silica and the total dye 
insulation render the FSNPs photostable, allowing imaging for an extended 
period of time. This feature may be put into use for tracking in real-time the 
endocytosis, intracellular fate, and exocytosis of the particles. 
The work reported in chapter 3 was only a first step in the cell labelling and 
opened new research possibilities. First of all, it is necessary to couple the 
evidence obtained by confocal microscopy to flow cytometry to quantitatively 
assess the labelling of PC3 and of PNT1A and prove the difference in uptake. In 
the same vein, it is necessary to assess the cellular response to the presence of 
nanoparticles via viability and apoptosis/necrosis assays as well as measuring 
the degree of oxidative stress and the generation of radical species within the 
cells. Lastly, the potential of the multifluorescent nanoparticles has yet to be 
investigated, notably via the coupling with appropriate ligands to target either 
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organelles or specific cell types for multiplexing analyses. Another point of 
interest is to investigate the effect of the particle surface as results produced 
during an MSC project showed a clear difference with a viability assay between 
bare FITC-doped particles produce by reverse microemulsion and the same 
particles modified with APTES [Traver, 2010].  
 
Despite the flexibility and ease of production of the multifluorescent 
nanoparticles, the matrix remains composed of silica exclusively and is not ideal 
for certain organic dyes. One hypothesis was that the affinity of hydrophobic 
dyes – among others - for the inorganic matrix would not be strong enough and 
the particles would fail to contain such dyes. Therefore, a modification of the 
particles composition was tried to favour the stabilisation of the fluorescent 
molecules in the growing nanoparticles. Silica is ideal for this strategy due to the 
large number of silicon precursors commercially available and is already 
employed for the creation of ORMOSIL structures (organically modified silica) 
such as xerogel or simply to solubilise the silicon precursors in the oil phase of 
oil-in-water emulsions [Li, 1992; Qian, 2009]. This role is often devoted to 
vinyltriethoxysilane (VTEOS) that possess a hydrophobic vinyl moiety and this 
silicon precursor appeared as an interesting candidate for the modification of 
the silica matrix [Law, 2008; Sharma, 2004]. The procedure was kept similar to 
the multifluorescent particles and VTEOS was introduced simultaneously to 
TEOS and co-condensed to form nanoparticles.  
The hybrid colloids displayed certain differences from TEOS-made particles: 
Ø The seed diameter increases with the proportion of VTEOS and ranges 
from 10 nm at 25 molar% to 110 nm at 75 % and pure VTEOS particles 
are in the submicrometer rather than in the nanometer range; 
Ø More material was recovered compared to TEOS particles; 
Ø VT-50 consistently produced particles 40 to 50 nm in diameter; 
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Ø A change of the silane/arginine/water molar ratio does not induce large 
variation of the particle diameter in the VT-50 case. 
Most ORMOSIL nanoparticles are obtained by mean of microemulsion, which 
automatically restricts their size to the tens of nanometre. Conversely, Dirè 
investigated the co-condensation of organosilane with short and long alkane 
chain moieties as well as amine, vinyl, and phenyl groups via the Stöber 
method, which yielded particles ranging from 100 to 1 µm according to the 
silane and the composition [Dire, 2011]. PhTEOS-TEOS systems have also 
been investigated and are known to create large particles of high hydrophobicity 
[Bagwe, 2002; Theaker, 2008]. Here, the PhTEOS hybrids were no more than 
50 nm or lower according to the PhTEOS/TEOS ratio but a strong 
hydrophobicity was noted even at low ratio. Other hybrids such as THPMP-
TEOS and TEOS-APTES were also small although the APTES hybrid was 
subject to a strong aggregation. Therefore, the amino acid route is suitable for 
the design of ORMOSILs and restrains the growth of particles to a few tens of 
nanometer without requiring any alteration of the synthesis procedure. 
The change of diameter in comparison to the small TEOS seeds may originate 
from repulsive interactions between silica and the vinyl moieties that may distort 
the matrix and/or create larger pores than in silica nanoparticles. Although 
infrared spectroscopy proved that the vinyl moiety had been integrated to the 
silica matrix, the actual morphology of the particles remains unknown. The 
organosilane hydrolysis rate is different from that of TEOS and it influences their 
condensation. The difference of rate may lead to heterogeneous structures 
where the core is made of VTEOS or of TEOS and covered by a layer made of 
the second silane. For instance, Wang’s initial attempts to create the FRET 
systems led to low FRET efficiency because each sylilated dye create a layer of 
its own [Wang, 2006]. The fact that the VTEOS particles were not hydrophobic 
– although a secondary hydrophobic population was detected in small quantity 
during the centrifugation step at high VTEOS concentration – discard the 
possibility that VTEOS creates an outer layer onto the TEOS seeds. In contrast, 
the hydrophobicity of PhTEOS at moderate PhTEOS/TEOS molar ratio 
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indicates that the organosilane may form an outer layer because of a slower 
hydrolysis rate. Ideally, VTEOS may form the core of the seeds and become 
protected by a hydrophilic layer made of TEOS. Such structure would be perfect 
for the embedding of hydrophobic dyes: due to the aqueous environment, the 
generation of hydrophobic seeds would provide a friendly environment for the 
fluorophores that would accumulate in the VTEOS core [Deng, 2006]. Next, 
TEOS would cover the seeds and protect the hydrophobic compounds, all 
without modifying the experimental conditions [Rampazzo, 2007]. In all 
likelihood, the hydrolysis rate of TEOS and VTEOS are similar and both 
precursors homogeneously condense during the seed nucleation. There may be 
two solutions to shed the light on the particles morphology: firstly, the nucleation 
and growth of particles can be followed by small angle x-ray scattering (SAXS) 
to determine the particle formation kinetics [Yokoi, 2009], but it is uncertain 
whether the technique can distinguish the organosilane contribution in the 
seeds. The second option consists in using 29Si NMR and 1H NMR in order to 
assess the composition of the seeds over time and whether the two silicon 
precursors are initially present in the seeds or if they enter at different stages of 
the particle growth. 
It was only possible to determine the particles diameters at different 
arginine/arginine/water molar ratios using DLS but this technique gives an 
approximation and cannot provide an actual value as soon as the particles 
cluster. However, the hydrodynamic and “number” diameters did not exceed 
100 nm, most likely due to the pH of 10 and the adsorption of arginine molecule 
that limit the particle growth. The principal issue was related to the unusual 
shape of the particles (submicrometric half-spheres with empty core). These 
shapes were not observed at all with the first organosilane solution but it is not 
certain that VTEOS is responsible for this phenomenon. The shape in itself is 
interesting and not necessarily a drawback: for example gold nanocages and 
nanostars exhibit new plasmonic behaviours whereas simulations have showed 
that shapes other than spheres and rods may have faster and optimal cellular 
uptake [Champion, 2007; Gratton, 2008].  At present, it is unknown whether 
these new particles may be of interest and the “cup-shaped” particles require 
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more investigation, firstly to reduce their dimensions, and secondly to probe 
their carriage capacities and functionalisation.  
 The first objective was partially fulfilled: it was demonstrated that the amino 
acid route is an easy way to synthesise ORMOSILs structures with better 
control over the particle dimensions than that reported with the Stöber method 
and without need for extensive purification. However, the mechanisms that led 
to the creation of the large and oddly shaped VTEOS particles are still obscure, 
although such changes were not observed with the other hybrid structures. 
 
With the new hybrid particles developed, the next stage was to investigate their 
capacity to entrap fluorescent dyes by using a larger variety of fluorophores 
than commonly found in the literature. Increasing the number of fluorescent 
dyes adds more flexibility to the fluorescent silica nanoparticles in terms of 
excitation choice, but also in terms of combination into multifluorescent 
nanoparticles. More importantly, the nanoparticles could be used for other 
application than imaging (luminescence) such as photodynamic therapy (cf 
methylene blue) but also in sensing since the emission of certain fluorophores 
may be modified by a change of pH or temperature or react to the presence of 
oxygen, ions, or other species. The coupling of sensing dyes into a single matrix 
has been proposed via the PEBBLE structure which is based on ratiometric 
measurements, i.e. the sensing dye fluorescence intensity is brought back to 
that of a reference dye, which implies that such structure must contain at least 
two fluorophores [Burns, 2006; Gao, 2011, Peng, 2010]  
As mentioned, few fluorophores have been investigated as van Blaaderen’s 
procedure and the sylilation of dye is favoured. Yet, Theaker and co-workers 
used a PhTEOS-TEOS hybrid in order to embed a larger choice of dyes and 
stains used in forensic analyses (fingerprints) but not all dyes were entrapped. 
Likewise, of the ten fluorophores tested for this thesis, half were not 
encapsulated during the particle growth. The mixed results meant that the 
VTEOS-TEOS structure as such is not a universal carrier and could not contain 
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the hydrophobic fluorescein, oregon green, and lucifer yellow. Where the 
reverse microemulsion was unable to contain RB, R6G, and R6G – or more 
precisely led to poorly fluorescent particles – the VT-50 produced very bright 
particles in the range 40 to 50 nm with an excellent repeatability and smaller 
than the RB-doped particles obtained by the Stöber method. However, it was 
impossible to compare the hybrid particles with the typical silica particles 
obtained by the amino acid route because of the low particle density of the 
latter. The problem of fluorophore leakage is occasionally raised for the 
electrostatic entrapment of dyes but there is no strong evidence of such 
phenomenon in the literature and many groups noticed the absence of dye 
diffusion over long periods of time [Estevez, 2009; He, 2009 b; Santra, 2006] 
and leak tests in chapter 5 did not detect any diffusion of the dyes away from 
the matrix. 
Based on a process similar to that developed for the multifluorescent 
nanoparticles, the hybrid seeds were enlarged by successive TEOS additions to 
form multi-layered structures. Each layer contained a different dye among AO, 
R6G, and RB; combined at different ratios in order to tune the spectral signature 
of the particles. By this means, the nanoparticles were able to emit light at long 
wavelength with high intensity by exciting the whole particles with the AO 
excitation whereas the excitation of R6G and RB only at the same wavelength 
is ordinary weak. The close proximity of AO and R6G had for principal effect a 
broadening of the emission band whereas combination of AO and RB produced 
patterns with two maxima, with relative intensity depending on the initial dye 
concentrations. The excitation and emission of the three dyes were too close to 
efficiently impart a distinctive signature and the whole system is not as efficient 
as Wang’s and would require a third dye emitting at longer wavelength than RB 
[Wang, 2006]. 
The fact that the first and second dyes were present in multiple layers was 
initially believed to be a weakness and a lack of control exerted over the particle 
optical properties. However, the mix of dye in a same layer may help in 
promoting FRET. This effect is distance-dependent and quickly diminishes 
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when the distance between donor and acceptor augments but the presence of 
the two dyes in the same layers increased the chance of energy transfer. The 
opposite effects arise if the fluorophores are too close, in which case quenching 
occurs. In fact, of the major drawbacks of the experiments carried out in this 
thesis is the initial high concentration of dyes: most of the fluorophores 
remained in the supernatant and were discarded during the centrifugation step, 
undesirable for expensive dyes. On the other hand, the saturation of the silica 
matrix led to dimmer signal which usually causes a loss of intensity and 
emissions at lower wavelength, lost by nonradiative pathways or caused by 
quenching in non-fluorescent aggregates [Anedda, 2007; Del Monte, 2000; 
Severino, 2003]. Therefore, there is a need for both controlling the minimal dye 
concentration to avoid unnecessary losses and experiments showed that 
reducing 2 to 5 times the dye concentration led to particles with sufficient 
brightness. 
 
The hybrid composition was modified as an answer to the failure to certain dyes 
incorporation. Theaker hypothesised that the dyes remained restrain within the 
particles by the combined action of steric hindrance and electrostatic interaction 
with the large and electron dense phenyl group [Theaker, 2006]. Certain studies 
such as that of Theaker and other teams focused on the co-condensation of 
TEOS and phenyltriethoxysilane (PhTEOS) for the encapsulation of dyes such 
as R6G or fluorescent dyes and stains of help in forensics [Theaker, 2008]. The 
hybrid structure had high fluorescence intensity and photostability but the very 
large and the hydrophobic nature of the particles quickly arose as the proportion 
of PhTEOS increased [Bagwe, 2002]. The same effect was noticed when 
PhTEOS substituted VTEOS and the particles became very hydrophobic at a 
molar ratio of 50% whereas no advantage was noticed in terms of dye 
entrapment. More importantly, where the particle size increased as the 
proportion of VTEOS increased no clear trends were noted but more 
experiments may be necessary to investigate this hybrid system. The solution 
arose from the addition of APTES to the hybrid structure: it was noted that the 
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use of this organosilane tended to augment the size of the particles and was 
noted by other groups as well [Dire, 2011], yet the presence of amine played a 
role in the stabilisation of fluorescein, lucifer yellow, and oregon green that were 
eventually included inside the silica matrix. The idea came from the comparison 
of the dye chemical structure and the three dyes all bore a negative charge and 
are consequently repulsed by the negatively charged silica matrix. The 
incorporation of amine creates regions of positive charges within the network 
and facilitates the stabilisation of the fluorophores and more brightness was 
obtained by increasing the APTES proportion.  
In summary, the hybrid nanoparticles offer an easier alternative to the synthesis 
of FSNPs and were able to embed some bright fluorescent dyes such as 
rhodamine B and 6G. The dyes were restrained by electrostatic interactions, 
admittedly not as efficient as the covalent binding of van Blaaderen’s method, 
but enough to partially tune the spectral signature of the nanoparticles. It may 
be interesting, though, to transpose van Blaaderen’s protocol to the amino acid 
route in order to verify if the FSNPs get smaller. If the hypothesis of correlating 
the choice of organosilane with the fluorophore charge proves correct, the 
hybrid particles may virtually be able to contain any dye by simply selected the 
appropriate precursor while maintaining the exact same procedure. At present, 
two points still have to be investigated: the actual effect of the organosilane – in 
particular APTES - on the particle diameter could not be assessed because of 
the formation of cup-shaped particles. Similarly, the potential aggregation 
induced by APTES might be attenuated by the choice of a different amino-
silane or by a positively charged silane unable to create hydrogen bonds with 
the silanol groups. The second point consists in translating the process to the 
growth of additional layer in order not to restrict the localisation of specific dyes 
into the hybrid core and add more flexibility with the aim of combining sensor 
dyes such as rhodamine B, fluorescein, or oregon green. 
 
Finally, silica was used as a common matrix for the combination of iron oxide, 
gold, and/or fluorescent dyes in order to design multifunctional nanoparticles. 
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The objective was to develop a modular structure where each component may 
be positioned according to the use but it was not possible to coat gold particles 
with enough precision or to cover the surface of silica nanoparticles with iron 
oxide. Therefore, the final chapter aimed at designing a magnetite-silica-gold 
structure where the initial magnetic core helped in manipulating the particles 
throughout the whole process.  
Gold is one of the most versatile nanomaterials for imaging, therapy and/or 
diagnostics but also for the creation of synergistic effects such as metal-
enhanced fluorescence. For instance, gold nanoshells can be used in combined 
NIR imaging and photothermal therapy but also enter in the composition of 
immunoassays [Hirsch, 2003 a and b]. The formation of gold nanoshells is well-
documented and typically requires the synthesis of small gold seeds that are 
then adsorbed onto a dielectric core such as silica followed by the reduction of 
gold ions to progressively form a homogeneous layer [Oldenburg, 1998]. The 
method is powerful but there exists the chance of seed desorption that could 
compromise the layer growth and/or adherence. Kah demonstrated that gold 
nanoshells can be produced without having recourse to the synthesis of gold 
seeds but instead by inducing their formation in situ onto the particles surface, 
suppressing at the same time the risk of desorption [Kah, 2008]. A part of the 
final chapter aimed at controlling the deposition-precipitation method in order to 
decorate the hybrid particles with gold seeds and to further create a full metallic 
layer. With this technique, the hybrid silica nanoparticles acquired plasmonic 
properties due to the decoration with small gold nanoparticles and the plasmon 
response depended on the gold ion concentration and reaction duration. In 
particular, the longer the reaction, the more clusters on the surface. It was found 
that the presence of clusters is detrimental for the creation of a uniform gold 
layer by promoting the growth in three-dimensions of the clusters rather than 
creating a smooth layer. 
Like gold, iron oxide is a key material in nanomedicine and is often integrated 
into nanocomposites and multifunctional systems because of its manipulation 
with a magnet. There is a strong need for magnetic-fluorescent nanoparticles in 
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diagnostics where nanoparticles are able to detect analytes and to retrieve them 
by magnetic separation [Mistlberger, 2010 a]. Magnetic nanoparticles are 
frequently combined with quantum dots or fluorescent dyes but usually one type 
at a time which limits the potential for multiplexed analyses [Hu, 2011; Wang, 
2010]. There exist two issues when synthesising magnetic-silica 
nanocomposites: first of all, the Stöber method employed to grow the silica layer 
produces relatively thick particles and generally entraps a random number of 
magnetite nanoparticles [Claesson, 2005]. Secondly, the magnetic properties of 
SPIO and USPIO, i.e. saturation magnetisation, are moderate but decrease with 
the presence of silica. Reverse microemulsion is a solution to make sure that 
each silica particle contains a single magnetic core but the amino acid route 
may provide a better and more flexible solution to the first issue by growing very 
thin layer of silica that reduces the chance of co-encapsulation of magnetite 
[Narita, 2009]. The second issue may be overcome by controlled aggregation of 
the iron oxide nanoparticles followed by the encapsulation of the resulting 
clusters into silica [Larsen, 2008; Wan, 2010]. Alternatively, the surface of silica 
may be decorated with iron oxide but the approach is not satisfactory for 
magnetic luminescent structures as the magnetic particles screen the 
fluorescence, unless a new layer of fluorescent silica is grown onto the 
structure. Chapter 6 reported for the first time the use of the amino acid route to 
coat iron oxide with silica and the first results seem to indicate that the layers 
are naturally thin. Furthermore, the protocol developed for the synthesis of 
hybrid nanoparticles was directly transposable and easily gave birth to 
multifluorescent magnetic nanoparticles containing two dyes and can be 
extended to more fluorophores. This new approach has the potential to 
enhance the magnetic luminescent particle potential by providing more flexibility 
to the structure and by multiplying their applications. 
The second step consisting in engineering magnetoplasmonic structures was 
more contrasted: on the one hand, the deposition-precipitation worked well the 
iron oxide-silica structure were decorated with gold seeds and clusters, 
achieving the first stage towards a full multifunctional platform. However, it was 
here again impossible to obtain a smooth and homogeneous metallic shell 
312 
because of the presence of gold clusters. Instead, the plasmon resonance of 
the “magnetoplasmonic” nanoparticles was red-shifted up to 700 nm via the 
iterative hydroxylamine seeding. Direct coating of iron oxide with gold does not 
allow a modification of the plasmon resonance frequency more than a few tens 
of nm and rarely by-pass 600 nm [Larson, 2007]. The presence of silica is 
indispensable to red-shift the nanoparticles as the structure becomes similar to 
silica-gold nanoshell and the effect may be linked to the silica thickness. Shifting 
the plasmon resonance was only possible when the reduction of gold ions 
proceeded in several stages though iterative seeding.  
One important point remains to be elucidated: the deposition-precipitation was 
originally developed by Haruta for catalytic purpose. The high specific surface 
and reactivity of small nanoparticles has a central role in “nanocatalysis” and 
gold seeds were initially used for the oxidation of amines and halogenated 
compounds, combustion of carbon monoxide and reduction of nitrogen oxides 
[Haruta, 1997]. Therefore, it is unknown how the multifunctional particles with 
incomplete gold shells or decorated with gold seeds would interact with the cell 
membrane. It is possible that, due to their reactivity, the gold seeds induces the 
oxidation of lipids or could play a role in damaging the plasma membrane. At 
the same time, the presence of clusters may reduce this effect but there are 
chances that such an incomplete structure may induce toxic effects. On the 
other hand, the close proximity of the clusters may create a resonance 
phenomenon between each aggregate and amplify the plasmonic response, in 
which case the decoration with gold may give rise to a powerful Raman 
spectroscopy probe. 
One of the aims was to develop a modular platform, i.e. a structure where gold, 
silica, and iron oxide could be permuted at will to create any morphology (for 
instance gold-silica-iron oxide or iron oxide-gold-silica, etc.). The amino acid 
route would in theory grow very thin layer of silica, which would be ideal to 
position fluorophores at a distance where their emission or excitation could be 
amplified by the plasmon resonance of the metallic surface in their vicinity. In 
the same vein, the objective of synthesising gold nanoshells failed. However, 
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part of the chapter 6 was dedicated to the testing of the deposition-precipitation 
and proved a very efficient tool to decorate the surface of hybrid particles with 
small seeds.  
The requirements for the development of magnetic-silica nanocomposites was 
met and led to multifluorescent magnetic particles. The novelty came from both 
the use of the amino acid route to coat with a thin layer of silica and the 
transposition of the hybrid structure to favour the incorporation of fluorophores. 
By extension, the deposition-precipitation functioned on the nanocomposites as 
well and led to a multifunctional platform where iron oxide, (fluorescent) silica, 
and gold were combined into a single structure with magnetic and plasmonic 
properties. The structure still needs to be optimised through the formation of a 
smooth gold layer and through the deposition of additional silica layer to impart 
fluorescence to the whole system. Moreover, the nanocomposites must be 
conjugated with targeting ligands for their use in biomedical applications. 
Attempts with folic acid and hyaluronic acid failed, yet the latter could have been 
directly employed to help in targeting PC3 cells and enhance the uptake of 
nanoparticles while reducing the aggregation. Both silica and gold surfaces 
possess a high affinity for a large variety of ligands and many procedures have 
been devised to conjugate these nanomaterials with antibodies, peptides, DNA, 
and polymers. This step is crucial for the biomedical applications of 
nanoparticles introduced in the first chapter. 
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8 Final conclusion and future work 
 
Nanoparticles offer promises in many field, including in medicine. The 
combination of optical, magnetic, and electrical properties of nanoparticles 
coupled to their dimensions similar to that of proteins makes them ideal to 
interact with the biological entities. More accurate and faster diagnostics, 
specific delivery of drugs or imaging probes, or direct treatment of diseases are 
some possibilities that nanoparticles offer. Among the biocompatible 
nanomaterials, inorganic nanoparticles have a distinct place: gold, iron oxide, 
quantum dots possess optical, magnetic, and electrical properties that can be of 
use in imaging, diagnostics and/or therapy whereas silica is a formidable carrier 
with a good affinity for virtually any material or compound. 
The research study reported in this thesis was centred on two axes: the 
synthesis of a new class of silica-based nanoparticles with enhanced 
fluorophore carriage capacity and the development of alternative approach for 
the production of multifunctional nanoparticles. For both aims, the amino acid 
catalysis played a key role to control the silica chemistry and create either 
nanoparticles or coatings. Furthermore, the amino acid catalysis was completed 
by the deposition-precipitation method in view of decorating the surface of 
nanoparticles with very small gold seeds as basis to fully integrate the noble 
metal into the final nanocomposites and multifunctional nanoparticles. 
 
The first part of the research focused on the understanding of the amino acid 
route and its difference with the other traditional synthesis methods. The amino 
acid route positions itself between the traditional synthesis approaches that are 
the Stöber and reverse microemulsion method: the particles were very small 
while obviating the necessity to use organic solvent and alcohols, which make 
the whole process easier, faster, and environmentally friendly. Furthermore, the 
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initial small seeds were easily enlarged by creation of successive silica layers to 
control the final particle diametre  
The very small seeds acted as a scaffold for the growth of three successive 
silica layers, each containing a different fluorophore, and not larger than 30 nm. 
The capacity to carry multiple dyes illustrates the flexibility of the system as the 
fluorophores can be incorporated either via electrostatic interactions or via 
covalent binding to the inorganic network indistinctively while exhibiting strong 
optical properties. The nanoparticles were suitable for the labelling of cells and 
subsequent imaging by a confocal microscope. The capacity of carrying multiple 
fluorophores was helpful to create a distinct signal from the stains by appearing 
in multiple channels simultaneously and revealed a cell-dependency in the 
uptake of nanoparticles, where the internalisation of the normal epithelial was 
very low compared to that of he cancerous cell line.  
Next, the silica particle composition was modified to take into account the 
different nature of fluorophores in order to create a universal carrier able to 
contain any dye. In particular, the hydrophilicity of many organic dyes governs 
the choice of the synthesis technique as the most hydrophobic fluorophores 
require a different emulsion. For this reason, the composition of the seeds was 
modified in order to incorporate vinyl moieties that ought to create hydrophobic 
sites within the silica matrix. ORMOSIL nanoparticles are generally several 
hundred of nanometres unless produced by oil-in-water emulsion, but the 
catalysis by arginine confined the particles in the 10 to 100 nm range. The 
optimisation of the procedure allowed the synthesis of 40 to 50 nm seeds with a 
good reproducibility.  
The hybrid particles appeared as good fluorophore carriers able to contain dyes 
of interest such as rhodamine B and 6G. The core composition could be further 
modified in accordance to the chemical structures of the dyes in order to 
facilitate their incorporation and enabled the encapsulation of all 10 dyes tested. 
With this approach it is likely that one entrap any fluorophore by simply tuning 
the particle composition to match the dye electrical charge. More work is 
necessary to control the final optical properties but it was nonetheless possible 
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to entrap up to three dyes simultaneously and their relative concentrations 
enabled to modulate the fluorescence patterns of the FSNPs. 
 
Finally, the hybrid nanoparticles acted as a linker to iron oxide and gold. The 
synthesis protocol of hybrid nanoparticles was directly transposed to the coating 
of magnetite and opens new possibilities for magnetic luminescent systems that 
suffer from a lack of fluorophore choice. The magnetic system was even able to 
contain two distinct fluorophores, which is rather unusual for magnetic 
luminescent nanocomposites. The incorporation of gold was linked to the 
deposition-precipitation technique and played a fundamental role in the design 
of multifunctional particles. Still, the system is incomplete as the final gold layer 
lack of homogeneity, although the plasmon resonance of the whole 
nanostructure was successfully red-shifted to 700 nm. More work is necessary 
for the design of a modular structure, whose composition can be tuned to meet 
ones requirement and where the three nanomaterials tested could be switched 
at will. 
 
In conclusion, the main purpose of this research project was to develop a 
flexible method for the design of fluorescent silica nanoparticles. The procedure 
developed achieved this aim and lays the first stone for newer applications of 
silica nanoparticles in imaging and diagnostics by allowing the analysis of 
multiple targets simultaneously. The potential of the nanoparticles is further 
enhanced by the easy combination with magnetic and metallic nanoparticles. 
The requirements for the multifunctional systems are partially met and with 
some optimisation, the multifunctional nanoparticles will be able to evolve into 
one of smart systems envisioned for the second phase of nanotechnology 
development and play a role in the improvement of nanomedicine.  
There exist several possibilities to improve the hybrid and multifunctional 
nanoparticles as well as to enhance their fluorescent properties. Moreover, 
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most of the experiments consisted in optimising the different types of 
nanoparticles and their applications have yet to be investigated. Here are some 
possibilities that could be exploredt. 
 
• Optimisation of the hybrid nanoparticles synthesis 
The synthesis of ORMOSIL by arginine catalysis developed in the chapters 4 
and 5 is a novel approach and as such opens many possibilities. There exists a 
large variety of organosilanes and each of them could generate new effects. For 
instance, addition of THPMP might have an effect on the particle porosity due to 
the repulsion between phosphonate groups between them or with the negative 
silanol. Other positively charged silanes might suppress the formation of 
hydrogen bonds that APTES suffers from while preserving its capacity to attract 
certain fluorophores. 
The assessment of VT-structures ought to be continued, for example to 
effectively analyse the influence of water and arginine on the actual particle 
diameter and to obviate the creation of large cup-shaped structures. Similarly, 
the PhTEOS hybrid might have a stronger effect on organic dyes but its 
hydrophobicity must be lowered to make them useful in aqueous environment. 
This could be achieved by growth of silica layers to improve the nanoparticle 
water solubility. In that respect, it was not possible to probe how to grow thicker 
layers of silica via the seed regrowth but this stage is highly important for the 
encapsulation of multiple targets in separate layers as well as for the creation of 
nanocomposites and multifunctional structures where silica acts as a linker. 
Moreover, the possibility to grow hybrid layers, in particular of APTES-TEOS 
layers, onto the seeds has yet to be determined. 
  
• Control of the carriage capacity and tuning of the optical properties  
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Although the hybrid structures were able to entrap fluorescein and lucifer 
yellow, the production of FSNPs is still in its early stage. For of all, it is 
necessary to test NIR/IR and multiphoton dyes that are of interests in bio-
imaging. There is no certainty how the fluorophores will react in the arginine 
solution and whether the molecules with aggregate before their containment – if 
it occurs – within the VTEOS core. It may be necessary to replace VTEOS by 
the more hydrophobic PhTEOS or by other silane that would enhance the 
affinity of the dyes for the inorganic matrix. 
In the same vein, the initial fluorophore concentration must be decreased to limit 
the loss of free molecules as well as to control the fluorescence emission with 
more precision. Besides, the high concentration was responsible for some 
aggregation within the particles as the signal from dimer and other excimers 
was detected in some occasion. This step is fundamental for the development 
of nanosensors (PEBBLE) where the fluorescence of the sensing dye is 
reported to that of a referent fluorophores, meaning that the concentration of the 
two populations of molecules must be known with exactitude.  
• Development of nanocomposites and multifunctional nanoparticles 
Chapter 6 was a first attempt to produce nanoparticles composed of two or 
more nanomaterials. The coating of iron oxide, gold, and other surface with 
silica via arginine catalysis has never been tested so far but is potentially a 
good solution to produce very thin layer of ceramic. This point is crucial to 
ensure that only one nanoparticle is contained within the silica, a common issue 
in the synthesis of nanocomposites. However, the technique consisting in 
controlling the aggregation of iron oxide is worth exploring as it strongly 
enhances the magnetic properties of nanocomposites. 
One of the aims was to design a modular structure, i.e. positioning iron oxide, 
gold, and/or silica in any order in function of the needs. So far, the coating of 
gold nanoparticles with silica failed which limits the modularity of the particles. 
Yet, gold-silica nanoparticles are interesting for fluorescence as it allows the 
right distance between metallic surface and fluorophores to take advantage of 
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the MEF effect, especially if the nanospheres were to be replaced by nanorods 
or nanostars due to their multiple plasmon resonance. Similarly, attempts to 
grow a full gold shell failed and more attention has to be paid to the deposition-
precipitation to determine ito what extent this step affect the homogeneity of the 
gold layer. Overall, more time is needed to determine the effects of all of the 
parameters involved in the creation of the iron oxide-silica-gold particles, from 
the thickness of the silica layer to the deposition of gold seeds and the factors 
intervening in the growth of gold shells. 
 
• Surface engineering and applications  
Modifying the surface of nanoparticles is a requirement to fully take advantage 
of the particles properties. So far, the bio-conjugation with FA and HA failed and 
must be attempted again. For example, coating with HA would enable the 
precise targeting of CD44 receptors of PC3 cells and procedures exist for the 
conjugation of DNA/RNA, peptides, or polymers on gold or silica surfaces.  
With the appropriate surface modification, the FSNPs and multifunctional 
structures could find multiple applications: the synthesis of multiple populations 
of particles with distinctive spectral properties may help in  
Ø Targeting specific organelles or detecting different cell types or 
molecules within tissues and complex samples; 
Ø The detection of biomolecules in blood for diagnostic purposes using 
magnetic properties to separate the analytes of interests and using 
fluorescence-based or Raman-based techniques for the analysis;  
Ø Combined imaging/photodynamic or photothermal therapy as the 
photoactivity of MB still has to be assessed;  
Ø Nanosensors could shed light on intracellular processes, including the 
probing of nanoparticles effects in the cytoplasm or simply as a follow-up 
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of the particles fate from their endocytosis to their exocytosis or their 
precise location. 
The final point is related to the toxicity of the nanoparticles developed 
throughout this thesis. Although the materials selected are in principle 
biocompatible, it is impossible to predict how the hybrid and nanocomposite 
would interact with the cells. This is particularly true for the gold-decorated 
nanoparticles that might prove cytotoxic due to the high reactivity of the small 
gold seeds. 
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Appendix A Supplementary materials for the 
synthesis of FNSPs by the Stöber and 
reverse microemulsion approaches 
 
A.1 Preparation of blank and FITC-doped nanoparticles following 
the Stöber method 
 
Table A-1: Parameters for the preparation of FITC-doped silica 
nanoparticles 
Experiment V (TEOS) V (NH4OH) V (FITC-APTES) V (H2O) V (EtOH) 
Blank 1 1.5 mL 2.8 mL X X 35 mL 
Blank 2 2.5 mL 2.8 mL X X 35 mL 
Blank 3 1.5 mL 2.8 mL X 5 mL 35 mL 
Blank 4 2.5 mL 2.8 mL X 5 mL 35 mL 
Stöb 1 500 µL (0.5 M) 100 µL 250 µL X 10 mL 
Stöb 2 250 µL (0.5 M) 100 µL 250 µL X 10 mL 
Stöb 3 250 µL (0.5 M) 50 µL 250 µL X 10 mL 
Stöb 4 250 µL (0.5 M) 100 µL 100 µL X 10 mL 
 
A.2 Dye-doped nanoparticles via the reverse microemulsion route 
 
Table A-2: Parameters for the preparation of fluorophores-doped silica 
nanoparticles. 
Experiment w (TX100) V (cyclohexane) V (hexanol) V (NH4OH) V (H2O) V (TEOS) 
Mic-RB 1 1.77 g 7.5 mL 1.6 mL 150 µL 500 µL 500 µL 
Mic-RB 2 1.77 g 7.5 mL 1.6 mL 300 µL 500 µL 500 µL 
Mic-R6G 1.77 g 7.5 mL 1.6 mL 150 µL 1 mL 500 µL 
Mic-AO 1.77 g 7.5 mL 1.6 mL 300 µL 1 mL 500 µL 
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Appendix B Principles of dynamic light scattering 
 
Dynamic light scattering (DLS) is a technique measuring the size of 
submicrometric particles through correlation with Brownian motion (the random 
movement of particles within a liquid due to the collision with the solvent 
molecules). DLS relies on the illumination of particles in a liquid and analysis of 
the fluctuation of light scattered by the particles. 
Small and large particles do not drift similarly in a liquid, and small particles tend 
to move more quickly than the larger one. Speed and size of particles in a liquid 
are related by the Stokes-Einstein relation: 
D
kT
DH πη3
=  (B-1) 
where DH is the hydrodynamic diameter of the particles, k is the Boltzmann 
constant (1.3806504 x 10-23 J.K-1), η is the solvent viscosity, T is the absolute 
temperature, and D is the diffusion coefficient.  
 
The correlation curve obtained through DLS measurements contains the 
information to determine the diffusion coefficient of particles and therefore to 
measure their hydrodynamic diameter. The Stokes-Einstein equation is based 
on the assumption that particles in solution are spherical; otherwise the Perrin 
factor is necessary to estimate the particles dimension. A DLS instrument uses 
a correlator, i.e. a component that compares the intensity of a signal at 
particular points in time to build the correlation curve of a sample. When 
recording the signal at an instant (t) and comparing it with the signal at an 
instant (t + δt), the two signals have high chances to be very similar provided 
that the instant δt is very short (Figure B-1).  
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Figure B-0-1: The intensity of light scattered is recorded at different time 
intervalles (t), (t+dt), (t+2dt), etc. in order to build the correlation curve 
necessary to measure the sioze of particles. 
 
At an instant (t + 2δt), the correlation between (t) and (t + 2δt) decreases 
because the particles have slightly moved and the intensity of light scattered is 
accordingly modified. As the signal at the instant (t) is compared with longer the 
signal, the correlation will continue to decrease until there is no correlation 
anymore. The correlation curve is built by measuring correlation at different time 
(t), (t + δt), (t + 2δt), (t + 3δt), (t + 4δt), etc. When comparing the signal at (t) 
with itself, the correlation is perfect and is reported as 1; when no correlation 
exists, the value is 0. Because of the difference of motion between small and 
large particles, their respective correlograms will be different: small particles 
move quickly so that the fluctuation of intensity is very fast so that the rate of 
decay of the correlation function will be much faster than for the slower large 
particles (Figure B-2). 
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Figure B-0-2: Correlograms values range between 1 and 0 and indicate the 
presence of small or large particles according to the rate of decay. Hence, 
small particles move more quickly and the decay rate occurs earlier than 
for large, slower particles. 
 
Once the correlation function is measured, size of particles is calculated using 
the Stokes-Einstein equation or more precisely the size distribution of particles 
in a sample. Typical DLS graph displays the relative intensity of light scattered 
compared to size distribution, also called intensity distribution. From the 
intensity distribution, volume distribution and number distribution can be 
extrapolated using Mie theory. In general,  
d(intensity) > d(volume) > d(number), which is easily understand when 
considering a sample containing two sizes of particles (for example 5 and 
50nm) at the same concentration (Figure B-3). In that case, the number 
distribution displays two peaks of same intensity since both populations are in 
equal number. When considering the volume distribution, the 50nm particle 
population present a peak 1,000 times larger than the 5nm peak. The volume of 
sphere is equal to 4/3πr3, meaning that the volume of 50 nm spherical sphere is 
103=1000 times higher than that of 5 nm particles. Finally, 50nm particles 
present a peak 1,000,000 times larger than the peak of 5 nm particles because 
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large particles scatter more light than small particles (I α d6 in the Rayleigh 
theory) 
 
Figure B-0-3: (From left to right) Number, volume, and intensity size 
distribution of a sample containing 5 and 50 nm particles at the same 
concentration. 
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Appendix C Supplementary materials for the 
synthesis of hybrid VTEOS-TEOS 
nanoparticles 
 
C.1 Influence of VTEOS content 
 
Table C-1: Volume of silicon precursors for the study of VTEOS 
concentration effect. 
 mol (VTEOS) V (VTEOS) mol (TEOS) V (TEOS) 
VTEOS 
composition 
VT-00 0 mmol 0 µL 3.5 mmol 775 µL 0% VTEOS 
VT-25 0.88 mmol 135 µL 2.6 mmol 580 µL 25% VTEOS 
VT-50 1.8 mmol 275 µL 1.8 mmol 385 µL 50% VTEOS 
VT-75 2.6 mmol 410 µL 0.88  mmol 195 µL 75% VTEOS 
VT-100 3.5 mmol 545 µL 0 mmol 0 µL 100% VTEOS 
 
C.2 Study of influencing parameters 
 
Table C-2: Concentration of reagents for the study of the arginine and 
water effects. 
V (VTEOS) V (TEOS) w (arginine) V (water) Silane/arginine/water molar ratio 
305 µL 430 µL 6.4 mg 7 mL 1/0.01/100 
205 µL 290 µL 4.3 mg 7 mL 1/0.01/150 
150 µL 215 µL 3.2 mg 7 mL 1/0.01/200 
305 µL 430 µL 32 mg 7 mL 1/0.05/100 
205 µL 290 µL 21 mg 7 mL 1/0.05/150 
150 µL 215 µL 16 mg 7 mL 1/0.05/200 
305 µL 430 µL 64 mg 7 mL 1/0.1/100 
205 µL 290 µL 43 mg 7 mL 1/0.1/150 
150 µL 215 µL 32 mg 7 mL 1/0.1/200 
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Appendix D Supplementary materials for the surface 
modification of hybrid nanoparticles 
 
D.1 Surface modification with APTES and THPMP 
 
Table D-1: Volumes of TEOS, APTES, and THPMP for the surface 
modification of silica nanoparticles with amine. 
V (TEOS) V (APTES) V (THPMP) V (arginine) Organosilane % 
220 µL 3 µL X 5 mL 1 % APTES 
200 µL 25 µL X 5 mL 10 % APTES 
165 µL 60 µL X 5 mL 25 % APTES 
110 µL 115 µL X 5 mL 50 % APTES 
55 µL 175 µL X 5 mL 75 % APTES 
X 235 µL X 5 mL 100 % APTES 
30 µL 20 µL 0 µL 5 mL 0% THPMP 
200 µL 15 µL 10 µL 5 mL 25% THPMP 
30 µL 10 µL 20 µL 5 mL 50% THPMP 
30 µL 5 µL 30 µL 5 mL 75% THPMP 
30 µL 0 µL 40 µL 5 mL 100% THPMP 
 
D.2 FA and HA bio-conjugation in arginine solution 
 
Table D-2: Volume of reagents employed for the bioconjugation of FA 
onto hybrid nanoparticles. 
V (FA) V (EDC) V (NHS) W (NP) Arginine 
250 µL 720 µL 860 µL 100 mg 5 mL 
250 µL 1.08 mL 1.29 mL 100 mg 5 mL 
250 µL 1.44 mL 1.72 mL 100 mg 5 mL 
500 µL 720 µL 860 µL 100 mg 5 mL 
500 µL 1.08 mL 1.29 mL 100 mg 5 mL 
500 µL 1.44 mL 1.72 mL 100 mg 5 mL 
500 µL 1.8 mL 2.15 mL 100 mg 5 mL 
750 µL 1.08 mL 1.29 mL 100 mg 5 mL 
750 µL 1.44 mL 1.72 mL 100 mg 5 mL 
750 µL 1.8 mL 2.15 mL 100 mg 5 mL 
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1 mL 1.44 mL 1.72 mL 100 mg 5 mL 
1 mL 1.8 mL 2.15 mL 100 mg 5 mL 
D.3 FA and HA bio-conjugation in MES buffer 
 
Table D-3: Volume of reagents used for the MES-solvated bioconjugation 
of FA and HA onto hybrid nanoparticles. 
V (FA) V (EDC) V (NHS) V (MES) W (SiNP) Arginine 
0.5 mL (FA) 720 µL 860 µL 10 mL 2 mg 10 mL 
1.5 mL (FA) 720 µL 860 µL 10 mL 2 mg 10 mL 
2 mL (FA) 1.08 mL 1.29 mL 10 mL 2 mg 10 mL 
2 mL (FA) 1.44 mL 1.72 mL 10 mL 2 mg 10 mL 
2 mL (FA) 1.8 mL 2.15 mL 10 mL 2 mg 10 mL 
5 mL (FA) 720 µL 860 µL 10 mL 2 mg 10 mL 
5 mL (FA) 1.8 mL 2.15 mL 10 mL 2 mg 10 mL 
250 µL (HA) 1.08 mL 1.29 mL 10 mL 2 mg 10 mL 
250 µL (HA) 1.44 mL 1.72 mL 10 mL 2 mg 10 mL 
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Appendix E Carbodiimide coupling chemistry 
 
Conjugation of nanoparticles requires two steps: firstly, the surface of the silica 
structure must be modified by a linker, usually an organosilane. Then, the 
chosen ligand can be bound to the surface in order to generate a nanoparticle 
targeting specific species. Frequently, APTES is used as linker for various 
species containing carboxylic groups such as folic acid. In that case, 
carbodiimide chemistry is employed to bind aminated surface and biomolecules. 
The first step of this process consists in activating the carboxylic groups via 1-
Ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC) following the equation: 
R1 OH
O
N C N
N
R1 O
O
C
HN
N
N
+
 
Then N-hydroxysuccinimide is introduced to react with the resulting unstable O-
urea derivative. Following a condensation reaction between the carboxylic 
group and NHS, an ester is formed: 
R1 O
O
C
HN
N
N
N OO
OH
N
O
O
OR1
O
+
 
The ester group reacts with the amine functional groups at the surface of the 
nanoparticles and finally form amide bond: 
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O
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O
+
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Appendix F Supplementary materials for the 
modification of hybrid composition 
 
Table F-1: Parameters for the preparation of hybrid silica nanoparticles 
Type V (TEOS) V (PhTEOS) V (VTEOS) V (organosilane) composition 
Ph-10 635 µL 65 µL X X 10% PhTEOS 
Ph-25 430 µL 160 µL X X 25% PhTEOS 
Ph-50 285 µL 320 µL X X 50% PhTEOS 
Ph-75 145 µL 480 µL X X 75% PhTEOS 
Ph-100 X 640 µL X X 100% PhTEOS 
TH-05 735 µL X X 79 µL (THPMP) 5 % THPMP 
TH-10 700 µL X X 158 µL (THPMP) 10 % THPMP 
TH-15 660 µL X X 238 µL (THPMP) 15 % THPMP 
VT-TH 5 370 µL X 260 µL 79 µL (THPMP) 5 % THPMP 
VT-TH 10 350 µL X 245 µL 158 µL (THPMP) 10 %THPP 
VT-AP 1 383 µL X 270 µL 8 µL (APTES) 1 % APTES 
VT-AP 2 380 µL X 267 µL 16 µL (APTES) 2 % APTES 
VT-AP 5 368 µL X 259 µL 41 µL (APTES) 5 % APTES 
VT-AP 10 349 µL X 246 µL 83 µL (APTES) 10 % APTES 
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Appendix G Deposition-precipitation 
 
Deposition-precipitation is based on the hydrolysis of the chloroauric ion AuCl4- 
under the action of a base, resulting in the formation of anions of the form 
[Au(OH)xCl4-x]-. The extent of hydrolysis depends on the pH but also on the 
temperature that promotes the replacement of Cl- with OH-. Of all potential 
species, only Au(OH)3 precipitates and is able to deposit on silica or other 
substrate – the other species remaining in solution - so that the control of pH is 
crucial for the proper decoration with gold seeds (Figure G-1). The optimal 
conditions for the generation of [Au(OH)3Cl]- species and their precipitation onto 
the substrate surface are a pH comprised between 8 and 10 and a temperature 
in the range 60 to 80°C. 
 
 
Appendix H Appendix Title (Use Heading 7) 
 
HAuCl4 [Au(OH)xCl4-x]- [Au(OH)3Cl] 
H2N 
H2N 
H2N 
H2N 
H2N 
[Au(OH)3Cl] 
[Au(OH)3Cl] 
[Au(OH)3Cl] 
[Au(OH)3Cl] 
∆pH pH = 8-9 
Temperature 
Figure G-1: Schematisation of the influence of pH over the deposition-
precipitation process and the formation of gold seeds onto amine-modified 
silica nanoparticles. 
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Nevertheless, the method does not function for all metal oxide surfaces: in the 
case of gold deposition, the isoelectric point of the substrate must be above 5. 
For example, Phonthammachai et al. found that gold seeds do not precipitate 
on bare silica particles because its isoelectric point is equal to 2 
[Phonthammachai, 2007]. For this reason, the silica surface is negatively 
charge for all pH above 2 and consequently repel the likewise negatively 
charged [Au(OH)xCl4-x]-. Surface functionalisation - in the silica case with amine 
groups - overcome this issue as the amine-modified particles have an 
isoelectric point of 9. In consequence, the particles are slightly positively 
charged below a pH of 9 whereas [Au(OH)xCl4-x]- species are predominantly 
formed at pH comprised between 7 and 9. Hence this pH condition is optimal for 
the precipitation of gold seed onto silica.  
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Appendix I Supplementary materials for the coating 
of magnetite nanoparticles with silica 
and hybrid silica 
 
I.1 TEOS-coated nanoparticles 
 
Table I-1: Parameters for the preparation of silica-coated magnetite 
nanoparticles. 
Sample V (Fe3O4) 
V 
(arginine) 
V 
(TEOS) V (dye) 
V 
(APTES) 
V 
(THPMP) 
1 700 µL 50 mL 350 µL 100 µL (MB) X X 
2 700 µL 50 mL 175 µL 75 µL (MB) X X 
3 1 mL 25 mL 250 µL 40 µL (MB) 20 µL 40 µL 
4 1 mL 25 mL 500 µL 40 µL (MB) 20 µL 40 µL 
5 1 mL 25 mL 1 mL 40 µL (MB) 20 µL 40 µL 
6 1 mL 25 mL 250 µL 30 µL (R6G) 30 µL 60 µL 
7 1 mL 25 mL 500 µL 30 µL (R6G) 30 µL 60 µL 
 
I.2 Deposition of a hybrid layer 
 
Table I-2: Parameters for the preparation of silica-coated magnetite 
nanoparticles. 
Sample V (Fe3O4) 
V 
(arginine) 
V 
(TEOS) 
V 
(VTEOS) V (dye) 
V 
(APTES) 
V 
(THPMP) 
8 1 mL 25 mL 200 µL 100 µL 30 µL (R6G) 20 µL 40 µL 
9 1 mL 25 mL 150 µL 150 µL 40 µL (MB) 20 µL 40 µL 
10 1 mL 25 mL 250 µL 50 µL 40 µL (MB) 20 µL 40 µL 
11 750 µL 30 mL 95 µL 65 µL 50 µL (R6G) 15 µL 15 µL 
12 750 µL 30 mL 190 µL 130 µL 40 µL (R6G) 30 µL 30 µL 
13 375 µL 15 mL 180 µL 130 µL 50 µL (MB) 20 µL 20 µL 
14 375 µL 15 mL 95/90 µL 65/X µL 50 µL (MB) 20 µL 20 µL 
15 375 µL 15 mL 130/90 X 50 µL (MB) 20 µL 20 µL 
16 1 mL 25 mL 200 µL X 40 µL (MB) X 50 µL 
17 1 mL 25 mL 230 µL X 5 µL (Fl) 20 µL X 
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I.3 Deposition of a second layer onto nanocomposites 
 
Table I-3: Parameters for the deposition of silica and hybrid layers onto 
magnetite-silica nanoparticles. 
Experiment V (batch) V (TEOS) V (VTEOS) V(APTES) V (dye) 
Batch 2-1 5 mL 5 µL X X 10 µL (AO) 
Batch 2-2 5 mL 10 µL X X 10 µL (AO) 
Batch 2-3 5 mL 10 µL 5 µL X 15 µL (AO) 
Batch 2-4 5 mL 10 µL 10 µL X 15 µL (AO) 
 
I.4 TEOS-coated nanoparticles 
 
Table I-4: Parameters for the deposition of hybrid layers onto magnetite-
nanoparticles. 
Sample V (arginine) 
V 
(TEOS) 
V 
(VTEOS) 
V 
(THPMP) 
V 
(APTES) V (dye) 
18 - Layer 1 30 mL 95 µL 65 µL X X 20 µL (R6G) 
18 - Layer 2 X 95 µL 65 µL 30 µL 30 µL 25 µL (MB) 
19 - Layer 1 30 mL 95 µL 65 µL X X 30 µL (MB) 
19 - Layer 2 X 95 µL 65 µL 15 µL 15 µL 25 µL (R6G) 
20 - Layer 1 30 mL 95 µL 65 µL 20 µL X 30 µL (MB) 
20 - Layer 2 X 95 µL 65 µL 15 µL 15 µL 40 µL (AO) 
21 – Layer 1 10 mL 60 µL 60 µL X 5 µL 15 µL (LY) 
21 – Layer 2 5 mL 100 µL X X X 20 µL (AO) 
22 – Layer 1 10 mL 60 µL 60 µL X 10 µL 15 µL (LY) 
22 – Layer 2 5 mL 100 µL X X X 20 µL (AO) 
23 – Layer 1 10 mL 60 µL 60 µL 5 µL X 40 µL (MB) 
23 – Layer 2 5 mL 60 µL X X X 20 µL (AO) 
24 – Layer 1 10 mL 60 µL 60 µL X 2.5 µL 15 µL (LY) 
24 – Layer 2 5 mL 60 µL X X X 20 µL (AO) 
25 – Layer 1 10 mL 30 µL 30 µL X 1.5 µL 15 µL (Fl) 
25 – Layer 2 5 mL 30 µL X X X 15 µL (R6G) 
26 – Layer 1 10 mL 30 µL 30 µL X 1.5 µL 15 µL (Fl) 
26 – Layer 2 5 mL 30 µL X X X 15 µL (RB) 
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Appendix J Supplementary materials for synthesis of 
multifunctional nanoparticles 
 
J.1 Deposition-precipitation onto magnetite-silica 
 
Table J-1: Volume of reagents for the decoration of nanocomposites with 
gold seeds. 
Sample 
V 
(Fe3O4) 
V 
(TEOS) 
V 
(APTES) 
V 
(THPMP) 
V (MB) 
Mg-DP 1 700 µL 100 µL 10 µL* 5 µL* 50 µL 
Mg-DP 2 500 µL 100 µL 10 µL 30 µL 50 µL 
Mg-DP 3 500 µL 100 µL 20 µL 40 µL 50 µL 
Mg-DP 4 500 µL 100 µL 10 µL 20 µL 50 µL 
Mg-DP 5 500 µL 125 µL 20 µL 40 µL 50 µL 
Mg-DP 6 500 µL 200 µL 20 µL (1h) 40 µL 50 µL 
Mg-DP 7 500 µL 300 µL 7.5 µL (30’) 25 µL 50 µL 
 
 
J.2 Effect of reducer concentration on the growth of gold shell 
 
Table J-2: Effect of sodium borohydride to grow a gold shell onto MgAu-1. 
Sample DP time V (batch) V (K-gold) V (NaBH4) 
MgAu-1 4 h 200 µL 10 mL 1 mL 
MgAu-1 4 h 200 µL 20 mL 2 mL 
MgAu-1 4 h 200 µL 40 mL 4 mL 
MgAu-1 4 h 200 µL 10 mL 100 µL 
MgAu-1 4 h 200 µL 10 mL 200 µL 
MgAu-1 4 h 200 µL 10 mL 500 µL 
MgAu-1 4 h 200 µL 10 mL 1 mL 
 
 
389 
Table J-3: Effect of sodium borohydride and formaldehyde to grow a gold 
shell onto MgAu-2. 
Sample DP time V (batch) V (K-gold) V (NaBH4) V (CH2OH) 
MgAu-2 1 h 200 µL 2 mL 50 µL X 
MgAu-2 1 h 200 µL 2 mL 100 µL X 
MgAu-2 1 h 200 µL 2 mL 200 µL X 
MgAu-2 2 h 100 µL 2 mL 50 µL X 
MgAu-2 2 h 100 µL 2 mL 200 µL X 
MgAu-2 2 h 100 µL 5 mL 50 µL X 
MgAu-2 2 h 100 µL 5 mL 100 µL X 
MgAu-2 2 h 100 µL 5 mL 200 µL X 
MgAu-2 2 h 100 µL 5 mL 500 µL X 
MgAu-2 3 h 100 µL 2 mL X 200 µL 
MgAu-2 3 h 100 µL 2 mL X 500 µL 
MgAu-2 3 h 100 µL 5 mL X 500 µL 
MgAu-2 3 h 100 µL 5 mL X 1 mL 
MgAu-2 3 h 100 µL 5 mL X 3 mL 
 
 
Table J-43: Effect of hydroxylamine to grow a gold shell onto MgAu-3. 
Sample DP time V (batch) V (K-gold) V (NH2OH) 
MgAu-3 1 h 30 100 µL 2 mL 1 mL 
MgAu-3 1 h 30 200 µL 2 mL 1 mL 
MgAu-3 1 h 30 300 µL 2 mL 1 mL 
MgAu-3 1 h 30 450 µL 2 mL 1 mL 
MgAu-3 1 h 30 250 µL 2 mL 500 µL 
MgAu-3 1 h 30 250 µL 2 mL 1 mL 
MgAu-3 1 h 30 250 µL 2 mL 2.5 mL 
MgAu-3 1 h 30 250 µL 2 mL 5 mL 
MgAu-3 1 h 30 250 µL 5 mL 2.5 mL 
MgAu-3 1 h 30 250 µL 10 mL 5 mL 
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J.3 Effect of gold platting solution 
 
Table J-5: Volume of K-gold solution used to grow a gold layer. 
Sample DP time V (batch) V (K-gold) pH V (NH2OH) 
Batch 12 15’ 250 µL 20 mL 9.9 1 mL 
Batch 12 15’ 250 µL 20 mL 10.1 1 mL 
Batch 12 15’ 250 µL 50 mL 9.9 2.5 mL 
Batch 12 15’ 250 µL 50 mL 10.1 2.5 mL 
Batch 6 2 h 1 mL 10 mL  250 µL 
Batch 6 2 h 1 mL 10 mL  500 µL 
Batch 6 2 h 1 mL 10 mL  750 µL 
Batch 6 2 h 1 mL 10 mL  1 mL 
 
J.4 Effect of deposition-precipitation on the final gold coating 
 
TableJ-6: Deposition-precipitation duration before gold ion nucleation. 
Sample DP time V (batch) V (K-gold) V (NH2OH) 
Batch 18 45 min 250 µL 10 mL 500 µL 
Batch 18 45 min 250 µL 15 mL 500 µL 
Batch 18 60 min 250 µL 10 mL 500 µL 
Batch 18 60 min 250 µL 15 mL 500 µL 
Batch 19 X 500 µL 15 mL 500 µL 
Batch 19 X 500 µL 15 mL 1 mL 
Batch 19 45 min 500 µL 15 mL 500 µL 
Batch 19 45 min 500 µL 15 mL 1 mL 
Batch 19 60 min 500 µL 15 mL 500 µL 
Batch 19 60 min 500 µL 15 mL 1 mL 
Batch 3 15 min 500 µL 15 mL 1 mL 
Batch 3 30 min 500 µL 15 mL 1 mL 
Batch 3 45 min 500 µL 15 mL 1 mL 
Batch 3 60 min 500 µL 15 mL 1 mL 
Batch 4 15 min 500 µL 10 mL 1 mL 
Batch 4 30 min 500 µL 10 mL 1 mL 
Batch 4 45 min 500 µL 10 mL 1 mL 
Batch 4 60 min 500 µL 10 mL 1 mL 
Batch 5 15 min 500 µL 5 mL 500 µL 
Batch 5 30 min 500 µL 5 mL 500 µL 
Batch 5 45 min 500 µL 5 mL 500 µL 
Batch 5 60 min 500 µL 5 mL 500 µL 
Batch 6 30 min 500 µL 10 mL 1 mL 
Batch 6 1 h 500 µL 10 mL 1 mL 
Batch 6 2 h 500 µL 10 mL 1 mL 
Batch 6 3 h 500 µL 10 mL 1 mL 
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J.5 Iterative hydroxylamine seeding technique 
 
Table J-74: Procedure for the regrowth of the gold layer in batches 8 and 
11 
Sample Regrowth step DP time V (batch) V (K-gold) V (NH2OH) 
Batch 11 X1 50 min 25 mL 25 mL 2.5 mL 
Batch 11 X2 X X 20 mL 2 mL 
Batch 11 X3 X X 15 mL 1.5 mL 
Batch 11 X4 X X 10 mL 1 mL 
Batch 11 X5 X X 5 mL 0.5 mL 
Batch 8 X1 2h 20 mL 20 mL 2 mL 
Batch 8 X3 X X 15 mL 1.5 mL 
Batch 8 X5 X X 10 mL 1 mL 
Batch 8 X7 X X 5 mL 0.5 mL 
 
